data_2m9m_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m9m _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.666 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.6 p-80 -136.53 152.39 50.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.856 0.36 . . . . 0.0 110.778 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.4 mm -122.98 135.51 62.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.261 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.7 t -97.04 151.63 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.802 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.3 128.26 25.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.502 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.425 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 55.5 t-20 -56.57 131.27 48.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.566 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -43.79 -38.3 3.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.681 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.607 ' C ' ' H ' ' A' ' 26' ' ' ARG . 15.5 ttpt -72.62 -48.41 39.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.48 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.514 ' CE2' ' OD2' ' A' ' 49' ' ' ASP . 24.2 t-105 -67.89 19.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.537 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.607 ' H ' ' C ' ' A' ' 24' ' ' LYS . 61.2 ttt-85 -89.47 -34.97 16.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.439 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.97 36.71 0.24 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.599 ' H ' ' C ' ' A' ' 26' ' ' ARG . 5.8 p -117.86 144.69 45.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.769 0.319 . . . . 0.0 110.644 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -72.93 -18.97 61.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.441 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.518 ' C ' ' CD1' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -68.56 -57.61 5.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.315 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -41.93 -23.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.531 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 30' ' ' LEU . 2.4 tp60 -72.12 -47.61 49.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.567 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 36' ' ' GLY . 3.5 mt-10 -50.94 -51.26 54.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.456 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.538 ' C ' ' H ' ' A' ' 36' ' ' GLY . 5.6 mtt -43.93 -42.14 5.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.573 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -71.1 17.16 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.598 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.538 ' H ' ' C ' ' A' ' 34' ' ' MET . . . -104.15 -10.69 33.68 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.5 mtmm -152.01 -43.1 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.854 0.359 . . . . 0.0 110.479 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.1 tp -109.36 160.65 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.519 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.8 tttm -86.19 146.05 26.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.582 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.9 tp -131.4 137.87 48.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.701 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.439 HG23 ' N ' ' A' ' 42' ' ' PHE . 57.8 mt -123.16 141.89 41.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.486 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -96.75 133.69 40.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.798 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.76 120.04 25.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.387 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -89.85 111.55 22.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.651 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 133.4 -8.52 5.01 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.425 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 66.3 mt -92.61 148.71 21.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.773 0.32 . . . . 0.0 110.67 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.536 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -96.04 -47.9 0.25 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 47' ' ' THR . 58.0 Cg_exo -47.87 164.35 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.727 2.285 . . . . 0.0 112.27 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.601 ' OD2' ' CD1' ' A' ' 60' ' ' TYR . 1.2 m-20 -85.44 -53.04 5.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.476 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.4 ' CD1' ' HE1' ' A' ' 34' ' ' MET . 79.0 m-85 -135.71 120.7 18.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.891 0.377 . . . . 0.0 110.607 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.549 ' CD1' ' O ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -99.48 112.78 24.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.383 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.91 -44.08 15.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.65 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.549 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 5.0 t -139.46 -162.23 1.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.676 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -90.22 -8.98 49.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.624 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.443 HH21 ' HZ2' ' A' ' 86' ' ' LYS . 11.2 mtp180 -125.83 -8.8 6.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.828 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.61 132.82 56.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.962 0.411 . . . . 0.0 111.1 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.1 163.67 30.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.892 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 96.5 mt -135.72 124.16 38.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.977 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.9 tp -115.82 138.21 51.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.372 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.601 ' CD1' ' OD2' ' A' ' 49' ' ' ASP . 2.8 p90 -96.17 132.91 41.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.91 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 92' ' ' GLU . 77.0 t -130.59 149.97 34.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.176 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.43 ' N ' HG11 ' A' ' 61' ' ' VAL . 1.0 OUTLIER -138.05 157.06 47.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.631 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 62' ' ' THR . 5.7 tm-20 -39.18 -43.16 1.04 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.32 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -47.0 -39.91 13.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.343 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 62' ' ' THR . 61.9 m-20 -69.01 -44.63 72.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.333 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.5 tt -49.05 -44.44 41.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.523 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 32.2 t -49.48 -41.22 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.552 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.41 -71.63 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.646 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.44 -52.82 1.89 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -97.09 103.23 15.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.789 0.328 . . . . 0.0 110.559 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.66 -51.43 0.8 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -67.37 -24.53 65.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.724 0.297 . . . . 0.0 110.902 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -42.19 97.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 110.589 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -46.31 -46.15 17.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.583 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -59.09 -38.05 78.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.747 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.6 mt -70.41 -34.81 72.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.708 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 63.8 t -61.45 -40.27 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.856 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 -56.85 -23.42 43.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.799 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.0 t -79.91 -49.51 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.561 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.6 ttt-85 -66.9 -25.54 66.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.645 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -71.05 -11.61 61.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.654 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.554 ' OG ' ' N ' ' A' ' 83' ' ' ASN . 60.4 p -67.92 -117.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.581 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.578 ' C ' HD21 ' A' ' 84' ' ' ASN . 7.1 t30 -121.02 -93.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.679 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.578 HD21 ' C ' ' A' ' 83' ' ' ASN . 1.5 m-80 -138.02 60.27 1.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.495 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.5 mp -93.48 123.43 36.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.575 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.443 ' HZ2' HH21 ' A' ' 55' ' ' ARG . 1.2 pttp -112.58 85.84 2.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.172 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -93.67 -165.33 37.21 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.8 mt -131.28 135.83 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.773 0.32 . . . . 0.0 110.488 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.2 t -107.99 118.82 56.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.614 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 61' ' ' VAL . 19.7 t -93.69 140.72 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.401 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.66 132.59 70.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.716 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 61' ' ' VAL . 3.6 tt0 -101.71 104.43 15.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.387 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -68.65 131.95 46.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.579 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.6 m -126.14 -74.26 0.6 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.633 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.3 mtp85 -140.84 -70.3 0.38 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.457 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.33 -1.93 7.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.49 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.609 ' O ' ' N ' ' A' ' 101' ' ' PHE . 4.1 t -68.7 -91.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.788 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 97' ' ' SER . 22.1 mt-10 -36.41 -27.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.954 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 97' ' ' SER . 2.3 mt-30 -71.64 -51.51 22.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.181 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -117.13 11.62 14.23 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.19 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.727 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 35.5 t80 -69.82 -32.9 3.23 Favored Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.78 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.727 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 10.8 Cg_exo -67.33 -42.34 7.67 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.588 2.192 . . . . 0.0 111.939 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.05 -48.32 78.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.635 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 tp -71.16 -47.99 54.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.585 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -50.59 -33.63 22.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.73 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -56.39 15.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.871 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.6 -52.14 62.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.787 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.1 m -42.18 -40.43 2.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.79 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.667 ' O ' ' N ' ' A' ' 113' ' ' GLY . 85.9 t -66.2 -58.66 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.476 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.56 -23.08 66.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.461 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.48 -55.51 4.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mt -106.33 -28.58 10.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.184 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 56.76 20.04 30.94 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 6.5 tpp -73.04 -161.09 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.724 0.297 . . . . 0.0 110.404 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.12 127.63 65.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.607 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.413 ' N ' HD13 ' A' ' 116' ' ' LEU . 5.0 mp -122.27 115.44 22.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.472 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.3 mt -124.99 88.32 54.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -53.25 171.56 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.629 2.219 . . . . 0.0 111.735 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.4 ' CG2' ' H ' ' A' ' 120' ' ' ALA . 4.0 m -143.06 -113.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.652 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.4 ' H ' ' CG2' ' A' ' 119' ' ' VAL . . . -177.51 -37.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.263 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.8 p -141.12 -170.74 3.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.348 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -81.26 -28.22 34.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.598 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -48.42 59.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.757 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 128' ' ' LEU . 0.4 OUTLIER -44.7 -46.1 10.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.25 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.66 -54.92 24.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.959 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 59.7 p -54.98 -30.85 60.1 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -85.19 -35.32 21.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.256 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.596 ' N ' ' O ' ' A' ' 124' ' ' GLU . 4.2 mp -74.58 -34.33 62.86 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.569 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.0 t -74.19 -55.0 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.562 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 97.2 mt -58.17 -50.93 76.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.581 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -48.94 -30.28 5.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.321 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.1 tp -82.58 -42.03 18.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.478 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.75 -36.79 77.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.644 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.96 -22.46 65.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.656 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.475 179.942 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.677 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -72.78 155.1 40.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.846 0.355 . . . . 0.0 110.702 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.442 HD12 HG23 ' A' ' 19' ' ' ILE . 17.9 mm -109.35 143.8 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.399 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.6 t -94.6 145.41 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.586 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -136.82 137.25 39.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.541 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 25' ' ' TRP . 63.2 t-20 -64.7 135.29 55.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.467 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.406 ' N ' ' OD1' ' A' ' 22' ' ' ASN . 7.2 tt0 -43.18 -32.3 0.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.369 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -70.36 -36.78 74.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.334 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.502 ' N ' ' O ' ' A' ' 22' ' ' ASN . 0.2 OUTLIER -68.46 -13.62 62.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.208 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.44 ' HD3' ' CD1' ' A' ' 42' ' ' PHE . 7.7 tpt85 -61.98 -40.85 97.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.611 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.6 51.01 0.85 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.69 152.16 37.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.794 0.33 . . . . 0.0 110.622 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -75.55 -21.05 58.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.363 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.566 ' C ' ' CD1' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -68.67 -56.61 7.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.598 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.426 ' N ' ' HG ' ' A' ' 30' ' ' LEU . . . -53.14 -33.08 50.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.831 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -82.4 -28.94 31.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.727 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -67.33 -31.78 72.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.52 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.689 ' N ' ' SD ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -74.83 -27.04 60.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.465 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -65.78 -8.65 22.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.681 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.35 -29.02 11.7 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.2 -48.85 3.75 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.98 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.424 HG12 ' H ' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -123.24 172.2 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.94 0.4 . . . . 0.0 110.882 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.424 ' H ' HG12 ' A' ' 38' ' ' ILE . 36.8 tttp -86.13 127.6 34.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.541 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.4 tp -118.59 129.75 55.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.755 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.447 HG23 HD13 ' A' ' 41' ' ' ILE . 2.0 mt -108.59 140.66 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.31 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.44 ' CD1' ' HD3' ' A' ' 26' ' ' ARG . 6.2 m-85 -104.14 129.05 51.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.719 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -130.63 113.2 13.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.439 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -75.18 128.47 35.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.477 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.65 -47.41 1.02 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.465 ' H ' HD13 ' A' ' 46' ' ' LEU . 9.7 mp -46.96 148.15 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.716 0.293 . . . . 0.0 110.387 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.56 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -99.45 -47.54 0.21 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.903 0.382 . . . . 0.0 110.668 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 47' ' ' THR . 31.4 Cg_exo -54.95 176.93 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.791 2.327 . . . . 0.0 112.153 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.47 ' OD1' ' CE2' ' A' ' 25' ' ' TRP . 8.1 m-20 -87.11 -56.14 3.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.436 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -129.65 143.62 50.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.357 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -116.61 108.35 15.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.71 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.78 -38.26 76.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.487 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.602 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 5.8 m -160.01 -143.54 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.439 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.31 18.81 17.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.584 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -144.49 9.84 1.41 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.602 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 86' ' ' LYS . 42.7 t -163.53 145.4 9.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.684 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.15 172.72 12.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.296 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.6 mt -131.08 126.33 59.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.72 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.24 117.73 30.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.27 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -87.74 117.46 26.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.95 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 73.2 t -99.3 149.48 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.948 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -121.29 156.37 32.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.842 0.353 . . . . 0.0 110.831 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.501 ' CG ' ' N ' ' A' ' 64' ' ' ALA . 12.0 pt-20 -46.05 -44.67 15.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.56 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.501 ' N ' ' CG ' ' A' ' 63' ' ' GLU . . . -51.39 -19.86 1.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.701 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.672 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -79.33 -53.08 7.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.698 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 tt -56.33 -50.23 72.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.662 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.0 t -52.98 -13.77 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.711 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.42 35.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.758 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 65' ' ' ASP . . . -65.36 -16.71 63.11 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -51.86 -45.85 64.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.762 0.315 . . . . 0.0 110.666 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.48 -47.55 6.34 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 75' ' ' ARG . 2.1 t80 -53.53 -26.39 20.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.862 0.363 . . . . 0.0 110.624 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.725 ' HE ' ' HZ2' ' A' ' 74' ' ' LYS . 6.2 ttp85 -36.28 -35.67 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.717 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.725 ' HZ2' ' HE ' ' A' ' 73' ' ' ARG . 2.7 mmtm -70.31 -48.79 55.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.654 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -54.44 -28.92 47.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.695 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 27.5 mt -70.61 -58.11 4.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.689 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 80' ' ' ARG . 65.3 t -50.76 -36.91 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.592 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.38 -21.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.465 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.478 ' N ' ' O ' ' A' ' 77' ' ' VAL . 41.1 t -77.88 -33.25 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.766 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.551 ' N ' ' O ' ' A' ' 77' ' ' VAL . 0.9 OUTLIER -82.31 -39.54 22.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.773 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -59.27 -21.24 59.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.901 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 t -95.19 -54.61 3.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.722 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -132.93 -171.0 2.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.652 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -147.03 45.76 1.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.27 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.415 ' N ' HD22 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -98.69 155.64 17.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.688 -179.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.523 ' O ' ' SG ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -80.41 122.27 26.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.239 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -127.89 164.19 21.31 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.5 mt -107.66 121.86 61.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.853 0.359 . . . . 0.0 110.448 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.1 t -97.2 125.68 50.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.872 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.66 149.4 5.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.047 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.0 t -132.77 145.08 34.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.892 0.377 . . . . 0.0 110.862 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -92.59 120.69 33.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.399 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -67.34 139.85 57.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.793 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.623 ' CG2' ' H ' ' A' ' 95' ' ' ARG . 1.9 t -151.08 -108.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.523 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.623 ' H ' ' CG2' ' A' ' 94' ' ' THR . 4.1 mtt180 -130.07 -74.7 0.54 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.259 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.472 ' SD ' ' OE1' ' A' ' 99' ' ' GLN . 26.6 mmt -55.36 -7.16 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.279 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.641 ' O ' ' N ' ' A' ' 101' ' ' PHE . 1.4 t -54.92 -88.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.671 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.449 ' N ' ' OG ' ' A' ' 97' ' ' SER . 2.2 mm-40 -43.01 -21.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.032 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.472 ' OE1' ' SD ' ' A' ' 96' ' ' MET . 47.9 mt-30 -71.11 -55.07 8.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.845 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -117.08 12.26 14.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.824 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.709 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 0.3 OUTLIER -63.7 -35.46 16.5 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.414 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.709 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 2.7 Cg_exo -71.9 -53.94 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.734 2.289 . . . . 0.0 111.813 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -45.88 -27.77 0.95 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.617 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.57 -44.38 12.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.507 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.455 ' NE2' ' CZ ' ' A' ' 101' ' ' PHE . 9.5 tt0 -60.64 -32.15 71.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.616 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -73.75 -34.94 64.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.739 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -81.95 -37.35 26.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.801 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.1 p -73.35 -35.78 66.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.928 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.696 ' O ' ' N ' ' A' ' 113' ' ' GLY . 4.0 t -66.84 -55.95 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.942 0.401 . . . . 0.0 110.652 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.35 -30.42 66.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.55 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -84.5 -51.22 7.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.438 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.85 -28.87 10.37 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.538 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.696 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 60.93 33.81 85.12 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 3.3 mtt -84.84 -179.5 7.1 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 110.543 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.0 t -103.05 124.25 57.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.628 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 116' ' ' LEU . 7.5 mp -105.35 143.78 33.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.241 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 tt -157.29 88.59 2.57 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.746 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -58.49 146.27 91.28 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.671 2.247 . . . . 0.0 111.823 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.439 ' CG2' ' H ' ' A' ' 120' ' ' ALA . 2.3 m -108.23 -107.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.548 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.439 ' H ' ' CG2' ' A' ' 119' ' ' VAL . . . 179.41 -30.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.391 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 97.2 p -144.23 -173.36 3.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.39 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -85.21 -24.45 27.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.588 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.412 ' O ' ' N ' ' A' ' 127' ' ' CYS . 37.9 mtt -81.37 -41.41 22.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.733 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 128' ' ' LEU . 6.5 mm-40 -45.03 -43.51 9.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.437 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.91 -57.78 6.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.007 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.434 ' HG ' ' N ' ' A' ' 127' ' ' CYS . 51.5 p -55.61 -29.67 59.57 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.434 ' N ' ' HG ' ' A' ' 126' ' ' SER . 47.1 t -85.04 -35.65 21.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.135 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.565 ' N ' ' O ' ' A' ' 124' ' ' GLU . 1.7 tp -72.1 -50.41 28.36 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.11 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.34 -57.0 8.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.781 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.5 mm -55.77 -45.28 79.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.679 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -57.17 -33.34 67.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.443 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.3 tp -67.17 -37.6 84.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.544 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -84.15 -42.44 17.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.636 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -61.01 -41.64 96.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.838 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.818 -179.78 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.644 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -133.34 148.83 51.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.343 . . . . 0.0 110.717 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.4 mm -116.75 149.34 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.474 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.1 t -119.32 135.0 61.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.65 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.58 137.23 52.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.31 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.622 HD21 ' N ' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -67.88 135.13 52.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.784 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.622 ' N ' HD21 ' A' ' 22' ' ' ASN . 4.8 tp10 -54.68 -38.21 66.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.587 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.5 ttmm -80.15 -65.89 0.95 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.514 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.614 ' NE1' ' OD2' ' A' ' 49' ' ' ASP . 19.3 t-105 -42.54 -48.41 5.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.507 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.671 ' O ' ' N ' ' A' ' 28' ' ' SER . 5.4 ttm180 26.33 85.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.481 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 28' ' ' SER . . . -43.39 -8.9 0.01 OUTLIER Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.671 ' N ' ' O ' ' A' ' 26' ' ' ARG . 0.4 OUTLIER 74.31 -143.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.849 0.357 . . . . 0.0 110.39 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 28' ' ' SER . 3.5 mt-30 -39.92 -20.08 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.326 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -71.57 -52.09 19.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.384 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.81 -29.75 68.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.647 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -65.35 -54.34 30.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.543 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.651 ' O ' ' N ' ' A' ' 36' ' ' GLY . 3.8 mm-40 -59.37 -41.14 88.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.38 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.478 ' C ' ' H ' ' A' ' 36' ' ' GLY . 4.7 mtt -36.85 -33.98 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.459 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 33' ' ' GLU . 42.5 mt-30 -75.28 17.22 0.27 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.434 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -106.62 -4.82 36.92 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm -138.58 -41.33 0.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.685 0.279 . . . . 0.0 110.903 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.489 HG13 ' H ' ' A' ' 39' ' ' LYS . 4.8 tp -132.78 172.43 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.536 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.489 ' H ' HG13 ' A' ' 38' ' ' ILE . 43.0 tttp -85.54 125.9 33.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.613 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.428 ' HG ' ' N ' ' A' ' 41' ' ' ILE . 18.5 tp -114.98 149.73 36.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.666 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.428 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 3.7 mt -132.14 151.16 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.676 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.429 ' CE2' ' NH2' ' A' ' 26' ' ' ARG . 81.7 m-85 -115.99 131.09 57.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.446 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -137.01 128.37 28.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.608 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -92.13 122.28 34.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.362 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 139.97 -30.96 2.32 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.526 ' O ' ' OD1' ' A' ' 22' ' ' ASN . 1.4 mt -68.61 161.82 27.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.748 0.309 . . . . 0.0 110.477 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.668 ' H ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -111.38 -40.54 0.1 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.914 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.668 ' CD ' ' H ' ' A' ' 47' ' ' THR . 24.7 Cg_exo -59.27 -173.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.59 2.193 . . . . 0.0 112.023 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.614 ' OD2' ' NE1' ' A' ' 25' ' ' TRP . 8.1 m-20 -97.47 -49.89 4.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.368 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -134.33 145.08 48.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.308 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.05 118.74 35.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.873 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 tp -100.75 -30.37 11.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.258 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.659 ' C ' ' H ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -173.35 147.69 1.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.45 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.531 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -56.02 2.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.513 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.659 ' H ' ' C ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -124.2 1.27 8.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.529 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 86' ' ' LYS . 7.6 t -156.44 139.26 15.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.962 0.41 . . . . 0.0 110.829 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -142.52 175.03 10.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.007 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.7 mt -137.68 133.15 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.847 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 tp -117.44 134.99 54.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.161 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.428 ' N ' ' OD2' ' A' ' 49' ' ' ASP . 41.6 t80 -107.99 126.66 52.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.881 0.372 . . . . 0.0 110.977 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.7 t -113.24 148.6 16.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.958 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.431 ' HG1' ' N ' ' A' ' 63' ' ' GLU . 9.7 t -115.65 150.79 36.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.586 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.566 ' CB ' ' OG1' ' A' ' 94' ' ' THR . 1.8 pp20? -47.68 -35.15 9.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.485 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.447 ' N ' ' HG3' ' A' ' 63' ' ' GLU . . . -57.88 -21.12 41.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.287 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -83.89 -37.73 22.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.776 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.445 ' CD2' ' O ' ' A' ' 96' ' ' MET . 0.9 OUTLIER -57.26 -47.09 82.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.568 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.0 p -49.75 -16.19 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.619 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.404 ' N ' ' C ' ' A' ' 66' ' ' LEU . . . -81.81 -76.0 0.27 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.624 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.622 ' O ' ' NH2' ' A' ' 73' ' ' ARG . . . 68.7 9.49 59.07 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.87 75.44 0.27 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.831 0.348 . . . . 0.0 110.602 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.13 -61.46 0.2 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -73.32 -27.41 61.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.719 0.295 . . . . 0.0 110.653 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.622 ' NH2' ' O ' ' A' ' 69' ' ' GLY . 4.9 ttp180 -48.27 -29.41 3.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.57 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.455 ' O ' ' CD ' ' A' ' 74' ' ' LYS . 1.2 tmtt? -66.58 -30.11 70.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.525 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -65.49 -35.67 81.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.59 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.2 mt -67.61 -50.07 59.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.661 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.6 t -54.46 -38.77 42.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.584 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.72 -41.0 75.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.607 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.2 t -64.91 -35.66 75.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.636 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.73 -28.5 26.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.661 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -80.98 -13.25 59.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.625 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -25.59 34.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.438 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.481 ' CG ' ' N ' ' A' ' 84' ' ' ASN . 51.4 t-20 -174.99 -112.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.635 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.481 ' N ' ' CG ' ' A' ' 83' ' ' ASN . 0.1 OUTLIER -170.82 74.42 0.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.416 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.461 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -133.03 161.37 34.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.714 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.537 ' O ' ' SG ' ' A' ' 56' ' ' CYS . 1.9 pttt -81.83 118.38 22.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.456 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.74 137.82 9.9 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.0 mt -93.09 141.17 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.764 0.316 . . . . 0.0 110.451 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.3 t -115.96 108.71 25.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.648 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -90.76 144.34 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.397 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.2 t -130.52 140.0 49.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.685 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -90.8 126.42 36.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.546 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -90.74 140.5 29.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.639 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.566 ' OG1' ' CB ' ' A' ' 63' ' ' GLU . 18.5 p -144.56 -73.1 0.26 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.473 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.434 ' C ' ' H ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -149.8 -72.65 0.18 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.456 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.445 ' O ' ' CD2' ' A' ' 66' ' ' LEU . 48.6 mtt -60.02 -5.82 1.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.457 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.604 ' O ' ' N ' ' A' ' 99' ' ' GLN . 0.2 OUTLIER -73.18 -84.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.522 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.541 ' H ' ' CD ' ' A' ' 98' ' ' GLU . 1.8 mp0 -36.27 -24.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.687 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.604 ' N ' ' O ' ' A' ' 97' ' ' SER . 1.6 mm100 -69.03 -55.88 9.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.01 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -117.55 10.89 13.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.725 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.582 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -60.8 -61.1 8.66 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.319 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 101' ' ' PHE . 9.5 Cg_endo -54.11 -42.28 68.43 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.678 2.252 . . . . 0.0 111.921 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.04 -41.54 35.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.332 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 tp -77.08 -41.2 43.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.399 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -51.23 -35.12 35.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.342 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.91 -51.0 64.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.275 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -62.88 -55.09 29.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.452 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.52 -40.67 27.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.429 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.686 ' O ' ' N ' ' A' ' 113' ' ' GLY . 6.7 t -67.57 -56.65 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.273 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.88 -28.32 68.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.558 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.48 -52.09 6.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.387 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.7 mp -105.91 -28.72 10.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.36 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 56.56 34.06 63.46 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -88.69 -155.8 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.75 0.31 . . . . 0.0 110.285 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.2 t -116.83 130.16 72.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.886 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 116' ' ' LEU . 7.0 mp -117.6 125.98 51.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.444 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.2 mp -126.2 85.28 60.11 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.546 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -58.94 156.94 30.97 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.81 2.34 . . . . 0.0 111.925 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.56 ' CG2' ' H ' ' A' ' 120' ' ' ALA . 5.9 m -126.16 -107.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.492 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.56 ' H ' ' CG2' ' A' ' 119' ' ' VAL . . . 172.92 -28.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.126 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.78 165.46 31.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.356 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -64.85 -41.24 95.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.6 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -62.48 -42.42 99.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.648 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.571 ' O ' ' N ' ' A' ' 128' ' ' LEU . 18.3 mm-40 -45.81 -53.53 9.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.247 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 128' ' ' LEU . . . -60.01 -57.99 10.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.702 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.488 ' OG ' ' CD1' ' A' ' 30' ' ' LEU . 14.6 m -46.23 -33.0 3.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 1.8 t -85.13 -35.6 21.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.947 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.571 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -71.28 -50.46 32.49 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.081 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.0 t -56.75 -56.4 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.171 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 mm -51.29 -51.7 22.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.329 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -50.4 -41.66 52.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.299 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.9 tp -46.41 -54.4 9.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.525 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.3 t -67.63 -46.07 83.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.283 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -51.0 -39.27 55.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.183 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.292 179.701 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.669 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -73.67 162.24 29.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.914 0.388 . . . . 0.0 110.616 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.432 HG22 HD12 ' A' ' 19' ' ' ILE . 72.5 mt -119.84 155.73 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.592 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.415 ' N ' ' CG2' ' A' ' 19' ' ' ILE . 58.3 t -108.84 148.61 12.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.458 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -136.0 141.2 44.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.666 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.604 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 66.4 t30 -73.99 132.94 42.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.702 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -48.89 -25.07 1.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.566 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -85.24 -33.12 22.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.533 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -79.49 -4.74 52.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.478 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.514 ' C ' ' H ' ' A' ' 28' ' ' SER . 24.2 ttp180 -70.69 -17.15 62.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.383 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.58 29.22 1.04 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 26' ' ' ARG . 6.1 m -127.66 138.06 52.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.343 . . . . 0.0 110.575 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -62.53 -24.48 67.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.53 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.543 ' C ' ' CD1' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -61.06 -53.31 58.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.378 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.03 -32.66 6.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.824 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.94 -27.89 49.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.692 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -63.9 -53.01 57.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.502 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.2 mtm -59.76 -16.49 28.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.486 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.31 -8.35 55.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.509 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.14 0.79 58.9 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -139.88 -33.68 0.58 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.817 0.342 . . . . 0.0 110.514 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 39' ' ' LYS . 1.7 mm -127.74 158.17 39.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.444 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.498 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 4.4 ttpm? -90.16 102.34 15.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.236 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mt -88.44 130.09 35.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.02 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 mm -108.25 113.71 44.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.086 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -75.72 125.16 28.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.022 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -127.16 115.75 19.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.314 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -79.38 125.9 30.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.447 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.82 -26.71 4.77 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.604 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 3.5 mm? -64.62 140.63 58.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.765 0.317 . . . . 0.0 110.59 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.675 ' HG1' ' N ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -92.36 -39.87 0.36 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.625 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.675 ' N ' ' HG1' ' A' ' 47' ' ' THR . 16.4 Cg_exo -64.73 -160.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.808 2.339 . . . . 0.0 111.92 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -111.46 -55.34 2.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.467 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -132.37 132.28 42.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.525 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.527 ' CD1' ' O ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -109.26 109.05 19.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.702 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.68 -41.2 72.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.44 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.482 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 79.3 p -165.66 -174.09 2.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.426 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.481 ' H ' ' ND2' ' A' ' 54' ' ' ASN . 0.3 OUTLIER -79.46 19.53 0.61 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.494 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.411 ' HG2' HH11 ' A' ' 55' ' ' ARG . 0.6 OUTLIER -142.22 3.34 1.55 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.159 -179.695 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.527 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 15.3 m -152.22 152.05 31.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.987 0.422 . . . . 0.0 111.091 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.485 ' SG ' ' CE1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -150.82 158.74 44.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.148 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.9 mt -130.4 132.81 64.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.902 0.382 . . . . 0.0 110.873 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.05 138.1 53.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.068 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -100.56 134.42 43.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.921 0.391 . . . . 0.0 110.931 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 t -131.33 138.66 52.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.336 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 65' ' ' ASP . 4.7 t -116.05 147.38 41.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.395 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -38.84 -37.24 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.49 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -50.25 -37.05 33.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.461 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 62' ' ' THR . 18.6 m-20 -71.74 -40.35 69.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.698 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 67' ' ' VAL . 1.3 tt -55.42 -43.42 75.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.492 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.438 ' N ' HD23 ' A' ' 66' ' ' LEU . 11.4 t -49.81 -38.21 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.515 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.39 -67.19 0.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.418 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.2 12.33 81.73 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -156.84 138.09 13.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 110.745 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.24 -38.93 3.04 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -82.52 -22.95 34.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.685 0.279 . . . . 0.0 110.805 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.3 ttp85 -68.81 -40.62 79.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.684 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.98 -24.4 2.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.683 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -70.04 -44.65 68.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.597 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.2 mt -58.19 -46.52 85.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.614 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.7 t -45.27 -42.37 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.697 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.4 mmm-85 -45.03 -51.75 9.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.666 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 t -62.44 -26.55 40.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.797 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -82.74 -37.51 24.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.72 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 81' ' ' ASN . 3.1 t-20 -82.31 -8.9 59.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.882 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.85 -78.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.558 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -153.22 -71.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.472 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -178.67 57.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.296 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.49 143.25 37.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.731 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.85 92.4 9.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.529 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -93.05 162.2 26.0 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.0 mt -116.7 148.48 19.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.809 0.338 . . . . 0.0 110.494 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.84 118.54 55.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.719 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.71 135.69 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.476 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.58 148.92 22.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.691 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -98.79 133.35 43.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.235 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -86.09 140.34 30.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.877 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.2 m -145.91 -79.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.256 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 64.6 mtt-85 -141.07 -70.45 0.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.358 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 20.7 mmt -63.09 -11.45 19.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.42 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.637 ' O ' ' N ' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -54.78 -95.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.669 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.626 ' N ' ' OG ' ' A' ' 97' ' ' SER . 3.0 pt-20 -36.27 -29.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.996 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.512 ' N ' ' O ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -65.9 -55.24 17.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.906 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -117.62 12.74 14.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.968 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.637 ' N ' ' O ' ' A' ' 97' ' ' SER . 21.2 t80 -68.24 -37.37 10.78 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.244 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 50.4 Cg_endo -78.3 -30.93 3.05 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.04 1.827 . . . . 0.0 111.959 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.84 95.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.962 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.6 tt -73.48 -45.84 51.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.044 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -54.65 -34.61 62.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.013 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -63.11 -36.75 84.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.162 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' A' ' 111' ' ' ASP . 1.7 m-85 -79.54 -53.33 6.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.194 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.7 m -51.99 -36.34 49.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.33 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.602 ' O ' ' N ' ' A' ' 113' ' ' GLY . 8.9 t -65.82 -59.9 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.494 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.498 ' CD2' ' O ' ' A' ' 110' ' ' LEU . 2.2 tt -67.04 -22.6 65.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.496 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 107' ' ' PHE . 1.3 m-20 -84.53 -55.41 4.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.81 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.9 mp -106.14 -28.42 10.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.987 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 49.69 50.05 32.36 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 2.3 mtm -105.84 -165.79 1.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.784 0.326 . . . . 0.0 110.368 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.8 t -90.44 110.5 22.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.538 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.457 HD23 ' N ' ' A' ' 117' ' ' LEU . 3.8 tt -111.15 126.17 54.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.522 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.457 ' N ' HD23 ' A' ' 116' ' ' LEU . 5.3 tp -146.15 107.6 4.22 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.682 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.417 ' HG3' ' CZ ' ' A' ' 101' ' ' PHE . 71.9 Cg_endo -78.78 169.58 19.37 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.388 2.058 . . . . 0.0 112.185 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.521 ' CG2' ' H ' ' A' ' 120' ' ' ALA . 19.4 m -131.91 -118.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.576 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.521 ' H ' ' CG2' ' A' ' 119' ' ' VAL . . . -167.27 -40.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.538 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.3 m -136.08 155.71 49.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.398 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -59.91 -20.75 59.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.547 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.683 ' SD ' ' N ' ' A' ' 123' ' ' MET . 0.8 OUTLIER -78.06 -33.05 51.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.585 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.634 ' O ' ' N ' ' A' ' 128' ' ' LEU . 1.6 mm-40 -54.26 -55.36 28.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.758 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -51.51 -58.22 6.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.249 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.439 ' OG ' ' CD1' ' A' ' 30' ' ' LEU . 3.9 t -48.89 -33.39 10.62 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.16 -30.13 24.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.874 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.634 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.5 OUTLIER -74.42 -49.72 21.34 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.074 179.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.99 -55.14 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.279 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 44.2 mt -51.03 -54.04 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.408 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -42.31 -35.15 0.92 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.596 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.96 -60.25 3.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.598 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.7 t -63.85 -38.63 82.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.351 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -60.03 -31.86 70.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.401 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.429 179.855 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.692 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.486 ' C ' ' ND1' ' A' ' 18' ' ' HIS . 4.1 p80 -112.55 155.06 24.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.659 0.266 . . . . 0.0 110.429 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 24.9 mm -107.24 159.41 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.737 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.96 141.22 46.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.609 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -126.12 143.87 50.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.586 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 25' ' ' TRP . 30.1 t30 -64.33 131.46 47.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.524 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -41.42 -32.89 0.36 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.515 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -78.15 -30.44 49.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.517 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.582 ' N ' ' O ' ' A' ' 22' ' ' ASN . 18.8 t-105 -77.91 -10.78 59.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.586 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.546 ' C ' ' H ' ' A' ' 28' ' ' SER . 10.8 ttt-85 -60.08 -37.0 78.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.732 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.06 40.81 0.26 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.546 ' H ' ' C ' ' A' ' 26' ' ' ARG . 69.8 m -128.47 136.54 50.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.753 0.311 . . . . 0.0 110.662 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -67.9 -21.25 65.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.222 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.586 ' C ' ' CD1' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -71.72 -52.48 17.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.288 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -49.02 -27.64 3.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.482 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -79.07 -34.7 43.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.738 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -58.34 -43.94 88.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.764 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.473 ' C ' ' H ' ' A' ' 36' ' ' GLY . 28.2 mtt -54.33 -32.64 57.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.804 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -71.0 8.96 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.593 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 34' ' ' MET . . . -95.34 -11.37 56.0 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -142.59 -49.19 0.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.812 0.339 . . . . 0.0 110.671 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.465 HG13 ' N ' ' A' ' 39' ' ' LYS . 10.4 tp -106.03 165.95 3.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.326 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.465 ' N ' HG13 ' A' ' 38' ' ' ILE . 22.7 tttp -85.68 143.99 28.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.285 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.444 ' HG ' ' N ' ' A' ' 41' ' ' ILE . 19.8 tp -127.82 156.25 42.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.444 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 50.1 mt -145.77 142.56 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.359 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.04 127.63 51.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.688 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -127.36 124.23 38.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.443 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.39 94.54 9.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.778 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 166.59 -32.26 0.21 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.474 ' O ' ' OD1' ' A' ' 22' ' ' ASN . 11.1 mp -66.92 159.62 27.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 110.491 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.548 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -103.79 -48.21 0.15 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.758 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 47' ' ' THR . 37.8 Cg_exo -56.36 -171.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.762 2.308 . . . . 0.0 112.039 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -97.92 -55.44 2.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.737 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -125.79 128.65 48.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.909 0.385 . . . . 0.0 110.649 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.687 ' CE2' ' O ' ' A' ' 53' ' ' SER . 4.0 t80 -107.87 105.43 15.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.594 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 mp -74.32 -30.53 62.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.438 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.687 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 2.0 p 177.41 -173.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.399 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -86.54 65.0 8.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.587 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -178.75 -30.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.824 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.2 m -140.29 132.4 27.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.918 0.389 . . . . 0.0 111.136 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 30.9 p -134.91 173.76 11.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.984 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.2 mt -139.99 131.74 32.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.289 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.0 tp -112.53 117.37 32.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.85 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.409 ' OH ' ' OE2' ' A' ' 92' ' ' GLU . 12.2 t80 -83.94 117.49 23.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.97 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.8 t -116.25 140.86 36.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.207 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.4 p -126.25 156.73 39.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.965 0.412 . . . . 0.0 110.92 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 96' ' ' MET . 2.9 tt0 -40.42 -43.43 1.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.731 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -43.48 -30.16 0.53 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.381 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -82.69 -47.72 11.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.308 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 tt -50.82 -38.3 47.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.357 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.2 t -45.95 -53.09 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.436 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -44.28 -76.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.481 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.29 -24.4 29.1 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -151.56 133.43 14.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 0.0 110.704 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.13 -54.94 0.73 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -62.68 -35.36 79.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.681 0.277 . . . . 0.0 110.6 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.475 ' HB3' HH11 ' A' ' 73' ' ' ARG . 0.2 OUTLIER -49.51 -40.78 38.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.877 0.37 . . . . 0.0 110.165 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.419 ' N ' ' HD2' ' A' ' 73' ' ' ARG . 1.8 ttpp -54.6 -35.87 63.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.043 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.2 ttt85 -69.22 -42.31 75.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.151 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 34.8 mt -61.71 -21.5 64.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.271 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.2 t -81.35 -39.28 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.486 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -61.04 -20.99 63.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.647 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.4 t -70.36 -50.06 49.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.012 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 49.2 ttt-85 -71.24 -43.58 66.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.907 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -52.66 -27.48 17.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.68 ' OG ' ' N ' ' A' ' 83' ' ' ASN . 0.3 OUTLIER -46.6 -74.42 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.82 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.68 ' N ' ' OG ' ' A' ' 82' ' ' SER . 1.8 m-80 -140.18 -98.22 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.834 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -165.56 37.59 0.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.781 0.324 . . . . 0.0 110.718 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.92 157.52 17.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.605 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -88.94 100.05 12.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.493 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -95.71 141.26 15.48 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 60.7 mt -103.02 135.65 39.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.816 0.341 . . . . 0.0 110.435 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.4 t -108.93 103.75 16.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.656 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.1 t -93.94 142.07 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.351 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.8 t -122.64 149.59 26.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.674 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.409 ' OE2' ' OH ' ' A' ' 60' ' ' TYR . 8.3 tt0 -107.67 107.12 17.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.633 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -68.17 132.82 47.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.211 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.622 ' H ' ' HG ' ' A' ' 97' ' ' SER . 7.2 m -137.42 -79.51 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.785 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.3 mtp85 -141.17 -70.25 0.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.581 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.553 ' N ' ' OE1' ' A' ' 63' ' ' GLU . 16.2 mtt -63.77 -10.78 21.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.496 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.643 ' O ' ' N ' ' A' ' 99' ' ' GLN . 82.8 p -62.02 -88.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.769 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.444 ' N ' ' OG ' ' A' ' 97' ' ' SER . 0.2 OUTLIER -36.09 -22.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.006 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.643 ' N ' ' O ' ' A' ' 97' ' ' SER . 7.0 mt-30 -73.62 -54.77 7.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.913 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.52 12.67 14.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.617 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.699 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 3.1 t80 -63.03 -34.94 15.16 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.647 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.699 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 14.7 Cg_exo -66.66 -49.99 1.43 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.604 2.203 . . . . 0.0 111.821 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -47.19 -49.2 23.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.423 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.569 ' O ' ' OG1' ' A' ' 108' ' ' THR . 2.7 tp -65.37 -51.2 62.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.423 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.439 ' O ' ' CG2' ' A' ' 109' ' ' VAL . 2.7 tt0 -49.93 -33.51 17.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.632 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.29 -52.98 15.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.571 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.92 -52.18 66.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.671 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.569 ' OG1' ' O ' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -58.82 -30.04 67.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.596 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.5 ' O ' ' CA ' ' A' ' 113' ' ' GLY . 2.3 t -70.98 -41.38 76.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.627 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 16.5 tp -81.36 -33.78 32.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.643 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.73 -47.19 10.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.471 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 113' ' ' GLY . 2.3 mm? -102.16 -28.33 12.37 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.184 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.5 ' CA ' ' O ' ' A' ' 109' ' ' VAL . . . 34.66 38.23 0.12 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -89.33 -156.12 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.734 0.302 . . . . 0.0 110.339 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.5 t -101.35 116.22 44.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.717 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.453 ' N ' HD13 ' A' ' 116' ' ' LEU . 7.4 mp -104.71 138.15 41.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.522 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.0 mp -147.32 85.63 6.74 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.732 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -61.72 165.59 13.52 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.751 2.301 . . . . 0.0 111.764 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.426 ' CG2' ' H ' ' A' ' 120' ' ' ALA . 6.8 m -132.74 -115.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.515 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.426 ' H ' ' CG2' ' A' ' 119' ' ' VAL . . . -178.71 -43.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.324 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.547 ' OG ' ' OE1' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -133.16 172.44 12.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.434 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -73.88 -16.63 61.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.645 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.481 ' O ' ' N ' ' A' ' 127' ' ' CYS . 54.8 mtp -85.57 -42.0 14.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.695 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.672 ' O ' ' N ' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -46.75 -53.92 10.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.527 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.16 -57.85 11.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.232 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 11.1 m -53.95 -33.3 56.48 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.481 ' N ' ' O ' ' A' ' 123' ' ' MET . 6.8 t -85.36 -29.37 24.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.666 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.672 ' N ' ' O ' ' A' ' 124' ' ' GLU . 1.6 tp -80.51 -36.53 33.1 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.608 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 64.4 t -63.92 -40.73 90.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.785 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.9 mt -63.32 -51.56 69.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.349 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.427 HE21 ' HB2' ' A' ' 131' ' ' GLN . 1.3 tp-100 -42.87 -42.24 3.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.316 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.7 mt -61.39 -57.36 12.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.528 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.6 t -49.07 -55.91 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.627 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -42.96 -30.62 0.43 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.533 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.398 179.86 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.679 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -148.81 154.65 39.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 110.639 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.454 HG22 HD11 ' A' ' 19' ' ' ILE . 33.0 mm -126.52 157.09 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.262 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 21' ' ' ALA . 63.3 t -113.11 148.36 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.015 0.436 . . . . 0.0 110.898 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 41' ' ' ILE . . . -137.84 159.33 42.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.203 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.564 ' O ' ' N ' ' A' ' 25' ' ' TRP . 57.6 t30 -92.15 139.49 30.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.839 0.352 . . . . 0.0 110.721 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -39.29 -47.49 1.7 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.585 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -63.28 -31.76 73.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.594 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.661 ' NE1' ' OD2' ' A' ' 49' ' ' ASP . 1.6 t-105 -76.79 -1.82 30.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.67 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.438 ' C ' ' HE ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -76.21 -26.93 56.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.538 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.82 33.11 3.1 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.4 m -122.7 142.38 50.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.8 0.333 . . . . 0.0 110.597 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -66.13 -23.11 66.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.33 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.526 ' C ' ' CD1' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -67.85 -55.33 13.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.539 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.404 ' N ' ' HG ' ' A' ' 30' ' ' LEU . . . -48.25 -22.59 0.69 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.023 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -81.41 -45.97 15.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.905 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -50.73 -33.37 22.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.834 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.535 ' O ' ' O ' ' A' ' 38' ' ' ILE . 11.9 mtt -66.18 -33.58 76.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.752 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -70.12 -17.36 63.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.658 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.97 4.31 86.07 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm -147.82 -56.7 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.899 0.38 . . . . 0.0 110.485 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.535 ' O ' ' O ' ' A' ' 34' ' ' MET . 7.8 tp -112.18 165.13 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.426 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.466 ' H ' HG13 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -88.03 110.54 20.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.573 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.422 HD13 ' SD ' ' A' ' 34' ' ' MET . 17.7 tp -96.96 137.0 36.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.757 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.429 ' O ' ' N ' ' A' ' 21' ' ' ALA . 20.6 mt -113.49 139.33 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.412 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -105.93 142.8 35.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.85 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -153.99 116.96 4.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.456 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -77.87 134.29 37.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.569 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 122.98 -32.2 4.48 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 75.2 mt -59.84 144.53 48.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.735 0.302 . . . . 0.0 110.668 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.535 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -88.42 -64.52 0.2 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.727 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.535 ' CD ' ' CB ' ' A' ' 47' ' ' THR . 9.6 Cg_endo -54.15 -174.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.779 2.32 . . . . 0.0 112.18 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.661 ' OD2' ' NE1' ' A' ' 25' ' ' TRP . 35.1 t0 -93.26 -66.17 0.94 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.431 ' CE2' ' CG ' ' A' ' 49' ' ' ASP . 68.6 m-85 -118.28 162.19 18.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.609 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.95 142.52 50.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.081 0.467 . . . . 0.0 110.977 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.412 ' C ' ' OG ' ' A' ' 53' ' ' SER . 0.8 OUTLIER -119.88 -24.85 6.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.776 179.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.412 ' OG ' ' C ' ' A' ' 52' ' ' LEU . 0.7 OUTLIER -169.77 179.27 3.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.059 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -77.69 4.64 11.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.818 0.342 . . . . 0.0 110.52 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -133.65 -4.39 2.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.879 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.7 m -129.66 134.66 47.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.95 0.405 . . . . 0.0 110.947 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.3 p -146.45 171.06 15.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.118 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 mt -138.82 138.48 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.995 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.44 HD23 ' N ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -124.11 136.49 54.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.135 179.659 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.537 ' HH ' ' CD ' ' A' ' 92' ' ' GLU . 29.5 t80 -96.98 115.3 27.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.846 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.7 t -121.75 149.05 24.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.193 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 65' ' ' ASP . 4.6 t -135.87 163.78 29.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 0.0 110.908 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.462 ' C ' ' CD ' ' A' ' 63' ' ' GLU . 4.8 tp10 -41.21 -48.68 3.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.589 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -47.61 -29.8 3.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.522 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 62' ' ' THR . 1.1 m-20 -77.43 -45.47 25.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.529 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 tt -48.94 -40.48 30.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.651 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.9 t -64.91 -42.57 95.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.672 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.557 ' C ' ' H ' ' A' ' 70' ' ' ASN . . . -91.16 26.3 2.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.597 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.95 -3.81 0.35 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.557 ' H ' ' C ' ' A' ' 68' ' ' ALA . 50.0 t30 -89.93 37.77 0.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.815 0.341 . . . . 0.0 110.504 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -175.54 -32.77 0.04 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -82.73 -38.27 23.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.842 0.353 . . . . 0.0 110.441 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.3 ttt-85 -48.34 -50.49 30.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.646 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -54.59 -43.76 72.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.569 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -49.95 -50.87 45.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.557 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.2 mt -53.52 -41.59 66.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.799 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 62.5 t -57.06 -33.36 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.762 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -49.22 77.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.622 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.8 t -47.42 -41.56 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.505 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.1 ttt-85 -82.02 -21.12 37.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.476 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -65.0 -25.0 67.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.588 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 t -58.04 -68.38 0.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.507 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -160.29 -69.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.577 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -178.5 66.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.541 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.6 mp -91.43 127.92 37.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.53 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.1 87.96 4.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.429 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -104.72 175.7 22.58 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.6 mt -106.27 137.62 35.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 0.0 110.454 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.6 t -109.48 116.92 53.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.779 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.5 t -104.38 134.89 44.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.427 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.6 t -124.6 134.61 66.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.636 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.537 ' CD ' ' HH ' ' A' ' 60' ' ' TYR . 5.0 tt0 -98.03 100.35 11.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.487 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.438 ' HB2' ' NZ ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -70.14 134.47 48.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.629 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.4 m -127.07 -64.97 0.97 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.637 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.404 ' C ' ' H ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -150.5 -73.1 0.17 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.395 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -64.14 -4.06 3.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.142 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.654 ' O ' ' N ' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -75.53 -87.6 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.361 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 97' ' ' SER . 1.7 mt-10 -35.84 -26.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.991 0.424 . . . . 0.0 110.365 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.69 ' OE1' ' CD2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -69.56 -56.08 8.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.972 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.69 ' CD2' ' OE1' ' A' ' 99' ' ' GLN . 2.7 m-85 -116.57 12.68 15.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.922 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.731 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 22.0 t80 -69.63 -32.69 3.22 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.075 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.731 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 16.0 Cg_exo -64.8 -50.24 2.47 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.526 2.151 . . . . 0.0 111.997 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.84 -36.84 49.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.66 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.466 ' O ' ' OG1' ' A' ' 108' ' ' THR . 1.3 tp -77.26 -34.59 55.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.394 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.524 ' O ' ' CG2' ' A' ' 109' ' ' VAL . 1.8 tt0 -68.07 -38.27 82.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.355 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -65.65 -28.19 68.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.34 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.69 -54.19 5.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.49 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -54.11 -32.05 53.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.703 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 113' ' ' GLY . 79.3 t -62.81 -62.75 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.743 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 85.8 mt -66.44 -20.01 65.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.776 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -83.99 -56.68 3.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.6 mp -105.93 -26.56 11.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.062 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 48.93 46.53 32.28 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 5.0 tpp -95.99 -156.92 0.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 0.0 110.448 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.68 106.39 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.56 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 mp -101.5 124.94 47.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.329 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.5 mt -137.9 87.27 16.92 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.711 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -55.27 165.67 2.89 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.601 2.201 . . . . 0.0 111.831 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.51 ' CG2' ' H ' ' A' ' 120' ' ' ALA . 15.3 m -133.11 -116.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.72 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.51 ' H ' ' CG2' ' A' ' 119' ' ' VAL . . . 172.68 -32.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.364 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.1 p -129.39 153.49 47.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.44 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -64.68 -22.58 67.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.682 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.612 ' SD ' ' N ' ' A' ' 123' ' ' MET . 0.0 OUTLIER -83.4 -40.46 19.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.816 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.636 ' O ' ' N ' ' A' ' 128' ' ' LEU . 3.5 mm-40 -45.71 -50.76 13.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.641 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.41 -58.01 10.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.865 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.419 ' OG ' ' CD1' ' A' ' 30' ' ' LEU . 6.3 m -49.86 -33.95 18.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -82.88 -31.68 27.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.667 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -72.92 -33.21 65.83 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.407 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 92.0 t -81.43 -51.41 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.557 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 54.6 mt -55.11 -44.6 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.702 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -52.23 -42.7 63.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.944 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 tp -52.18 -56.64 13.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.821 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 86.7 t -55.25 -55.85 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.009 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -47.07 -48.15 22.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.99 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.018 -179.562 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.646 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.61 166.15 13.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.418 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.7 mt -128.18 144.33 38.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.717 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -103.44 141.2 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.461 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.17 138.07 54.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.611 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.414 HD21 ' N ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -74.2 122.92 23.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.548 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.414 ' N ' HD21 ' A' ' 22' ' ' ASN . 1.6 tp10 -47.18 -25.22 0.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.556 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -76.34 -36.11 58.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.412 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.565 ' O ' ' CG ' ' A' ' 25' ' ' TRP . 34.8 t-105 -91.43 -1.34 57.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.501 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.588 ' C ' ' H ' ' A' ' 28' ' ' SER . 24.0 ttt180 -70.46 -15.16 62.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.571 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.56 24.19 0.49 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.588 ' H ' ' C ' ' A' ' 26' ' ' ARG . 0.4 OUTLIER -123.8 144.03 49.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.826 0.346 . . . . 0.0 110.618 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.56 ' O ' ' OE2' ' A' ' 33' ' ' GLU . 40.9 mt-30 -75.13 -16.93 60.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.537 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.676 ' CD2' ' HG ' ' A' ' 126' ' ' SER . 1.9 tm? -53.26 -65.05 0.63 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.238 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.516 ' N ' ' CD1' ' A' ' 30' ' ' LEU . . . -49.69 -37.91 30.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.829 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.14 -30.85 60.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.896 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.647 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 0.4 OUTLIER -72.75 -45.94 56.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.746 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.502 ' C ' ' H ' ' A' ' 36' ' ' GLY . 3.8 mtm -44.84 -31.39 1.21 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.364 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -69.46 9.74 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.676 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 34' ' ' MET . . . -89.51 -31.39 11.58 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -131.24 -43.86 1.04 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.929 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' N ' ' A' ' 39' ' ' LYS . 10.1 tp -103.03 162.33 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.698 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.423 ' N ' HG13 ' A' ' 38' ' ' ILE . 8.1 tttt -86.34 150.02 24.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.435 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.2 tp -137.17 131.6 32.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 mt -115.21 123.73 71.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.272 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.453 ' CD1' ' HD2' ' A' ' 26' ' ' ARG . 75.0 m-85 -88.74 120.35 30.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.801 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -126.14 132.45 51.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.45 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -95.2 103.75 15.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.628 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 154.29 -19.33 0.63 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.492 ' CD2' ' N ' ' A' ' 46' ' ' LEU . 3.9 mm? -66.8 146.13 54.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 0.0 110.599 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.469 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -87.3 -58.54 0.28 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.804 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 47' ' ' THR . 37.7 Cg_endo -69.14 -158.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.616 2.211 . . . . 0.0 112.158 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.581 ' CG ' ' H ' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -90.76 -61.34 1.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.776 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -121.84 160.32 24.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.83 0.347 . . . . 0.0 110.871 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.06 101.48 3.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.535 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 mp -76.89 -38.7 53.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.465 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.448 ' HG ' ' N ' ' A' ' 54' ' ' ASN . 15.1 t -168.39 176.01 6.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.471 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.448 ' N ' ' HG ' ' A' ' 53' ' ' SER . 20.2 m-80 -76.65 49.49 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.451 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -161.28 -37.63 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.595 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.7 t -120.25 143.15 48.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.846 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.681 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -150.64 165.93 31.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.011 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.681 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 75.1 mt -137.55 131.64 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.76 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.434 ' CD2' ' HH ' ' A' ' 72' ' ' TYR . 0.4 OUTLIER -118.39 127.04 53.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.202 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.581 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 19.5 t80 -90.28 130.02 36.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.005 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 37.3 t -126.75 146.95 31.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.204 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.7 t -129.46 153.72 47.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.923 0.392 . . . . 0.0 110.944 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.406 ' CB ' ' OG1' ' A' ' 94' ' ' THR . 0.5 OUTLIER -41.35 -44.42 2.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.617 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -48.41 -30.13 4.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.604 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.51 -31.13 37.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.528 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -64.45 -43.15 95.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.362 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.463 ' N ' HD22 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -46.03 -32.33 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.59 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 69' ' ' GLY . . . -103.2 -53.8 2.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.656 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 68' ' ' ALA . . . 36.12 37.41 0.18 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -115.38 -57.55 2.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.76 0.314 . . . . 0.0 110.639 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.8 -37.77 33.1 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.434 ' HH ' ' CD2' ' A' ' 59' ' ' LEU . 1.1 t80 -67.69 -23.37 65.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 0.0 110.653 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.2 tmm_? -60.51 -46.65 89.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.668 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -68.65 -24.63 64.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.33 -50.33 54.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.751 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.0 mt -58.07 -26.04 62.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 80' ' ' ARG . 92.4 t -73.52 -45.7 50.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.028 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -42.17 -48.78 4.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.836 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 37.4 t -58.48 -27.46 33.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -80.6 -37.65 30.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.57 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -63.33 -15.13 56.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.671 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.485 ' HG ' ' N ' ' A' ' 83' ' ' ASN . 92.9 p -59.79 -111.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.521 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.531 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER -117.86 -68.34 0.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.539 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.531 ' CG ' ' O ' ' A' ' 83' ' ' ASN . 16.0 m-20 176.98 63.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.428 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.461 ' CD1' ' OD1' ' A' ' 83' ' ' ASN . 4.0 mp -98.05 133.87 41.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.743 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -84.83 101.39 12.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.299 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.65 129.56 9.21 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.3 mt -86.51 135.86 24.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.796 0.332 . . . . 0.0 110.453 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.3 t -101.7 107.47 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.663 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.5 t -89.95 138.29 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.336 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.1 t -125.53 148.55 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.367 . . . . 0.0 110.899 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -118.97 110.1 16.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.188 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -66.45 146.33 54.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.749 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.406 ' OG1' ' CB ' ' A' ' 63' ' ' GLU . 5.1 m -141.67 -75.39 0.3 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.468 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -141.22 -69.62 0.38 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.702 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 5.6 mmt -69.3 -10.77 59.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.631 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.632 ' O ' ' N ' ' A' ' 101' ' ' PHE . 5.3 p -50.56 -94.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.737 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 97' ' ' SER . 5.3 mt-10 -36.31 -25.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.906 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.583 ' N ' ' O ' ' A' ' 97' ' ' SER . 3.4 mm100 -73.75 -51.31 16.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.709 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.42 ' N ' ' O ' ' A' ' 97' ' ' SER . 1.1 t80 -114.59 11.83 17.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.649 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.729 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 28.8 t80 -69.76 -32.58 3.09 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.889 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.729 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 11.0 Cg_exo -67.1 -58.93 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.553 2.169 . . . . 0.0 111.938 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -47.85 -38.53 16.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.836 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 38.8 tp -73.15 -53.78 10.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.658 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -47.69 -36.5 11.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.642 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -64.53 -41.28 96.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.412 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -73.16 -46.0 53.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.648 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -35.19 74.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.894 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.672 ' O ' ' N ' ' A' ' 113' ' ' GLY . 3.6 t -76.65 -54.41 13.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.892 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.63 -29.73 69.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.915 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -84.66 -51.04 7.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.377 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.9 mp -105.04 -28.5 11.01 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.584 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 55.01 16.13 7.67 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.768 ' N ' ' SD ' ' A' ' 114' ' ' MET . 0.0 OUTLIER -70.94 -155.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 0.0 110.762 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.2 t -109.65 138.21 38.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.711 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.5 pp -129.38 127.05 40.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.508 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 mp -132.73 101.24 14.27 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.482 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -79.01 156.36 26.56 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.526 2.151 . . . . 0.0 112.256 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.522 ' CG2' ' H ' ' A' ' 120' ' ' ALA . 5.6 m -130.35 -110.64 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.545 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.522 ' H ' ' CG2' ' A' ' 119' ' ' VAL . . . 170.96 -29.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.563 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.567 ' OG ' ' N ' ' A' ' 122' ' ' GLN . 0.4 OUTLIER -149.22 179.94 7.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.553 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.567 ' N ' ' OG ' ' A' ' 121' ' ' SER . 0.4 OUTLIER -73.69 -45.76 50.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.584 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.421 ' CG ' ' N ' ' A' ' 124' ' ' GLU . 8.7 ptt? -45.28 -43.21 10.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.646 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.624 ' O ' ' N ' ' A' ' 128' ' ' LEU . 16.6 mm-40 -59.74 -56.24 24.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.549 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.94 -58.38 8.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.104 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.676 ' HG ' ' CD2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -47.47 -34.16 7.04 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 42.1 t -85.51 -31.02 22.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.321 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.624 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -76.01 -45.25 35.47 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.842 0.353 . . . . 0.0 110.625 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.8 t -58.82 -54.67 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.616 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 96.3 mt -54.79 -52.62 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.616 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -48.9 -32.0 8.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.429 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.2 tp -61.71 -62.92 1.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.474 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.4 t -68.47 -36.89 76.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.506 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -58.35 -31.94 68.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.542 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.559 -179.954 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.681 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -150.09 159.65 44.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.68 0.276 . . . . 0.0 110.302 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.0 159.5 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.893 0.377 . . . . 0.0 110.77 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.0 t -114.26 143.46 23.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.347 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -133.96 150.51 51.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.697 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.667 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 18.3 t-20 -80.78 138.68 36.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.612 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -58.47 -32.69 68.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.778 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -75.5 -76.54 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.462 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.701 ' O ' ' N ' ' A' ' 27' ' ' GLY . 65.5 t-105 -54.86 -24.31 22.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.065 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.678 ' O ' ' N ' ' A' ' 28' ' ' SER . 4.8 ttt-85 22.39 39.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.953 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.701 ' N ' ' O ' ' A' ' 25' ' ' TRP . . . 16.47 47.49 0.01 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 26' ' ' ARG . 3.0 m 46.3 174.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 0.0 110.53 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -42.07 -23.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.477 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.555 ' C ' ' CD1' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -46.67 -45.4 19.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.781 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.441 ' N ' ' HG ' ' A' ' 30' ' ' LEU . . . -63.59 -25.73 68.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.54 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.8 -30.85 35.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -68.94 -37.38 78.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.624 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.43 ' O ' ' O ' ' A' ' 38' ' ' ILE . 6.0 mtt -48.22 -26.26 1.86 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.537 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -69.63 -2.46 11.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.569 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.61 -8.78 62.03 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -136.51 -46.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.399 . . . . 0.0 110.458 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.498 HG13 ' H ' ' A' ' 39' ' ' LYS . 6.1 tp -126.0 172.31 13.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.183 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.498 ' H ' HG13 ' A' ' 38' ' ' ILE . 52.0 tttp -85.5 127.13 34.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.889 0.376 . . . . 0.0 110.525 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.4 HD22 ' SD ' ' A' ' 34' ' ' MET . 0.4 OUTLIER -120.07 131.03 54.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.397 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.9 mt -114.14 152.68 15.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.533 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 3.1 m-85 -118.39 121.06 39.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.687 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -125.34 126.87 45.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.343 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -88.15 144.51 26.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.756 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.51 5.42 57.86 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.667 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 8.1 mt -77.39 155.6 31.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 0.0 110.693 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.515 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -93.87 -63.72 0.14 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.788 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.515 ' CD ' ' CB ' ' A' ' 47' ' ' THR . 18.6 Cg_endo -61.47 -178.31 0.27 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.662 2.242 . . . . 0.0 111.811 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.63 ' OD2' ' NE1' ' A' ' 25' ' ' TRP . 4.1 m-20 -97.91 -32.86 11.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.562 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -147.03 125.09 12.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.412 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.437 ' OH ' ' CD2' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -108.4 110.29 21.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.698 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.18 -43.71 32.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.394 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 55' ' ' ARG . 0.7 OUTLIER -163.38 153.08 15.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.622 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -58.95 70.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.718 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.589 ' N ' ' O ' ' A' ' 53' ' ' SER . 4.6 ttt-85 173.59 -26.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.652 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.6 m -140.56 131.32 25.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.497 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -121.88 175.38 6.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.561 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.419 HD11 HG22 ' A' ' 58' ' ' ILE . 69.0 mt -138.54 130.77 38.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.611 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.1 tp -111.75 131.81 55.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.383 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -100.92 122.72 43.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.558 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.9 t -117.78 146.37 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.501 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -121.18 141.78 50.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.694 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -38.67 -37.92 0.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.511 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -50.02 -39.72 42.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.544 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.67 -40.75 84.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.512 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 68' ' ' ALA . 1.3 tt -57.66 -37.97 74.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.479 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.7 t -45.48 -15.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.361 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 66' ' ' LEU . . . -110.3 -56.88 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.456 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 47.75 24.82 3.13 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -155.71 43.17 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.792 0.329 . . . . 0.0 110.652 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -166.55 -37.83 0.02 OUTLIER Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.478 ' O ' ' N ' ' A' ' 75' ' ' ARG . 20.7 t80 -82.67 -25.15 33.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.763 0.316 . . . . 0.0 110.888 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -45.52 -33.04 2.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.495 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.96 -26.91 67.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.461 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.724 HH21 ' HE ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -76.68 -34.11 58.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.349 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.0 -38.13 89.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.577 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.05 -41.0 89.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.497 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.724 ' HE ' HH21 ' A' ' 75' ' ' ARG . 0.0 OUTLIER -47.62 -28.52 2.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.85 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.7 t -71.19 -27.81 30.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.876 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -79.06 -48.02 15.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.709 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.466 ' O ' ' C ' ' A' ' 82' ' ' SER . 12.7 t-20 -50.88 -49.82 58.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.773 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.466 ' C ' ' O ' ' A' ' 81' ' ' ASN . 1.7 t -33.88 -66.47 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.679 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -155.66 -141.15 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.628 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -129.02 54.06 1.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.587 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.571 ' CB ' ' O ' ' A' ' 55' ' ' ARG . 0.4 OUTLIER -99.99 140.4 34.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.523 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.48 88.96 6.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.478 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.01 179.6 51.05 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 44.1 mt -121.8 115.75 47.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.801 0.334 . . . . 0.0 110.415 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.0 t -85.13 109.84 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.592 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.5 t -95.05 145.25 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.65 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.4 t -132.87 142.67 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.547 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -103.74 129.84 51.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.74 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.409 ' HZ2' ' HB2' ' A' ' 118' ' ' PRO . 3.4 mtpp -83.58 131.48 34.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.373 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.2 m -134.82 -84.47 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.758 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 41.4 mtp180 -131.39 -69.49 0.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.58 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -9.16 57.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.547 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.635 ' O ' ' N ' ' A' ' 101' ' ' PHE . 44.3 p -61.47 -92.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.812 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 97' ' ' SER . 8.3 pt-20 -36.28 -26.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.239 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.556 ' N ' ' O ' ' A' ' 97' ' ' SER . 35.6 mt-30 -70.53 -55.2 9.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 0.0 110.937 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -115.21 12.59 16.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.814 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.726 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 1.1 t80 -68.04 -33.9 5.54 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.674 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.726 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 17.3 Cg_exo -64.0 -55.38 0.65 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.587 2.191 . . . . 0.0 111.897 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.66 -36.82 26.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.465 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.4 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.5 OUTLIER -73.06 -41.19 64.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.465 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.39 -31.54 71.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.321 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.458 ' HZ1' ' HB2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -71.03 -46.3 62.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.231 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -74.66 -49.43 21.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.401 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 104' ' ' LEU . 76.4 m -43.83 -36.42 2.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.289 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' A' ' 113' ' ' GLY . 2.3 t -70.3 -54.01 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.206 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.4 mt -66.25 -24.75 66.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.573 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -84.53 -52.88 5.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.338 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.83 -28.38 10.67 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.5 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 54.27 43.33 75.07 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 2.2 ttm -110.68 -172.96 2.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.706 0.288 . . . . 0.0 110.335 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.5 t -89.0 120.4 37.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.645 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.8 tt -110.34 124.27 51.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.479 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 tt -131.83 104.99 14.06 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.734 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.409 ' HB2' ' HZ2' ' A' ' 93' ' ' LYS . 72.4 Cg_endo -82.23 156.97 17.27 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.703 2.269 . . . . 0.0 112.097 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.12 -101.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.592 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 175.16 -45.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.632 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.8 m -130.13 167.24 18.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.557 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -70.09 -22.68 63.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.656 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 29.9 mtp -73.6 -43.78 58.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.676 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 128' ' ' LEU . 4.9 mm-40 -47.42 -55.69 8.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.666 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 128' ' ' LEU . . . -57.43 -57.93 10.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.134 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 65.0 m -44.74 -36.01 2.97 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.48 -31.72 22.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.005 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.591 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.7 OUTLIER -73.49 -31.36 63.69 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.749 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 25.4 t -80.05 -42.33 21.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.576 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.5 mt -62.05 -49.37 84.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.626 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -57.09 -37.87 72.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.589 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.11 -40.89 70.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.815 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 45.4 t -74.42 -42.53 49.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.631 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -56.37 -52.78 63.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.627 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.657 -179.787 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.68 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -87.96 166.15 14.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.711 0.291 . . . . 0.0 110.523 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 91.0 mt -113.67 149.6 15.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.621 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.3 t -97.48 147.03 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.494 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 41' ' ' ILE . . . -133.58 160.41 37.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.491 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 56.5 t30 -93.82 141.23 28.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.531 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -55.22 -34.88 64.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.639 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.548 ' C ' ' H ' ' A' ' 26' ' ' ARG . 2.9 ttpp -79.42 -50.45 10.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.659 ' CE2' ' OD2' ' A' ' 49' ' ' ASP . 53.5 t-105 -64.58 6.11 0.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.926 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.548 ' H ' ' C ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -85.44 1.26 49.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.627 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.84 20.79 26.5 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.4 m -116.77 155.28 29.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.854 0.359 . . . . 0.0 110.688 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -73.28 -21.64 60.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.469 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.556 ' C ' ' CD1' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -57.16 -65.73 0.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.089 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -42.5 -32.76 0.58 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.303 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -70.68 -56.85 5.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.345 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 36' ' ' GLY . 96.0 mt-10 -54.16 -40.83 67.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.347 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.592 ' C ' ' H ' ' A' ' 36' ' ' GLY . 4.5 mtp -45.0 -47.63 11.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.404 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -65.82 11.68 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.499 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 34' ' ' MET . . . -86.06 -29.38 25.78 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.443 ' HZ1' HE22 ' A' ' 134' ' ' GLN . 7.1 mtmt -125.62 -47.95 1.68 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.852 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.467 HG12 ' H ' ' A' ' 39' ' ' LYS . 0.2 OUTLIER -109.93 171.84 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.742 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.467 ' H ' HG12 ' A' ' 38' ' ' ILE . 11.3 ttpp -90.2 140.38 29.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.597 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.7 tp -126.09 144.57 50.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.666 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.45 ' O ' ' N ' ' A' ' 21' ' ' ALA . 29.5 mt -120.36 151.34 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.503 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -117.65 139.79 50.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.668 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -148.24 120.2 8.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.485 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.13 124.47 27.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.595 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 132.38 -27.94 3.51 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.488 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 48.2 mt -59.39 139.46 57.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.604 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.614 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 1.1 m -90.08 -39.22 0.41 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.061 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 47' ' ' THR . 58.5 Cg_endo -80.67 -163.93 0.25 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.271 1.981 . . . . 0.0 112.074 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.659 ' OD2' ' CE2' ' A' ' 25' ' ' TRP . 30.5 m-20 -99.0 -46.23 5.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.795 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -140.8 155.88 46.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.688 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.51 94.03 3.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.493 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.547 ' O ' ' OG ' ' A' ' 53' ' ' SER . 1.7 tp -64.05 -20.34 65.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.332 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.659 ' C ' ' H ' ' A' ' 55' ' ' ARG . 4.2 m 173.05 161.55 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.423 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.2 22.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.962 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.659 ' H ' ' C ' ' A' ' 53' ' ' SER . 4.8 mmt85 -132.02 -29.11 1.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.645 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 57' ' ' CYS . 2.3 t -132.77 152.94 51.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.859 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.502 ' N ' ' SG ' ' A' ' 56' ' ' CYS . 0.5 OUTLIER -148.13 171.4 15.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.286 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.4 mt -138.77 134.88 43.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.818 0.342 . . . . 0.0 110.824 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.441 HD23 ' N ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -129.01 125.22 36.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.504 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.46 ' HB3' ' CZ2' ' A' ' 25' ' ' TRP . 14.4 t80 -87.65 128.78 35.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.615 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.2 t -121.52 149.85 24.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.492 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.8 p -126.1 145.35 50.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.664 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -44.31 -41.91 6.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.422 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -44.0 -31.11 0.83 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.362 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -82.84 -39.31 21.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.531 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 tt -49.14 -38.31 24.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.35 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 87.9 t -46.03 -36.16 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.594 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.69 116.72 9.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.54 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' A' ' 71' ' ' GLY . . . -121.77 3.56 10.89 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.58 4.77 2.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.813 0.339 . . . . 0.0 110.543 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 69' ' ' GLY . . . -134.88 -33.48 0.29 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.474 ' O ' ' N ' ' A' ' 75' ' ' ARG . 4.3 t80 -80.11 -35.63 36.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.765 0.317 . . . . 0.0 110.532 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.404 ' NH2' ' HB3' ' A' ' 107' ' ' PHE . 22.0 ttt85 -43.58 -36.13 1.99 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.528 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -63.66 -34.79 78.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.507 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.474 ' N ' ' O ' ' A' ' 72' ' ' TYR . 0.3 OUTLIER -62.16 -35.91 80.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.47 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 mt -68.19 -40.47 82.2 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.424 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.8 t -63.46 -47.13 93.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.388 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -41.41 -32.33 0.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.329 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.562 ' O ' ' OG ' ' A' ' 82' ' ' SER . 97.1 t -71.05 -55.4 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.515 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.453 ' HB3' ' NH1' ' A' ' 80' ' ' ARG . 0.9 OUTLIER -54.08 -31.77 52.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.568 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.51 ' O ' ' C ' ' A' ' 82' ' ' SER . 3.7 t30 -54.37 -49.44 69.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.499 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.562 ' OG ' ' O ' ' A' ' 79' ' ' VAL . 17.1 p -30.79 -76.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.428 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.458 ' OD1' ' OD1' ' A' ' 84' ' ' ASN . 1.5 t-20 -161.08 -89.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.476 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.564 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 3.0 p-10 -151.48 48.47 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.295 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.1 mt -69.32 154.93 41.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.6 pttt -126.56 89.08 2.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.234 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.437 ' CA ' ' O ' ' A' ' 57' ' ' CYS . . . -109.26 176.28 19.55 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.7 mt -114.36 129.63 70.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.789 0.328 . . . . 0.0 110.646 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 t -104.24 107.35 22.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.46 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.3 t -90.24 143.82 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.652 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 82.0 t -129.0 143.24 41.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.53 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -102.4 115.62 30.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.565 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -71.6 143.2 49.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.514 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.6 ' H ' ' HG ' ' A' ' 97' ' ' SER . 89.9 m -137.49 -82.1 0.35 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.484 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.515 ' CG ' ' N ' ' A' ' 96' ' ' MET . 14.1 ptm180 -151.14 -44.79 0.12 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.464 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.515 ' N ' ' CG ' ' A' ' 95' ' ' ARG . 1.7 mtt -88.52 -2.92 58.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.139 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.612 ' O ' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -70.65 -71.91 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.492 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -40.76 -22.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.609 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.524 ' N ' ' O ' ' A' ' 97' ' ' SER . 10.3 mm100 -72.3 -54.44 9.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.038 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -116.6 12.15 14.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.038 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.612 ' N ' ' O ' ' A' ' 97' ' ' SER . 0.3 OUTLIER -62.51 -62.18 6.2 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.604 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 101' ' ' PHE . 9.6 Cg_endo -53.49 -48.75 20.24 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.653 2.235 . . . . 0.0 112.013 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.05 -31.36 7.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.51 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.545 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.7 OUTLIER -85.31 -22.29 28.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.511 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 102' ' ' PRO . 1.4 tt0 -84.63 -32.37 23.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.699 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.77 -41.93 71.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.671 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.51 ' O ' ' CG ' ' A' ' 111' ' ' ASP . 2.9 m-85 -78.62 -51.01 10.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.603 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.545 ' OG1' ' O ' ' A' ' 104' ' ' LEU . 97.1 m -51.37 -37.49 48.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.485 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 113' ' ' GLY . 22.2 t -67.55 -59.15 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.452 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.2 -19.05 65.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.526 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.51 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 12.5 m-20 -84.39 -57.8 3.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.029 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.7 mt -107.5 -29.01 9.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.629 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 72.04 42.48 51.55 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -86.62 -171.05 3.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.576 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 40.7 t -117.76 105.23 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.587 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.447 HD11 ' N ' ' A' ' 116' ' ' LEU . 6.0 mp -95.64 142.39 28.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.514 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 tp -156.23 88.92 2.82 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.527 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -56.04 163.82 5.6 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.751 2.301 . . . . 0.0 112.085 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.529 ' O ' ' CB ' ' A' ' 120' ' ' ALA . 1.5 m -129.37 -106.83 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.655 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 119' ' ' VAL . . . 159.24 -47.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.434 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.13 143.68 51.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.544 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -51.94 -24.98 7.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.708 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 5.4 mtp -70.24 -51.72 28.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.623 ' O ' ' N ' ' A' ' 128' ' ' LEU . 9.6 mm-40 -44.71 -52.32 8.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.679 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 129' ' ' VAL . . . -55.18 -58.1 9.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.225 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.456 ' N ' HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -49.73 -37.01 27.61 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.223 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.87 -31.2 35.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.128 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.623 ' N ' ' O ' ' A' ' 124' ' ' GLU . 1.8 mt -79.91 -26.94 40.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.879 0.371 . . . . 0.0 110.501 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 125' ' ' ALA . 61.3 t -81.56 -41.0 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.566 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 70.5 mt -73.16 -39.94 57.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.67 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -58.64 -25.58 62.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.533 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.9 tp -77.01 -58.01 3.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.466 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.1 t -60.45 -41.79 88.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.605 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.443 HE22 ' HZ1' ' A' ' 37' ' ' LYS . 16.7 tt0 -52.76 -49.82 64.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.602 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.527 -179.937 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.644 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -114.22 154.6 27.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.804 0.335 . . . . 0.0 110.602 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.485 HG21 HD11 ' A' ' 19' ' ' ILE . 73.3 mt -106.21 153.49 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.625 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.9 t -110.47 124.04 66.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.654 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.01 149.88 27.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.66 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -74.78 140.65 44.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.424 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.71 -28.65 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.417 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.52 ' C ' ' H ' ' A' ' 26' ' ' ARG . 12.5 ttmm -83.54 -52.88 6.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.395 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.458 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 42.5 t-105 -74.79 24.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.307 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.52 ' H ' ' C ' ' A' ' 24' ' ' LYS . 18.7 ttp85 -81.28 -63.89 1.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.704 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.78 52.46 0.51 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.1 p -111.85 141.21 45.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.337 . . . . 0.0 110.634 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.681 HE21 ' NE2' ' A' ' 122' ' ' GLN . 7.5 mt-30 -56.35 -28.55 59.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.713 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.563 ' C ' ' CD1' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -61.07 -66.07 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.393 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.06 -24.67 63.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.923 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.02 -51.25 68.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.814 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -70.33 -45.83 65.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.857 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.422 ' SD ' HG13 ' A' ' 130' ' ' ILE . 36.0 mmt -49.92 -26.62 4.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.815 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -77.01 -0.54 24.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 0.0 110.562 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.22 6.83 50.98 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.441 ' HZ1' HD11 ' A' ' 130' ' ' ILE . 2.8 mtmp? -148.79 -47.85 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.812 0.339 . . . . 0.0 110.537 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.489 HG12 ' H ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -113.56 169.78 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.595 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.489 ' H ' HG12 ' A' ' 38' ' ' ILE . 5.4 tptm -94.94 152.82 18.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.487 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.86 137.99 28.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.48 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.4 mt -116.62 131.72 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.531 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -88.15 132.42 34.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.799 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -139.94 121.8 15.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.544 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -79.77 145.04 33.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.647 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.4 -33.89 5.83 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 77.3 mt -48.83 137.6 12.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 110.619 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.519 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -88.11 -52.63 0.38 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.929 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 47' ' ' THR . 33.9 Cg_endo -67.61 -157.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.04 1.826 . . . . 0.0 112.15 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.433 ' OD2' ' CD2' ' A' ' 25' ' ' TRP . 1.6 m-20 -98.63 -54.91 2.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.879 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.458 ' CZ ' ' CD1' ' A' ' 25' ' ' TRP . 83.0 m-85 -124.12 145.77 49.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.794 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.17 103.07 8.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.488 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.71 -35.11 30.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.493 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.661 ' C ' ' H ' ' A' ' 55' ' ' ARG . 4.2 t -178.28 164.59 1.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.426 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -67.38 23.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.477 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.661 ' H ' ' C ' ' A' ' 53' ' ' SER . 5.4 ttt-85 -134.72 -4.93 2.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.142 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.555 ' SG ' ' C ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -161.57 144.98 12.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.87 0.366 . . . . 0.0 110.974 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.402 ' SG ' ' HA2' ' A' ' 87' ' ' GLY . 12.5 p -151.13 164.38 36.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.438 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.0 mt -129.06 148.67 33.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.678 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.7 tt -133.78 120.02 19.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.287 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -85.71 121.66 28.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.792 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.425 ' N ' ' O ' ' A' ' 90' ' ' VAL . 74.7 t -122.15 143.98 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.229 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 63' ' ' GLU . 42.1 p -124.09 148.25 47.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.627 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 66' ' ' LEU . 3.3 tm-20 -38.57 -40.51 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.73 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -44.85 -33.32 1.9 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.661 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.562 ' OD2' ' CE1' ' A' ' 72' ' ' TYR . 3.6 m-20 -82.06 -26.34 33.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.634 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 63' ' ' GLU . 1.4 tt -68.41 -50.07 55.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.671 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.459 ' N ' HD22 ' A' ' 66' ' ' LEU . 2.3 p -62.43 -27.67 43.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.424 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.47 -64.96 0.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.561 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 70' ' ' ASN . . . 71.3 111.17 0.04 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.512 ' CB ' ' O ' ' A' ' 69' ' ' GLY . 5.1 t-20 81.75 139.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.77 0.319 . . . . 0.0 110.51 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.43 -71.31 0.38 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.562 ' CE1' ' OD2' ' A' ' 65' ' ' ASP . 4.0 t80 -50.56 -47.49 57.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.928 0.395 . . . . 0.0 110.375 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -43.15 -36.01 1.55 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.701 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -67.25 -43.94 80.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.542 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 12.3 mtt85 -58.36 -25.41 61.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.544 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 mt -79.42 -38.45 34.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.36 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.3 t -49.25 -30.46 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.278 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.455 ' NH1' ' HG1' ' A' ' 47' ' ' THR . 8.3 tpt180 -54.65 -29.3 51.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.349 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.6 t -69.12 -35.94 70.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.218 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -79.53 -20.22 47.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.405 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -51.03 -59.69 3.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.471 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.459 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 0.1 OUTLIER -69.0 -68.99 0.36 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.454 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 82' ' ' SER . 4.5 t-20 78.01 60.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.491 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.538 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 2.1 p30 -148.48 11.82 0.9 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.757 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 pp -155.09 153.09 30.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.809 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.7 mmtm -76.62 110.0 10.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.126 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.402 ' HA2' ' SG ' ' A' ' 57' ' ' CYS . . . -86.64 101.76 2.67 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.427 HD12 HG21 ' A' ' 88' ' ' ILE . 46.8 mt -84.48 138.57 18.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 37.0 t -117.96 127.6 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.858 0.361 . . . . 0.0 111.149 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 61' ' ' VAL . 14.7 t -117.49 121.84 68.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.166 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.0 t -114.79 139.69 39.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.783 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -98.75 129.53 45.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.679 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.634 ' NZ ' ' O ' ' A' ' 119' ' ' VAL . 21.7 mttp -78.57 138.39 38.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.428 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.456 ' HG1' ' HB3' ' A' ' 63' ' ' GLU . 12.2 m -140.12 -85.22 0.22 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.669 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -128.8 -63.38 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.592 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.734 ' SD ' ' N ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -77.91 -9.24 58.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.48 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 99' ' ' GLN . 4.7 p -48.47 -102.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.348 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 97' ' ' SER . 24.2 mt-10 -36.31 -21.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.589 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.68 ' N ' ' O ' ' A' ' 97' ' ' SER . 11.5 tp60 -69.56 -55.61 9.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.094 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 103' ' ' ALA . 4.8 t80 -117.33 3.11 12.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.801 0.334 . . . . 0.0 110.797 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.601 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -47.06 -58.77 6.44 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.507 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 101' ' ' PHE . 14.9 Cg_endo -59.05 -48.68 13.33 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.556 2.171 . . . . 0.0 112.277 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 100' ' ' TYR . . . -45.47 -32.39 2.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.855 0.359 . . . . 0.0 110.227 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 tp -87.29 -30.95 20.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.806 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 102' ' ' PRO . 38.1 tt0 -58.26 -40.09 80.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.16 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -63.51 -37.08 85.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.088 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.27 -38.78 34.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.472 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.0 m -72.93 -30.84 64.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.569 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.584 ' O ' ' CA ' ' A' ' 113' ' ' GLY . 10.8 t -77.36 -43.93 30.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.989 0.423 . . . . 0.0 110.53 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.3 tp -70.92 -31.15 67.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.613 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -84.51 -50.14 7.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.308 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mt -104.88 -28.32 11.19 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.597 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.584 ' CA ' ' O ' ' A' ' 109' ' ' VAL . . . 43.47 35.19 2.75 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.93 -159.62 0.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.362 . . . . 0.0 110.547 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 49.4 t -96.29 123.13 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.426 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.14 133.91 53.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.67 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.8 mt -146.07 88.28 6.39 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.481 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -80.56 158.99 22.22 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.883 2.389 . . . . 0.0 112.189 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.634 ' O ' ' NZ ' ' A' ' 93' ' ' LYS . 28.2 m -127.2 -136.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.428 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.415 ' N ' ' CG2' ' A' ' 119' ' ' VAL . . . -153.5 -40.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.279 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.9 p -138.39 158.34 44.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.357 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.681 ' NE2' HE21 ' A' ' 29' ' ' GLN . 21.1 mt-30 -58.17 -26.36 62.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.62 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.85 -45.23 90.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.74 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.638 ' O ' ' N ' ' A' ' 128' ' ' LEU . 1.2 mp0 -54.97 -58.41 7.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.657 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 128' ' ' LEU . . . -52.18 -58.06 7.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.296 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.68 -40.29 4.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.7 m -85.39 -27.12 26.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.208 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.638 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.5 OUTLIER -77.35 -26.86 52.43 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.942 0.401 . . . . 0.0 110.742 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 125' ' ' ALA . 3.5 t -68.87 -61.45 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.642 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.441 HD11 ' HZ1' ' A' ' 37' ' ' LYS . 6.8 mt -58.33 -45.08 89.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.441 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -45.7 -29.62 1.32 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.829 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.4 mt -76.44 -48.75 18.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.772 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.2 t -67.81 -51.93 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.817 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.75 -33.72 49.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.841 -179.776 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.42 ' C ' ' H ' ' A' ' 3' ' ' LYS . 34.7 mtt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -73.01 8.23 1.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.635 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.42 ' H ' ' C ' ' A' ' 1' ' ' MET . 1.2 tttt -91.83 -166.57 1.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.568 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.33 155.22 78.78 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.591 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.98 162.8 40.77 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.841 2.361 . . . . 0.0 112.078 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -64.31 160.17 40.19 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.801 2.334 . . . . 0.0 112.063 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.526 ' O ' ' CG ' ' A' ' 7' ' ' ASP . 12.9 t70 -107.1 49.25 0.81 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.705 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 7' ' ' ASP . 36.1 m-20 35.33 73.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.814 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 t -81.47 -1.32 45.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.006 0.431 . . . . 0.0 110.217 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.35 70.98 0.09 OUTLIER Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.563 ' C ' ' H ' ' A' ' 13' ' ' HIS . 66.4 Cg_endo -78.33 97.71 1.15 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.949 2.432 . . . . 0.0 112.567 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 t -74.0 27.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.131 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.563 ' H ' ' C ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -109.76 38.82 2.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.467 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.747 ' N ' ' CD ' ' A' ' 15' ' ' PRO . 2.3 t -86.3 -33.09 0.45 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.715 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.747 ' CD ' ' N ' ' A' ' 14' ' ' VAL . 24.6 Cg_exo -59.11 -4.75 2.35 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.608 2.206 . . . . 0.0 112.139 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -68.57 -89.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.484 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -123.02 92.75 0.47 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.6 p-80 -136.53 152.39 50.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.856 0.36 . . . . 0.0 110.778 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.4 mm -122.98 135.51 62.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.261 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.7 t -97.04 151.63 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.802 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.3 128.26 25.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.502 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.425 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 55.5 t-20 -56.57 131.27 48.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.566 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -43.79 -38.3 3.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.681 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.607 ' C ' ' H ' ' A' ' 26' ' ' ARG . 15.5 ttpt -72.62 -48.41 39.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.48 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.514 ' CE2' ' OD2' ' A' ' 49' ' ' ASP . 24.2 t-105 -67.89 19.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.537 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.607 ' H ' ' C ' ' A' ' 24' ' ' LYS . 61.2 ttt-85 -89.47 -34.97 16.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.439 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.97 36.71 0.24 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.599 ' H ' ' C ' ' A' ' 26' ' ' ARG . 5.8 p -117.86 144.69 45.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.769 0.319 . . . . 0.0 110.644 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -72.93 -18.97 61.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.441 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.518 ' C ' ' CD1' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -68.56 -57.61 5.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.315 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -41.93 -23.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.531 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 30' ' ' LEU . 2.4 tp60 -72.12 -47.61 49.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.567 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 36' ' ' GLY . 3.5 mt-10 -50.94 -51.26 54.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.456 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.538 ' C ' ' H ' ' A' ' 36' ' ' GLY . 5.6 mtt -43.93 -42.14 5.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.573 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -71.1 17.16 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.598 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.538 ' H ' ' C ' ' A' ' 34' ' ' MET . . . -104.15 -10.69 33.68 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.5 mtmm -152.01 -43.1 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.854 0.359 . . . . 0.0 110.479 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.1 tp -109.36 160.65 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.519 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.8 tttm -86.19 146.05 26.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.582 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.9 tp -131.4 137.87 48.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.701 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.439 HG23 ' N ' ' A' ' 42' ' ' PHE . 57.8 mt -123.16 141.89 41.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.486 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -96.75 133.69 40.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.798 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.76 120.04 25.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.387 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -89.85 111.55 22.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.651 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 133.4 -8.52 5.01 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.425 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 66.3 mt -92.61 148.71 21.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.773 0.32 . . . . 0.0 110.67 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.536 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -96.04 -47.9 0.25 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 47' ' ' THR . 58.0 Cg_exo -47.87 164.35 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.727 2.285 . . . . 0.0 112.27 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.601 ' OD2' ' CD1' ' A' ' 60' ' ' TYR . 1.2 m-20 -85.44 -53.04 5.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.476 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.4 ' CD1' ' HE1' ' A' ' 34' ' ' MET . 79.0 m-85 -135.71 120.7 18.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.891 0.377 . . . . 0.0 110.607 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.549 ' CD1' ' O ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -99.48 112.78 24.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.383 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.402 HD21 HE22 ' A' ' 136' ' ' GLN . 0.5 OUTLIER -82.91 -44.08 15.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.65 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.549 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 5.0 t -139.46 -162.23 1.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.676 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -90.22 -8.98 49.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.624 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.443 HH21 ' HZ2' ' A' ' 86' ' ' LYS . 11.2 mtp180 -125.83 -8.8 6.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.828 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.61 132.82 56.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.962 0.411 . . . . 0.0 111.1 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.1 163.67 30.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.892 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 96.5 mt -135.72 124.16 38.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.977 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.9 tp -115.82 138.21 51.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.372 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.601 ' CD1' ' OD2' ' A' ' 49' ' ' ASP . 2.8 p90 -96.17 132.91 41.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.91 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 92' ' ' GLU . 77.0 t -130.59 149.97 34.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.176 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.43 ' N ' HG11 ' A' ' 61' ' ' VAL . 1.0 OUTLIER -138.05 157.06 47.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.631 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 62' ' ' THR . 5.7 tm-20 -39.18 -43.16 1.04 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.32 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -47.0 -39.91 13.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.343 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 62' ' ' THR . 61.9 m-20 -69.01 -44.63 72.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.333 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.5 tt -49.05 -44.44 41.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.523 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 32.2 t -49.48 -41.22 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.552 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.41 -71.63 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.646 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.44 -52.82 1.89 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -97.09 103.23 15.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.789 0.328 . . . . 0.0 110.559 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.66 -51.43 0.8 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -67.37 -24.53 65.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.724 0.297 . . . . 0.0 110.902 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -42.19 97.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 110.589 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -46.31 -46.15 17.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.583 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -59.09 -38.05 78.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.747 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.6 mt -70.41 -34.81 72.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.708 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 63.8 t -61.45 -40.27 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.856 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 -56.85 -23.42 43.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.799 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.0 t -79.91 -49.51 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.561 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.6 ttt-85 -66.9 -25.54 66.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.645 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -71.05 -11.61 61.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.654 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.554 ' OG ' ' N ' ' A' ' 83' ' ' ASN . 60.4 p -67.92 -117.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.581 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.578 ' C ' HD21 ' A' ' 84' ' ' ASN . 7.1 t30 -121.02 -93.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.679 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.578 HD21 ' C ' ' A' ' 83' ' ' ASN . 1.5 m-80 -138.02 60.27 1.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.495 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.5 mp -93.48 123.43 36.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.575 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.443 ' HZ2' HH21 ' A' ' 55' ' ' ARG . 1.2 pttp -112.58 85.84 2.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.172 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -93.67 -165.33 37.21 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.8 mt -131.28 135.83 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.773 0.32 . . . . 0.0 110.488 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.2 t -107.99 118.82 56.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.614 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 61' ' ' VAL . 19.7 t -93.69 140.72 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.401 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.66 132.59 70.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.716 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 61' ' ' VAL . 3.6 tt0 -101.71 104.43 15.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.387 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -68.65 131.95 46.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.579 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.6 m -126.14 -74.26 0.6 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.633 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.3 mtp85 -140.84 -70.3 0.38 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.457 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.33 -1.93 7.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.49 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.609 ' O ' ' N ' ' A' ' 101' ' ' PHE . 4.1 t -68.7 -91.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.788 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 97' ' ' SER . 22.1 mt-10 -36.41 -27.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.954 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 97' ' ' SER . 2.3 mt-30 -71.64 -51.51 22.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.181 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -117.13 11.62 14.23 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.19 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.727 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 35.5 t80 -69.82 -32.9 3.23 Favored Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.78 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.727 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 10.8 Cg_exo -67.33 -42.34 7.67 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.588 2.192 . . . . 0.0 111.939 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.05 -48.32 78.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.635 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 tp -71.16 -47.99 54.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.585 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -50.59 -33.63 22.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.73 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -56.39 15.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.871 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.6 -52.14 62.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.787 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.1 m -42.18 -40.43 2.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.79 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.667 ' O ' ' N ' ' A' ' 113' ' ' GLY . 85.9 t -66.2 -58.66 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.476 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.56 -23.08 66.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.461 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.48 -55.51 4.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mt -106.33 -28.58 10.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.184 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 56.76 20.04 30.94 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 6.5 tpp -73.04 -161.09 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.724 0.297 . . . . 0.0 110.404 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.12 127.63 65.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.607 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.413 ' N ' HD13 ' A' ' 116' ' ' LEU . 5.0 mp -122.27 115.44 22.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.472 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.3 mt -124.99 88.32 54.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -53.25 171.56 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.629 2.219 . . . . 0.0 111.735 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.4 ' CG2' ' H ' ' A' ' 120' ' ' ALA . 4.0 m -143.06 -113.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.652 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.4 ' H ' ' CG2' ' A' ' 119' ' ' VAL . . . -177.51 -37.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.263 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.8 p -141.12 -170.74 3.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.348 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -81.26 -28.22 34.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.598 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -48.42 59.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.757 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 128' ' ' LEU . 0.4 OUTLIER -44.7 -46.1 10.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.25 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.66 -54.92 24.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.959 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 59.7 p -54.98 -30.85 60.1 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -85.19 -35.32 21.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.256 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.596 ' N ' ' O ' ' A' ' 124' ' ' GLU . 4.2 mp -74.58 -34.33 62.86 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.569 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.0 t -74.19 -55.0 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.562 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 97.2 mt -58.17 -50.93 76.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.581 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -48.94 -30.28 5.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.321 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.1 tp -82.58 -42.03 18.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.478 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.75 -36.79 77.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.644 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.96 -22.46 65.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.656 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -81.5 -38.41 26.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.475 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.402 HE22 HD21 ' A' ' 52' ' ' LEU . 6.5 tt0 -66.65 -50.84 61.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.525 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -38.95 -57.78 1.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.485 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.518 ' O ' ' C ' ' A' ' 139' ' ' GLU . 1.3 mtpp -35.65 153.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.479 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.518 ' C ' ' O ' ' A' ' 138' ' ' LYS . 3.2 mm-40 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.554 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 mmt . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -79.21 132.06 36.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.689 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.0 55.61 1.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.356 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.413 ' N ' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -85.49 -54.63 0.42 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.924 -179.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 4' ' ' ASN . 73.6 Cg_endo -79.69 146.3 18.79 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.661 2.241 . . . . 0.0 112.353 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -74.0 102.98 1.59 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.665 2.243 . . . . 0.0 112.067 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.538 ' O ' ' C ' ' A' ' 8' ' ' ASP . 4.6 m-20 -117.88 57.02 0.84 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.65 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.538 ' C ' ' O ' ' A' ' 7' ' ' ASP . 14.5 p-10 28.82 51.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.639 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.4 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 7.7 t -73.45 15.14 0.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.557 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 8' ' ' ASP . . . -59.23 -70.98 0.84 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -64.39 87.42 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.822 2.348 . . . . 0.0 112.109 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.4 ' CG2' ' O ' ' A' ' 9' ' ' THR . 5.8 t -103.81 -31.37 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.489 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.615 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 2.8 p80 -148.98 106.06 3.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.625 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.495 ' N ' ' CD ' ' A' ' 15' ' ' PRO . 3.9 m -127.09 51.65 6.87 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.469 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 14' ' ' VAL . 29.1 Cg_endo -66.2 -28.9 47.71 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.838 2.359 . . . . 0.0 112.209 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mt -72.23 2.48 5.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.582 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -102.44 -66.92 0.76 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -72.78 155.1 40.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.846 0.355 . . . . 0.0 110.702 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.442 HD12 HG23 ' A' ' 19' ' ' ILE . 17.9 mm -109.35 143.8 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.399 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.6 t -94.6 145.41 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.586 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -136.82 137.25 39.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.541 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 25' ' ' TRP . 63.2 t-20 -64.7 135.29 55.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.467 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.406 ' N ' ' OD1' ' A' ' 22' ' ' ASN . 7.2 tt0 -43.18 -32.3 0.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.369 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -70.36 -36.78 74.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.334 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.502 ' N ' ' O ' ' A' ' 22' ' ' ASN . 0.2 OUTLIER -68.46 -13.62 62.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.208 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.44 ' HD3' ' CD1' ' A' ' 42' ' ' PHE . 7.7 tpt85 -61.98 -40.85 97.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.611 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.6 51.01 0.85 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.69 152.16 37.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.794 0.33 . . . . 0.0 110.622 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -75.55 -21.05 58.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.363 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.566 ' C ' ' CD1' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -68.67 -56.61 7.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.598 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.426 ' N ' ' HG ' ' A' ' 30' ' ' LEU . . . -53.14 -33.08 50.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.831 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -82.4 -28.94 31.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.727 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -67.33 -31.78 72.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.52 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.689 ' N ' ' SD ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -74.83 -27.04 60.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.465 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -65.78 -8.65 22.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.681 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.35 -29.02 11.7 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.2 -48.85 3.75 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.98 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.424 HG12 ' H ' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -123.24 172.2 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.94 0.4 . . . . 0.0 110.882 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.424 ' H ' HG12 ' A' ' 38' ' ' ILE . 36.8 tttp -86.13 127.6 34.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.541 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.4 tp -118.59 129.75 55.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.755 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.447 HG23 HD13 ' A' ' 41' ' ' ILE . 2.0 mt -108.59 140.66 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.31 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.44 ' CD1' ' HD3' ' A' ' 26' ' ' ARG . 6.2 m-85 -104.14 129.05 51.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.719 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -130.63 113.2 13.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.439 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -75.18 128.47 35.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.477 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.65 -47.41 1.02 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.465 ' H ' HD13 ' A' ' 46' ' ' LEU . 9.7 mp -46.96 148.15 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.716 0.293 . . . . 0.0 110.387 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.56 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -99.45 -47.54 0.21 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.903 0.382 . . . . 0.0 110.668 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 47' ' ' THR . 31.4 Cg_exo -54.95 176.93 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.791 2.327 . . . . 0.0 112.153 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.47 ' OD1' ' CE2' ' A' ' 25' ' ' TRP . 8.1 m-20 -87.11 -56.14 3.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.436 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -129.65 143.62 50.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.357 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -116.61 108.35 15.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.71 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.78 -38.26 76.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.487 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.602 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 5.8 m -160.01 -143.54 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.439 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.31 18.81 17.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.584 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -144.49 9.84 1.41 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.602 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 86' ' ' LYS . 42.7 t -163.53 145.4 9.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.684 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.15 172.72 12.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.296 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.6 mt -131.08 126.33 59.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.72 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.24 117.73 30.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.27 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -87.74 117.46 26.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.95 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 73.2 t -99.3 149.48 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.948 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -121.29 156.37 32.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.842 0.353 . . . . 0.0 110.831 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.501 ' CG ' ' N ' ' A' ' 64' ' ' ALA . 12.0 pt-20 -46.05 -44.67 15.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.56 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.501 ' N ' ' CG ' ' A' ' 63' ' ' GLU . . . -51.39 -19.86 1.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.701 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.672 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -79.33 -53.08 7.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.698 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 tt -56.33 -50.23 72.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.662 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.0 t -52.98 -13.77 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.711 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.42 35.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.758 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 65' ' ' ASP . . . -65.36 -16.71 63.11 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -51.86 -45.85 64.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.762 0.315 . . . . 0.0 110.666 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.48 -47.55 6.34 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 75' ' ' ARG . 2.1 t80 -53.53 -26.39 20.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.862 0.363 . . . . 0.0 110.624 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.725 ' HE ' ' HZ2' ' A' ' 74' ' ' LYS . 6.2 ttp85 -36.28 -35.67 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.717 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.725 ' HZ2' ' HE ' ' A' ' 73' ' ' ARG . 2.7 mmtm -70.31 -48.79 55.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.654 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -54.44 -28.92 47.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.695 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 27.5 mt -70.61 -58.11 4.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.689 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 80' ' ' ARG . 65.3 t -50.76 -36.91 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.592 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.38 -21.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.465 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.478 ' N ' ' O ' ' A' ' 77' ' ' VAL . 41.1 t -77.88 -33.25 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.766 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.551 ' N ' ' O ' ' A' ' 77' ' ' VAL . 0.9 OUTLIER -82.31 -39.54 22.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.773 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -59.27 -21.24 59.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.901 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 t -95.19 -54.61 3.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.722 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -132.93 -171.0 2.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.652 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -147.03 45.76 1.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.27 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.415 ' N ' HD22 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -98.69 155.64 17.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.688 -179.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.523 ' O ' ' SG ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -80.41 122.27 26.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.239 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -127.89 164.19 21.31 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.5 mt -107.66 121.86 61.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.853 0.359 . . . . 0.0 110.448 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.1 t -97.2 125.68 50.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.872 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.66 149.4 5.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.047 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.0 t -132.77 145.08 34.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.892 0.377 . . . . 0.0 110.862 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -92.59 120.69 33.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.399 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -67.34 139.85 57.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.793 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.623 ' CG2' ' H ' ' A' ' 95' ' ' ARG . 1.9 t -151.08 -108.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.523 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.623 ' H ' ' CG2' ' A' ' 94' ' ' THR . 4.1 mtt180 -130.07 -74.7 0.54 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.259 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.472 ' SD ' ' OE1' ' A' ' 99' ' ' GLN . 26.6 mmt -55.36 -7.16 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.279 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.641 ' O ' ' N ' ' A' ' 101' ' ' PHE . 1.4 t -54.92 -88.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.671 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.449 ' N ' ' OG ' ' A' ' 97' ' ' SER . 2.2 mm-40 -43.01 -21.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.032 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.472 ' OE1' ' SD ' ' A' ' 96' ' ' MET . 47.9 mt-30 -71.11 -55.07 8.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.845 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -117.08 12.26 14.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.824 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.709 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 0.3 OUTLIER -63.7 -35.46 16.5 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.414 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.709 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 2.7 Cg_exo -71.9 -53.94 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.734 2.289 . . . . 0.0 111.813 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -45.88 -27.77 0.95 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.617 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.57 -44.38 12.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.507 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.455 ' NE2' ' CZ ' ' A' ' 101' ' ' PHE . 9.5 tt0 -60.64 -32.15 71.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.616 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -73.75 -34.94 64.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.739 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -81.95 -37.35 26.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.801 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.1 p -73.35 -35.78 66.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.928 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.696 ' O ' ' N ' ' A' ' 113' ' ' GLY . 4.0 t -66.84 -55.95 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.942 0.401 . . . . 0.0 110.652 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.35 -30.42 66.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.55 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -84.5 -51.22 7.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.438 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.85 -28.87 10.37 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.538 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.696 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 60.93 33.81 85.12 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 3.3 mtt -84.84 -179.5 7.1 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 110.543 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.0 t -103.05 124.25 57.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.628 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 116' ' ' LEU . 7.5 mp -105.35 143.78 33.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.241 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 tt -157.29 88.59 2.57 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.746 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -58.49 146.27 91.28 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.671 2.247 . . . . 0.0 111.823 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.439 ' CG2' ' H ' ' A' ' 120' ' ' ALA . 2.3 m -108.23 -107.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.548 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.439 ' H ' ' CG2' ' A' ' 119' ' ' VAL . . . 179.41 -30.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.391 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 97.2 p -144.23 -173.36 3.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.39 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -85.21 -24.45 27.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.588 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.412 ' O ' ' N ' ' A' ' 127' ' ' CYS . 37.9 mtt -81.37 -41.41 22.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.733 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 128' ' ' LEU . 6.5 mm-40 -45.03 -43.51 9.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.437 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.91 -57.78 6.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.007 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.434 ' HG ' ' N ' ' A' ' 127' ' ' CYS . 51.5 p -55.61 -29.67 59.57 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.434 ' N ' ' HG ' ' A' ' 126' ' ' SER . 47.1 t -85.04 -35.65 21.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.135 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.565 ' N ' ' O ' ' A' ' 124' ' ' GLU . 1.7 tp -72.1 -50.41 28.36 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.11 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.34 -57.0 8.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.781 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.5 mm -55.77 -45.28 79.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.679 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -57.17 -33.34 67.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.443 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.3 tp -67.17 -37.6 84.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.544 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -84.15 -42.44 17.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.636 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -61.01 -41.64 96.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.838 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 136' ' ' GLN . 8.2 pt-20 -76.1 -33.71 59.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.818 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.422 ' N ' ' HG2' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -49.09 -42.75 39.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.634 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 58.1 p -103.88 40.79 1.38 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.816 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.1 pttp -49.84 159.15 0.42 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.468 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.668 -179.969 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 mtt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER -118.37 177.85 4.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.595 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -173.96 41.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.659 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -131.93 163.73 48.01 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.563 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -44.16 154.71 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.725 2.283 . . . . 0.0 112.07 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.42 160.4 49.31 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.805 2.336 . . . . 0.0 111.997 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 8' ' ' ASP . 4.8 p-10 -106.02 40.11 1.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.651 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.472 ' O ' ' C ' ' A' ' 9' ' ' THR . 0.6 OUTLIER 79.89 -76.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.891 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.491 ' CG2' ' O ' ' A' ' 9' ' ' THR . 98.8 m 33.39 44.81 0.07 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.514 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.66 65.22 0.06 OUTLIER Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -46.98 142.1 11.38 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.893 2.395 . . . . 0.0 112.363 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 p -101.08 -1.29 9.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.528 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -72.66 170.72 13.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.6 m -126.39 148.93 65.9 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.394 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -72.13 179.86 4.56 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.74 2.293 . . . . 0.0 112.16 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 27.0 tp -132.44 -43.47 0.93 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.729 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.52 84.71 0.06 OUTLIER Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -133.34 148.83 51.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.343 . . . . 0.0 110.717 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.4 mm -116.75 149.34 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.474 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.1 t -119.32 135.0 61.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.65 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.58 137.23 52.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.31 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.622 HD21 ' N ' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -67.88 135.13 52.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.784 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.622 ' N ' HD21 ' A' ' 22' ' ' ASN . 4.8 tp10 -54.68 -38.21 66.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.587 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.5 ttmm -80.15 -65.89 0.95 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.514 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.614 ' NE1' ' OD2' ' A' ' 49' ' ' ASP . 19.3 t-105 -42.54 -48.41 5.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.507 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.671 ' O ' ' N ' ' A' ' 28' ' ' SER . 5.4 ttm180 26.33 85.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.481 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 28' ' ' SER . . . -43.39 -8.9 0.01 OUTLIER Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.671 ' N ' ' O ' ' A' ' 26' ' ' ARG . 0.4 OUTLIER 74.31 -143.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.849 0.357 . . . . 0.0 110.39 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 28' ' ' SER . 3.5 mt-30 -39.92 -20.08 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.326 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -71.57 -52.09 19.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.384 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.81 -29.75 68.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.647 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -65.35 -54.34 30.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.543 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.651 ' O ' ' N ' ' A' ' 36' ' ' GLY . 3.8 mm-40 -59.37 -41.14 88.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.38 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.478 ' C ' ' H ' ' A' ' 36' ' ' GLY . 4.7 mtt -36.85 -33.98 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.459 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 33' ' ' GLU . 42.5 mt-30 -75.28 17.22 0.27 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.434 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -106.62 -4.82 36.92 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm -138.58 -41.33 0.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.685 0.279 . . . . 0.0 110.903 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.489 HG13 ' H ' ' A' ' 39' ' ' LYS . 4.8 tp -132.78 172.43 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.536 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.489 ' H ' HG13 ' A' ' 38' ' ' ILE . 43.0 tttp -85.54 125.9 33.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.613 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.428 ' HG ' ' N ' ' A' ' 41' ' ' ILE . 18.5 tp -114.98 149.73 36.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.666 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.428 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 3.7 mt -132.14 151.16 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.676 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.429 ' CE2' ' NH2' ' A' ' 26' ' ' ARG . 81.7 m-85 -115.99 131.09 57.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.446 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -137.01 128.37 28.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.608 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -92.13 122.28 34.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.362 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 139.97 -30.96 2.32 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.526 ' O ' ' OD1' ' A' ' 22' ' ' ASN . 1.4 mt -68.61 161.82 27.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.748 0.309 . . . . 0.0 110.477 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.668 ' H ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -111.38 -40.54 0.1 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.914 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.668 ' CD ' ' H ' ' A' ' 47' ' ' THR . 24.7 Cg_exo -59.27 -173.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.59 2.193 . . . . 0.0 112.023 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.614 ' OD2' ' NE1' ' A' ' 25' ' ' TRP . 8.1 m-20 -97.47 -49.89 4.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.368 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -134.33 145.08 48.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.308 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.05 118.74 35.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.873 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 tp -100.75 -30.37 11.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.258 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.659 ' C ' ' H ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -173.35 147.69 1.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.45 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.531 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -56.02 2.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.513 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.659 ' H ' ' C ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -124.2 1.27 8.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.529 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 86' ' ' LYS . 7.6 t -156.44 139.26 15.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.962 0.41 . . . . 0.0 110.829 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -142.52 175.03 10.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.007 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.7 mt -137.68 133.15 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.847 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 tp -117.44 134.99 54.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.161 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.428 ' N ' ' OD2' ' A' ' 49' ' ' ASP . 41.6 t80 -107.99 126.66 52.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.881 0.372 . . . . 0.0 110.977 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.7 t -113.24 148.6 16.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.958 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.431 ' HG1' ' N ' ' A' ' 63' ' ' GLU . 9.7 t -115.65 150.79 36.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.586 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.566 ' CB ' ' OG1' ' A' ' 94' ' ' THR . 1.8 pp20? -47.68 -35.15 9.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.485 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.447 ' N ' ' HG3' ' A' ' 63' ' ' GLU . . . -57.88 -21.12 41.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.287 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -83.89 -37.73 22.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.776 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.445 ' CD2' ' O ' ' A' ' 96' ' ' MET . 0.9 OUTLIER -57.26 -47.09 82.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.568 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.0 p -49.75 -16.19 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.619 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.404 ' N ' ' C ' ' A' ' 66' ' ' LEU . . . -81.81 -76.0 0.27 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.624 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.622 ' O ' ' NH2' ' A' ' 73' ' ' ARG . . . 68.7 9.49 59.07 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.87 75.44 0.27 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.831 0.348 . . . . 0.0 110.602 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.13 -61.46 0.2 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -73.32 -27.41 61.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.719 0.295 . . . . 0.0 110.653 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.622 ' NH2' ' O ' ' A' ' 69' ' ' GLY . 4.9 ttp180 -48.27 -29.41 3.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.57 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.455 ' O ' ' CD ' ' A' ' 74' ' ' LYS . 1.2 tmtt? -66.58 -30.11 70.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.525 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -65.49 -35.67 81.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.59 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.2 mt -67.61 -50.07 59.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.661 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.6 t -54.46 -38.77 42.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.584 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.72 -41.0 75.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.607 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.2 t -64.91 -35.66 75.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.636 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.73 -28.5 26.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.661 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -80.98 -13.25 59.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.625 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -25.59 34.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.438 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.481 ' CG ' ' N ' ' A' ' 84' ' ' ASN . 51.4 t-20 -174.99 -112.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.635 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.481 ' N ' ' CG ' ' A' ' 83' ' ' ASN . 0.1 OUTLIER -170.82 74.42 0.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.416 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.461 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -133.03 161.37 34.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.714 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.537 ' O ' ' SG ' ' A' ' 56' ' ' CYS . 1.9 pttt -81.83 118.38 22.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.456 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.74 137.82 9.9 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.0 mt -93.09 141.17 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.764 0.316 . . . . 0.0 110.451 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.3 t -115.96 108.71 25.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.648 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -90.76 144.34 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.397 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.2 t -130.52 140.0 49.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.685 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -90.8 126.42 36.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.546 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -90.74 140.5 29.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.639 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.566 ' OG1' ' CB ' ' A' ' 63' ' ' GLU . 18.5 p -144.56 -73.1 0.26 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.473 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.434 ' C ' ' H ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -149.8 -72.65 0.18 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.456 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.445 ' O ' ' CD2' ' A' ' 66' ' ' LEU . 48.6 mtt -60.02 -5.82 1.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.457 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.604 ' O ' ' N ' ' A' ' 99' ' ' GLN . 0.2 OUTLIER -73.18 -84.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.522 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.541 ' H ' ' CD ' ' A' ' 98' ' ' GLU . 1.8 mp0 -36.27 -24.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.687 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.604 ' N ' ' O ' ' A' ' 97' ' ' SER . 1.6 mm100 -69.03 -55.88 9.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.01 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -117.55 10.89 13.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.725 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.582 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -60.8 -61.1 8.66 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.319 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 101' ' ' PHE . 9.5 Cg_endo -54.11 -42.28 68.43 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.678 2.252 . . . . 0.0 111.921 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.04 -41.54 35.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.332 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 tp -77.08 -41.2 43.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.399 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -51.23 -35.12 35.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.342 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.91 -51.0 64.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.275 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -62.88 -55.09 29.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.452 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.52 -40.67 27.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.429 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.686 ' O ' ' N ' ' A' ' 113' ' ' GLY . 6.7 t -67.57 -56.65 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.273 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.88 -28.32 68.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.558 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.48 -52.09 6.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.387 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.7 mp -105.91 -28.72 10.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.36 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 56.56 34.06 63.46 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -88.69 -155.8 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.75 0.31 . . . . 0.0 110.285 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.2 t -116.83 130.16 72.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.886 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 116' ' ' LEU . 7.0 mp -117.6 125.98 51.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.444 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.2 mp -126.2 85.28 60.11 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.546 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -58.94 156.94 30.97 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.81 2.34 . . . . 0.0 111.925 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.56 ' CG2' ' H ' ' A' ' 120' ' ' ALA . 5.9 m -126.16 -107.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.492 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.56 ' H ' ' CG2' ' A' ' 119' ' ' VAL . . . 172.92 -28.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.126 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.78 165.46 31.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.356 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -64.85 -41.24 95.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.6 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -62.48 -42.42 99.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.648 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.571 ' O ' ' N ' ' A' ' 128' ' ' LEU . 18.3 mm-40 -45.81 -53.53 9.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.247 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 128' ' ' LEU . . . -60.01 -57.99 10.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.702 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.488 ' OG ' ' CD1' ' A' ' 30' ' ' LEU . 14.6 m -46.23 -33.0 3.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 1.8 t -85.13 -35.6 21.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.947 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.571 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -71.28 -50.46 32.49 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.081 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.0 t -56.75 -56.4 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.171 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 mm -51.29 -51.7 22.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.329 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -50.4 -41.66 52.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.299 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.9 tp -46.41 -54.4 9.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.525 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.3 t -67.63 -46.07 83.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.283 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -51.0 -39.27 55.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.183 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.494 ' O ' ' C ' ' A' ' 139' ' ' GLU . 4.0 mm-40 -68.03 -30.62 69.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.292 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -82.3 -43.17 17.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.213 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.44 -35.11 65.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.375 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -133.99 76.14 1.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.432 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.494 ' C ' ' O ' ' A' ' 135' ' ' GLU . 1.4 mt-10 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.489 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 mmt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -176.18 117.34 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.551 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -99.67 -87.32 0.36 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.502 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.526 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 7.1 p30 -149.34 49.91 0.74 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.687 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 4' ' ' ASN . 37.5 Cg_endo -70.1 111.05 2.78 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.743 2.295 . . . . 0.0 111.953 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -47.14 109.49 0.22 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.582 2.188 . . . . 0.0 112.233 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -129.89 40.6 3.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.454 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 66.09 90.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.656 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -100.95 1.98 40.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.251 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.58 -72.24 0.09 OUTLIER Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.99 121.46 8.32 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.712 2.275 . . . . 0.0 111.813 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.1 t -84.12 -56.43 5.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.842 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.656 ' HD1' ' H ' ' A' ' 13' ' ' HIS . 3.2 p-80 -127.52 33.86 4.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.877 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.467 ' C ' ' O ' ' A' ' 13' ' ' HIS . 0.0 OUTLIER 35.19 79.52 0.29 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.958 0.409 . . . . 0.0 110.58 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.596 ' C ' ' H ' ' A' ' 17' ' ' GLY . 61.5 Cg_endo -78.03 -7.12 16.23 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.789 2.326 . . . . 0.0 112.187 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mt -69.97 31.3 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.482 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.596 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . -127.9 -61.19 0.13 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -73.67 162.24 29.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.914 0.388 . . . . 0.0 110.616 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.432 HG22 HD12 ' A' ' 19' ' ' ILE . 72.5 mt -119.84 155.73 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.592 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.415 ' N ' ' CG2' ' A' ' 19' ' ' ILE . 58.3 t -108.84 148.61 12.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.458 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -136.0 141.2 44.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.666 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.604 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 66.4 t30 -73.99 132.94 42.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.702 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -48.89 -25.07 1.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.566 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -85.24 -33.12 22.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.533 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -79.49 -4.74 52.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.478 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.514 ' C ' ' H ' ' A' ' 28' ' ' SER . 24.2 ttp180 -70.69 -17.15 62.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.383 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.58 29.22 1.04 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 26' ' ' ARG . 6.1 m -127.66 138.06 52.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.343 . . . . 0.0 110.575 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -62.53 -24.48 67.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.53 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.543 ' C ' ' CD1' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -61.06 -53.31 58.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.378 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.03 -32.66 6.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.824 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.94 -27.89 49.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.692 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -63.9 -53.01 57.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.502 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.2 mtm -59.76 -16.49 28.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.486 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.31 -8.35 55.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.509 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.14 0.79 58.9 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -139.88 -33.68 0.58 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.817 0.342 . . . . 0.0 110.514 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 39' ' ' LYS . 1.7 mm -127.74 158.17 39.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.444 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.498 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 4.4 ttpm? -90.16 102.34 15.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.236 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mt -88.44 130.09 35.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.02 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 mm -108.25 113.71 44.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.086 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -75.72 125.16 28.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.022 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -127.16 115.75 19.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.314 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -79.38 125.9 30.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.447 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.82 -26.71 4.77 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.604 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 3.5 mm? -64.62 140.63 58.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.765 0.317 . . . . 0.0 110.59 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.675 ' HG1' ' N ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -92.36 -39.87 0.36 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.625 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.675 ' N ' ' HG1' ' A' ' 47' ' ' THR . 16.4 Cg_exo -64.73 -160.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.808 2.339 . . . . 0.0 111.92 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -111.46 -55.34 2.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.467 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -132.37 132.28 42.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.525 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.527 ' CD1' ' O ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -109.26 109.05 19.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.702 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.68 -41.2 72.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.44 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.482 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 79.3 p -165.66 -174.09 2.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.426 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.481 ' H ' ' ND2' ' A' ' 54' ' ' ASN . 0.3 OUTLIER -79.46 19.53 0.61 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.494 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.411 ' HG2' HH11 ' A' ' 55' ' ' ARG . 0.6 OUTLIER -142.22 3.34 1.55 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.159 -179.695 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.527 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 15.3 m -152.22 152.05 31.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.987 0.422 . . . . 0.0 111.091 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.485 ' SG ' ' CE1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -150.82 158.74 44.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.148 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.9 mt -130.4 132.81 64.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.902 0.382 . . . . 0.0 110.873 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.05 138.1 53.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.068 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -100.56 134.42 43.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.921 0.391 . . . . 0.0 110.931 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 t -131.33 138.66 52.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.336 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 65' ' ' ASP . 4.7 t -116.05 147.38 41.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.395 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -38.84 -37.24 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.49 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -50.25 -37.05 33.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.461 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 62' ' ' THR . 18.6 m-20 -71.74 -40.35 69.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.698 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 67' ' ' VAL . 1.3 tt -55.42 -43.42 75.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.492 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.438 ' N ' HD23 ' A' ' 66' ' ' LEU . 11.4 t -49.81 -38.21 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.515 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.39 -67.19 0.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.418 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.2 12.33 81.73 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -156.84 138.09 13.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 110.745 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.24 -38.93 3.04 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -82.52 -22.95 34.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.685 0.279 . . . . 0.0 110.805 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.3 ttp85 -68.81 -40.62 79.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.684 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.98 -24.4 2.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.683 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -70.04 -44.65 68.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.597 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.2 mt -58.19 -46.52 85.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.614 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.7 t -45.27 -42.37 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.697 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.4 mmm-85 -45.03 -51.75 9.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.666 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 t -62.44 -26.55 40.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.797 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -82.74 -37.51 24.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.72 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 81' ' ' ASN . 3.1 t-20 -82.31 -8.9 59.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.882 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.85 -78.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.558 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -153.22 -71.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.472 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -178.67 57.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.296 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.49 143.25 37.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.731 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.85 92.4 9.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.529 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -93.05 162.2 26.0 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.0 mt -116.7 148.48 19.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.809 0.338 . . . . 0.0 110.494 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.84 118.54 55.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.719 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.71 135.69 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.476 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.58 148.92 22.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.691 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -98.79 133.35 43.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.235 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -86.09 140.34 30.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.877 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.2 m -145.91 -79.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.256 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 64.6 mtt-85 -141.07 -70.45 0.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.358 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 20.7 mmt -63.09 -11.45 19.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.42 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.637 ' O ' ' N ' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -54.78 -95.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.669 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.626 ' N ' ' OG ' ' A' ' 97' ' ' SER . 3.0 pt-20 -36.27 -29.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.996 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.512 ' N ' ' O ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -65.9 -55.24 17.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.906 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -117.62 12.74 14.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.968 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.637 ' N ' ' O ' ' A' ' 97' ' ' SER . 21.2 t80 -68.24 -37.37 10.78 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.244 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 50.4 Cg_endo -78.3 -30.93 3.05 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.04 1.827 . . . . 0.0 111.959 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.84 95.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.962 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.6 tt -73.48 -45.84 51.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.044 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -54.65 -34.61 62.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.013 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -63.11 -36.75 84.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.162 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' A' ' 111' ' ' ASP . 1.7 m-85 -79.54 -53.33 6.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.194 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.7 m -51.99 -36.34 49.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.33 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.602 ' O ' ' N ' ' A' ' 113' ' ' GLY . 8.9 t -65.82 -59.9 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.494 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.498 ' CD2' ' O ' ' A' ' 110' ' ' LEU . 2.2 tt -67.04 -22.6 65.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.496 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 107' ' ' PHE . 1.3 m-20 -84.53 -55.41 4.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.81 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.9 mp -106.14 -28.42 10.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.987 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 49.69 50.05 32.36 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 2.3 mtm -105.84 -165.79 1.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.784 0.326 . . . . 0.0 110.368 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.8 t -90.44 110.5 22.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.538 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.457 HD23 ' N ' ' A' ' 117' ' ' LEU . 3.8 tt -111.15 126.17 54.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.522 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.457 ' N ' HD23 ' A' ' 116' ' ' LEU . 5.3 tp -146.15 107.6 4.22 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.682 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.417 ' HG3' ' CZ ' ' A' ' 101' ' ' PHE . 71.9 Cg_endo -78.78 169.58 19.37 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.388 2.058 . . . . 0.0 112.185 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.521 ' CG2' ' H ' ' A' ' 120' ' ' ALA . 19.4 m -131.91 -118.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.576 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.521 ' H ' ' CG2' ' A' ' 119' ' ' VAL . . . -167.27 -40.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.538 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.3 m -136.08 155.71 49.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.398 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -59.91 -20.75 59.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.547 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.683 ' SD ' ' N ' ' A' ' 123' ' ' MET . 0.8 OUTLIER -78.06 -33.05 51.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.585 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.634 ' O ' ' N ' ' A' ' 128' ' ' LEU . 1.6 mm-40 -54.26 -55.36 28.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.758 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -51.51 -58.22 6.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.249 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.439 ' OG ' ' CD1' ' A' ' 30' ' ' LEU . 3.9 t -48.89 -33.39 10.62 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.16 -30.13 24.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.874 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.634 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.5 OUTLIER -74.42 -49.72 21.34 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.074 179.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.99 -55.14 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.279 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 44.2 mt -51.03 -54.04 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.408 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -42.31 -35.15 0.92 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.596 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.96 -60.25 3.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.598 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.7 t -63.85 -38.63 82.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.351 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -60.03 -31.86 70.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.401 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -61.74 -50.18 73.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.429 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.538 ' C ' ' H ' ' A' ' 138' ' ' LYS . 3.9 tp-100 -50.5 -53.08 32.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.389 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.537 ' O ' ' O ' ' A' ' 138' ' ' LYS . 14.5 p -71.7 15.03 0.15 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.495 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.538 ' H ' ' C ' ' A' ' 136' ' ' GLN . 19.8 mmtm 46.67 107.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.583 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.527 -179.996 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mmm . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -115.6 168.76 9.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.509 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -145.87 -109.88 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.674 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -123.51 66.4 35.09 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.748 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.98 163.85 35.89 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.777 2.318 . . . . 0.0 112.117 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.23 170.79 17.4 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.807 2.338 . . . . 0.0 112.028 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.49 ' O ' ' CB ' ' A' ' 8' ' ' ASP . 9.5 t0 -118.47 43.13 2.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.727 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.68 ' O ' ' N ' ' A' ' 10' ' ' GLY . 6.6 t0 80.38 -23.36 0.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.6 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.528 ' C ' ' O ' ' A' ' 8' ' ' ASP . 3.3 t 25.91 36.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.802 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.68 ' N ' ' O ' ' A' ' 8' ' ' ASP . . . -62.68 -58.1 13.58 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 12' ' ' VAL . 60.9 Cg_exo -46.28 74.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.884 2.389 . . . . 0.0 112.091 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.65 ' N ' ' O ' ' A' ' 10' ' ' GLY . 1.3 p -37.61 121.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.723 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.551 ' O ' ' C ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -117.43 78.5 1.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.414 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.551 ' C ' ' O ' ' A' ' 13' ' ' HIS . 22.6 m -24.83 94.98 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.939 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.452 ' N ' ' O ' ' A' ' 13' ' ' HIS . 66.3 Cg_endo -80.33 150.5 19.84 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.71 2.273 . . . . 0.0 112.083 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.44 -83.06 0.65 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.566 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.11 103.61 1.11 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.486 ' C ' ' ND1' ' A' ' 18' ' ' HIS . 4.1 p80 -112.55 155.06 24.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.659 0.266 . . . . 0.0 110.429 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 24.9 mm -107.24 159.41 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.737 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.96 141.22 46.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.609 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -126.12 143.87 50.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.586 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 25' ' ' TRP . 30.1 t30 -64.33 131.46 47.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.524 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -41.42 -32.89 0.36 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.515 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -78.15 -30.44 49.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.517 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.582 ' N ' ' O ' ' A' ' 22' ' ' ASN . 18.8 t-105 -77.91 -10.78 59.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.586 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.546 ' C ' ' H ' ' A' ' 28' ' ' SER . 10.8 ttt-85 -60.08 -37.0 78.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.732 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.06 40.81 0.26 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.546 ' H ' ' C ' ' A' ' 26' ' ' ARG . 69.8 m -128.47 136.54 50.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.753 0.311 . . . . 0.0 110.662 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -67.9 -21.25 65.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.222 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.586 ' C ' ' CD1' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -71.72 -52.48 17.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.288 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -49.02 -27.64 3.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.482 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -79.07 -34.7 43.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.738 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -58.34 -43.94 88.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.764 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.473 ' C ' ' H ' ' A' ' 36' ' ' GLY . 28.2 mtt -54.33 -32.64 57.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.804 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -71.0 8.96 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.593 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 34' ' ' MET . . . -95.34 -11.37 56.0 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -142.59 -49.19 0.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.812 0.339 . . . . 0.0 110.671 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.465 HG13 ' N ' ' A' ' 39' ' ' LYS . 10.4 tp -106.03 165.95 3.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.326 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.465 ' N ' HG13 ' A' ' 38' ' ' ILE . 22.7 tttp -85.68 143.99 28.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.285 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.444 ' HG ' ' N ' ' A' ' 41' ' ' ILE . 19.8 tp -127.82 156.25 42.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.444 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 50.1 mt -145.77 142.56 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.359 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.04 127.63 51.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.688 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -127.36 124.23 38.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.443 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.39 94.54 9.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.778 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 166.59 -32.26 0.21 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.474 ' O ' ' OD1' ' A' ' 22' ' ' ASN . 11.1 mp -66.92 159.62 27.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 110.491 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.548 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -103.79 -48.21 0.15 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.758 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 47' ' ' THR . 37.8 Cg_exo -56.36 -171.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.762 2.308 . . . . 0.0 112.039 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -97.92 -55.44 2.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.737 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -125.79 128.65 48.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.909 0.385 . . . . 0.0 110.649 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.687 ' CE2' ' O ' ' A' ' 53' ' ' SER . 4.0 t80 -107.87 105.43 15.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.594 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 mp -74.32 -30.53 62.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.438 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.687 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 2.0 p 177.41 -173.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.399 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -86.54 65.0 8.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.587 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -178.75 -30.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.824 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.2 m -140.29 132.4 27.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.918 0.389 . . . . 0.0 111.136 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 30.9 p -134.91 173.76 11.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.984 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.2 mt -139.99 131.74 32.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.289 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.0 tp -112.53 117.37 32.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.85 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.409 ' OH ' ' OE2' ' A' ' 92' ' ' GLU . 12.2 t80 -83.94 117.49 23.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.97 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.8 t -116.25 140.86 36.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.207 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.4 p -126.25 156.73 39.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.965 0.412 . . . . 0.0 110.92 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 96' ' ' MET . 2.9 tt0 -40.42 -43.43 1.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.731 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -43.48 -30.16 0.53 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.381 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -82.69 -47.72 11.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.308 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 tt -50.82 -38.3 47.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.357 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.2 t -45.95 -53.09 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.436 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -44.28 -76.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.481 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.29 -24.4 29.1 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -151.56 133.43 14.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 0.0 110.704 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.13 -54.94 0.73 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -62.68 -35.36 79.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.681 0.277 . . . . 0.0 110.6 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.475 ' HB3' HH11 ' A' ' 73' ' ' ARG . 0.2 OUTLIER -49.51 -40.78 38.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.877 0.37 . . . . 0.0 110.165 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.419 ' N ' ' HD2' ' A' ' 73' ' ' ARG . 1.8 ttpp -54.6 -35.87 63.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.043 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.2 ttt85 -69.22 -42.31 75.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.151 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 34.8 mt -61.71 -21.5 64.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.271 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.2 t -81.35 -39.28 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.486 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -61.04 -20.99 63.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.647 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.4 t -70.36 -50.06 49.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.012 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 49.2 ttt-85 -71.24 -43.58 66.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.907 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -52.66 -27.48 17.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.68 ' OG ' ' N ' ' A' ' 83' ' ' ASN . 0.3 OUTLIER -46.6 -74.42 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.82 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.68 ' N ' ' OG ' ' A' ' 82' ' ' SER . 1.8 m-80 -140.18 -98.22 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.834 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -165.56 37.59 0.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.781 0.324 . . . . 0.0 110.718 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.92 157.52 17.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.605 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -88.94 100.05 12.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.493 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -95.71 141.26 15.48 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 60.7 mt -103.02 135.65 39.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.816 0.341 . . . . 0.0 110.435 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.4 t -108.93 103.75 16.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.656 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.1 t -93.94 142.07 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.351 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.8 t -122.64 149.59 26.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.674 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.409 ' OE2' ' OH ' ' A' ' 60' ' ' TYR . 8.3 tt0 -107.67 107.12 17.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.633 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -68.17 132.82 47.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.211 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.622 ' H ' ' HG ' ' A' ' 97' ' ' SER . 7.2 m -137.42 -79.51 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.785 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.3 mtp85 -141.17 -70.25 0.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.581 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.553 ' N ' ' OE1' ' A' ' 63' ' ' GLU . 16.2 mtt -63.77 -10.78 21.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.496 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.643 ' O ' ' N ' ' A' ' 99' ' ' GLN . 82.8 p -62.02 -88.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.769 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.444 ' N ' ' OG ' ' A' ' 97' ' ' SER . 0.2 OUTLIER -36.09 -22.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.006 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.643 ' N ' ' O ' ' A' ' 97' ' ' SER . 7.0 mt-30 -73.62 -54.77 7.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.913 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.52 12.67 14.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.617 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.699 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 3.1 t80 -63.03 -34.94 15.16 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.647 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.699 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 14.7 Cg_exo -66.66 -49.99 1.43 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.604 2.203 . . . . 0.0 111.821 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -47.19 -49.2 23.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.423 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.569 ' O ' ' OG1' ' A' ' 108' ' ' THR . 2.7 tp -65.37 -51.2 62.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.423 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.439 ' O ' ' CG2' ' A' ' 109' ' ' VAL . 2.7 tt0 -49.93 -33.51 17.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.632 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.29 -52.98 15.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.571 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.92 -52.18 66.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.671 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.569 ' OG1' ' O ' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -58.82 -30.04 67.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.596 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.5 ' O ' ' CA ' ' A' ' 113' ' ' GLY . 2.3 t -70.98 -41.38 76.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.627 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 16.5 tp -81.36 -33.78 32.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.643 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.73 -47.19 10.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.471 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 113' ' ' GLY . 2.3 mm? -102.16 -28.33 12.37 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.184 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.5 ' CA ' ' O ' ' A' ' 109' ' ' VAL . . . 34.66 38.23 0.12 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -89.33 -156.12 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.734 0.302 . . . . 0.0 110.339 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.5 t -101.35 116.22 44.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.717 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.453 ' N ' HD13 ' A' ' 116' ' ' LEU . 7.4 mp -104.71 138.15 41.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.522 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.0 mp -147.32 85.63 6.74 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.732 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -61.72 165.59 13.52 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.751 2.301 . . . . 0.0 111.764 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.426 ' CG2' ' H ' ' A' ' 120' ' ' ALA . 6.8 m -132.74 -115.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.515 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.426 ' H ' ' CG2' ' A' ' 119' ' ' VAL . . . -178.71 -43.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.324 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.547 ' OG ' ' OE1' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -133.16 172.44 12.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.434 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -73.88 -16.63 61.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.645 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.481 ' O ' ' N ' ' A' ' 127' ' ' CYS . 54.8 mtp -85.57 -42.0 14.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.695 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.672 ' O ' ' N ' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -46.75 -53.92 10.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.527 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.16 -57.85 11.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.232 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 11.1 m -53.95 -33.3 56.48 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.481 ' N ' ' O ' ' A' ' 123' ' ' MET . 6.8 t -85.36 -29.37 24.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.666 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.672 ' N ' ' O ' ' A' ' 124' ' ' GLU . 1.6 tp -80.51 -36.53 33.1 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.608 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 64.4 t -63.92 -40.73 90.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.785 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.9 mt -63.32 -51.56 69.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.349 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.427 HE21 ' HB2' ' A' ' 131' ' ' GLN . 1.3 tp-100 -42.87 -42.24 3.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.316 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.7 mt -61.39 -57.36 12.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.528 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.6 t -49.07 -55.91 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.627 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -42.96 -30.62 0.43 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.533 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.69 -52.22 33.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.398 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -59.68 -31.84 69.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.434 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 86.2 m -86.08 -16.88 36.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.527 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.48 106.75 1.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.63 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.545 179.966 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 mtp . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -74.28 105.44 5.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.499 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.441 ' HZ1' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -89.28 -172.81 3.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.523 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -95.89 146.46 31.36 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.496 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -41.32 132.79 3.32 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.646 2.231 . . . . 0.0 112.11 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.83 87.85 1.36 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.478 2.119 . . . . 0.0 112.063 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.581 ' O ' ' O ' ' A' ' 8' ' ' ASP . 9.5 t0 -138.98 68.78 1.37 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.672 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.581 ' O ' ' O ' ' A' ' 7' ' ' ASP . 1.4 m-20 29.71 99.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.681 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 t -118.43 18.55 13.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.605 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.33 67.03 1.52 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -65.02 104.82 0.61 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.6 2.2 . . . . 0.0 112.01 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.5 p -84.19 138.04 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.682 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -159.05 52.81 0.4 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.484 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.2 m -100.17 148.45 34.9 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.534 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -40.05 159.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.835 2.357 . . . . 0.0 112.223 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.65 -84.37 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.302 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -167.79 44.25 0.24 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -148.81 154.65 39.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 110.639 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.454 HG22 HD11 ' A' ' 19' ' ' ILE . 33.0 mm -126.52 157.09 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.262 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 21' ' ' ALA . 63.3 t -113.11 148.36 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.015 0.436 . . . . 0.0 110.898 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 41' ' ' ILE . . . -137.84 159.33 42.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.203 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.564 ' O ' ' N ' ' A' ' 25' ' ' TRP . 57.6 t30 -92.15 139.49 30.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.839 0.352 . . . . 0.0 110.721 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -39.29 -47.49 1.7 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.585 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -63.28 -31.76 73.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.594 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.661 ' NE1' ' OD2' ' A' ' 49' ' ' ASP . 1.6 t-105 -76.79 -1.82 30.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.67 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.438 ' C ' ' HE ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -76.21 -26.93 56.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.538 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.82 33.11 3.1 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.4 m -122.7 142.38 50.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.8 0.333 . . . . 0.0 110.597 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -66.13 -23.11 66.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.33 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.526 ' C ' ' CD1' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -67.85 -55.33 13.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.539 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.404 ' N ' ' HG ' ' A' ' 30' ' ' LEU . . . -48.25 -22.59 0.69 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.023 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -81.41 -45.97 15.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.905 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -50.73 -33.37 22.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.834 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.535 ' O ' ' O ' ' A' ' 38' ' ' ILE . 11.9 mtt -66.18 -33.58 76.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.752 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -70.12 -17.36 63.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.658 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.97 4.31 86.07 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm -147.82 -56.7 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.899 0.38 . . . . 0.0 110.485 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.535 ' O ' ' O ' ' A' ' 34' ' ' MET . 7.8 tp -112.18 165.13 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.426 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.466 ' H ' HG13 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -88.03 110.54 20.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.573 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.422 HD13 ' SD ' ' A' ' 34' ' ' MET . 17.7 tp -96.96 137.0 36.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.757 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.429 ' O ' ' N ' ' A' ' 21' ' ' ALA . 20.6 mt -113.49 139.33 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.412 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -105.93 142.8 35.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.85 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -153.99 116.96 4.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.456 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -77.87 134.29 37.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.569 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 122.98 -32.2 4.48 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 75.2 mt -59.84 144.53 48.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.735 0.302 . . . . 0.0 110.668 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.535 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -88.42 -64.52 0.2 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.727 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.535 ' CD ' ' CB ' ' A' ' 47' ' ' THR . 9.6 Cg_endo -54.15 -174.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.779 2.32 . . . . 0.0 112.18 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.661 ' OD2' ' NE1' ' A' ' 25' ' ' TRP . 35.1 t0 -93.26 -66.17 0.94 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.431 ' CE2' ' CG ' ' A' ' 49' ' ' ASP . 68.6 m-85 -118.28 162.19 18.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.609 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.95 142.52 50.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.081 0.467 . . . . 0.0 110.977 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.412 ' C ' ' OG ' ' A' ' 53' ' ' SER . 0.8 OUTLIER -119.88 -24.85 6.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.776 179.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.412 ' OG ' ' C ' ' A' ' 52' ' ' LEU . 0.7 OUTLIER -169.77 179.27 3.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.059 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -77.69 4.64 11.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.818 0.342 . . . . 0.0 110.52 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -133.65 -4.39 2.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.879 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.7 m -129.66 134.66 47.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.95 0.405 . . . . 0.0 110.947 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.3 p -146.45 171.06 15.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.118 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 mt -138.82 138.48 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.995 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.44 HD23 ' N ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -124.11 136.49 54.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.135 179.659 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.537 ' HH ' ' CD ' ' A' ' 92' ' ' GLU . 29.5 t80 -96.98 115.3 27.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.846 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.7 t -121.75 149.05 24.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.193 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 65' ' ' ASP . 4.6 t -135.87 163.78 29.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 0.0 110.908 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.462 ' C ' ' CD ' ' A' ' 63' ' ' GLU . 4.8 tp10 -41.21 -48.68 3.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.589 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -47.61 -29.8 3.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.522 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 62' ' ' THR . 1.1 m-20 -77.43 -45.47 25.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.529 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 tt -48.94 -40.48 30.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.651 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.9 t -64.91 -42.57 95.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.672 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.557 ' C ' ' H ' ' A' ' 70' ' ' ASN . . . -91.16 26.3 2.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.597 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.95 -3.81 0.35 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.557 ' H ' ' C ' ' A' ' 68' ' ' ALA . 50.0 t30 -89.93 37.77 0.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.815 0.341 . . . . 0.0 110.504 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -175.54 -32.77 0.04 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -82.73 -38.27 23.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.842 0.353 . . . . 0.0 110.441 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.3 ttt-85 -48.34 -50.49 30.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.646 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -54.59 -43.76 72.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.569 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -49.95 -50.87 45.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.557 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.2 mt -53.52 -41.59 66.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.799 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 62.5 t -57.06 -33.36 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.762 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -49.22 77.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.622 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.8 t -47.42 -41.56 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.505 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.1 ttt-85 -82.02 -21.12 37.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.476 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -65.0 -25.0 67.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.588 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 t -58.04 -68.38 0.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.507 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -160.29 -69.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.577 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -178.5 66.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.541 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.6 mp -91.43 127.92 37.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.53 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.1 87.96 4.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.429 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -104.72 175.7 22.58 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.6 mt -106.27 137.62 35.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 0.0 110.454 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.6 t -109.48 116.92 53.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.779 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.5 t -104.38 134.89 44.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.427 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.6 t -124.6 134.61 66.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.636 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.537 ' CD ' ' HH ' ' A' ' 60' ' ' TYR . 5.0 tt0 -98.03 100.35 11.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.487 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.438 ' HB2' ' NZ ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -70.14 134.47 48.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.629 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.4 m -127.07 -64.97 0.97 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.637 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.404 ' C ' ' H ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -150.5 -73.1 0.17 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.395 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -64.14 -4.06 3.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.142 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.654 ' O ' ' N ' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -75.53 -87.6 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.361 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 97' ' ' SER . 1.7 mt-10 -35.84 -26.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.991 0.424 . . . . 0.0 110.365 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.69 ' OE1' ' CD2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -69.56 -56.08 8.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.972 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.69 ' CD2' ' OE1' ' A' ' 99' ' ' GLN . 2.7 m-85 -116.57 12.68 15.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.922 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.731 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 22.0 t80 -69.63 -32.69 3.22 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.075 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.731 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 16.0 Cg_exo -64.8 -50.24 2.47 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.526 2.151 . . . . 0.0 111.997 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.84 -36.84 49.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.66 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.466 ' O ' ' OG1' ' A' ' 108' ' ' THR . 1.3 tp -77.26 -34.59 55.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.394 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.524 ' O ' ' CG2' ' A' ' 109' ' ' VAL . 1.8 tt0 -68.07 -38.27 82.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.355 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -65.65 -28.19 68.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.34 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.69 -54.19 5.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.49 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -54.11 -32.05 53.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.703 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 113' ' ' GLY . 79.3 t -62.81 -62.75 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.743 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 85.8 mt -66.44 -20.01 65.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.776 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -83.99 -56.68 3.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.6 mp -105.93 -26.56 11.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.062 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 48.93 46.53 32.28 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 5.0 tpp -95.99 -156.92 0.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 0.0 110.448 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.68 106.39 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.56 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 mp -101.5 124.94 47.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.329 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.5 mt -137.9 87.27 16.92 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.711 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -55.27 165.67 2.89 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.601 2.201 . . . . 0.0 111.831 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.51 ' CG2' ' H ' ' A' ' 120' ' ' ALA . 15.3 m -133.11 -116.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.72 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.51 ' H ' ' CG2' ' A' ' 119' ' ' VAL . . . 172.68 -32.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.364 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.1 p -129.39 153.49 47.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.44 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -64.68 -22.58 67.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.682 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.612 ' SD ' ' N ' ' A' ' 123' ' ' MET . 0.0 OUTLIER -83.4 -40.46 19.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.816 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.636 ' O ' ' N ' ' A' ' 128' ' ' LEU . 3.5 mm-40 -45.71 -50.76 13.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.641 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.41 -58.01 10.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.865 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.419 ' OG ' ' CD1' ' A' ' 30' ' ' LEU . 6.3 m -49.86 -33.95 18.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -82.88 -31.68 27.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.667 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -72.92 -33.21 65.83 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.407 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 92.0 t -81.43 -51.41 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.557 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 54.6 mt -55.11 -44.6 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.702 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -52.23 -42.7 63.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.944 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 tp -52.18 -56.64 13.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.821 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 86.7 t -55.25 -55.85 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.009 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -47.07 -48.15 22.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.99 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -74.79 -21.91 59.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.018 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -78.75 -42.59 27.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.719 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.9 t -114.26 31.52 6.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.575 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.2 tptt -50.96 101.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.492 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.587 -179.893 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 mtt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -139.09 -36.76 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.447 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.485 ' C ' ' CG ' ' A' ' 4' ' ' ASN . 9.1 mtpp -81.95 95.62 7.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.53 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.485 ' CG ' ' C ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -164.77 145.78 6.39 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.467 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.81 150.62 73.96 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.575 2.183 . . . . 0.0 112.025 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -38.62 99.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.923 2.415 . . . . 0.0 112.278 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -111.72 70.36 0.71 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.489 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.596 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 0.0 OUTLIER 35.9 48.62 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.735 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 t -61.19 0.4 0.26 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.425 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.532 ' H ' ' C ' ' A' ' 8' ' ' ASP . . . -174.09 -86.11 0.06 OUTLIER Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -58.34 159.03 20.54 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.801 2.334 . . . . 0.0 111.939 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.589 ' O ' ' N ' ' A' ' 14' ' ' VAL . 41.1 t -109.61 112.42 40.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.734 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 58.66 -72.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.692 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -127.94 153.92 78.28 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.657 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.75 72.98 3.66 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.015 2.477 . . . . 0.0 112.094 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mt -81.42 -1.56 46.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.793 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 65.12 57.4 11.89 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.61 166.15 13.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.418 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.7 mt -128.18 144.33 38.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.717 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -103.44 141.2 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.461 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.17 138.07 54.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.611 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.414 HD21 ' N ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -74.2 122.92 23.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.548 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.414 ' N ' HD21 ' A' ' 22' ' ' ASN . 1.6 tp10 -47.18 -25.22 0.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.556 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -76.34 -36.11 58.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.412 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.565 ' O ' ' CG ' ' A' ' 25' ' ' TRP . 34.8 t-105 -91.43 -1.34 57.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.501 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.588 ' C ' ' H ' ' A' ' 28' ' ' SER . 24.0 ttt180 -70.46 -15.16 62.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.571 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.56 24.19 0.49 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.588 ' H ' ' C ' ' A' ' 26' ' ' ARG . 0.4 OUTLIER -123.8 144.03 49.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.826 0.346 . . . . 0.0 110.618 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.56 ' O ' ' OE2' ' A' ' 33' ' ' GLU . 40.9 mt-30 -75.13 -16.93 60.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.537 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.676 ' CD2' ' HG ' ' A' ' 126' ' ' SER . 1.9 tm? -53.26 -65.05 0.63 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.238 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.516 ' N ' ' CD1' ' A' ' 30' ' ' LEU . . . -49.69 -37.91 30.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.829 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.14 -30.85 60.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.896 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.647 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 0.4 OUTLIER -72.75 -45.94 56.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.746 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.502 ' C ' ' H ' ' A' ' 36' ' ' GLY . 3.8 mtm -44.84 -31.39 1.21 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.364 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -69.46 9.74 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.676 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 34' ' ' MET . . . -89.51 -31.39 11.58 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -131.24 -43.86 1.04 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.929 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' N ' ' A' ' 39' ' ' LYS . 10.1 tp -103.03 162.33 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.698 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.423 ' N ' HG13 ' A' ' 38' ' ' ILE . 8.1 tttt -86.34 150.02 24.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.435 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.2 tp -137.17 131.6 32.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 mt -115.21 123.73 71.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.272 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.453 ' CD1' ' HD2' ' A' ' 26' ' ' ARG . 75.0 m-85 -88.74 120.35 30.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.801 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -126.14 132.45 51.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.45 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -95.2 103.75 15.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.628 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 154.29 -19.33 0.63 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.492 ' CD2' ' N ' ' A' ' 46' ' ' LEU . 3.9 mm? -66.8 146.13 54.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 0.0 110.599 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.469 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -87.3 -58.54 0.28 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.804 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 47' ' ' THR . 37.7 Cg_endo -69.14 -158.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.616 2.211 . . . . 0.0 112.158 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.581 ' CG ' ' H ' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -90.76 -61.34 1.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.776 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -121.84 160.32 24.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.83 0.347 . . . . 0.0 110.871 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.06 101.48 3.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.535 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 mp -76.89 -38.7 53.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.465 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.448 ' HG ' ' N ' ' A' ' 54' ' ' ASN . 15.1 t -168.39 176.01 6.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.471 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.448 ' N ' ' HG ' ' A' ' 53' ' ' SER . 20.2 m-80 -76.65 49.49 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.451 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -161.28 -37.63 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.595 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.7 t -120.25 143.15 48.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.846 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.681 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -150.64 165.93 31.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.011 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.681 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 75.1 mt -137.55 131.64 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.76 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.434 ' CD2' ' HH ' ' A' ' 72' ' ' TYR . 0.4 OUTLIER -118.39 127.04 53.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.202 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.581 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 19.5 t80 -90.28 130.02 36.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.005 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 37.3 t -126.75 146.95 31.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.204 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.7 t -129.46 153.72 47.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.923 0.392 . . . . 0.0 110.944 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.406 ' CB ' ' OG1' ' A' ' 94' ' ' THR . 0.5 OUTLIER -41.35 -44.42 2.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.617 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -48.41 -30.13 4.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.604 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.51 -31.13 37.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.528 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -64.45 -43.15 95.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.362 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.463 ' N ' HD22 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -46.03 -32.33 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.59 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 69' ' ' GLY . . . -103.2 -53.8 2.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.656 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 68' ' ' ALA . . . 36.12 37.41 0.18 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -115.38 -57.55 2.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.76 0.314 . . . . 0.0 110.639 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.8 -37.77 33.1 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.434 ' HH ' ' CD2' ' A' ' 59' ' ' LEU . 1.1 t80 -67.69 -23.37 65.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 0.0 110.653 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.2 tmm_? -60.51 -46.65 89.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.668 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -68.65 -24.63 64.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.33 -50.33 54.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.751 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.0 mt -58.07 -26.04 62.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 80' ' ' ARG . 92.4 t -73.52 -45.7 50.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.028 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -42.17 -48.78 4.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.836 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 37.4 t -58.48 -27.46 33.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -80.6 -37.65 30.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.57 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -63.33 -15.13 56.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.671 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.485 ' HG ' ' N ' ' A' ' 83' ' ' ASN . 92.9 p -59.79 -111.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.521 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.531 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER -117.86 -68.34 0.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.539 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.531 ' CG ' ' O ' ' A' ' 83' ' ' ASN . 16.0 m-20 176.98 63.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.428 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.461 ' CD1' ' OD1' ' A' ' 83' ' ' ASN . 4.0 mp -98.05 133.87 41.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.743 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -84.83 101.39 12.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.299 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.65 129.56 9.21 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.3 mt -86.51 135.86 24.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.796 0.332 . . . . 0.0 110.453 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.3 t -101.7 107.47 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.663 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.5 t -89.95 138.29 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.336 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.1 t -125.53 148.55 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.367 . . . . 0.0 110.899 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -118.97 110.1 16.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.188 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -66.45 146.33 54.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.749 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.406 ' OG1' ' CB ' ' A' ' 63' ' ' GLU . 5.1 m -141.67 -75.39 0.3 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.468 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -141.22 -69.62 0.38 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.702 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 5.6 mmt -69.3 -10.77 59.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.631 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.632 ' O ' ' N ' ' A' ' 101' ' ' PHE . 5.3 p -50.56 -94.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.737 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 97' ' ' SER . 5.3 mt-10 -36.31 -25.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.906 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.583 ' N ' ' O ' ' A' ' 97' ' ' SER . 3.4 mm100 -73.75 -51.31 16.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.709 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.42 ' N ' ' O ' ' A' ' 97' ' ' SER . 1.1 t80 -114.59 11.83 17.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.649 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.729 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 28.8 t80 -69.76 -32.58 3.09 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.889 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.729 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 11.0 Cg_exo -67.1 -58.93 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.553 2.169 . . . . 0.0 111.938 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -47.85 -38.53 16.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.836 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 38.8 tp -73.15 -53.78 10.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.658 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -47.69 -36.5 11.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.642 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -64.53 -41.28 96.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.412 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -73.16 -46.0 53.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.648 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -35.19 74.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.894 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.672 ' O ' ' N ' ' A' ' 113' ' ' GLY . 3.6 t -76.65 -54.41 13.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.892 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.63 -29.73 69.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.915 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -84.66 -51.04 7.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.377 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.9 mp -105.04 -28.5 11.01 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.584 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 55.01 16.13 7.67 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.768 ' N ' ' SD ' ' A' ' 114' ' ' MET . 0.0 OUTLIER -70.94 -155.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 0.0 110.762 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.2 t -109.65 138.21 38.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.711 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.5 pp -129.38 127.05 40.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.508 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 mp -132.73 101.24 14.27 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.482 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -79.01 156.36 26.56 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.526 2.151 . . . . 0.0 112.256 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.522 ' CG2' ' H ' ' A' ' 120' ' ' ALA . 5.6 m -130.35 -110.64 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.545 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.522 ' H ' ' CG2' ' A' ' 119' ' ' VAL . . . 170.96 -29.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.563 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.567 ' OG ' ' N ' ' A' ' 122' ' ' GLN . 0.4 OUTLIER -149.22 179.94 7.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.553 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.567 ' N ' ' OG ' ' A' ' 121' ' ' SER . 0.4 OUTLIER -73.69 -45.76 50.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.584 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.421 ' CG ' ' N ' ' A' ' 124' ' ' GLU . 8.7 ptt? -45.28 -43.21 10.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.646 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.624 ' O ' ' N ' ' A' ' 128' ' ' LEU . 16.6 mm-40 -59.74 -56.24 24.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.549 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.94 -58.38 8.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.104 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.676 ' HG ' ' CD2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -47.47 -34.16 7.04 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 42.1 t -85.51 -31.02 22.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.321 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.624 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -76.01 -45.25 35.47 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.842 0.353 . . . . 0.0 110.625 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.8 t -58.82 -54.67 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.616 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 96.3 mt -54.79 -52.62 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.616 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -48.9 -32.0 8.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.429 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.2 tp -61.71 -62.92 1.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.474 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.4 t -68.47 -36.89 76.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.506 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.43 ' O ' ' OG1' ' A' ' 137' ' ' THR . 28.7 tt0 -58.35 -31.94 68.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.542 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -63.59 -55.7 21.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.559 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -48.58 -38.61 21.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.567 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 134' ' ' GLN . 25.3 m 41.68 30.98 0.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.739 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -86.67 123.53 31.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.544 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.543 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 mmt . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.62 91.45 8.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.562 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 pttp -152.52 28.68 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.555 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 63.19 74.06 0.47 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.561 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.62 155.16 44.83 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.778 2.319 . . . . 0.0 112.06 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -39.16 162.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 123.045 2.497 . . . . 0.0 112.28 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -83.68 56.17 3.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.541 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.53 ' C ' ' H ' ' A' ' 10' ' ' GLY . 1.1 m-20 68.24 54.69 0.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.557 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.1 t -72.58 23.0 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.641 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.53 ' H ' ' C ' ' A' ' 8' ' ' ASP . . . 49.89 71.12 0.66 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -42.6 130.21 5.2 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.973 2.448 . . . . 0.0 112.297 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 p -61.29 103.46 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.645 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.467 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 12.9 p-80 -141.26 127.05 19.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.53 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.1 m -95.82 148.19 34.17 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.548 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -67.21 177.98 3.37 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.731 2.287 . . . . 0.0 112.235 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.425 HD13 ' N ' ' A' ' 16' ' ' LEU . 5.0 mp -127.44 8.43 6.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.637 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.74 103.37 0.75 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -150.09 159.65 44.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.68 0.276 . . . . 0.0 110.302 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.0 159.5 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.893 0.377 . . . . 0.0 110.77 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.0 t -114.26 143.46 23.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.347 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -133.96 150.51 51.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.697 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.667 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 18.3 t-20 -80.78 138.68 36.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.612 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -58.47 -32.69 68.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.778 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -75.5 -76.54 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.462 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.701 ' O ' ' N ' ' A' ' 27' ' ' GLY . 65.5 t-105 -54.86 -24.31 22.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.065 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.678 ' O ' ' N ' ' A' ' 28' ' ' SER . 4.8 ttt-85 22.39 39.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.953 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.701 ' N ' ' O ' ' A' ' 25' ' ' TRP . . . 16.47 47.49 0.01 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 26' ' ' ARG . 3.0 m 46.3 174.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 0.0 110.53 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -42.07 -23.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.477 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.555 ' C ' ' CD1' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -46.67 -45.4 19.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.781 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.441 ' N ' ' HG ' ' A' ' 30' ' ' LEU . . . -63.59 -25.73 68.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.54 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.8 -30.85 35.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -68.94 -37.38 78.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.624 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.43 ' O ' ' O ' ' A' ' 38' ' ' ILE . 6.0 mtt -48.22 -26.26 1.86 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.537 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -69.63 -2.46 11.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.569 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.61 -8.78 62.03 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -136.51 -46.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.399 . . . . 0.0 110.458 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.498 HG13 ' H ' ' A' ' 39' ' ' LYS . 6.1 tp -126.0 172.31 13.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.183 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.498 ' H ' HG13 ' A' ' 38' ' ' ILE . 52.0 tttp -85.5 127.13 34.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.889 0.376 . . . . 0.0 110.525 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.4 HD22 ' SD ' ' A' ' 34' ' ' MET . 0.4 OUTLIER -120.07 131.03 54.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.397 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.9 mt -114.14 152.68 15.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.533 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 3.1 m-85 -118.39 121.06 39.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.687 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -125.34 126.87 45.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.343 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -88.15 144.51 26.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.756 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.51 5.42 57.86 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.667 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 8.1 mt -77.39 155.6 31.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 0.0 110.693 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.515 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -93.87 -63.72 0.14 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.788 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.515 ' CD ' ' CB ' ' A' ' 47' ' ' THR . 18.6 Cg_endo -61.47 -178.31 0.27 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.662 2.242 . . . . 0.0 111.811 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.63 ' OD2' ' NE1' ' A' ' 25' ' ' TRP . 4.1 m-20 -97.91 -32.86 11.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.562 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -147.03 125.09 12.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.412 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.437 ' OH ' ' CD2' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -108.4 110.29 21.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.698 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.18 -43.71 32.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.394 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 55' ' ' ARG . 0.7 OUTLIER -163.38 153.08 15.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.622 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -58.95 70.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.718 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.589 ' N ' ' O ' ' A' ' 53' ' ' SER . 4.6 ttt-85 173.59 -26.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.652 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.6 m -140.56 131.32 25.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.497 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -121.88 175.38 6.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.561 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.419 HD11 HG22 ' A' ' 58' ' ' ILE . 69.0 mt -138.54 130.77 38.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.611 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.1 tp -111.75 131.81 55.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.383 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -100.92 122.72 43.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.558 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.9 t -117.78 146.37 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.501 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -121.18 141.78 50.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.694 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -38.67 -37.92 0.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.511 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -50.02 -39.72 42.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.544 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.67 -40.75 84.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.512 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 68' ' ' ALA . 1.3 tt -57.66 -37.97 74.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.479 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.7 t -45.48 -15.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.361 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 66' ' ' LEU . . . -110.3 -56.88 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.456 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 47.75 24.82 3.13 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -155.71 43.17 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.792 0.329 . . . . 0.0 110.652 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -166.55 -37.83 0.02 OUTLIER Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.478 ' O ' ' N ' ' A' ' 75' ' ' ARG . 20.7 t80 -82.67 -25.15 33.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.763 0.316 . . . . 0.0 110.888 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -45.52 -33.04 2.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.495 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.96 -26.91 67.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.461 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.724 HH21 ' HE ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -76.68 -34.11 58.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.349 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.0 -38.13 89.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.577 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.05 -41.0 89.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.497 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.724 ' HE ' HH21 ' A' ' 75' ' ' ARG . 0.0 OUTLIER -47.62 -28.52 2.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.85 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.7 t -71.19 -27.81 30.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.876 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -79.06 -48.02 15.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.709 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.466 ' O ' ' C ' ' A' ' 82' ' ' SER . 12.7 t-20 -50.88 -49.82 58.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.773 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.466 ' C ' ' O ' ' A' ' 81' ' ' ASN . 1.7 t -33.88 -66.47 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.679 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -155.66 -141.15 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.628 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -129.02 54.06 1.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.587 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.571 ' CB ' ' O ' ' A' ' 55' ' ' ARG . 0.4 OUTLIER -99.99 140.4 34.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.523 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.48 88.96 6.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.478 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.01 179.6 51.05 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 44.1 mt -121.8 115.75 47.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.801 0.334 . . . . 0.0 110.415 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.0 t -85.13 109.84 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.592 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.5 t -95.05 145.25 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.65 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.4 t -132.87 142.67 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.547 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -103.74 129.84 51.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.74 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.409 ' HZ2' ' HB2' ' A' ' 118' ' ' PRO . 3.4 mtpp -83.58 131.48 34.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.373 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.2 m -134.82 -84.47 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.758 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 41.4 mtp180 -131.39 -69.49 0.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.58 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -9.16 57.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.547 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.635 ' O ' ' N ' ' A' ' 101' ' ' PHE . 44.3 p -61.47 -92.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.812 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 97' ' ' SER . 8.3 pt-20 -36.28 -26.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.239 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.556 ' N ' ' O ' ' A' ' 97' ' ' SER . 35.6 mt-30 -70.53 -55.2 9.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 0.0 110.937 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -115.21 12.59 16.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.814 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.726 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 1.1 t80 -68.04 -33.9 5.54 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.674 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.726 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 17.3 Cg_exo -64.0 -55.38 0.65 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.587 2.191 . . . . 0.0 111.897 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.66 -36.82 26.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.465 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.4 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.5 OUTLIER -73.06 -41.19 64.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.465 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.39 -31.54 71.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.321 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.458 ' HZ1' ' HB2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -71.03 -46.3 62.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.231 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -74.66 -49.43 21.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.401 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 104' ' ' LEU . 76.4 m -43.83 -36.42 2.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.289 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' A' ' 113' ' ' GLY . 2.3 t -70.3 -54.01 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.206 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.4 mt -66.25 -24.75 66.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.573 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -84.53 -52.88 5.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.338 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.83 -28.38 10.67 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.5 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 54.27 43.33 75.07 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 2.2 ttm -110.68 -172.96 2.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.706 0.288 . . . . 0.0 110.335 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.5 t -89.0 120.4 37.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.645 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.8 tt -110.34 124.27 51.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.479 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 tt -131.83 104.99 14.06 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.734 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.409 ' HB2' ' HZ2' ' A' ' 93' ' ' LYS . 72.4 Cg_endo -82.23 156.97 17.27 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.703 2.269 . . . . 0.0 112.097 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.12 -101.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.592 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 175.16 -45.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.632 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.8 m -130.13 167.24 18.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.557 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -70.09 -22.68 63.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.656 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 29.9 mtp -73.6 -43.78 58.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.676 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 128' ' ' LEU . 4.9 mm-40 -47.42 -55.69 8.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.666 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 128' ' ' LEU . . . -57.43 -57.93 10.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.134 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 65.0 m -44.74 -36.01 2.97 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.48 -31.72 22.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.005 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.591 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.7 OUTLIER -73.49 -31.36 63.69 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.749 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 25.4 t -80.05 -42.33 21.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.576 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.5 mt -62.05 -49.37 84.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.626 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -57.09 -37.87 72.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.589 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.11 -40.89 70.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.815 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 45.4 t -74.42 -42.53 49.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.631 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.422 ' O ' ' OG1' ' A' ' 137' ' ' THR . 2.9 mt-30 -56.37 -52.78 63.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.627 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -56.17 -39.52 72.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.657 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -58.51 -58.89 6.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.552 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 134' ' ' GLN . 71.9 p -44.08 -72.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.553 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -158.33 -168.16 2.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.619 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.552 179.966 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.448 ' O ' ' C ' ' A' ' 2' ' ' GLU . 45.8 mtt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 1' ' ' MET . 14.7 mm-40 36.4 80.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.534 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -94.99 138.86 32.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.362 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -86.59 152.85 55.14 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.55 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.465 ' O ' ' CG ' ' A' ' 7' ' ' ASP . 20.9 Cg_endo -64.61 109.85 1.31 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.905 2.404 . . . . 0.0 111.964 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.61 112.33 0.67 Allowed 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.482 2.121 . . . . 0.0 112.115 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.465 ' CG ' ' O ' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -155.77 50.78 0.55 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.588 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 10' ' ' GLY . 2.0 m-20 38.87 41.24 0.51 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.475 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.8 t -43.97 -13.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.46 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 8' ' ' ASP . . . 173.97 89.86 0.08 OUTLIER Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -81.62 46.12 2.15 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.892 2.395 . . . . 0.0 112.124 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.5 t -117.81 150.11 20.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.581 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.521 ' ND1' ' N ' ' A' ' 13' ' ' HIS . 1.1 p-80 -97.35 178.98 5.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.508 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.1 m -140.47 84.19 14.38 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.545 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -80.57 -9.84 13.39 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.947 2.431 . . . . 0.0 112.286 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -159.54 150.64 19.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.699 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 134.11 -110.56 0.88 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -87.96 166.15 14.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.711 0.291 . . . . 0.0 110.523 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 91.0 mt -113.67 149.6 15.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.621 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.3 t -97.48 147.03 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.494 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 41' ' ' ILE . . . -133.58 160.41 37.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.491 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 56.5 t30 -93.82 141.23 28.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.531 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -55.22 -34.88 64.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.639 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.548 ' C ' ' H ' ' A' ' 26' ' ' ARG . 2.9 ttpp -79.42 -50.45 10.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.659 ' CE2' ' OD2' ' A' ' 49' ' ' ASP . 53.5 t-105 -64.58 6.11 0.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.926 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.548 ' H ' ' C ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -85.44 1.26 49.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.627 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.84 20.79 26.5 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.4 m -116.77 155.28 29.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.854 0.359 . . . . 0.0 110.688 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -73.28 -21.64 60.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.469 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.556 ' C ' ' CD1' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -57.16 -65.73 0.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.089 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -42.5 -32.76 0.58 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.303 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -70.68 -56.85 5.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.345 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 36' ' ' GLY . 96.0 mt-10 -54.16 -40.83 67.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.347 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.592 ' C ' ' H ' ' A' ' 36' ' ' GLY . 4.5 mtp -45.0 -47.63 11.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.404 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -65.82 11.68 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.499 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 34' ' ' MET . . . -86.06 -29.38 25.78 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.443 ' HZ1' HE22 ' A' ' 134' ' ' GLN . 7.1 mtmt -125.62 -47.95 1.68 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.852 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.467 HG12 ' H ' ' A' ' 39' ' ' LYS . 0.2 OUTLIER -109.93 171.84 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.742 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.467 ' H ' HG12 ' A' ' 38' ' ' ILE . 11.3 ttpp -90.2 140.38 29.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.597 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.7 tp -126.09 144.57 50.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.666 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.45 ' O ' ' N ' ' A' ' 21' ' ' ALA . 29.5 mt -120.36 151.34 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.503 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -117.65 139.79 50.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.668 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -148.24 120.2 8.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.485 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.13 124.47 27.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.595 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 132.38 -27.94 3.51 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.488 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 48.2 mt -59.39 139.46 57.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.604 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.614 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 1.1 m -90.08 -39.22 0.41 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.061 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 47' ' ' THR . 58.5 Cg_endo -80.67 -163.93 0.25 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.271 1.981 . . . . 0.0 112.074 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.659 ' OD2' ' CE2' ' A' ' 25' ' ' TRP . 30.5 m-20 -99.0 -46.23 5.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.795 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -140.8 155.88 46.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.688 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.51 94.03 3.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.493 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.547 ' O ' ' OG ' ' A' ' 53' ' ' SER . 1.7 tp -64.05 -20.34 65.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.332 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.659 ' C ' ' H ' ' A' ' 55' ' ' ARG . 4.2 m 173.05 161.55 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.423 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.2 22.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.962 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.659 ' H ' ' C ' ' A' ' 53' ' ' SER . 4.8 mmt85 -132.02 -29.11 1.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.645 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 57' ' ' CYS . 2.3 t -132.77 152.94 51.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.859 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.502 ' N ' ' SG ' ' A' ' 56' ' ' CYS . 0.5 OUTLIER -148.13 171.4 15.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.286 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.4 mt -138.77 134.88 43.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.818 0.342 . . . . 0.0 110.824 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.441 HD23 ' N ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -129.01 125.22 36.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.504 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.46 ' HB3' ' CZ2' ' A' ' 25' ' ' TRP . 14.4 t80 -87.65 128.78 35.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.615 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.2 t -121.52 149.85 24.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.492 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.8 p -126.1 145.35 50.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.664 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -44.31 -41.91 6.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.422 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -44.0 -31.11 0.83 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.362 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -82.84 -39.31 21.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.531 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 tt -49.14 -38.31 24.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.35 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 87.9 t -46.03 -36.16 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.594 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.69 116.72 9.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.54 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' A' ' 71' ' ' GLY . . . -121.77 3.56 10.89 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.58 4.77 2.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.813 0.339 . . . . 0.0 110.543 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 69' ' ' GLY . . . -134.88 -33.48 0.29 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.474 ' O ' ' N ' ' A' ' 75' ' ' ARG . 4.3 t80 -80.11 -35.63 36.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.765 0.317 . . . . 0.0 110.532 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.404 ' NH2' ' HB3' ' A' ' 107' ' ' PHE . 22.0 ttt85 -43.58 -36.13 1.99 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.528 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -63.66 -34.79 78.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.507 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.474 ' N ' ' O ' ' A' ' 72' ' ' TYR . 0.3 OUTLIER -62.16 -35.91 80.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.47 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 mt -68.19 -40.47 82.2 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.424 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.8 t -63.46 -47.13 93.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.388 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -41.41 -32.33 0.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.329 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.562 ' O ' ' OG ' ' A' ' 82' ' ' SER . 97.1 t -71.05 -55.4 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.515 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.453 ' HB3' ' NH1' ' A' ' 80' ' ' ARG . 0.9 OUTLIER -54.08 -31.77 52.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.568 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.51 ' O ' ' C ' ' A' ' 82' ' ' SER . 3.7 t30 -54.37 -49.44 69.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.499 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.562 ' OG ' ' O ' ' A' ' 79' ' ' VAL . 17.1 p -30.79 -76.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.428 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.458 ' OD1' ' OD1' ' A' ' 84' ' ' ASN . 1.5 t-20 -161.08 -89.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.476 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.564 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 3.0 p-10 -151.48 48.47 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.295 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.1 mt -69.32 154.93 41.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.6 pttt -126.56 89.08 2.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.234 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.437 ' CA ' ' O ' ' A' ' 57' ' ' CYS . . . -109.26 176.28 19.55 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.7 mt -114.36 129.63 70.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.789 0.328 . . . . 0.0 110.646 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 t -104.24 107.35 22.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.46 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.3 t -90.24 143.82 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.652 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 82.0 t -129.0 143.24 41.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.53 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -102.4 115.62 30.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.565 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -71.6 143.2 49.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.514 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.6 ' H ' ' HG ' ' A' ' 97' ' ' SER . 89.9 m -137.49 -82.1 0.35 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.484 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.515 ' CG ' ' N ' ' A' ' 96' ' ' MET . 14.1 ptm180 -151.14 -44.79 0.12 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.464 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.515 ' N ' ' CG ' ' A' ' 95' ' ' ARG . 1.7 mtt -88.52 -2.92 58.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.139 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.612 ' O ' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -70.65 -71.91 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.492 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -40.76 -22.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.609 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.524 ' N ' ' O ' ' A' ' 97' ' ' SER . 10.3 mm100 -72.3 -54.44 9.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.038 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -116.6 12.15 14.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.038 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.612 ' N ' ' O ' ' A' ' 97' ' ' SER . 0.3 OUTLIER -62.51 -62.18 6.2 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.604 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 101' ' ' PHE . 9.6 Cg_endo -53.49 -48.75 20.24 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.653 2.235 . . . . 0.0 112.013 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.05 -31.36 7.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.51 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.545 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.7 OUTLIER -85.31 -22.29 28.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.511 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 102' ' ' PRO . 1.4 tt0 -84.63 -32.37 23.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.699 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.77 -41.93 71.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.671 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.51 ' O ' ' CG ' ' A' ' 111' ' ' ASP . 2.9 m-85 -78.62 -51.01 10.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.603 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.545 ' OG1' ' O ' ' A' ' 104' ' ' LEU . 97.1 m -51.37 -37.49 48.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.485 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 113' ' ' GLY . 22.2 t -67.55 -59.15 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.452 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.2 -19.05 65.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.526 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.51 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 12.5 m-20 -84.39 -57.8 3.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.029 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.7 mt -107.5 -29.01 9.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.629 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 72.04 42.48 51.55 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -86.62 -171.05 3.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.576 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 40.7 t -117.76 105.23 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.587 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.447 HD11 ' N ' ' A' ' 116' ' ' LEU . 6.0 mp -95.64 142.39 28.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.514 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 tp -156.23 88.92 2.82 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.527 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -56.04 163.82 5.6 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.751 2.301 . . . . 0.0 112.085 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.529 ' O ' ' CB ' ' A' ' 120' ' ' ALA . 1.5 m -129.37 -106.83 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.655 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 119' ' ' VAL . . . 159.24 -47.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.434 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.13 143.68 51.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.544 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -51.94 -24.98 7.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.708 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 5.4 mtp -70.24 -51.72 28.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.623 ' O ' ' N ' ' A' ' 128' ' ' LEU . 9.6 mm-40 -44.71 -52.32 8.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.679 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 129' ' ' VAL . . . -55.18 -58.1 9.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.225 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.456 ' N ' HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -49.73 -37.01 27.61 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.223 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.87 -31.2 35.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.128 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.623 ' N ' ' O ' ' A' ' 124' ' ' GLU . 1.8 mt -79.91 -26.94 40.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.879 0.371 . . . . 0.0 110.501 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 125' ' ' ALA . 61.3 t -81.56 -41.0 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.566 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 70.5 mt -73.16 -39.94 57.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.67 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -58.64 -25.58 62.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.533 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.9 tp -77.01 -58.01 3.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.466 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.1 t -60.45 -41.79 88.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.605 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.443 HE22 ' HZ1' ' A' ' 37' ' ' LYS . 16.7 tt0 -52.76 -49.82 64.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.602 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -64.25 -28.71 69.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.527 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -87.58 -12.02 46.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.525 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.455 ' O ' ' C ' ' A' ' 138' ' ' LYS . 47.5 m -95.69 -45.88 6.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.551 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.551 ' O ' ' O ' ' A' ' 139' ' ' GLU . 13.7 tttp -35.18 144.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.628 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.551 ' O ' ' O ' ' A' ' 138' ' ' LYS . 1.7 tp10 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.566 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.512 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.8 mmt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.3 122.21 37.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.545 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.445 ' O ' ' CB ' ' A' ' 4' ' ' ASN . 44.9 mttm -119.36 -63.13 1.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.732 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.469 ' N ' ' HD2' ' A' ' 5' ' ' PRO . 0.8 OUTLIER 166.1 -53.85 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.913 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 4' ' ' ASN . 87.9 Cg_exo -41.59 157.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.792 2.328 . . . . 0.0 112.444 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -39.62 117.05 0.35 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.024 2.483 . . . . 0.0 112.37 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 14.1 p-10 -160.53 51.47 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.454 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 9' ' ' THR . 92.6 m-20 60.54 -82.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.566 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.48 ' CG2' ' O ' ' A' ' 9' ' ' THR . 90.1 m 37.46 37.61 0.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.633 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.28 63.58 0.04 OUTLIER Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -67.87 140.02 49.32 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.712 2.275 . . . . 0.0 112.087 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.9 t -132.8 -64.26 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.571 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.22 21.07 9.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.5 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.82 59.47 7.22 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.441 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.54 -52.8 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.95 2.434 . . . . 0.0 112.265 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.5 tp -129.37 114.28 16.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.808 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -153.34 17.24 0.68 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -114.22 154.6 27.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.804 0.335 . . . . 0.0 110.602 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.485 HG21 HD11 ' A' ' 19' ' ' ILE . 73.3 mt -106.21 153.49 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.625 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.9 t -110.47 124.04 66.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.654 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.01 149.88 27.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.66 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -74.78 140.65 44.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.424 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.71 -28.65 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.417 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.52 ' C ' ' H ' ' A' ' 26' ' ' ARG . 12.5 ttmm -83.54 -52.88 6.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.395 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.458 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 42.5 t-105 -74.79 24.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.307 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.52 ' H ' ' C ' ' A' ' 24' ' ' LYS . 18.7 ttp85 -81.28 -63.89 1.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.704 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.78 52.46 0.51 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.1 p -111.85 141.21 45.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.337 . . . . 0.0 110.634 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.681 HE21 ' NE2' ' A' ' 122' ' ' GLN . 7.5 mt-30 -56.35 -28.55 59.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.713 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.563 ' C ' ' CD1' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -61.07 -66.07 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.393 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.06 -24.67 63.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.923 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.02 -51.25 68.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.814 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -70.33 -45.83 65.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.857 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.422 ' SD ' HG13 ' A' ' 130' ' ' ILE . 36.0 mmt -49.92 -26.62 4.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.815 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -77.01 -0.54 24.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 0.0 110.562 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.22 6.83 50.98 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.441 ' HZ1' HD11 ' A' ' 130' ' ' ILE . 2.8 mtmp? -148.79 -47.85 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.812 0.339 . . . . 0.0 110.537 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.489 HG12 ' H ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -113.56 169.78 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.595 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.489 ' H ' HG12 ' A' ' 38' ' ' ILE . 5.4 tptm -94.94 152.82 18.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.487 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.86 137.99 28.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.48 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.4 mt -116.62 131.72 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.531 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -88.15 132.42 34.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.799 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -139.94 121.8 15.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.544 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -79.77 145.04 33.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.647 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.4 -33.89 5.83 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 77.3 mt -48.83 137.6 12.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 110.619 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.519 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -88.11 -52.63 0.38 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.929 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 47' ' ' THR . 33.9 Cg_endo -67.61 -157.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.04 1.826 . . . . 0.0 112.15 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.433 ' OD2' ' CD2' ' A' ' 25' ' ' TRP . 1.6 m-20 -98.63 -54.91 2.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.879 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.458 ' CZ ' ' CD1' ' A' ' 25' ' ' TRP . 83.0 m-85 -124.12 145.77 49.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.794 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.17 103.07 8.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.488 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.71 -35.11 30.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.493 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.661 ' C ' ' H ' ' A' ' 55' ' ' ARG . 4.2 t -178.28 164.59 1.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.426 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -67.38 23.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.477 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.661 ' H ' ' C ' ' A' ' 53' ' ' SER . 5.4 ttt-85 -134.72 -4.93 2.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.142 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.555 ' SG ' ' C ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -161.57 144.98 12.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.87 0.366 . . . . 0.0 110.974 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.402 ' SG ' ' HA2' ' A' ' 87' ' ' GLY . 12.5 p -151.13 164.38 36.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.438 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.0 mt -129.06 148.67 33.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.678 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.7 tt -133.78 120.02 19.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.287 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -85.71 121.66 28.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.792 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.425 ' N ' ' O ' ' A' ' 90' ' ' VAL . 74.7 t -122.15 143.98 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.229 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 63' ' ' GLU . 42.1 p -124.09 148.25 47.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.627 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 66' ' ' LEU . 3.3 tm-20 -38.57 -40.51 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.73 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -44.85 -33.32 1.9 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.661 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.562 ' OD2' ' CE1' ' A' ' 72' ' ' TYR . 3.6 m-20 -82.06 -26.34 33.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.634 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 63' ' ' GLU . 1.4 tt -68.41 -50.07 55.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.671 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.459 ' N ' HD22 ' A' ' 66' ' ' LEU . 2.3 p -62.43 -27.67 43.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.424 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.47 -64.96 0.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.561 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 70' ' ' ASN . . . 71.3 111.17 0.04 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.512 ' CB ' ' O ' ' A' ' 69' ' ' GLY . 5.1 t-20 81.75 139.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.77 0.319 . . . . 0.0 110.51 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.43 -71.31 0.38 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.562 ' CE1' ' OD2' ' A' ' 65' ' ' ASP . 4.0 t80 -50.56 -47.49 57.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.928 0.395 . . . . 0.0 110.375 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -43.15 -36.01 1.55 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.701 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -67.25 -43.94 80.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.542 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 12.3 mtt85 -58.36 -25.41 61.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.544 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 mt -79.42 -38.45 34.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.36 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.3 t -49.25 -30.46 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.278 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.455 ' NH1' ' HG1' ' A' ' 47' ' ' THR . 8.3 tpt180 -54.65 -29.3 51.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.349 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.6 t -69.12 -35.94 70.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.218 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -79.53 -20.22 47.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.405 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -51.03 -59.69 3.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.471 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.459 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 0.1 OUTLIER -69.0 -68.99 0.36 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.454 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 82' ' ' SER . 4.5 t-20 78.01 60.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.491 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.538 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 2.1 p30 -148.48 11.82 0.9 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.757 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 pp -155.09 153.09 30.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.809 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.7 mmtm -76.62 110.0 10.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.126 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.402 ' HA2' ' SG ' ' A' ' 57' ' ' CYS . . . -86.64 101.76 2.67 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.427 HD12 HG21 ' A' ' 88' ' ' ILE . 46.8 mt -84.48 138.57 18.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 37.0 t -117.96 127.6 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.858 0.361 . . . . 0.0 111.149 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 61' ' ' VAL . 14.7 t -117.49 121.84 68.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.166 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.0 t -114.79 139.69 39.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.783 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -98.75 129.53 45.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.679 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.634 ' NZ ' ' O ' ' A' ' 119' ' ' VAL . 21.7 mttp -78.57 138.39 38.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.428 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.456 ' HG1' ' HB3' ' A' ' 63' ' ' GLU . 12.2 m -140.12 -85.22 0.22 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.669 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -128.8 -63.38 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.592 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.734 ' SD ' ' N ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -77.91 -9.24 58.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.48 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 99' ' ' GLN . 4.7 p -48.47 -102.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.348 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 97' ' ' SER . 24.2 mt-10 -36.31 -21.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.589 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.68 ' N ' ' O ' ' A' ' 97' ' ' SER . 11.5 tp60 -69.56 -55.61 9.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.094 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 103' ' ' ALA . 4.8 t80 -117.33 3.11 12.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.801 0.334 . . . . 0.0 110.797 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.601 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -47.06 -58.77 6.44 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.507 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 101' ' ' PHE . 14.9 Cg_endo -59.05 -48.68 13.33 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.556 2.171 . . . . 0.0 112.277 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 100' ' ' TYR . . . -45.47 -32.39 2.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.855 0.359 . . . . 0.0 110.227 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 tp -87.29 -30.95 20.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.806 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 102' ' ' PRO . 38.1 tt0 -58.26 -40.09 80.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.16 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -63.51 -37.08 85.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.088 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.27 -38.78 34.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.472 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.0 m -72.93 -30.84 64.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.569 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.584 ' O ' ' CA ' ' A' ' 113' ' ' GLY . 10.8 t -77.36 -43.93 30.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.989 0.423 . . . . 0.0 110.53 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.3 tp -70.92 -31.15 67.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.613 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -84.51 -50.14 7.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.308 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mt -104.88 -28.32 11.19 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.597 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.584 ' CA ' ' O ' ' A' ' 109' ' ' VAL . . . 43.47 35.19 2.75 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.93 -159.62 0.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.362 . . . . 0.0 110.547 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 49.4 t -96.29 123.13 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.426 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.14 133.91 53.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.67 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.8 mt -146.07 88.28 6.39 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.481 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -80.56 158.99 22.22 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.883 2.389 . . . . 0.0 112.189 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.634 ' O ' ' NZ ' ' A' ' 93' ' ' LYS . 28.2 m -127.2 -136.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.428 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.415 ' N ' ' CG2' ' A' ' 119' ' ' VAL . . . -153.5 -40.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.279 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.9 p -138.39 158.34 44.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.357 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.681 ' NE2' HE21 ' A' ' 29' ' ' GLN . 21.1 mt-30 -58.17 -26.36 62.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.62 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.85 -45.23 90.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.74 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.638 ' O ' ' N ' ' A' ' 128' ' ' LEU . 1.2 mp0 -54.97 -58.41 7.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.657 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 128' ' ' LEU . . . -52.18 -58.06 7.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.296 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.68 -40.29 4.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.7 m -85.39 -27.12 26.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.208 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.638 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.5 OUTLIER -77.35 -26.86 52.43 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.942 0.401 . . . . 0.0 110.742 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 125' ' ' ALA . 3.5 t -68.87 -61.45 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.642 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.441 HD11 ' HZ1' ' A' ' 37' ' ' LYS . 6.8 mt -58.33 -45.08 89.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.441 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -45.7 -29.62 1.32 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.829 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.4 mt -76.44 -48.75 18.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.772 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.57 ' O ' ' OG1' ' A' ' 137' ' ' THR . 19.2 t -67.81 -51.93 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.817 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.433 ' HA ' ' HG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -52.75 -33.72 49.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -63.69 -58.96 5.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.841 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.459 ' C ' ' H ' ' A' ' 138' ' ' LYS . 2.0 pt20 -62.77 -41.06 99.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.943 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.57 ' OG1' ' O ' ' A' ' 133' ' ' VAL . 1.0 OUTLIER -68.98 47.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.784 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.459 ' H ' ' C ' ' A' ' 136' ' ' GLN . 2.7 ttmp? -108.74 157.91 18.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.403 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.427 ' N ' ' HG2' ' A' ' 138' ' ' LYS . 3.1 pt-20 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.628 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.666 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.6 p-80 -136.53 152.39 50.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.856 0.36 . . . . 0.0 110.778 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.446 ' HB ' HD12 ' A' ' 40' ' ' LEU . 3.4 mm -122.98 135.51 62.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.261 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.7 t -97.04 151.63 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.802 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.3 128.26 25.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.502 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.425 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 55.5 t-20 -56.57 131.27 48.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.566 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -43.79 -38.3 3.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.681 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.596 ' C ' ' H ' ' A' ' 26' ' ' ARG . 15.5 ttpt -72.62 -48.41 39.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.48 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.514 ' CE2' ' OD2' ' A' ' 49' ' ' ASP . 24.2 t-105 -67.89 19.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.537 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.596 ' H ' ' C ' ' A' ' 24' ' ' LYS . 61.2 ttt-85 -89.47 -34.97 16.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.439 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.97 36.71 0.24 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.561 ' H ' ' C ' ' A' ' 26' ' ' ARG . 5.8 p -117.86 144.69 45.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.769 0.319 . . . . 0.0 110.644 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -72.93 -18.97 61.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.441 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.802 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -68.56 -57.61 5.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.315 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.406 ' N ' ' HG ' ' A' ' 30' ' ' LEU . . . -41.93 -23.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.531 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 30' ' ' LEU . 1.9 tp-100 -72.12 -47.61 49.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.567 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 36' ' ' GLY . 3.5 mt-10 -50.94 -51.26 54.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.456 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.522 ' C ' ' H ' ' A' ' 36' ' ' GLY . 5.6 mtt -43.93 -42.14 5.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.573 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -71.1 17.16 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.598 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.522 ' H ' ' C ' ' A' ' 34' ' ' MET . . . -104.15 -10.69 33.68 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.5 mtmm -152.01 -43.1 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.854 0.359 . . . . 0.0 110.479 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.445 ' HA ' HD12 ' A' ' 38' ' ' ILE . 10.1 tp -109.36 160.65 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.519 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.8 tttm -86.19 146.05 26.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.582 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.446 HD12 ' HB ' ' A' ' 19' ' ' ILE . 13.9 tp -131.4 137.87 48.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.701 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 57.8 mt -123.16 141.89 41.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.486 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -96.75 133.69 40.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.798 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.76 120.04 25.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.387 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -89.85 111.55 22.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.651 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 133.4 -8.52 5.01 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.425 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 66.3 mt -92.61 148.71 21.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.773 0.32 . . . . 0.0 110.67 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.536 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -96.04 -47.9 0.25 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 47' ' ' THR . 58.0 Cg_exo -47.87 164.35 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.727 2.285 . . . . 0.0 112.27 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.601 ' OD2' ' CD1' ' A' ' 60' ' ' TYR . 1.2 m-20 -85.44 -53.04 5.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.476 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -135.71 120.7 18.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.891 0.377 . . . . 0.0 110.607 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.549 ' CD1' ' O ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -99.48 112.78 24.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.383 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.91 -44.08 15.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.65 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.549 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 5.0 t -139.46 -162.23 1.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.676 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -90.22 -8.98 49.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.624 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.422 HH21 ' HZ1' ' A' ' 86' ' ' LYS . 11.2 mtp180 -125.83 -8.8 6.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.828 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.61 132.82 56.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.962 0.411 . . . . 0.0 111.1 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.1 163.67 30.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.892 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 96.5 mt -135.72 124.16 38.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.977 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.9 tp -115.82 138.21 51.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.372 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.601 ' CD1' ' OD2' ' A' ' 49' ' ' ASP . 2.8 p90 -96.17 132.91 41.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.91 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 92' ' ' GLU . 77.0 t -130.59 149.97 34.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.176 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.42 ' O ' ' C ' ' A' ' 63' ' ' GLU . 1.0 OUTLIER -138.05 157.06 47.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.631 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 62' ' ' THR . 5.7 tm-20 -39.18 -43.16 1.04 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.32 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -47.0 -39.91 13.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.343 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 62' ' ' THR . 61.9 m-20 -69.01 -44.63 72.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.333 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.407 HD11 ' C ' ' A' ' 100' ' ' TYR . 1.5 tt -49.05 -44.44 41.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.523 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 32.2 t -49.48 -41.22 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.552 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.41 -71.63 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.646 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.44 -52.82 1.89 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -97.09 103.23 15.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.789 0.328 . . . . 0.0 110.559 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.66 -51.43 0.8 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -67.37 -24.53 65.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.724 0.297 . . . . 0.0 110.902 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -42.19 97.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 110.589 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -46.31 -46.15 17.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.583 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -59.09 -38.05 78.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.747 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 76' ' ' LEU . 97.6 mt -70.41 -34.81 72.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.708 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 63.8 t -61.45 -40.27 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.856 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 -56.85 -23.42 43.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.799 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.0 t -79.91 -49.51 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.561 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.6 ttt-85 -66.9 -25.54 66.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.645 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -71.05 -11.61 61.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.654 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.554 ' OG ' ' N ' ' A' ' 83' ' ' ASN . 60.4 p -67.92 -117.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.581 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.554 ' N ' ' OG ' ' A' ' 82' ' ' SER . 7.1 t30 -121.02 -93.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.679 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.491 ' N ' ' CG ' ' A' ' 83' ' ' ASN . 2.6 m120 -138.02 60.27 1.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.495 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.5 mp -93.48 123.43 36.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.575 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.422 ' HZ1' HH21 ' A' ' 55' ' ' ARG . 1.2 pttp -112.58 85.84 2.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.172 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -93.67 -165.33 37.21 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.8 mt -131.28 135.83 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.773 0.32 . . . . 0.0 110.488 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.2 t -107.99 118.82 56.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.614 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 61' ' ' VAL . 19.7 t -93.69 140.72 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.401 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.66 132.59 70.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.716 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 61' ' ' VAL . 3.6 tt0 -101.71 104.43 15.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.387 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -68.65 131.95 46.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.579 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.6 m -126.14 -74.26 0.6 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.633 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.3 mtp85 -140.84 -70.3 0.38 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.457 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.33 -1.93 7.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.49 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.609 ' O ' ' N ' ' A' ' 101' ' ' PHE . 4.1 t -68.7 -91.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.788 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 97' ' ' SER . 22.1 mt-10 -36.41 -27.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.954 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 97' ' ' SER . 2.3 mt-30 -71.64 -51.51 22.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.181 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.407 ' C ' HD11 ' A' ' 66' ' ' LEU . 6.1 m-85 -117.13 11.62 14.23 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.19 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.727 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 35.5 t80 -69.82 -32.9 3.23 Favored Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.78 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.727 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 10.8 Cg_exo -67.33 -42.34 7.67 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.588 2.192 . . . . 0.0 111.939 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.05 -48.32 78.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.635 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 tp -71.16 -47.99 54.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.585 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.682 ' O ' HG23 ' A' ' 109' ' ' VAL . 7.7 tt0 -50.59 -33.63 22.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.73 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -56.39 15.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.871 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.6 -52.14 62.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.787 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.1 m -42.18 -40.43 2.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.79 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 105' ' ' GLN . 85.9 t -66.2 -58.66 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.476 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.435 ' HA ' HD13 ' A' ' 110' ' ' LEU . 0.9 OUTLIER -62.56 -23.08 66.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.461 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.48 -55.51 4.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mt -106.33 -28.58 10.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.184 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 56.76 20.04 30.94 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 6.5 tpp -73.04 -161.09 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.724 0.297 . . . . 0.0 110.404 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.12 127.63 65.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.607 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.596 ' N ' HD12 ' A' ' 116' ' ' LEU . 5.0 mp -122.27 115.44 22.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.472 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.3 mt -124.99 88.32 54.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -53.25 171.56 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.629 2.219 . . . . 0.0 111.735 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 120' ' ' ALA . 4.0 m -143.06 -113.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.652 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.404 ' H ' HG23 ' A' ' 119' ' ' VAL . . . -177.51 -37.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.263 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.8 p -141.12 -170.74 3.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.348 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -81.26 -28.22 34.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.598 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -48.42 59.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.757 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 128' ' ' LEU . 0.4 OUTLIER -44.7 -46.1 10.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.25 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.66 -54.92 24.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.959 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.791 ' HB3' HD13 ' A' ' 30' ' ' LEU . 59.7 p -54.98 -30.85 60.1 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -85.19 -35.32 21.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.256 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.596 ' N ' ' O ' ' A' ' 124' ' ' GLU . 4.2 mp -74.58 -34.33 62.86 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.569 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 133' ' ' VAL . 62.0 t -74.19 -55.0 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.562 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 97.2 mt -58.17 -50.93 76.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.581 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -48.94 -30.28 5.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.321 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.1 tp -82.58 -42.03 18.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.478 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 129' ' ' VAL . 95.8 t -63.75 -36.79 77.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.644 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.96 -22.46 65.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.656 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.475 179.942 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.677 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -72.78 155.1 40.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.846 0.355 . . . . 0.0 110.702 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.406 ' HB ' HD12 ' A' ' 40' ' ' LEU . 17.9 mm -109.35 143.8 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.399 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.6 t -94.6 145.41 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.586 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -136.82 137.25 39.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.541 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 25' ' ' TRP . 63.2 t-20 -64.7 135.29 55.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.467 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.406 ' N ' ' OD1' ' A' ' 22' ' ' ASN . 7.2 tt0 -43.18 -32.3 0.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.369 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -70.36 -36.78 74.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.334 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.502 ' N ' ' O ' ' A' ' 22' ' ' ASN . 0.2 OUTLIER -68.46 -13.62 62.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.208 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.448 ' HD3' ' CD1' ' A' ' 42' ' ' PHE . 7.7 tpt85 -61.98 -40.85 97.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.611 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.6 51.01 0.85 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.69 152.16 37.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.794 0.33 . . . . 0.0 110.622 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -75.55 -21.05 58.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.363 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.849 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -68.67 -56.61 7.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.598 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.432 ' N ' ' HG ' ' A' ' 30' ' ' LEU . . . -53.14 -33.08 50.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.831 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -82.4 -28.94 31.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.727 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -67.33 -31.78 72.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.52 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.689 ' N ' ' SD ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -74.83 -27.04 60.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.465 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -65.78 -8.65 22.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.681 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.35 -29.02 11.7 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.2 -48.85 3.75 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.98 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.429 HG23 ' N ' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -123.24 172.2 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.94 0.4 . . . . 0.0 110.882 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.429 ' N ' HG23 ' A' ' 38' ' ' ILE . 36.8 tttp -86.13 127.6 34.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.541 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.406 HD12 ' HB ' ' A' ' 19' ' ' ILE . 13.4 tp -118.59 129.75 55.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.755 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 mt -108.59 140.66 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.31 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.448 ' CD1' ' HD3' ' A' ' 26' ' ' ARG . 6.2 m-85 -104.14 129.05 51.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.719 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.416 ' HB3' HD13 ' A' ' 46' ' ' LEU . 2.8 mt-10 -130.63 113.2 13.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.439 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -75.18 128.47 35.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.477 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.65 -47.41 1.02 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 46' ' ' LEU . 9.7 mp -46.96 148.15 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.716 0.293 . . . . 0.0 110.387 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.56 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -99.45 -47.54 0.21 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.903 0.382 . . . . 0.0 110.668 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 47' ' ' THR . 31.4 Cg_exo -54.95 176.93 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.791 2.327 . . . . 0.0 112.153 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.47 ' OD1' ' CE2' ' A' ' 25' ' ' TRP . 8.1 m-20 -87.11 -56.14 3.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.436 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -129.65 143.62 50.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.357 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -116.61 108.35 15.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.71 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.78 -38.26 76.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.487 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.602 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 5.8 m -160.01 -143.54 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.439 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.31 18.81 17.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.584 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.537 ' HA ' HD13 ' A' ' 85' ' ' LEU . 7.6 mtp180 -144.49 9.84 1.41 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.602 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 86' ' ' LYS . 42.7 t -163.53 145.4 9.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.684 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.15 172.72 12.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.296 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.6 mt -131.08 126.33 59.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.72 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.24 117.73 30.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.27 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -87.74 117.46 26.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.95 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 73.2 t -99.3 149.48 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.948 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.446 ' H ' ' CG ' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -121.29 156.37 32.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.842 0.353 . . . . 0.0 110.831 -179.665 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.732 ' HB2' HG21 ' A' ' 94' ' ' THR . 12.0 pt-20 -46.05 -44.67 15.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.56 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.501 ' N ' ' CG ' ' A' ' 63' ' ' GLU . . . -51.39 -19.86 1.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.701 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.672 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -79.33 -53.08 7.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.698 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.683 HD13 ' HA ' ' A' ' 97' ' ' SER . 1.3 tt -56.33 -50.23 72.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.662 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.0 t -52.98 -13.77 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.711 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.42 35.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.758 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 65' ' ' ASP . . . -65.36 -16.71 63.11 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -51.86 -45.85 64.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.762 0.315 . . . . 0.0 110.666 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.48 -47.55 6.34 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 75' ' ' ARG . 2.1 t80 -53.53 -26.39 20.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.862 0.363 . . . . 0.0 110.624 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 72' ' ' TYR . 6.2 ttp85 -36.28 -35.67 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.717 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.523 ' HA ' ' HZ2' ' A' ' 74' ' ' LYS . 2.7 mmtm -70.31 -48.79 55.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.654 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -54.44 -28.92 47.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.695 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 27.5 mt -70.61 -58.11 4.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.689 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 80' ' ' ARG . 65.3 t -50.76 -36.91 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.592 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.38 -21.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.465 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.478 ' N ' ' O ' ' A' ' 77' ' ' VAL . 41.1 t -77.88 -33.25 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.766 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.551 ' N ' ' O ' ' A' ' 77' ' ' VAL . 0.9 OUTLIER -82.31 -39.54 22.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.773 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -59.27 -21.24 59.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.901 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 t -95.19 -54.61 3.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.722 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -132.93 -171.0 2.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.652 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -147.03 45.76 1.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.27 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.537 HD13 ' HA ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -98.69 155.64 17.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.688 -179.852 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.523 ' O ' ' SG ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -80.41 122.27 26.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.239 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.433 ' H ' ' HG2' ' A' ' 114' ' ' MET . . . -127.89 164.19 21.31 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.5 mt -107.66 121.86 61.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.853 0.359 . . . . 0.0 110.448 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.1 t -97.2 125.68 50.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.872 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.66 149.4 5.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.047 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.0 t -132.77 145.08 34.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.892 0.377 . . . . 0.0 110.862 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -92.59 120.69 33.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.399 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -67.34 139.85 57.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.793 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.777 HG23 ' H ' ' A' ' 95' ' ' ARG . 1.9 t -151.08 -108.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.523 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.777 ' H ' HG23 ' A' ' 94' ' ' THR . 4.1 mtt180 -130.07 -74.7 0.54 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.259 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.472 ' SD ' ' OE1' ' A' ' 99' ' ' GLN . 26.6 mmt -55.36 -7.16 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.279 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.683 ' HA ' HD13 ' A' ' 66' ' ' LEU . 1.4 t -54.92 -88.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.671 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.449 ' N ' ' OG ' ' A' ' 97' ' ' SER . 2.2 mm-40 -43.01 -21.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.032 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.472 ' OE1' ' SD ' ' A' ' 96' ' ' MET . 47.9 mt-30 -71.11 -55.07 8.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.845 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -117.08 12.26 14.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.824 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.709 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 0.3 OUTLIER -63.7 -35.46 16.5 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.414 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.709 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 2.7 Cg_exo -71.9 -53.94 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.734 2.289 . . . . 0.0 111.813 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -45.88 -27.77 0.95 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.617 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.57 -44.38 12.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.507 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.64 -32.15 71.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.616 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -73.75 -34.94 64.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.739 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -81.95 -37.35 26.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.801 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.1 p -73.35 -35.78 66.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.928 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.696 ' O ' ' N ' ' A' ' 113' ' ' GLY . 4.0 t -66.84 -55.95 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.942 0.401 . . . . 0.0 110.652 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.35 -30.42 66.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.55 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -84.5 -51.22 7.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.438 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.85 -28.87 10.37 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.538 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.696 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 60.93 33.81 85.12 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.433 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 3.3 mtt -84.84 -179.5 7.1 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 110.543 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.0 t -103.05 124.25 57.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.628 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.5 mp -105.35 143.78 33.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.241 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.421 ' C ' HD23 ' A' ' 117' ' ' LEU . 2.1 tt -157.29 88.59 2.57 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.746 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -58.49 146.27 91.28 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.671 2.247 . . . . 0.0 111.823 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.461 HG23 ' H ' ' A' ' 120' ' ' ALA . 2.3 m -108.23 -107.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.548 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.461 ' H ' HG23 ' A' ' 119' ' ' VAL . . . 179.41 -30.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.391 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 97.2 p -144.23 -173.36 3.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.39 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -85.21 -24.45 27.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.588 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.412 ' O ' ' N ' ' A' ' 127' ' ' CYS . 37.9 mtt -81.37 -41.41 22.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.733 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 128' ' ' LEU . 6.5 mm-40 -45.03 -43.51 9.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.437 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.91 -57.78 6.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.007 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.651 ' CB ' HD13 ' A' ' 30' ' ' LEU . 51.5 p -55.61 -29.67 59.57 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.412 ' N ' ' O ' ' A' ' 123' ' ' MET . 47.1 t -85.04 -35.65 21.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.135 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.721 ' O ' HD12 ' A' ' 128' ' ' LEU . 1.7 tp -72.1 -50.41 28.36 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.11 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.512 ' O ' HG23 ' A' ' 133' ' ' VAL . 54.2 t -55.34 -57.0 8.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.781 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.5 mm -55.77 -45.28 79.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.679 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -57.17 -33.34 67.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.443 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.3 tp -67.17 -37.6 84.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.544 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 129' ' ' VAL . 0.4 OUTLIER -84.15 -42.44 17.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.636 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -61.01 -41.64 96.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.838 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.818 -179.78 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.644 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -133.34 148.83 51.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.343 . . . . 0.0 110.717 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.4 mm -116.75 149.34 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.474 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.1 t -119.32 135.0 61.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.65 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.58 137.23 52.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.31 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.674 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 17.3 t-20 -67.88 135.13 52.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.784 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -54.68 -38.21 66.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.587 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.5 ttmm -80.15 -65.89 0.95 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.514 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.614 ' NE1' ' OD2' ' A' ' 49' ' ' ASP . 19.3 t-105 -42.54 -48.41 5.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.507 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.671 ' O ' ' N ' ' A' ' 28' ' ' SER . 5.4 ttm180 26.33 85.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.481 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 28' ' ' SER . . . -43.39 -8.9 0.01 OUTLIER Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.671 ' N ' ' O ' ' A' ' 26' ' ' ARG . 0.4 OUTLIER 74.31 -143.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.849 0.357 . . . . 0.0 110.39 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 28' ' ' SER . 3.5 mt-30 -39.92 -20.08 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.326 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.029 HD13 ' OG ' ' A' ' 126' ' ' SER . 0.3 OUTLIER -71.57 -52.09 19.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.384 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.81 -29.75 68.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.647 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -65.35 -54.34 30.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.543 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.651 ' O ' ' N ' ' A' ' 36' ' ' GLY . 3.8 mm-40 -59.37 -41.14 88.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.38 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.636 ' SD ' HD13 ' A' ' 40' ' ' LEU . 4.7 mtt -36.85 -33.98 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.459 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 33' ' ' GLU . 42.5 mt-30 -75.28 17.22 0.27 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.434 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -106.62 -4.82 36.92 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm -138.58 -41.33 0.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.685 0.279 . . . . 0.0 110.903 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.479 HG13 ' H ' ' A' ' 39' ' ' LYS . 4.8 tp -132.78 172.43 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.536 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.479 ' H ' HG13 ' A' ' 38' ' ' ILE . 43.0 tttp -85.54 125.9 33.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.613 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.636 HD13 ' SD ' ' A' ' 34' ' ' MET . 18.5 tp -114.98 149.73 36.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.666 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.436 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 3.7 mt -132.14 151.16 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.676 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.429 ' CE2' ' NH2' ' A' ' 26' ' ' ARG . 81.7 m-85 -115.99 131.09 57.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.446 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -137.01 128.37 28.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.608 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -92.13 122.28 34.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.362 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 139.97 -30.96 2.32 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.674 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 1.4 mt -68.61 161.82 27.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.748 0.309 . . . . 0.0 110.477 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.735 ' H ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -111.38 -40.54 0.1 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.914 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.735 ' CD ' ' H ' ' A' ' 47' ' ' THR . 24.7 Cg_exo -59.27 -173.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.59 2.193 . . . . 0.0 112.023 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.614 ' OD2' ' NE1' ' A' ' 25' ' ' TRP . 8.1 m-20 -97.47 -49.89 4.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.368 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -134.33 145.08 48.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.308 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.05 118.74 35.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.873 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 tp -100.75 -30.37 11.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.258 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.624 ' C ' ' H ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -173.35 147.69 1.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.45 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -56.02 2.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.513 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.624 ' H ' ' C ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -124.2 1.27 8.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.529 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 86' ' ' LYS . 7.6 t -156.44 139.26 15.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.962 0.41 . . . . 0.0 110.829 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -142.52 175.03 10.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.007 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.7 mt -137.68 133.15 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.847 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 tp -117.44 134.99 54.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.161 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.428 ' N ' ' OD2' ' A' ' 49' ' ' ASP . 41.6 t80 -107.99 126.66 52.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.881 0.372 . . . . 0.0 110.977 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.407 ' HB ' HG22 ' A' ' 91' ' ' VAL . 98.7 t -113.24 148.6 16.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.958 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.7 t -115.65 150.79 36.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.586 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.585 ' HG2' HG21 ' A' ' 94' ' ' THR . 1.8 pp20? -47.68 -35.15 9.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.485 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.645 ' O ' HG12 ' A' ' 67' ' ' VAL . . . -57.88 -21.12 41.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.287 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 88.7 m-20 -83.89 -37.73 22.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.776 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.572 HD13 ' HA ' ' A' ' 97' ' ' SER . 0.9 OUTLIER -57.26 -47.09 82.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.568 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.645 HG12 ' O ' ' A' ' 64' ' ' ALA . 15.0 p -49.75 -16.19 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.619 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 65' ' ' ASP . . . -81.81 -76.0 0.27 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.624 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.622 ' O ' ' NH2' ' A' ' 73' ' ' ARG . . . 68.7 9.49 59.07 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -164.87 75.44 0.27 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.831 0.348 . . . . 0.0 110.602 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.13 -61.46 0.2 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -73.32 -27.41 61.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.719 0.295 . . . . 0.0 110.653 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.622 ' NH2' ' O ' ' A' ' 69' ' ' GLY . 4.9 ttp180 -48.27 -29.41 3.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.57 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.455 ' CD ' ' O ' ' A' ' 74' ' ' LYS . 1.2 tmtt? -66.58 -30.11 70.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.525 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.403 ' HE ' ' HB2' ' A' ' 75' ' ' ARG . 16.2 tpp180 -65.49 -35.67 81.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.59 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.2 mt -67.61 -50.07 59.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.661 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.6 t -54.46 -38.77 42.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.584 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.72 -41.0 75.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.607 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.2 t -64.91 -35.66 75.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.636 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.73 -28.5 26.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.661 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -80.98 -13.25 59.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.625 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -25.59 34.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.438 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.481 ' CG ' ' N ' ' A' ' 84' ' ' ASN . 51.4 t-20 -174.99 -112.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.635 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.481 ' N ' ' CG ' ' A' ' 83' ' ' ASN . 0.1 OUTLIER -170.82 74.42 0.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.416 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.845 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -133.03 161.37 34.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.714 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 86' ' ' LYS . 1.9 pttt -81.83 118.38 22.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.456 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.74 137.82 9.9 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.0 mt -93.09 141.17 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.764 0.316 . . . . 0.0 110.451 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 89' ' ' VAL . 3.3 t -115.96 108.71 25.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.648 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 117' ' ' LEU . 0.8 OUTLIER -90.76 144.34 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.397 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.407 HG22 ' HB ' ' A' ' 61' ' ' VAL . 59.2 t -130.52 140.0 49.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.685 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -90.8 126.42 36.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.546 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -90.74 140.5 29.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.639 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.585 HG21 ' HG2' ' A' ' 63' ' ' GLU . 18.5 p -144.56 -73.1 0.26 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.473 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.411 ' O ' ' OE1' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -149.8 -72.65 0.18 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.456 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.445 ' O ' ' CD2' ' A' ' 66' ' ' LEU . 48.6 mtt -60.02 -5.82 1.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.457 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.604 ' O ' ' N ' ' A' ' 99' ' ' GLN . 0.2 OUTLIER -73.18 -84.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.522 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 98' ' ' GLU . 1.8 mp0 -36.27 -24.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.687 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.604 ' N ' ' O ' ' A' ' 97' ' ' SER . 1.6 mm100 -69.03 -55.88 9.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.01 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.419 ' C ' HD11 ' A' ' 66' ' ' LEU . 17.8 m-85 -117.55 10.89 13.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.725 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.582 ' CD1' ' C ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -60.8 -61.1 8.66 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.319 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 101' ' ' PHE . 9.5 Cg_endo -54.11 -42.28 68.43 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.678 2.252 . . . . 0.0 111.921 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.04 -41.54 35.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.332 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 tp -77.08 -41.2 43.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.399 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.501 ' HG3' HD22 ' A' ' 116' ' ' LEU . 65.5 tt0 -51.23 -35.12 35.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.342 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.91 -51.0 64.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.275 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -62.88 -55.09 29.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.452 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.52 -40.67 27.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.429 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.686 ' O ' ' N ' ' A' ' 113' ' ' GLY . 6.7 t -67.57 -56.65 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.273 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.88 -28.32 68.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.558 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.48 -52.09 6.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.387 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.7 mp -105.91 -28.72 10.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.36 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 56.56 34.06 63.46 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -88.69 -155.8 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.75 0.31 . . . . 0.0 110.285 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.601 ' C ' HD12 ' A' ' 116' ' ' LEU . 6.2 t -116.83 130.16 72.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.886 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 116' ' ' LEU . 7.0 mp -117.6 125.98 51.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.444 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.646 ' O ' HG13 ' A' ' 90' ' ' VAL . 1.2 mp -126.2 85.28 60.11 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.546 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -58.94 156.94 30.97 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.81 2.34 . . . . 0.0 111.925 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.662 HG23 ' H ' ' A' ' 120' ' ' ALA . 5.9 m -126.16 -107.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.492 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.662 ' H ' HG23 ' A' ' 119' ' ' VAL . . . 172.92 -28.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.126 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.78 165.46 31.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.356 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -64.85 -41.24 95.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.6 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -62.48 -42.42 99.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.648 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.571 ' O ' ' N ' ' A' ' 128' ' ' LEU . 18.3 mm-40 -45.81 -53.53 9.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.247 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 128' ' ' LEU . . . -60.01 -57.99 10.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.702 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . 1.029 ' OG ' HD13 ' A' ' 30' ' ' LEU . 14.6 m -46.23 -33.0 3.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 1.8 t -85.13 -35.6 21.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.947 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.571 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -71.28 -50.46 32.49 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.081 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.0 t -56.75 -56.4 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.171 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 mm -51.29 -51.7 22.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.329 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -50.4 -41.66 52.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.299 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.9 tp -46.41 -54.4 9.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.525 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.429 HG23 ' H ' ' A' ' 133' ' ' VAL . 1.3 t -67.63 -46.07 83.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.283 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -51.0 -39.27 55.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.183 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.292 179.701 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.669 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -73.67 162.24 29.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.914 0.388 . . . . 0.0 110.616 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 20' ' ' VAL . 72.5 mt -119.84 155.73 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.592 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.439 ' N ' HG22 ' A' ' 19' ' ' ILE . 58.3 t -108.84 148.61 12.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.458 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.563 ' HB2' HD22 ' A' ' 40' ' ' LEU . . . -136.0 141.2 44.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.666 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.604 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 66.4 t30 -73.99 132.94 42.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.702 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -48.89 -25.07 1.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.566 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -85.24 -33.12 22.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.533 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -79.49 -4.74 52.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.478 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.469 ' C ' ' H ' ' A' ' 28' ' ' SER . 24.2 ttp180 -70.69 -17.15 62.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.383 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.58 29.22 1.04 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 26' ' ' ARG . 6.1 m -127.66 138.06 52.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.343 . . . . 0.0 110.575 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -62.53 -24.48 67.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.53 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.86 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -61.06 -53.31 58.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.378 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.03 -32.66 6.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.824 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.94 -27.89 49.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.692 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -63.9 -53.01 57.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.502 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.433 ' SD ' HD12 ' A' ' 19' ' ' ILE . 4.2 mtm -59.76 -16.49 28.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.486 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.31 -8.35 55.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.509 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.14 0.79 58.9 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -139.88 -33.68 0.58 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.817 0.342 . . . . 0.0 110.514 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.506 HD13 ' HA ' ' A' ' 38' ' ' ILE . 1.7 mm -127.74 158.17 39.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.444 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.498 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 4.4 ttpm? -90.16 102.34 15.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.236 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.563 HD22 ' HB2' ' A' ' 21' ' ' ALA . 4.7 mt -88.44 130.09 35.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.02 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 mm -108.25 113.71 44.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.086 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -75.72 125.16 28.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.022 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -127.16 115.75 19.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.314 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -79.38 125.9 30.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.447 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.82 -26.71 4.77 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.604 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 3.5 mm? -64.62 140.63 58.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.765 0.317 . . . . 0.0 110.59 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.674 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -92.36 -39.87 0.36 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.625 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.674 ' CD ' ' N ' ' A' ' 47' ' ' THR . 16.4 Cg_exo -64.73 -160.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.808 2.339 . . . . 0.0 111.92 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -111.46 -55.34 2.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.467 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -132.37 132.28 42.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.525 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.527 ' CD1' ' O ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -109.26 109.05 19.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.702 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.68 -41.2 72.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.44 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.482 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 79.3 p -165.66 -174.09 2.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.426 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -79.46 19.53 0.61 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.494 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.42 HH11 ' HG2' ' A' ' 55' ' ' ARG . 0.6 OUTLIER -142.22 3.34 1.55 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.159 -179.695 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.527 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 15.3 m -152.22 152.05 31.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.987 0.422 . . . . 0.0 111.091 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.475 ' SG ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -150.82 158.74 44.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.148 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.9 mt -130.4 132.81 64.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.902 0.382 . . . . 0.0 110.873 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.05 138.1 53.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.068 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -100.56 134.42 43.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.921 0.391 . . . . 0.0 110.931 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 t -131.33 138.66 52.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.336 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 64' ' ' ALA . 4.7 t -116.05 147.38 41.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.395 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -38.84 -37.24 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.49 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.469 ' HB3' HG23 ' A' ' 62' ' ' THR . . . -50.25 -37.05 33.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.461 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 62' ' ' THR . 18.6 m-20 -71.74 -40.35 69.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.698 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.58 HD11 ' C ' ' A' ' 100' ' ' TYR . 1.3 tt -55.42 -43.42 75.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.492 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.456 ' N ' HD23 ' A' ' 66' ' ' LEU . 11.4 t -49.81 -38.21 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.515 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.39 -67.19 0.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.418 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.2 12.33 81.73 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -156.84 138.09 13.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 110.745 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.24 -38.93 3.04 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -82.52 -22.95 34.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.685 0.279 . . . . 0.0 110.805 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.3 ttp85 -68.81 -40.62 79.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.684 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.98 -24.4 2.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.683 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -70.04 -44.65 68.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.597 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.2 mt -58.19 -46.52 85.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.614 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.7 t -45.27 -42.37 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.697 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.4 mmm-85 -45.03 -51.75 9.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.666 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 t -62.44 -26.55 40.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.797 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -82.74 -37.51 24.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.72 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 81' ' ' ASN . 3.1 t-20 -82.31 -8.9 59.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.882 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.5 ' HB3' HD11 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -51.85 -78.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.558 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -153.22 -71.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.472 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -178.67 57.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.296 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.77 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -108.49 143.25 37.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.731 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.85 92.4 9.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.529 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -93.05 162.2 26.0 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.0 mt -116.7 148.48 19.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.809 0.338 . . . . 0.0 110.494 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.84 118.54 55.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.719 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.71 135.69 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.476 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.422 ' H ' ' HA ' ' A' ' 118' ' ' PRO . 46.8 t -119.58 148.92 22.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.691 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -98.79 133.35 43.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.235 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -86.09 140.34 30.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.877 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.417 ' HB ' ' H ' ' A' ' 95' ' ' ARG . 2.2 m -145.91 -79.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.256 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.417 ' H ' ' HB ' ' A' ' 94' ' ' THR . 64.6 mtt-85 -141.07 -70.45 0.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.358 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 20.7 mmt -63.09 -11.45 19.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.42 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.637 ' O ' ' N ' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -54.78 -95.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.669 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.626 ' N ' ' OG ' ' A' ' 97' ' ' SER . 3.0 pt-20 -36.27 -29.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.996 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.512 ' N ' ' O ' ' A' ' 97' ' ' SER . 2.3 mm-40 -65.9 -55.24 17.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.906 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.58 ' C ' HD11 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -117.62 12.74 14.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.968 -179.564 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.637 ' N ' ' O ' ' A' ' 97' ' ' SER . 21.2 t80 -68.24 -37.37 10.78 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.244 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 50.4 Cg_endo -78.3 -30.93 3.05 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.04 1.827 . . . . 0.0 111.959 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.84 95.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.962 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.476 ' O ' HD23 ' A' ' 104' ' ' LEU . 4.6 tt -73.48 -45.84 51.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.044 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.457 ' O ' HG23 ' A' ' 109' ' ' VAL . 5.3 tt0 -54.65 -34.61 62.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.013 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -63.11 -36.75 84.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.162 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' A' ' 111' ' ' ASP . 1.7 m-85 -79.54 -53.33 6.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.194 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.7 m -51.99 -36.34 49.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.33 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.602 ' O ' ' N ' ' A' ' 113' ' ' GLY . 8.9 t -65.82 -59.9 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.494 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.879 ' O ' HD23 ' A' ' 110' ' ' LEU . 2.2 tt -67.04 -22.6 65.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.496 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 107' ' ' PHE . 1.3 m-20 -84.53 -55.41 4.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.81 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.9 mp -106.14 -28.42 10.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.987 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 49.69 50.05 32.36 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 2.3 mtm -105.84 -165.79 1.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.784 0.326 . . . . 0.0 110.368 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.8 t -90.44 110.5 22.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.538 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 117' ' ' LEU . 3.8 tt -111.15 126.17 54.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.522 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.551 ' N ' HD23 ' A' ' 116' ' ' LEU . 5.3 tp -146.15 107.6 4.22 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.682 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.422 ' HA ' ' H ' ' A' ' 91' ' ' VAL . 71.9 Cg_endo -78.78 169.58 19.37 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.388 2.058 . . . . 0.0 112.185 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.604 HG23 ' N ' ' A' ' 120' ' ' ALA . 19.4 m -131.91 -118.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.576 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.604 ' N ' HG23 ' A' ' 119' ' ' VAL . . . -167.27 -40.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.538 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.3 m -136.08 155.71 49.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.398 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -59.91 -20.75 59.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.547 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.683 ' N ' ' SD ' ' A' ' 123' ' ' MET . 0.8 OUTLIER -78.06 -33.05 51.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.585 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.634 ' O ' ' N ' ' A' ' 128' ' ' LEU . 1.6 mm-40 -54.26 -55.36 28.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.758 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -51.51 -58.22 6.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.249 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.729 ' HB2' HD13 ' A' ' 30' ' ' LEU . 3.9 t -48.89 -33.39 10.62 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.16 -30.13 24.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.874 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.634 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.5 OUTLIER -74.42 -49.72 21.34 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.074 179.676 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.99 -55.14 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.279 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 44.2 mt -51.03 -54.04 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.408 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -42.31 -35.15 0.92 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.596 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.96 -60.25 3.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.598 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.7 t -63.85 -38.63 82.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.351 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -60.03 -31.86 70.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.401 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.429 179.855 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.509 ' O ' HD11 ' A' ' 38' ' ' ILE . . . . . . . . 0 CA--C 1.525 0.692 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.486 ' C ' ' ND1' ' A' ' 18' ' ' HIS . 4.1 p80 -112.55 155.06 24.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.659 0.266 . . . . 0.0 110.429 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 20' ' ' VAL . 24.9 mm -107.24 159.41 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.737 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.545 HG11 ' OE2' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -125.96 141.22 46.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.609 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -126.12 143.87 50.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.586 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 25' ' ' TRP . 30.1 t30 -64.33 131.46 47.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.524 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -41.42 -32.89 0.36 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.515 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -78.15 -30.44 49.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.517 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.582 ' N ' ' O ' ' A' ' 22' ' ' ASN . 18.8 t-105 -77.91 -10.78 59.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.586 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.508 ' C ' ' H ' ' A' ' 28' ' ' SER . 10.8 ttt-85 -60.08 -37.0 78.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.732 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.06 40.81 0.26 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.508 ' H ' ' C ' ' A' ' 26' ' ' ARG . 69.8 m -128.47 136.54 50.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.753 0.311 . . . . 0.0 110.662 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -67.9 -21.25 65.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.222 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.942 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -71.72 -52.48 17.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.288 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.523 ' O ' HD22 ' A' ' 40' ' ' LEU . . . -49.02 -27.64 3.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.482 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -79.07 -34.7 43.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.738 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -58.34 -43.94 88.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.764 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.429 ' C ' ' H ' ' A' ' 36' ' ' GLY . 28.2 mtt -54.33 -32.64 57.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.804 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -71.0 8.96 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.593 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 34' ' ' MET . . . -95.34 -11.37 56.0 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -142.59 -49.19 0.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.812 0.339 . . . . 0.0 110.671 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.509 HD11 ' O ' ' A' ' 17' ' ' GLY . 10.4 tp -106.03 165.95 3.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.326 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.451 ' N ' HG13 ' A' ' 38' ' ' ILE . 22.7 tttp -85.68 143.99 28.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.285 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.523 HD22 ' O ' ' A' ' 31' ' ' ALA . 19.8 tp -127.82 156.25 42.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.449 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 50.1 mt -145.77 142.56 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.359 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.04 127.63 51.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.688 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.545 ' OE2' HG11 ' A' ' 20' ' ' VAL . 57.3 mt-10 -127.36 124.23 38.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.443 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.39 94.54 9.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.778 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 166.59 -32.26 0.21 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.474 ' O ' ' OD1' ' A' ' 22' ' ' ASN . 11.1 mp -66.92 159.62 27.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 110.491 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.555 ' H ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -103.79 -48.21 0.15 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.758 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.555 ' CD ' ' H ' ' A' ' 47' ' ' THR . 37.8 Cg_exo -56.36 -171.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.762 2.308 . . . . 0.0 112.039 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -97.92 -55.44 2.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.737 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -125.79 128.65 48.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.909 0.385 . . . . 0.0 110.649 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.687 ' CE2' ' O ' ' A' ' 53' ' ' SER . 4.0 t80 -107.87 105.43 15.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.594 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 mp -74.32 -30.53 62.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.438 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.687 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 2.0 p 177.41 -173.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.399 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -86.54 65.0 8.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.587 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -178.75 -30.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.824 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.422 ' HG ' ' HB2' ' A' ' 86' ' ' LYS . 1.2 m -140.29 132.4 27.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.918 0.389 . . . . 0.0 111.136 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 30.9 p -134.91 173.76 11.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.984 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.2 mt -139.99 131.74 32.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.289 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.0 tp -112.53 117.37 32.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.85 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -83.94 117.49 23.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.97 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.8 t -116.25 140.86 36.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.207 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.4 p -126.25 156.73 39.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.965 0.412 . . . . 0.0 110.92 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 96' ' ' MET . 2.9 tt0 -40.42 -43.43 1.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.731 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -43.48 -30.16 0.53 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.381 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -82.69 -47.72 11.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.308 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.538 HD11 ' C ' ' A' ' 100' ' ' TYR . 1.3 tt -50.82 -38.3 47.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.357 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.555 HG22 ' SD ' ' A' ' 96' ' ' MET . 3.2 t -45.95 -53.09 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.436 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -44.28 -76.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.481 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.29 -24.4 29.1 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -151.56 133.43 14.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 0.0 110.704 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.13 -54.94 0.73 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -62.68 -35.36 79.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.681 0.277 . . . . 0.0 110.6 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.475 HH11 ' HB3' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -49.51 -40.78 38.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.877 0.37 . . . . 0.0 110.165 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.431 ' N ' ' HD2' ' A' ' 73' ' ' ARG . 1.8 ttpp -54.6 -35.87 63.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.043 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.2 ttt85 -69.22 -42.31 75.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.151 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 34.8 mt -61.71 -21.5 64.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.271 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.2 t -81.35 -39.28 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.486 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -61.04 -20.99 63.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.647 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.4 t -70.36 -50.06 49.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.012 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 49.2 ttt-85 -71.24 -43.58 66.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.907 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -52.66 -27.48 17.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.68 ' OG ' ' N ' ' A' ' 83' ' ' ASN . 0.3 OUTLIER -46.6 -74.42 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.82 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.68 ' N ' ' OG ' ' A' ' 82' ' ' SER . 2.7 m120 -140.18 -98.22 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.834 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -165.56 37.59 0.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.781 0.324 . . . . 0.0 110.718 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.92 157.52 17.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.605 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.422 ' HB2' ' HG ' ' A' ' 56' ' ' CYS . 7.6 mmmt -88.94 100.05 12.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.493 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -95.71 141.26 15.48 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 60.7 mt -103.02 135.65 39.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.816 0.341 . . . . 0.0 110.435 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.4 t -108.93 103.75 16.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.656 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.1 t -93.94 142.07 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.351 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.486 ' O ' HG22 ' A' ' 119' ' ' VAL . 93.8 t -122.64 149.59 26.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.674 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -107.67 107.12 17.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.633 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -68.17 132.82 47.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.211 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.2 m -137.42 -79.51 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.785 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.3 mtp85 -141.17 -70.25 0.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.581 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.555 ' SD ' HG22 ' A' ' 67' ' ' VAL . 16.2 mtt -63.77 -10.78 21.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.496 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.643 ' O ' ' N ' ' A' ' 99' ' ' GLN . 82.8 p -62.02 -88.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.769 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.444 ' N ' ' OG ' ' A' ' 97' ' ' SER . 0.2 OUTLIER -36.09 -22.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.006 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.643 ' N ' ' O ' ' A' ' 97' ' ' SER . 7.0 mt-30 -73.62 -54.77 7.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.913 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.538 ' C ' HD11 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -117.52 12.67 14.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.617 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.699 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 3.1 t80 -63.03 -34.94 15.16 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.647 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.699 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 14.7 Cg_exo -66.66 -49.99 1.43 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.604 2.203 . . . . 0.0 111.821 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -47.19 -49.2 23.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.423 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.568 ' O ' ' OG1' ' A' ' 108' ' ' THR . 2.7 tp -65.37 -51.2 62.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.423 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.543 ' O ' HG23 ' A' ' 109' ' ' VAL . 2.7 tt0 -49.93 -33.51 17.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.632 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.29 -52.98 15.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.571 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.92 -52.18 66.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.671 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.568 ' OG1' ' O ' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -58.82 -30.04 67.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.596 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 105' ' ' GLN . 2.3 t -70.98 -41.38 76.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.627 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 110' ' ' LEU . 16.5 tp -81.36 -33.78 32.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.643 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.73 -47.19 10.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.471 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 113' ' ' GLY . 2.3 mm? -102.16 -28.33 12.37 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.184 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.5 ' CA ' ' O ' ' A' ' 109' ' ' VAL . . . 34.66 38.23 0.12 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -89.33 -156.12 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.734 0.302 . . . . 0.0 110.339 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.5 t -101.35 116.22 44.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.717 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.839 ' C ' HD12 ' A' ' 117' ' ' LEU . 7.4 mp -104.71 138.15 41.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.522 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.839 HD12 ' C ' ' A' ' 116' ' ' LEU . 6.0 mp -147.32 85.63 6.74 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.732 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -61.72 165.59 13.52 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.751 2.301 . . . . 0.0 111.764 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 91' ' ' VAL . 6.8 m -132.74 -115.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.515 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.454 ' N ' HG23 ' A' ' 119' ' ' VAL . . . -178.71 -43.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.324 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.498 ' OG ' ' OE1' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -133.16 172.44 12.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.434 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -73.88 -16.63 61.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.645 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.481 ' O ' ' N ' ' A' ' 127' ' ' CYS . 54.8 mtp -85.57 -42.0 14.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.695 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.672 ' O ' ' N ' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -46.75 -53.92 10.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.527 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.16 -57.85 11.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.232 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.792 ' OG ' HD13 ' A' ' 30' ' ' LEU . 11.1 m -53.95 -33.3 56.48 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.481 ' N ' ' O ' ' A' ' 123' ' ' MET . 6.8 t -85.36 -29.37 24.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.666 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.856 ' O ' HD12 ' A' ' 128' ' ' LEU . 1.6 tp -80.51 -36.53 33.1 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.608 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 64.4 t -63.92 -40.73 90.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.785 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.9 mt -63.32 -51.56 69.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.349 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -42.87 -42.24 3.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.316 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.7 mt -61.39 -57.36 12.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.528 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.6 t -49.07 -55.91 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.627 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -42.96 -30.62 0.43 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.533 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.398 179.86 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.679 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -148.81 154.65 39.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 110.639 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.465 HG22 ' N ' ' A' ' 20' ' ' VAL . 33.0 mm -126.52 157.09 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.262 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.465 ' N ' HG22 ' A' ' 19' ' ' ILE . 63.3 t -113.11 148.36 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.015 0.436 . . . . 0.0 110.898 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 41' ' ' ILE . . . -137.84 159.33 42.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.203 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.564 ' O ' ' N ' ' A' ' 25' ' ' TRP . 57.6 t30 -92.15 139.49 30.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.839 0.352 . . . . 0.0 110.721 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -39.29 -47.49 1.7 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.585 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -63.28 -31.76 73.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.594 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.661 ' NE1' ' OD2' ' A' ' 49' ' ' ASP . 1.6 t-105 -76.79 -1.82 30.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.67 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.473 ' C ' ' HE ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -76.21 -26.93 56.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.538 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.82 33.11 3.1 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.4 m -122.7 142.38 50.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.8 0.333 . . . . 0.0 110.597 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -66.13 -23.11 66.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.33 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.917 HD13 ' OG ' ' A' ' 126' ' ' SER . 0.4 OUTLIER -67.85 -55.33 13.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.539 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.412 ' N ' ' HG ' ' A' ' 30' ' ' LEU . . . -48.25 -22.59 0.69 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.023 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -81.41 -45.97 15.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.905 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -50.73 -33.37 22.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.834 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.69 ' SD ' HD13 ' A' ' 40' ' ' LEU . 11.9 mtt -66.18 -33.58 76.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.752 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -70.12 -17.36 63.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.658 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.97 4.31 86.07 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm -147.82 -56.7 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.899 0.38 . . . . 0.0 110.485 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.535 ' O ' ' O ' ' A' ' 34' ' ' MET . 7.8 tp -112.18 165.13 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.426 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.433 ' H ' HG13 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -88.03 110.54 20.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.573 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.69 HD13 ' SD ' ' A' ' 34' ' ' MET . 17.7 tp -96.96 137.0 36.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.757 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.456 ' O ' ' N ' ' A' ' 21' ' ' ALA . 20.6 mt -113.49 139.33 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.412 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -105.93 142.8 35.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.85 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -153.99 116.96 4.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.456 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -77.87 134.29 37.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.569 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 122.98 -32.2 4.48 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 75.2 mt -59.84 144.53 48.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.735 0.302 . . . . 0.0 110.668 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.535 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -88.42 -64.52 0.2 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.727 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.535 ' CD ' ' CB ' ' A' ' 47' ' ' THR . 9.6 Cg_endo -54.15 -174.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.779 2.32 . . . . 0.0 112.18 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.661 ' OD2' ' NE1' ' A' ' 25' ' ' TRP . 35.1 t0 -93.26 -66.17 0.94 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.431 ' CE2' ' CG ' ' A' ' 49' ' ' ASP . 68.6 m-85 -118.28 162.19 18.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.609 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.95 142.52 50.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.081 0.467 . . . . 0.0 110.977 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.437 ' HA ' HD13 ' A' ' 52' ' ' LEU . 0.8 OUTLIER -119.88 -24.85 6.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.776 179.502 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.412 ' OG ' ' C ' ' A' ' 52' ' ' LEU . 0.7 OUTLIER -169.77 179.27 3.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.059 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -77.69 4.64 11.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.818 0.342 . . . . 0.0 110.52 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -133.65 -4.39 2.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.879 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.7 m -129.66 134.66 47.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.95 0.405 . . . . 0.0 110.947 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.3 p -146.45 171.06 15.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.118 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 mt -138.82 138.48 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.995 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.11 136.49 54.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.135 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.424 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 29.5 t80 -96.98 115.3 27.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.846 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 92' ' ' GLU . 6.7 t -121.75 149.05 24.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.193 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.6 t -135.87 163.78 29.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 0.0 110.908 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.784 ' OE2' HG23 ' A' ' 67' ' ' VAL . 4.8 tp10 -41.21 -48.68 3.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.589 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -47.61 -29.8 3.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.522 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 1.1 m-20 -77.43 -45.47 25.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.529 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.407 ' CD1' ' HA ' ' A' ' 101' ' ' PHE . 1.6 tt -48.94 -40.48 30.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.651 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.784 HG23 ' OE2' ' A' ' 63' ' ' GLU . 24.9 t -64.91 -42.57 95.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.672 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.529 ' C ' ' H ' ' A' ' 70' ' ' ASN . . . -91.16 26.3 2.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.597 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.95 -3.81 0.35 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 68' ' ' ALA . 50.0 t30 -89.93 37.77 0.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.815 0.341 . . . . 0.0 110.504 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -175.54 -32.77 0.04 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -82.73 -38.27 23.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.842 0.353 . . . . 0.0 110.441 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.3 ttt-85 -48.34 -50.49 30.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.646 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -54.59 -43.76 72.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.569 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -49.95 -50.87 45.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.557 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.2 mt -53.52 -41.59 66.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.799 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 62.5 t -57.06 -33.36 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.762 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -49.22 77.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.622 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.8 t -47.42 -41.56 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.505 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.1 ttt-85 -82.02 -21.12 37.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.476 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -65.0 -25.0 67.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.588 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 t -58.04 -68.38 0.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.507 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -160.29 -69.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.577 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -178.5 66.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.541 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.6 mp -91.43 127.92 37.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.53 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.1 87.96 4.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.429 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -104.72 175.7 22.58 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.6 mt -106.27 137.62 35.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 0.0 110.454 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.6 t -109.48 116.92 53.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.779 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.5 t -104.38 134.89 44.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.427 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.6 t -124.6 134.61 66.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.636 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 61' ' ' VAL . 5.0 tt0 -98.03 100.35 11.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.487 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.435 ' HB2' ' NZ ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -70.14 134.47 48.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.629 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.622 HG22 ' HG2' ' A' ' 95' ' ' ARG . 6.4 m -127.07 -64.97 0.97 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.637 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.622 ' HG2' HG22 ' A' ' 94' ' ' THR . 0.0 OUTLIER -150.5 -73.1 0.17 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.395 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -64.14 -4.06 3.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.142 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.654 ' O ' ' N ' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -75.53 -87.6 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.361 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 97' ' ' SER . 1.7 mt-10 -35.84 -26.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.991 0.424 . . . . 0.0 110.365 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.833 ' NE2' ' CD2' ' A' ' 100' ' ' TYR . 0.1 OUTLIER -69.56 -56.08 8.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.972 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.833 ' CD2' ' NE2' ' A' ' 99' ' ' GLN . 2.7 m-85 -116.57 12.68 15.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.922 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.731 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 22.0 t80 -69.63 -32.69 3.22 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.075 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.731 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 16.0 Cg_exo -64.8 -50.24 2.47 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.526 2.151 . . . . 0.0 111.997 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.84 -36.84 49.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.66 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.466 ' O ' ' OG1' ' A' ' 108' ' ' THR . 1.3 tp -77.26 -34.59 55.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.394 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.95 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.8 OUTLIER -68.07 -38.27 82.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.355 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -65.65 -28.19 68.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.34 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.69 -54.19 5.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.49 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -54.11 -32.05 53.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.703 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 105' ' ' GLN . 79.3 t -62.81 -62.75 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.743 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 85.8 mt -66.44 -20.01 65.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.776 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -83.99 -56.68 3.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.6 mp -105.93 -26.56 11.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.062 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 48.93 46.53 32.28 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 5.0 tpp -95.99 -156.92 0.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 0.0 110.448 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.68 106.39 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.56 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 mp -101.5 124.94 47.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.329 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.5 mt -137.9 87.27 16.92 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.711 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -55.27 165.67 2.89 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.601 2.201 . . . . 0.0 111.831 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.536 HG23 ' H ' ' A' ' 120' ' ' ALA . 15.3 m -133.11 -116.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.72 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.536 ' H ' HG23 ' A' ' 119' ' ' VAL . . . 172.68 -32.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.364 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.1 p -129.39 153.49 47.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.44 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -64.68 -22.58 67.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.682 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.612 ' N ' ' SD ' ' A' ' 123' ' ' MET . 0.0 OUTLIER -83.4 -40.46 19.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.816 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.636 ' O ' ' N ' ' A' ' 128' ' ' LEU . 3.5 mm-40 -45.71 -50.76 13.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.641 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.41 -58.01 10.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.865 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.917 ' OG ' HD13 ' A' ' 30' ' ' LEU . 6.3 m -49.86 -33.95 18.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -82.88 -31.68 27.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.667 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -72.92 -33.21 65.83 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.407 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 92.0 t -81.43 -51.41 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.557 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 54.6 mt -55.11 -44.6 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.702 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -52.23 -42.7 63.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.944 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 tp -52.18 -56.64 13.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.821 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 86.7 t -55.25 -55.85 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.009 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -47.07 -48.15 22.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.99 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.018 -179.562 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.646 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.61 166.15 13.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.418 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.7 mt -128.18 144.33 38.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.717 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -103.44 141.2 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.461 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.17 138.07 54.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.611 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 47.7 t30 -74.2 122.92 23.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.548 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -47.18 -25.22 0.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.556 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.484 ' HB3' ' ND2' ' A' ' 22' ' ' ASN . 7.6 tttm -76.34 -36.11 58.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.412 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.565 ' CG ' ' O ' ' A' ' 25' ' ' TRP . 34.8 t-105 -91.43 -1.34 57.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.501 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.54 ' C ' ' H ' ' A' ' 28' ' ' SER . 24.0 ttt180 -70.46 -15.16 62.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.571 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.56 24.19 0.49 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.54 ' H ' ' C ' ' A' ' 26' ' ' ARG . 0.4 OUTLIER -123.8 144.03 49.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.826 0.346 . . . . 0.0 110.618 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.56 ' O ' ' OE2' ' A' ' 33' ' ' GLU . 40.9 mt-30 -75.13 -16.93 60.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.537 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.803 HD13 ' N ' ' A' ' 31' ' ' ALA . 1.9 tm? -53.26 -65.05 0.63 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.238 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.803 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -49.69 -37.91 30.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.829 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -55.14 -30.85 60.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.896 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.647 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 0.4 OUTLIER -72.75 -45.94 56.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.746 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.593 ' SD ' HG11 ' A' ' 129' ' ' VAL . 3.8 mtm -44.84 -31.39 1.21 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.364 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -69.46 9.74 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.676 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -89.51 -31.39 11.58 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -131.24 -43.86 1.04 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.929 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.466 ' HA ' HD12 ' A' ' 38' ' ' ILE . 10.1 tp -103.03 162.33 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.698 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.415 ' N ' HG13 ' A' ' 38' ' ' ILE . 8.1 tttt -86.34 150.02 24.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.435 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.571 ' CD2' ' HB1' ' A' ' 31' ' ' ALA . 13.2 tp -137.17 131.6 32.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 mt -115.21 123.73 71.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.272 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.444 ' CD1' ' HD2' ' A' ' 26' ' ' ARG . 75.0 m-85 -88.74 120.35 30.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.801 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -126.14 132.45 51.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.45 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -95.2 103.75 15.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.628 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 154.29 -19.33 0.63 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.51 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 3.9 mm? -66.8 146.13 54.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 0.0 110.599 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.498 ' H ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -87.3 -58.54 0.28 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.804 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.498 ' HD2' ' H ' ' A' ' 47' ' ' THR . 37.7 Cg_endo -69.14 -158.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.616 2.211 . . . . 0.0 112.158 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.604 ' CG ' ' H ' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -90.76 -61.34 1.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.776 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -121.84 160.32 24.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.83 0.347 . . . . 0.0 110.871 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.505 ' CD2' HD12 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -142.06 101.48 3.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.535 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 mp -76.89 -38.7 53.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.465 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 54' ' ' ASN . 15.1 t -168.39 176.01 6.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.471 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.426 ' N ' ' OG ' ' A' ' 53' ' ' SER . 20.2 m-80 -76.65 49.49 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.451 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -161.28 -37.63 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.595 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.7 t -120.25 143.15 48.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.846 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.681 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -150.64 165.93 31.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.011 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.681 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 75.1 mt -137.55 131.64 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.76 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.495 HD23 ' OD1' ' A' ' 49' ' ' ASP . 0.4 OUTLIER -118.39 127.04 53.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.202 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.604 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 19.5 t80 -90.28 130.02 36.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.005 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 37.3 t -126.75 146.95 31.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.204 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.7 t -129.46 153.72 47.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.923 0.392 . . . . 0.0 110.944 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.426 ' HG3' ' H ' ' A' ' 97' ' ' SER . 0.5 OUTLIER -41.35 -44.42 2.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.617 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -48.41 -30.13 4.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.604 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.51 -31.13 37.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.528 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.734 HD23 ' N ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -64.45 -43.15 95.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.362 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.734 ' N ' HD23 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -46.03 -32.33 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.59 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 69' ' ' GLY . . . -103.2 -53.8 2.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.656 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 68' ' ' ALA . . . 36.12 37.41 0.18 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -115.38 -57.55 2.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.76 0.314 . . . . 0.0 110.639 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.8 -37.77 33.1 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.409 ' OH ' HD21 ' A' ' 59' ' ' LEU . 1.1 t80 -67.69 -23.37 65.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 0.0 110.653 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.2 tmm_? -60.51 -46.65 89.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.668 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -68.65 -24.63 64.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.33 -50.33 54.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.751 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.519 ' O ' HD21 ' A' ' 112' ' ' LEU . 22.0 mt -58.07 -26.04 62.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 80' ' ' ARG . 92.4 t -73.52 -45.7 50.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.028 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -42.17 -48.78 4.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.836 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 37.4 t -58.48 -27.46 33.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.453 ' N ' ' O ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -80.6 -37.65 30.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.57 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -63.33 -15.13 56.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.671 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 83' ' ' ASN . 92.9 p -59.79 -111.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.521 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.531 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER -117.86 -68.34 0.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.539 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.531 ' CG ' ' O ' ' A' ' 83' ' ' ASN . 16.0 m-20 176.98 63.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.428 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.461 ' CD1' ' OD1' ' A' ' 83' ' ' ASN . 4.0 mp -98.05 133.87 41.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.743 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -84.83 101.39 12.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.299 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.65 129.56 9.21 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.3 mt -86.51 135.86 24.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.796 0.332 . . . . 0.0 110.453 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.3 t -101.7 107.47 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.663 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.5 t -89.95 138.29 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.336 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.1 t -125.53 148.55 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.367 . . . . 0.0 110.899 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -118.97 110.1 16.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.188 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -66.45 146.33 54.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.749 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.424 HG22 ' CG ' ' A' ' 95' ' ' ARG . 5.1 m -141.67 -75.39 0.3 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.468 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.424 ' CG ' HG22 ' A' ' 94' ' ' THR . 5.8 mtp85 -141.22 -69.62 0.38 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.702 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 5.6 mmt -69.3 -10.77 59.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.631 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.645 ' HA ' HD13 ' A' ' 66' ' ' LEU . 5.3 p -50.56 -94.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.737 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 97' ' ' SER . 5.3 mt-10 -36.31 -25.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.906 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.583 ' N ' ' O ' ' A' ' 97' ' ' SER . 3.4 mm100 -73.75 -51.31 16.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.709 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.61 ' C ' HD11 ' A' ' 66' ' ' LEU . 1.1 t80 -114.59 11.83 17.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.649 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.729 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 28.8 t80 -69.76 -32.58 3.09 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.889 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.729 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 11.0 Cg_exo -67.1 -58.93 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.553 2.169 . . . . 0.0 111.938 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -47.85 -38.53 16.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.836 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 38.8 tp -73.15 -53.78 10.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.658 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -47.69 -36.5 11.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.642 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -64.53 -41.28 96.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.412 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -73.16 -46.0 53.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.648 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -35.19 74.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.894 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.672 ' O ' ' N ' ' A' ' 113' ' ' GLY . 3.6 t -76.65 -54.41 13.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.892 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.63 -29.73 69.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.915 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -84.66 -51.04 7.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.377 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.519 HD21 ' O ' ' A' ' 76' ' ' LEU . 8.9 mp -105.04 -28.5 11.01 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.584 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 55.01 16.13 7.67 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.768 ' N ' ' SD ' ' A' ' 114' ' ' MET . 0.0 OUTLIER -70.94 -155.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 0.0 110.762 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.2 t -109.65 138.21 38.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.711 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.606 ' O ' HD12 ' A' ' 117' ' ' LEU . 1.5 pp -129.38 127.05 40.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.508 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.606 HD12 ' O ' ' A' ' 116' ' ' LEU . 1.3 mp -132.73 101.24 14.27 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.482 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -79.01 156.36 26.56 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.526 2.151 . . . . 0.0 112.256 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.573 HG23 ' H ' ' A' ' 120' ' ' ALA . 5.6 m -130.35 -110.64 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.545 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.573 ' H ' HG23 ' A' ' 119' ' ' VAL . . . 170.96 -29.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.563 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.567 ' OG ' ' N ' ' A' ' 122' ' ' GLN . 0.4 OUTLIER -149.22 179.94 7.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.553 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.567 ' N ' ' OG ' ' A' ' 121' ' ' SER . 1.7 pt20 -73.69 -45.76 50.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.584 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.421 ' CG ' ' N ' ' A' ' 124' ' ' GLU . 8.7 ptt? -45.28 -43.21 10.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.646 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.624 ' O ' ' N ' ' A' ' 128' ' ' LEU . 16.6 mm-40 -59.74 -56.24 24.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.549 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.94 -58.38 8.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.104 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 122' ' ' GLN . 0.0 OUTLIER -47.47 -34.16 7.04 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 42.1 t -85.51 -31.02 22.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.321 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.624 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -76.01 -45.25 35.47 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.842 0.353 . . . . 0.0 110.625 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.593 HG11 ' SD ' ' A' ' 34' ' ' MET . 14.8 t -58.82 -54.67 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.616 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 96.3 mt -54.79 -52.62 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.616 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -48.9 -32.0 8.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.429 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.2 tp -61.71 -62.92 1.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.474 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.4 t -68.47 -36.89 76.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.506 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -58.35 -31.94 68.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.542 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.559 -179.954 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.681 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -150.09 159.65 44.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.68 0.276 . . . . 0.0 110.302 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.0 159.5 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.893 0.377 . . . . 0.0 110.77 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.0 t -114.26 143.46 23.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.347 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -133.96 150.51 51.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.697 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.667 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 18.3 t-20 -80.78 138.68 36.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.612 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -58.47 -32.69 68.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.778 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -75.5 -76.54 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.462 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.701 ' O ' ' N ' ' A' ' 27' ' ' GLY . 65.5 t-105 -54.86 -24.31 22.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.065 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.678 ' O ' ' N ' ' A' ' 28' ' ' SER . 4.8 ttt-85 22.39 39.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.953 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.701 ' N ' ' O ' ' A' ' 25' ' ' TRP . . . 16.47 47.49 0.01 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 26' ' ' ARG . 3.0 m 46.3 174.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 0.0 110.53 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -42.07 -23.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.477 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.879 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -46.67 -45.4 19.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.781 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.452 ' N ' ' HG ' ' A' ' 30' ' ' LEU . . . -63.59 -25.73 68.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.54 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -80.8 -30.85 35.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -68.94 -37.38 78.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.624 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.431 ' CE ' HD11 ' A' ' 30' ' ' LEU . 6.0 mtt -48.22 -26.26 1.86 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.537 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -69.63 -2.46 11.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.569 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.61 -8.78 62.03 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -136.51 -46.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.399 . . . . 0.0 110.458 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.504 ' HA ' HD12 ' A' ' 38' ' ' ILE . 6.1 tp -126.0 172.31 13.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.183 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.479 ' H ' HG13 ' A' ' 38' ' ' ILE . 52.0 tttp -85.5 127.13 34.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.889 0.376 . . . . 0.0 110.525 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.821 HD13 ' N ' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -120.07 131.03 54.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.397 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.821 ' N ' HD13 ' A' ' 40' ' ' LEU . 44.9 mt -114.14 152.68 15.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.533 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 3.1 m-85 -118.39 121.06 39.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.687 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -125.34 126.87 45.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.343 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -88.15 144.51 26.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.756 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.51 5.42 57.86 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.667 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 8.1 mt -77.39 155.6 31.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 0.0 110.693 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.562 ' H ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -93.87 -63.72 0.14 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.788 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.562 ' HD2' ' H ' ' A' ' 47' ' ' THR . 18.6 Cg_endo -61.47 -178.31 0.27 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.662 2.242 . . . . 0.0 111.811 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.63 ' OD2' ' NE1' ' A' ' 25' ' ' TRP . 4.1 m-20 -97.91 -32.86 11.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.562 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -147.03 125.09 12.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.412 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.437 ' OH ' ' CD2' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -108.4 110.29 21.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.698 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.18 -43.71 32.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.394 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 55' ' ' ARG . 0.7 OUTLIER -163.38 153.08 15.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.622 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -58.95 70.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.718 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.589 ' N ' ' O ' ' A' ' 53' ' ' SER . 4.6 ttt-85 173.59 -26.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.652 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.6 m -140.56 131.32 25.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.497 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.591 ' SG ' HD13 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -121.88 175.38 6.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.561 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.0 mt -138.54 130.77 38.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.611 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.1 tp -111.75 131.81 55.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.383 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -100.92 122.72 43.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.558 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.463 ' HB ' HG22 ' A' ' 91' ' ' VAL . 61.9 t -117.78 146.37 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.501 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -121.18 141.78 50.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.694 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -38.67 -37.92 0.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.511 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -50.02 -39.72 42.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.544 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.67 -40.75 84.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.512 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.516 HD13 ' HA ' ' A' ' 97' ' ' SER . 1.3 tt -57.66 -37.97 74.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.479 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 67' ' ' VAL . 71.7 t -45.48 -15.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.361 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 66' ' ' LEU . . . -110.3 -56.88 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.456 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 47.75 24.82 3.13 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -155.71 43.17 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.792 0.329 . . . . 0.0 110.652 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -166.55 -37.83 0.02 OUTLIER Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.478 ' O ' ' N ' ' A' ' 75' ' ' ARG . 20.7 t80 -82.67 -25.15 33.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.763 0.316 . . . . 0.0 110.888 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -45.52 -33.04 2.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.495 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.96 -26.91 67.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.461 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.774 HH21 ' HE ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -76.68 -34.11 58.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.349 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.0 -38.13 89.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.577 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.05 -41.0 89.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.497 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.774 ' HE ' HH21 ' A' ' 75' ' ' ARG . 0.0 OUTLIER -47.62 -28.52 2.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.85 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.7 t -71.19 -27.81 30.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.876 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -79.06 -48.02 15.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.709 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.466 ' O ' ' C ' ' A' ' 82' ' ' SER . 12.7 t-20 -50.88 -49.82 58.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.773 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.466 ' C ' ' O ' ' A' ' 81' ' ' ASN . 1.7 t -33.88 -66.47 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.679 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -155.66 -141.15 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.628 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -129.02 54.06 1.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.587 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.832 ' O ' HD12 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -99.99 140.4 34.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.523 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.48 88.96 6.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.478 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.01 179.6 51.05 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 44.1 mt -121.8 115.75 47.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.801 0.334 . . . . 0.0 110.415 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.0 t -85.13 109.84 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.592 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.5 t -95.05 145.25 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.65 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.463 HG22 ' HB ' ' A' ' 61' ' ' VAL . 18.4 t -132.87 142.67 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.547 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -103.74 129.84 51.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.74 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -83.58 131.48 34.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.373 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.2 m -134.82 -84.47 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.758 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 41.4 mtp180 -131.39 -69.49 0.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.58 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -9.16 57.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.547 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.635 ' O ' ' N ' ' A' ' 101' ' ' PHE . 44.3 p -61.47 -92.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.812 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 97' ' ' SER . 8.3 pt-20 -36.28 -26.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.239 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.556 ' N ' ' O ' ' A' ' 97' ' ' SER . 35.6 mt-30 -70.53 -55.2 9.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 0.0 110.937 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.51 ' C ' HD11 ' A' ' 66' ' ' LEU . 2.7 t80 -115.21 12.59 16.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.814 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.726 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 1.1 t80 -68.04 -33.9 5.54 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.674 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.726 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 17.3 Cg_exo -64.0 -55.38 0.65 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.587 2.191 . . . . 0.0 111.897 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.66 -36.82 26.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.465 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.06 -41.19 64.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.465 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.39 -31.54 71.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.321 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.41 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -71.03 -46.3 62.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.231 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.406 ' O ' ' N ' ' A' ' 111' ' ' ASP . 1.3 m-85 -74.66 -49.43 21.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.401 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.4 m -43.83 -36.42 2.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.289 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' A' ' 113' ' ' GLY . 2.3 t -70.3 -54.01 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.206 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 106' ' ' LYS . 1.4 mt -66.25 -24.75 66.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.573 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 107' ' ' PHE . 16.0 t0 -84.53 -52.88 5.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.338 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.401 ' HA ' HD13 ' A' ' 112' ' ' LEU . 3.2 mm? -105.83 -28.38 10.67 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.5 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 54.27 43.33 75.07 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 2.2 ttm -110.68 -172.96 2.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.706 0.288 . . . . 0.0 110.335 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.5 t -89.0 120.4 37.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.645 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.668 HD23 ' N ' ' A' ' 117' ' ' LEU . 4.8 tt -110.34 124.27 51.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.479 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.668 ' N ' HD23 ' A' ' 116' ' ' LEU . 2.0 tt -131.83 104.99 14.06 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.734 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.23 156.97 17.27 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.703 2.269 . . . . 0.0 112.097 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 120' ' ' ALA . 0.3 OUTLIER -130.12 -101.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.592 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 119' ' ' VAL . . . 175.16 -45.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.632 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.8 m -130.13 167.24 18.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.557 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -70.09 -22.68 63.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.656 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 29.9 mtp -73.6 -43.78 58.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.676 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 128' ' ' LEU . 4.9 mm-40 -47.42 -55.69 8.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.666 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 128' ' ' LEU . . . -57.43 -57.93 10.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.134 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.615 ' OG ' HD13 ' A' ' 30' ' ' LEU . 65.0 m -44.74 -36.01 2.97 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.48 -31.72 22.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.005 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.591 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.7 OUTLIER -73.49 -31.36 63.69 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.749 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 25.4 t -80.05 -42.33 21.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.576 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.5 mt -62.05 -49.37 84.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.626 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -57.09 -37.87 72.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.589 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.4 ' HA ' HD22 ' A' ' 132' ' ' LEU . 0.2 OUTLIER -55.11 -40.89 70.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.815 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 45.4 t -74.42 -42.53 49.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.631 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -56.37 -52.78 63.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.627 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.657 -179.787 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.451 ' O ' HD11 ' A' ' 38' ' ' ILE . . . . . . . . 0 CA--C 1.525 0.68 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -87.96 166.15 14.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.711 0.291 . . . . 0.0 110.523 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.663 HD11 HG21 ' A' ' 133' ' ' VAL . 91.0 mt -113.67 149.6 15.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.621 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.3 t -97.48 147.03 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.494 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 41' ' ' ILE . . . -133.58 160.41 37.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.491 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 56.5 t30 -93.82 141.23 28.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.531 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -55.22 -34.88 64.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.639 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.501 ' C ' ' H ' ' A' ' 26' ' ' ARG . 2.9 ttpp -79.42 -50.45 10.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.659 ' CE2' ' OD2' ' A' ' 49' ' ' ASP . 53.5 t-105 -64.58 6.11 0.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.926 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.501 ' H ' ' C ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -85.44 1.26 49.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.627 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.84 20.79 26.5 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.4 m -116.77 155.28 29.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.854 0.359 . . . . 0.0 110.688 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -73.28 -21.64 60.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.469 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.556 ' CD1' ' C ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -57.16 -65.73 0.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.089 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -42.5 -32.76 0.58 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.303 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -70.68 -56.85 5.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.345 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 36' ' ' GLY . 96.0 mt-10 -54.16 -40.83 67.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.347 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.569 ' C ' ' H ' ' A' ' 36' ' ' GLY . 4.5 mtp -45.0 -47.63 11.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.404 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -65.82 11.68 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.499 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.569 ' H ' ' C ' ' A' ' 34' ' ' MET . . . -86.06 -29.38 25.78 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -125.62 -47.95 1.68 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.852 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.451 HD11 ' O ' ' A' ' 17' ' ' GLY . 0.2 OUTLIER -109.93 171.84 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.742 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.445 ' H ' HG12 ' A' ' 38' ' ' ILE . 11.3 ttpp -90.2 140.38 29.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.597 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.7 tp -126.09 144.57 50.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.666 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.45 ' O ' ' N ' ' A' ' 21' ' ' ALA . 29.5 mt -120.36 151.34 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.503 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -117.65 139.79 50.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.668 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -148.24 120.2 8.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.485 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.13 124.47 27.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.595 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 132.38 -27.94 3.51 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.488 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 48.2 mt -59.39 139.46 57.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.604 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.614 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 1.1 m -90.08 -39.22 0.41 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.061 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 47' ' ' THR . 58.5 Cg_endo -80.67 -163.93 0.25 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.271 1.981 . . . . 0.0 112.074 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.659 ' OD2' ' CE2' ' A' ' 25' ' ' TRP . 30.5 m-20 -99.0 -46.23 5.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.795 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -140.8 155.88 46.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.688 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.51 94.03 3.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.493 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.615 ' CD1' HG22 ' A' ' 133' ' ' VAL . 1.7 tp -64.05 -20.34 65.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.332 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.647 ' C ' ' H ' ' A' ' 55' ' ' ARG . 4.2 m 173.05 161.55 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.423 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.2 22.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.962 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.647 ' H ' ' C ' ' A' ' 53' ' ' SER . 4.8 mmt85 -132.02 -29.11 1.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.645 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 57' ' ' CYS . 2.3 t -132.77 152.94 51.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.859 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.502 ' N ' ' SG ' ' A' ' 56' ' ' CYS . 0.5 OUTLIER -148.13 171.4 15.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.286 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.4 mt -138.77 134.88 43.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.818 0.342 . . . . 0.0 110.824 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.01 125.22 36.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.504 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.48 ' HB3' ' CZ2' ' A' ' 25' ' ' TRP . 14.4 t80 -87.65 128.78 35.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.615 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.421 ' HB ' HG22 ' A' ' 91' ' ' VAL . 58.2 t -121.52 149.85 24.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.492 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.8 p -126.1 145.35 50.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.664 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -44.31 -41.91 6.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.422 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -44.0 -31.11 0.83 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.362 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -82.84 -39.31 21.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.531 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.72 HD11 ' C ' ' A' ' 100' ' ' TYR . 1.3 tt -49.14 -38.31 24.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.35 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 87.9 t -46.03 -36.16 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.594 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.69 116.72 9.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.54 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -121.77 3.56 10.89 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.58 4.77 2.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.813 0.339 . . . . 0.0 110.543 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -134.88 -33.48 0.29 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.474 ' O ' ' N ' ' A' ' 75' ' ' ARG . 4.3 t80 -80.11 -35.63 36.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.765 0.317 . . . . 0.0 110.532 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.423 ' NH2' ' HB3' ' A' ' 107' ' ' PHE . 22.0 ttt85 -43.58 -36.13 1.99 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.528 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -63.66 -34.79 78.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.507 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.474 ' N ' ' O ' ' A' ' 72' ' ' TYR . 0.3 OUTLIER -62.16 -35.91 80.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.47 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 mt -68.19 -40.47 82.2 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.424 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.8 t -63.46 -47.13 93.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.388 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -41.41 -32.33 0.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.329 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.1 t -71.05 -55.4 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.515 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.46 ' HB3' ' NH1' ' A' ' 80' ' ' ARG . 0.9 OUTLIER -54.08 -31.77 52.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.568 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.51 ' O ' ' C ' ' A' ' 82' ' ' SER . 3.7 t30 -54.37 -49.44 69.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.499 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.51 ' C ' ' O ' ' A' ' 81' ' ' ASN . 17.1 p -30.79 -76.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.428 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.458 ' OD1' ' OD1' ' A' ' 84' ' ' ASN . 1.5 t-20 -161.08 -89.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.476 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.564 ' ND2' ' O ' ' A' ' 84' ' ' ASN . 3.0 p-10 -151.48 48.47 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.295 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.1 mt -69.32 154.93 41.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.6 pttt -126.56 89.08 2.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.234 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.437 ' CA ' ' O ' ' A' ' 57' ' ' CYS . . . -109.26 176.28 19.55 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.7 mt -114.36 129.63 70.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.789 0.328 . . . . 0.0 110.646 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 t -104.24 107.35 22.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.46 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.3 t -90.24 143.82 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.652 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.421 HG22 ' HB ' ' A' ' 61' ' ' VAL . 82.0 t -129.0 143.24 41.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.53 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -102.4 115.62 30.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.565 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -71.6 143.2 49.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.514 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 89.9 m -137.49 -82.1 0.35 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.484 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.515 ' CG ' ' N ' ' A' ' 96' ' ' MET . 14.1 ptm180 -151.14 -44.79 0.12 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.464 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.515 ' N ' ' CG ' ' A' ' 95' ' ' ARG . 1.7 mtt -88.52 -2.92 58.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.139 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.718 ' HA ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -70.65 -71.91 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.492 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -40.76 -22.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.609 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.524 ' N ' ' O ' ' A' ' 97' ' ' SER . 68.3 mm-40 -72.3 -54.44 9.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.038 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.72 ' C ' HD11 ' A' ' 66' ' ' LEU . 1.1 t80 -116.6 12.15 14.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.038 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.612 ' N ' ' O ' ' A' ' 97' ' ' SER . 0.3 OUTLIER -62.51 -62.18 6.2 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.604 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 101' ' ' PHE . 9.6 Cg_endo -53.49 -48.75 20.24 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.653 2.235 . . . . 0.0 112.013 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.05 -31.36 7.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.51 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.752 HD23 ' HG1' ' A' ' 108' ' ' THR . 0.7 OUTLIER -85.31 -22.29 28.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.511 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.523 ' O ' HG23 ' A' ' 109' ' ' VAL . 1.4 tt0 -84.63 -32.37 23.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.699 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.77 -41.93 71.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.671 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.51 ' O ' ' CG ' ' A' ' 111' ' ' ASP . 2.9 m-85 -78.62 -51.01 10.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.603 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.752 ' HG1' HD23 ' A' ' 104' ' ' LEU . 97.1 m -51.37 -37.49 48.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.485 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 105' ' ' GLN . 22.2 t -67.55 -59.15 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.452 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.2 -19.05 65.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.526 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.51 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 12.5 m-20 -84.39 -57.8 3.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.029 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.47 HD23 ' C ' ' A' ' 111' ' ' ASP . 2.7 mt -107.5 -29.01 9.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.629 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 72.04 42.48 51.55 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -86.62 -171.05 3.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.576 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 40.7 t -117.76 105.23 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.587 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.491 ' N ' HD12 ' A' ' 116' ' ' LEU . 6.0 mp -95.64 142.39 28.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.514 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 tp -156.23 88.92 2.82 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.527 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -56.04 163.82 5.6 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.751 2.301 . . . . 0.0 112.085 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.703 ' O ' ' HB2' ' A' ' 120' ' ' ALA . 1.5 m -129.37 -106.83 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.655 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 119' ' ' VAL . . . 159.24 -47.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.434 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.13 143.68 51.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.544 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -51.94 -24.98 7.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.708 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 5.4 mtp -70.24 -51.72 28.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.623 ' O ' ' N ' ' A' ' 128' ' ' LEU . 9.6 mm-40 -44.71 -52.32 8.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.679 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.628 ' O ' HG23 ' A' ' 129' ' ' VAL . . . -55.18 -58.1 9.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.225 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.516 ' N ' HD21 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -49.73 -37.01 27.61 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.223 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.87 -31.2 35.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.128 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.623 ' N ' ' O ' ' A' ' 124' ' ' GLU . 1.8 mt -79.91 -26.94 40.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.879 0.371 . . . . 0.0 110.501 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 125' ' ' ALA . 61.3 t -81.56 -41.0 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.566 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 70.5 mt -73.16 -39.94 57.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.67 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -58.64 -25.58 62.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.533 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 132' ' ' LEU . 10.9 tp -77.01 -58.01 3.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.466 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.663 HG21 HD11 ' A' ' 19' ' ' ILE . 11.1 t -60.45 -41.79 88.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.605 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -52.76 -49.82 64.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.602 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.527 -179.937 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.644 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -114.22 154.6 27.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.804 0.335 . . . . 0.0 110.602 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 73.3 mt -106.21 153.49 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.625 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.9 t -110.47 124.04 66.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.654 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.01 149.88 27.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.66 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -74.78 140.65 44.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.424 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.71 -28.65 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.417 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.5 ' C ' ' H ' ' A' ' 26' ' ' ARG . 12.5 ttmm -83.54 -52.88 6.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.395 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.458 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 42.5 t-105 -74.79 24.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.307 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.5 ' H ' ' C ' ' A' ' 24' ' ' LYS . 18.7 ttp85 -81.28 -63.89 1.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.704 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.78 52.46 0.51 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 26' ' ' ARG . 11.1 p -111.85 141.21 45.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.337 . . . . 0.0 110.634 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.41 ' OE1' ' NE2' ' A' ' 122' ' ' GLN . 45.2 mt-30 -56.35 -28.55 59.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.713 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.563 ' CD1' ' C ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -61.07 -66.07 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.393 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.06 -24.67 63.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.923 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.02 -51.25 68.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.814 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -70.33 -45.83 65.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.857 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.457 ' HE1' ' O ' ' A' ' 126' ' ' SER . 36.0 mmt -49.92 -26.62 4.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.815 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -77.01 -0.54 24.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 0.0 110.562 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.22 6.83 50.98 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -148.79 -47.85 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.812 0.339 . . . . 0.0 110.537 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.456 HG12 ' H ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -113.56 169.78 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.595 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.456 ' H ' HG12 ' A' ' 38' ' ' ILE . 5.4 tptm -94.94 152.82 18.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.487 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.86 137.99 28.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.48 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.4 mt -116.62 131.72 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.531 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -88.15 132.42 34.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.799 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -139.94 121.8 15.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.544 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -79.77 145.04 33.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.647 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.4 -33.89 5.83 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.597 HD22 ' CD2' ' A' ' 51' ' ' TYR . 77.3 mt -48.83 137.6 12.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 110.619 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.536 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -88.11 -52.63 0.38 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.929 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 47' ' ' THR . 33.9 Cg_endo -67.61 -157.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.04 1.826 . . . . 0.0 112.15 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.433 ' OD2' ' CD2' ' A' ' 25' ' ' TRP . 1.6 m-20 -98.63 -54.91 2.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.879 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.458 ' CZ ' ' CD1' ' A' ' 25' ' ' TRP . 83.0 m-85 -124.12 145.77 49.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.794 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.597 ' CD2' HD22 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -123.17 103.07 8.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.488 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.551 ' O ' HD23 ' A' ' 52' ' ' LEU . 1.0 OUTLIER -81.71 -35.11 30.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.493 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.626 ' C ' ' H ' ' A' ' 55' ' ' ARG . 4.2 t -178.28 164.59 1.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.426 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -67.38 23.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.477 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.626 ' H ' ' C ' ' A' ' 53' ' ' SER . 5.4 ttt-85 -134.72 -4.93 2.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.142 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.555 ' SG ' ' C ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -161.57 144.98 12.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.87 0.366 . . . . 0.0 110.974 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.419 ' SG ' ' HA2' ' A' ' 87' ' ' GLY . 12.5 p -151.13 164.38 36.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.438 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.0 mt -129.06 148.67 33.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.678 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.7 tt -133.78 120.02 19.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.287 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -85.71 121.66 28.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.792 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.425 ' N ' ' O ' ' A' ' 90' ' ' VAL . 74.7 t -122.15 143.98 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.229 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 63' ' ' GLU . 42.1 p -124.09 148.25 47.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.627 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 66' ' ' LEU . 3.3 tm-20 -38.57 -40.51 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.73 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -44.85 -33.32 1.9 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.661 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.562 ' OD2' ' CE1' ' A' ' 72' ' ' TYR . 3.6 m-20 -82.06 -26.34 33.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.634 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.533 HD23 ' N ' ' A' ' 67' ' ' VAL . 1.4 tt -68.41 -50.07 55.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.671 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.533 ' N ' HD23 ' A' ' 66' ' ' LEU . 2.3 p -62.43 -27.67 43.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.424 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.47 -64.96 0.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.561 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 70' ' ' ASN . . . 71.3 111.17 0.04 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.512 ' CB ' ' O ' ' A' ' 69' ' ' GLY . 5.1 t-20 81.75 139.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.77 0.319 . . . . 0.0 110.51 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.43 -71.31 0.38 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.562 ' CE1' ' OD2' ' A' ' 65' ' ' ASP . 4.0 t80 -50.56 -47.49 57.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.928 0.395 . . . . 0.0 110.375 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -43.15 -36.01 1.55 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.701 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -67.25 -43.94 80.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.542 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 12.3 mtt85 -58.36 -25.41 61.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.544 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 mt -79.42 -38.45 34.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.36 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.3 t -49.25 -30.46 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.278 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -54.65 -29.3 51.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.349 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.6 t -69.12 -35.94 70.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.218 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -79.53 -20.22 47.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.405 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -51.03 -59.69 3.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.471 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.459 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 0.1 OUTLIER -69.0 -68.99 0.36 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.454 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 82' ' ' SER . 4.5 t-20 78.01 60.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.491 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.538 ' OD1' ' O ' ' A' ' 84' ' ' ASN . 2.1 p30 -148.48 11.82 0.9 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.757 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 pp -155.09 153.09 30.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.809 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.7 mmtm -76.62 110.0 10.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.126 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.419 ' HA2' ' SG ' ' A' ' 57' ' ' CYS . . . -86.64 101.76 2.67 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.8 mt -84.48 138.57 18.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 37.0 t -117.96 127.6 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.858 0.361 . . . . 0.0 111.149 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 61' ' ' VAL . 14.7 t -117.49 121.84 68.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.166 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.0 t -114.79 139.69 39.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.783 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -98.75 129.53 45.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.679 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.56 ' NZ ' ' O ' ' A' ' 119' ' ' VAL . 21.7 mttp -78.57 138.39 38.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.428 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 12.2 m -140.12 -85.22 0.22 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.669 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -128.8 -63.38 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.592 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.734 ' N ' ' SD ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -77.91 -9.24 58.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.48 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 99' ' ' GLN . 4.7 p -48.47 -102.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.348 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 97' ' ' SER . 24.2 mt-10 -36.31 -21.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.589 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.68 ' N ' ' O ' ' A' ' 97' ' ' SER . 3.8 tp-100 -69.56 -55.61 9.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.094 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.422 ' CZ ' ' HB1' ' A' ' 103' ' ' ALA . 4.8 t80 -117.33 3.11 12.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.801 0.334 . . . . 0.0 110.797 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.601 ' CD1' ' C ' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -47.06 -58.77 6.44 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.507 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 101' ' ' PHE . 14.9 Cg_endo -59.05 -48.68 13.33 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.556 2.171 . . . . 0.0 112.277 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.422 ' HB1' ' CZ ' ' A' ' 100' ' ' TYR . . . -45.47 -32.39 2.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.855 0.359 . . . . 0.0 110.227 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 tp -87.29 -30.95 20.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.806 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 102' ' ' PRO . 38.1 tt0 -58.26 -40.09 80.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.16 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -63.51 -37.08 85.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.088 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.27 -38.78 34.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.472 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.0 m -72.93 -30.84 64.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.569 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.584 ' O ' ' CA ' ' A' ' 113' ' ' GLY . 10.8 t -77.36 -43.93 30.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.989 0.423 . . . . 0.0 110.53 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.3 tp -70.92 -31.15 67.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.613 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -84.51 -50.14 7.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.308 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mt -104.88 -28.32 11.19 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.597 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.584 ' CA ' ' O ' ' A' ' 109' ' ' VAL . . . 43.47 35.19 2.75 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.93 -159.62 0.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.362 . . . . 0.0 110.547 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 49.4 t -96.29 123.13 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.426 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.14 133.91 53.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.67 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.8 mt -146.07 88.28 6.39 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.481 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -80.56 158.99 22.22 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.883 2.389 . . . . 0.0 112.189 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.57 HG23 ' N ' ' A' ' 120' ' ' ALA . 28.2 m -127.2 -136.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.428 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.57 ' N ' HG23 ' A' ' 119' ' ' VAL . . . -153.5 -40.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.279 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.9 p -138.39 158.34 44.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.357 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.41 ' NE2' ' OE1' ' A' ' 29' ' ' GLN . 21.1 mt-30 -58.17 -26.36 62.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.62 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.85 -45.23 90.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.74 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.638 ' O ' ' N ' ' A' ' 128' ' ' LEU . 1.2 mp0 -54.97 -58.41 7.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.657 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 129' ' ' VAL . . . -52.18 -58.06 7.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.296 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.499 ' N ' HD21 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -43.68 -40.29 4.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.327 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.7 m -85.39 -27.12 26.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.208 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.638 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.5 OUTLIER -77.35 -26.86 52.43 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.942 0.401 . . . . 0.0 110.742 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 125' ' ' ALA . 3.5 t -68.87 -61.45 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.642 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.412 HG13 ' SD ' ' A' ' 34' ' ' MET . 6.8 mt -58.33 -45.08 89.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.441 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -45.7 -29.62 1.32 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.829 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.4 mt -76.44 -48.75 18.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.772 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.2 t -67.81 -51.93 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.817 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.75 -33.72 49.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.841 -179.776 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.7 mtt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -73.01 8.23 1.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.635 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -91.83 -166.57 1.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.568 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.33 155.22 78.78 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.591 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.98 162.8 40.77 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.841 2.361 . . . . 0.0 112.078 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -64.31 160.17 40.19 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.801 2.334 . . . . 0.0 112.063 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.526 ' CG ' ' O ' ' A' ' 7' ' ' ASP . 12.9 t70 -107.1 49.25 0.81 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.705 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 7' ' ' ASP . 36.1 m-20 35.33 73.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.814 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.439 HG22 ' H ' ' A' ' 9' ' ' THR . 2.3 t -81.47 -1.32 45.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.006 0.431 . . . . 0.0 110.217 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.35 70.98 0.09 OUTLIER Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.532 ' C ' ' H ' ' A' ' 13' ' ' HIS . 66.4 Cg_endo -78.33 97.71 1.15 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.949 2.432 . . . . 0.0 112.567 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.437 ' H ' HG23 ' A' ' 12' ' ' VAL . 2.1 t -74.0 27.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.131 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.532 ' H ' ' C ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -109.76 38.82 2.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.467 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.747 ' N ' ' CD ' ' A' ' 15' ' ' PRO . 2.3 t -86.3 -33.09 0.45 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.715 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.747 ' CD ' ' N ' ' A' ' 14' ' ' VAL . 24.6 Cg_exo -59.11 -4.75 2.35 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.608 2.206 . . . . 0.0 112.139 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.42 ' HA ' HD22 ' A' ' 16' ' ' LEU . 1.4 mm? -68.57 -89.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.484 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -123.02 92.75 0.47 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.6 p-80 -136.53 152.39 50.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.856 0.36 . . . . 0.0 110.778 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.446 ' HB ' HD12 ' A' ' 40' ' ' LEU . 3.4 mm -122.98 135.51 62.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.261 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.7 t -97.04 151.63 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.802 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.3 128.26 25.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.502 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.425 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 55.5 t-20 -56.57 131.27 48.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.566 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -43.79 -38.3 3.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.681 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.596 ' C ' ' H ' ' A' ' 26' ' ' ARG . 15.5 ttpt -72.62 -48.41 39.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.48 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.514 ' CE2' ' OD2' ' A' ' 49' ' ' ASP . 24.2 t-105 -67.89 19.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.537 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.596 ' H ' ' C ' ' A' ' 24' ' ' LYS . 61.2 ttt-85 -89.47 -34.97 16.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.439 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.97 36.71 0.24 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.561 ' H ' ' C ' ' A' ' 26' ' ' ARG . 5.8 p -117.86 144.69 45.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.769 0.319 . . . . 0.0 110.644 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -72.93 -18.97 61.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.441 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.802 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -68.56 -57.61 5.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.315 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.406 ' N ' ' HG ' ' A' ' 30' ' ' LEU . . . -41.93 -23.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.531 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 30' ' ' LEU . 1.9 tp-100 -72.12 -47.61 49.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.567 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 36' ' ' GLY . 3.5 mt-10 -50.94 -51.26 54.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.456 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.522 ' C ' ' H ' ' A' ' 36' ' ' GLY . 5.6 mtt -43.93 -42.14 5.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.573 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -71.1 17.16 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.598 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.522 ' H ' ' C ' ' A' ' 34' ' ' MET . . . -104.15 -10.69 33.68 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.5 mtmm -152.01 -43.1 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.854 0.359 . . . . 0.0 110.479 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.445 ' HA ' HD12 ' A' ' 38' ' ' ILE . 10.1 tp -109.36 160.65 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.519 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.8 tttm -86.19 146.05 26.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.582 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.446 HD12 ' HB ' ' A' ' 19' ' ' ILE . 13.9 tp -131.4 137.87 48.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.701 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 57.8 mt -123.16 141.89 41.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.486 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -96.75 133.69 40.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.798 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.76 120.04 25.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.387 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -89.85 111.55 22.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.651 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 133.4 -8.52 5.01 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.425 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 66.3 mt -92.61 148.71 21.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.773 0.32 . . . . 0.0 110.67 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.536 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -96.04 -47.9 0.25 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 47' ' ' THR . 58.0 Cg_exo -47.87 164.35 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.727 2.285 . . . . 0.0 112.27 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.601 ' OD2' ' CD1' ' A' ' 60' ' ' TYR . 1.2 m-20 -85.44 -53.04 5.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.476 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -135.71 120.7 18.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.891 0.377 . . . . 0.0 110.607 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.549 ' CD1' ' O ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -99.48 112.78 24.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.383 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.91 -44.08 15.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.65 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.549 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 5.0 t -139.46 -162.23 1.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.676 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -90.22 -8.98 49.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.624 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.422 HH21 ' HZ1' ' A' ' 86' ' ' LYS . 11.2 mtp180 -125.83 -8.8 6.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.828 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.61 132.82 56.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.962 0.411 . . . . 0.0 111.1 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.1 163.67 30.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.892 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 96.5 mt -135.72 124.16 38.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.977 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.9 tp -115.82 138.21 51.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.372 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.601 ' CD1' ' OD2' ' A' ' 49' ' ' ASP . 2.8 p90 -96.17 132.91 41.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.91 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 92' ' ' GLU . 77.0 t -130.59 149.97 34.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.176 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.42 ' O ' ' C ' ' A' ' 63' ' ' GLU . 1.0 OUTLIER -138.05 157.06 47.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.631 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 62' ' ' THR . 5.7 tm-20 -39.18 -43.16 1.04 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.32 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -47.0 -39.91 13.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.343 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 62' ' ' THR . 61.9 m-20 -69.01 -44.63 72.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.333 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.407 HD11 ' C ' ' A' ' 100' ' ' TYR . 1.5 tt -49.05 -44.44 41.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.523 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 32.2 t -49.48 -41.22 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.552 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.41 -71.63 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.646 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.44 -52.82 1.89 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -97.09 103.23 15.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.789 0.328 . . . . 0.0 110.559 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.66 -51.43 0.8 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -67.37 -24.53 65.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.724 0.297 . . . . 0.0 110.902 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -42.19 97.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 110.589 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -46.31 -46.15 17.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.583 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -59.09 -38.05 78.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.747 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 76' ' ' LEU . 97.6 mt -70.41 -34.81 72.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.708 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 63.8 t -61.45 -40.27 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.856 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 -56.85 -23.42 43.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.799 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.0 t -79.91 -49.51 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.561 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.6 ttt-85 -66.9 -25.54 66.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.645 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -71.05 -11.61 61.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.654 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.554 ' OG ' ' N ' ' A' ' 83' ' ' ASN . 60.4 p -67.92 -117.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.581 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.554 ' N ' ' OG ' ' A' ' 82' ' ' SER . 7.1 t30 -121.02 -93.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.679 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.491 ' N ' ' CG ' ' A' ' 83' ' ' ASN . 2.6 m120 -138.02 60.27 1.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.495 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.5 mp -93.48 123.43 36.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.575 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.422 ' HZ1' HH21 ' A' ' 55' ' ' ARG . 1.2 pttp -112.58 85.84 2.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.172 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -93.67 -165.33 37.21 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.8 mt -131.28 135.83 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.773 0.32 . . . . 0.0 110.488 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.2 t -107.99 118.82 56.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.614 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 61' ' ' VAL . 19.7 t -93.69 140.72 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.401 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.66 132.59 70.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.716 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 61' ' ' VAL . 3.6 tt0 -101.71 104.43 15.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.387 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -68.65 131.95 46.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.579 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.6 m -126.14 -74.26 0.6 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.633 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.3 mtp85 -140.84 -70.3 0.38 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.457 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.33 -1.93 7.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.49 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.609 ' O ' ' N ' ' A' ' 101' ' ' PHE . 4.1 t -68.7 -91.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.788 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 97' ' ' SER . 22.1 mt-10 -36.41 -27.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.954 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 97' ' ' SER . 2.3 mt-30 -71.64 -51.51 22.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.181 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.407 ' C ' HD11 ' A' ' 66' ' ' LEU . 6.1 m-85 -117.13 11.62 14.23 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.19 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.727 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 35.5 t80 -69.82 -32.9 3.23 Favored Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.78 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.727 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 10.8 Cg_exo -67.33 -42.34 7.67 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.588 2.192 . . . . 0.0 111.939 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.05 -48.32 78.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.635 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 tp -71.16 -47.99 54.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.585 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.682 ' O ' HG23 ' A' ' 109' ' ' VAL . 7.7 tt0 -50.59 -33.63 22.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.73 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -56.39 15.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.871 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.6 -52.14 62.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.787 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.1 m -42.18 -40.43 2.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.79 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 105' ' ' GLN . 85.9 t -66.2 -58.66 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.476 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.435 ' HA ' HD13 ' A' ' 110' ' ' LEU . 0.9 OUTLIER -62.56 -23.08 66.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.461 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.48 -55.51 4.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mt -106.33 -28.58 10.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.184 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 56.76 20.04 30.94 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 6.5 tpp -73.04 -161.09 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.724 0.297 . . . . 0.0 110.404 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.12 127.63 65.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.607 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.596 ' N ' HD12 ' A' ' 116' ' ' LEU . 5.0 mp -122.27 115.44 22.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.472 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.3 mt -124.99 88.32 54.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -53.25 171.56 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.629 2.219 . . . . 0.0 111.735 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 120' ' ' ALA . 4.0 m -143.06 -113.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.652 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.404 ' H ' HG23 ' A' ' 119' ' ' VAL . . . -177.51 -37.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.263 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.8 p -141.12 -170.74 3.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.348 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -81.26 -28.22 34.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.598 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -48.42 59.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.757 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 128' ' ' LEU . 0.4 OUTLIER -44.7 -46.1 10.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.25 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.66 -54.92 24.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.959 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.791 ' HB3' HD13 ' A' ' 30' ' ' LEU . 59.7 p -54.98 -30.85 60.1 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -85.19 -35.32 21.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.256 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.596 ' N ' ' O ' ' A' ' 124' ' ' GLU . 4.2 mp -74.58 -34.33 62.86 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.569 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 133' ' ' VAL . 62.0 t -74.19 -55.0 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.562 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 97.2 mt -58.17 -50.93 76.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.581 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -48.94 -30.28 5.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.321 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.1 tp -82.58 -42.03 18.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.478 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 129' ' ' VAL . 95.8 t -63.75 -36.79 77.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.644 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.96 -22.46 65.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.656 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -81.5 -38.41 26.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.475 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 137' ' ' THR . 36.7 tt0 -66.65 -50.84 61.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.525 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -38.95 -57.78 1.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.485 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.518 ' O ' ' C ' ' A' ' 139' ' ' GLU . 1.3 mtpp -35.65 153.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.479 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.518 ' C ' ' O ' ' A' ' 138' ' ' LYS . 3.2 mm-40 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.554 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 mmt . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -79.21 132.06 36.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.689 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.0 55.61 1.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.356 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.428 ' N ' ' HD2' ' A' ' 5' ' ' PRO . 1.4 m-20 -85.49 -54.63 0.42 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.924 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 4' ' ' ASN . 73.6 Cg_endo -79.69 146.3 18.79 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.661 2.241 . . . . 0.0 112.353 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -74.0 102.98 1.59 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.665 2.243 . . . . 0.0 112.067 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.538 ' O ' ' C ' ' A' ' 8' ' ' ASP . 4.6 m-20 -117.88 57.02 0.84 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.65 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.538 ' C ' ' O ' ' A' ' 7' ' ' ASP . 14.5 p-10 28.82 51.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.639 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.4 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 7.7 t -73.45 15.14 0.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.557 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.606 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -59.23 -70.98 0.84 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -64.39 87.42 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.822 2.348 . . . . 0.0 112.109 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 10' ' ' GLY . 5.8 t -103.81 -31.37 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.489 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.615 ' CG ' ' O ' ' A' ' 13' ' ' HIS . 2.8 p80 -148.98 106.06 3.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.625 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.495 ' N ' ' CD ' ' A' ' 15' ' ' PRO . 3.9 m -127.09 51.65 6.87 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.469 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 14' ' ' VAL . 29.1 Cg_endo -66.2 -28.9 47.71 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.838 2.359 . . . . 0.0 112.209 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mt -72.23 2.48 5.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.582 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -102.44 -66.92 0.76 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.417 ' NE2' HG23 ' A' ' 14' ' ' VAL . 1.4 m-70 -72.78 155.1 40.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.846 0.355 . . . . 0.0 110.702 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.406 ' HB ' HD12 ' A' ' 40' ' ' LEU . 17.9 mm -109.35 143.8 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.399 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.6 t -94.6 145.41 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.586 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -136.82 137.25 39.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.541 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 25' ' ' TRP . 63.2 t-20 -64.7 135.29 55.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.467 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.406 ' N ' ' OD1' ' A' ' 22' ' ' ASN . 7.2 tt0 -43.18 -32.3 0.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.369 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -70.36 -36.78 74.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.334 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.502 ' N ' ' O ' ' A' ' 22' ' ' ASN . 0.2 OUTLIER -68.46 -13.62 62.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.208 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.448 ' HD3' ' CD1' ' A' ' 42' ' ' PHE . 7.7 tpt85 -61.98 -40.85 97.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.611 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.6 51.01 0.85 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.69 152.16 37.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.794 0.33 . . . . 0.0 110.622 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -75.55 -21.05 58.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.363 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.849 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -68.67 -56.61 7.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.598 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.432 ' N ' ' HG ' ' A' ' 30' ' ' LEU . . . -53.14 -33.08 50.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.831 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -82.4 -28.94 31.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.727 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -67.33 -31.78 72.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.52 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.689 ' N ' ' SD ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -74.83 -27.04 60.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.465 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -65.78 -8.65 22.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.681 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.35 -29.02 11.7 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.2 -48.85 3.75 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.98 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.429 HG23 ' N ' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -123.24 172.2 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.94 0.4 . . . . 0.0 110.882 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.429 ' N ' HG23 ' A' ' 38' ' ' ILE . 36.8 tttp -86.13 127.6 34.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.541 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.406 HD12 ' HB ' ' A' ' 19' ' ' ILE . 13.4 tp -118.59 129.75 55.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.755 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 mt -108.59 140.66 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.31 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.448 ' CD1' ' HD3' ' A' ' 26' ' ' ARG . 6.2 m-85 -104.14 129.05 51.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.719 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.416 ' HB3' HD13 ' A' ' 46' ' ' LEU . 2.8 mt-10 -130.63 113.2 13.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.439 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -75.18 128.47 35.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.477 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.65 -47.41 1.02 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 46' ' ' LEU . 9.7 mp -46.96 148.15 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.716 0.293 . . . . 0.0 110.387 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.56 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -99.45 -47.54 0.21 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.903 0.382 . . . . 0.0 110.668 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 47' ' ' THR . 31.4 Cg_exo -54.95 176.93 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.791 2.327 . . . . 0.0 112.153 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.47 ' OD1' ' CE2' ' A' ' 25' ' ' TRP . 8.1 m-20 -87.11 -56.14 3.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.436 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -129.65 143.62 50.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.357 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -116.61 108.35 15.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.71 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.78 -38.26 76.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.487 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.602 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 5.8 m -160.01 -143.54 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.439 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.31 18.81 17.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.584 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.537 ' HA ' HD13 ' A' ' 85' ' ' LEU . 7.6 mtp180 -144.49 9.84 1.41 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.602 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 86' ' ' LYS . 42.7 t -163.53 145.4 9.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.684 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.15 172.72 12.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.296 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.6 mt -131.08 126.33 59.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.72 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.24 117.73 30.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.27 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -87.74 117.46 26.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.95 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 73.2 t -99.3 149.48 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.948 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.446 ' H ' ' CG ' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -121.29 156.37 32.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.842 0.353 . . . . 0.0 110.831 -179.665 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.732 ' HB2' HG21 ' A' ' 94' ' ' THR . 12.0 pt-20 -46.05 -44.67 15.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.56 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.501 ' N ' ' CG ' ' A' ' 63' ' ' GLU . . . -51.39 -19.86 1.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.701 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.672 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -79.33 -53.08 7.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.698 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.683 HD13 ' HA ' ' A' ' 97' ' ' SER . 1.3 tt -56.33 -50.23 72.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.662 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.0 t -52.98 -13.77 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.711 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.42 35.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.758 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 65' ' ' ASP . . . -65.36 -16.71 63.11 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -51.86 -45.85 64.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.762 0.315 . . . . 0.0 110.666 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.48 -47.55 6.34 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 75' ' ' ARG . 2.1 t80 -53.53 -26.39 20.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.862 0.363 . . . . 0.0 110.624 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 72' ' ' TYR . 6.2 ttp85 -36.28 -35.67 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.717 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.523 ' HA ' ' HZ2' ' A' ' 74' ' ' LYS . 2.7 mmtm -70.31 -48.79 55.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.654 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -54.44 -28.92 47.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.695 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 27.5 mt -70.61 -58.11 4.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.689 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 80' ' ' ARG . 65.3 t -50.76 -36.91 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.592 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.38 -21.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.465 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.478 ' N ' ' O ' ' A' ' 77' ' ' VAL . 41.1 t -77.88 -33.25 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.766 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.551 ' N ' ' O ' ' A' ' 77' ' ' VAL . 0.9 OUTLIER -82.31 -39.54 22.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.773 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -59.27 -21.24 59.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.901 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 t -95.19 -54.61 3.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.722 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -132.93 -171.0 2.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.652 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -147.03 45.76 1.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.27 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.537 HD13 ' HA ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -98.69 155.64 17.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.688 -179.852 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.523 ' O ' ' SG ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -80.41 122.27 26.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.239 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.433 ' H ' ' HG2' ' A' ' 114' ' ' MET . . . -127.89 164.19 21.31 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.5 mt -107.66 121.86 61.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.853 0.359 . . . . 0.0 110.448 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.1 t -97.2 125.68 50.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.872 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.66 149.4 5.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.047 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.0 t -132.77 145.08 34.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.892 0.377 . . . . 0.0 110.862 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -92.59 120.69 33.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.399 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -67.34 139.85 57.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.793 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.777 HG23 ' H ' ' A' ' 95' ' ' ARG . 1.9 t -151.08 -108.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.523 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.777 ' H ' HG23 ' A' ' 94' ' ' THR . 4.1 mtt180 -130.07 -74.7 0.54 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.259 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.472 ' SD ' ' OE1' ' A' ' 99' ' ' GLN . 26.6 mmt -55.36 -7.16 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.279 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.683 ' HA ' HD13 ' A' ' 66' ' ' LEU . 1.4 t -54.92 -88.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.671 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.449 ' N ' ' OG ' ' A' ' 97' ' ' SER . 2.2 mm-40 -43.01 -21.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.032 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.472 ' OE1' ' SD ' ' A' ' 96' ' ' MET . 47.9 mt-30 -71.11 -55.07 8.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.845 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -117.08 12.26 14.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.824 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.709 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 0.3 OUTLIER -63.7 -35.46 16.5 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.414 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.709 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 2.7 Cg_exo -71.9 -53.94 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.734 2.289 . . . . 0.0 111.813 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -45.88 -27.77 0.95 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.617 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.57 -44.38 12.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.507 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.64 -32.15 71.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.616 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -73.75 -34.94 64.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.739 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -81.95 -37.35 26.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.801 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.1 p -73.35 -35.78 66.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.928 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.696 ' O ' ' N ' ' A' ' 113' ' ' GLY . 4.0 t -66.84 -55.95 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.942 0.401 . . . . 0.0 110.652 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.35 -30.42 66.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.55 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -84.5 -51.22 7.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.438 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.85 -28.87 10.37 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.538 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.696 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 60.93 33.81 85.12 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.433 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 3.3 mtt -84.84 -179.5 7.1 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 110.543 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.0 t -103.05 124.25 57.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.628 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.5 mp -105.35 143.78 33.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.241 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.421 ' C ' HD23 ' A' ' 117' ' ' LEU . 2.1 tt -157.29 88.59 2.57 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.746 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -58.49 146.27 91.28 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.671 2.247 . . . . 0.0 111.823 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.461 HG23 ' H ' ' A' ' 120' ' ' ALA . 2.3 m -108.23 -107.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.548 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.461 ' H ' HG23 ' A' ' 119' ' ' VAL . . . 179.41 -30.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.391 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 97.2 p -144.23 -173.36 3.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.39 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -85.21 -24.45 27.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.588 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.412 ' O ' ' N ' ' A' ' 127' ' ' CYS . 37.9 mtt -81.37 -41.41 22.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.733 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 128' ' ' LEU . 6.5 mm-40 -45.03 -43.51 9.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.437 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.91 -57.78 6.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.007 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.651 ' CB ' HD13 ' A' ' 30' ' ' LEU . 51.5 p -55.61 -29.67 59.57 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.412 ' N ' ' O ' ' A' ' 123' ' ' MET . 47.1 t -85.04 -35.65 21.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.135 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.721 ' O ' HD12 ' A' ' 128' ' ' LEU . 1.7 tp -72.1 -50.41 28.36 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.11 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.512 ' O ' HG23 ' A' ' 133' ' ' VAL . 54.2 t -55.34 -57.0 8.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.781 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.5 mm -55.77 -45.28 79.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.679 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -57.17 -33.34 67.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.443 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.3 tp -67.17 -37.6 84.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.544 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 129' ' ' VAL . 0.4 OUTLIER -84.15 -42.44 17.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.636 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -61.01 -41.64 96.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.838 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.438 ' HG2' ' N ' ' A' ' 136' ' ' GLN . 8.2 pt-20 -76.1 -33.71 59.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.818 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.438 ' N ' ' HG2' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -49.09 -42.75 39.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.634 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 58.1 p -103.88 40.79 1.38 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.816 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.1 pttp -49.84 159.15 0.42 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.468 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.668 -179.969 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 mtt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER -118.37 177.85 4.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.595 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -173.96 41.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.659 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -131.93 163.73 48.01 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.563 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -44.16 154.71 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.725 2.283 . . . . 0.0 112.07 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.42 160.4 49.31 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.805 2.336 . . . . 0.0 111.997 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 8' ' ' ASP . 4.8 p-10 -106.02 40.11 1.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.651 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.472 ' O ' ' C ' ' A' ' 9' ' ' THR . 0.6 OUTLIER 79.89 -76.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.891 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.763 HG22 ' O ' ' A' ' 9' ' ' THR . 98.8 m 33.39 44.81 0.07 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.514 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.66 65.22 0.06 OUTLIER Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -46.98 142.1 11.38 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.893 2.395 . . . . 0.0 112.363 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 12' ' ' VAL . 14.8 p -101.08 -1.29 9.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.528 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -72.66 170.72 13.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.6 m -126.39 148.93 65.9 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.394 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -72.13 179.86 4.56 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.74 2.293 . . . . 0.0 112.16 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 27.0 tp -132.44 -43.47 0.93 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.729 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.52 84.71 0.06 OUTLIER Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -133.34 148.83 51.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.343 . . . . 0.0 110.717 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.4 mm -116.75 149.34 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.474 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.1 t -119.32 135.0 61.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.65 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.58 137.23 52.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.31 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.674 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 17.3 t-20 -67.88 135.13 52.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.784 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -54.68 -38.21 66.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.587 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.5 ttmm -80.15 -65.89 0.95 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.514 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.614 ' NE1' ' OD2' ' A' ' 49' ' ' ASP . 19.3 t-105 -42.54 -48.41 5.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.507 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.671 ' O ' ' N ' ' A' ' 28' ' ' SER . 5.4 ttm180 26.33 85.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.481 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 28' ' ' SER . . . -43.39 -8.9 0.01 OUTLIER Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.671 ' N ' ' O ' ' A' ' 26' ' ' ARG . 0.4 OUTLIER 74.31 -143.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.849 0.357 . . . . 0.0 110.39 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 28' ' ' SER . 3.5 mt-30 -39.92 -20.08 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.326 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.029 HD13 ' OG ' ' A' ' 126' ' ' SER . 0.3 OUTLIER -71.57 -52.09 19.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.384 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.81 -29.75 68.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.647 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -65.35 -54.34 30.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.543 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.651 ' O ' ' N ' ' A' ' 36' ' ' GLY . 3.8 mm-40 -59.37 -41.14 88.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.38 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.636 ' SD ' HD13 ' A' ' 40' ' ' LEU . 4.7 mtt -36.85 -33.98 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.459 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 33' ' ' GLU . 42.5 mt-30 -75.28 17.22 0.27 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.434 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -106.62 -4.82 36.92 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm -138.58 -41.33 0.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.685 0.279 . . . . 0.0 110.903 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.479 HG13 ' H ' ' A' ' 39' ' ' LYS . 4.8 tp -132.78 172.43 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.536 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.479 ' H ' HG13 ' A' ' 38' ' ' ILE . 43.0 tttp -85.54 125.9 33.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.613 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.636 HD13 ' SD ' ' A' ' 34' ' ' MET . 18.5 tp -114.98 149.73 36.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.666 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.436 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 3.7 mt -132.14 151.16 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.676 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.429 ' CE2' ' NH2' ' A' ' 26' ' ' ARG . 81.7 m-85 -115.99 131.09 57.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.446 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -137.01 128.37 28.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.608 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -92.13 122.28 34.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.362 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 139.97 -30.96 2.32 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.674 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 1.4 mt -68.61 161.82 27.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.748 0.309 . . . . 0.0 110.477 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.735 ' H ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -111.38 -40.54 0.1 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.914 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.735 ' CD ' ' H ' ' A' ' 47' ' ' THR . 24.7 Cg_exo -59.27 -173.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.59 2.193 . . . . 0.0 112.023 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.614 ' OD2' ' NE1' ' A' ' 25' ' ' TRP . 8.1 m-20 -97.47 -49.89 4.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.368 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -134.33 145.08 48.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.308 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.05 118.74 35.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.873 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 tp -100.75 -30.37 11.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.258 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.624 ' C ' ' H ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -173.35 147.69 1.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.45 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -56.02 2.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.513 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.624 ' H ' ' C ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -124.2 1.27 8.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.529 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 86' ' ' LYS . 7.6 t -156.44 139.26 15.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.962 0.41 . . . . 0.0 110.829 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -142.52 175.03 10.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.007 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.7 mt -137.68 133.15 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.847 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 tp -117.44 134.99 54.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.161 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.428 ' N ' ' OD2' ' A' ' 49' ' ' ASP . 41.6 t80 -107.99 126.66 52.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.881 0.372 . . . . 0.0 110.977 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.407 ' HB ' HG22 ' A' ' 91' ' ' VAL . 98.7 t -113.24 148.6 16.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.958 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.7 t -115.65 150.79 36.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.586 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.585 ' HG2' HG21 ' A' ' 94' ' ' THR . 1.8 pp20? -47.68 -35.15 9.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.485 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.645 ' O ' HG12 ' A' ' 67' ' ' VAL . . . -57.88 -21.12 41.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.287 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 88.7 m-20 -83.89 -37.73 22.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.776 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.572 HD13 ' HA ' ' A' ' 97' ' ' SER . 0.9 OUTLIER -57.26 -47.09 82.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.568 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.645 HG12 ' O ' ' A' ' 64' ' ' ALA . 15.0 p -49.75 -16.19 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.619 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 65' ' ' ASP . . . -81.81 -76.0 0.27 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.624 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.622 ' O ' ' NH2' ' A' ' 73' ' ' ARG . . . 68.7 9.49 59.07 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -164.87 75.44 0.27 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.831 0.348 . . . . 0.0 110.602 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.13 -61.46 0.2 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -73.32 -27.41 61.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.719 0.295 . . . . 0.0 110.653 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.622 ' NH2' ' O ' ' A' ' 69' ' ' GLY . 4.9 ttp180 -48.27 -29.41 3.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.57 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.455 ' CD ' ' O ' ' A' ' 74' ' ' LYS . 1.2 tmtt? -66.58 -30.11 70.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.525 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.403 ' HE ' ' HB2' ' A' ' 75' ' ' ARG . 16.2 tpp180 -65.49 -35.67 81.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.59 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.2 mt -67.61 -50.07 59.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.661 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.6 t -54.46 -38.77 42.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.584 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.72 -41.0 75.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.607 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.2 t -64.91 -35.66 75.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.636 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.73 -28.5 26.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.661 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -80.98 -13.25 59.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.625 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -25.59 34.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.438 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.481 ' CG ' ' N ' ' A' ' 84' ' ' ASN . 51.4 t-20 -174.99 -112.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.635 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.481 ' N ' ' CG ' ' A' ' 83' ' ' ASN . 0.1 OUTLIER -170.82 74.42 0.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.416 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.845 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -133.03 161.37 34.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.714 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 86' ' ' LYS . 1.9 pttt -81.83 118.38 22.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.456 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.74 137.82 9.9 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.0 mt -93.09 141.17 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.764 0.316 . . . . 0.0 110.451 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 89' ' ' VAL . 3.3 t -115.96 108.71 25.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.648 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 117' ' ' LEU . 0.8 OUTLIER -90.76 144.34 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.397 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.407 HG22 ' HB ' ' A' ' 61' ' ' VAL . 59.2 t -130.52 140.0 49.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.685 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -90.8 126.42 36.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.546 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -90.74 140.5 29.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.639 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.585 HG21 ' HG2' ' A' ' 63' ' ' GLU . 18.5 p -144.56 -73.1 0.26 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.473 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.411 ' O ' ' OE1' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -149.8 -72.65 0.18 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.456 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.445 ' O ' ' CD2' ' A' ' 66' ' ' LEU . 48.6 mtt -60.02 -5.82 1.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.457 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.604 ' O ' ' N ' ' A' ' 99' ' ' GLN . 0.2 OUTLIER -73.18 -84.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.522 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 98' ' ' GLU . 1.8 mp0 -36.27 -24.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.687 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.604 ' N ' ' O ' ' A' ' 97' ' ' SER . 1.6 mm100 -69.03 -55.88 9.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.01 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.419 ' C ' HD11 ' A' ' 66' ' ' LEU . 17.8 m-85 -117.55 10.89 13.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.725 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.582 ' CD1' ' C ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -60.8 -61.1 8.66 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.319 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 101' ' ' PHE . 9.5 Cg_endo -54.11 -42.28 68.43 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.678 2.252 . . . . 0.0 111.921 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.04 -41.54 35.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.332 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 tp -77.08 -41.2 43.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.399 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.501 ' HG3' HD22 ' A' ' 116' ' ' LEU . 65.5 tt0 -51.23 -35.12 35.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.342 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.91 -51.0 64.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.275 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -62.88 -55.09 29.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.452 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.52 -40.67 27.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.429 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.686 ' O ' ' N ' ' A' ' 113' ' ' GLY . 6.7 t -67.57 -56.65 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.273 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.88 -28.32 68.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.558 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.48 -52.09 6.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.387 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.7 mp -105.91 -28.72 10.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.36 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 56.56 34.06 63.46 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -88.69 -155.8 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.75 0.31 . . . . 0.0 110.285 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.601 ' C ' HD12 ' A' ' 116' ' ' LEU . 6.2 t -116.83 130.16 72.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.886 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 116' ' ' LEU . 7.0 mp -117.6 125.98 51.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.444 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.646 ' O ' HG13 ' A' ' 90' ' ' VAL . 1.2 mp -126.2 85.28 60.11 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.546 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -58.94 156.94 30.97 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.81 2.34 . . . . 0.0 111.925 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.662 HG23 ' H ' ' A' ' 120' ' ' ALA . 5.9 m -126.16 -107.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.492 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.662 ' H ' HG23 ' A' ' 119' ' ' VAL . . . 172.92 -28.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.126 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.78 165.46 31.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.356 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -64.85 -41.24 95.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.6 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -62.48 -42.42 99.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.648 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.571 ' O ' ' N ' ' A' ' 128' ' ' LEU . 18.3 mm-40 -45.81 -53.53 9.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.247 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 128' ' ' LEU . . . -60.01 -57.99 10.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.702 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . 1.029 ' OG ' HD13 ' A' ' 30' ' ' LEU . 14.6 m -46.23 -33.0 3.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 1.8 t -85.13 -35.6 21.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.947 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.571 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -71.28 -50.46 32.49 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.081 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.0 t -56.75 -56.4 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.171 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 mm -51.29 -51.7 22.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.329 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -50.4 -41.66 52.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.299 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.9 tp -46.41 -54.4 9.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.525 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.429 HG23 ' H ' ' A' ' 133' ' ' VAL . 1.3 t -67.63 -46.07 83.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.283 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -51.0 -39.27 55.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.183 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.494 ' O ' ' C ' ' A' ' 139' ' ' GLU . 4.0 mm-40 -68.03 -30.62 69.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.292 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -82.3 -43.17 17.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.213 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.44 -35.11 65.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.375 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -133.99 76.14 1.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.432 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.494 ' C ' ' O ' ' A' ' 135' ' ' GLU . 1.4 mt-10 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.489 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 mmt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -176.18 117.34 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.551 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -99.67 -87.32 0.36 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.502 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.526 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 7.1 p30 -149.34 49.91 0.74 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.687 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 4' ' ' ASN . 37.5 Cg_endo -70.1 111.05 2.78 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.743 2.295 . . . . 0.0 111.953 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -47.14 109.49 0.22 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.582 2.188 . . . . 0.0 112.233 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -129.89 40.6 3.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.454 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 66.09 90.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.656 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -100.95 1.98 40.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.251 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.58 -72.24 0.09 OUTLIER Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.99 121.46 8.32 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.712 2.275 . . . . 0.0 111.813 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.1 t -84.12 -56.43 5.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.842 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.467 ' O ' ' C ' ' A' ' 14' ' ' VAL . 3.2 p-80 -127.52 33.86 4.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.877 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.467 ' C ' ' O ' ' A' ' 13' ' ' HIS . 0.0 OUTLIER 35.19 79.52 0.29 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.958 0.409 . . . . 0.0 110.58 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.56 ' C ' ' H ' ' A' ' 17' ' ' GLY . 61.5 Cg_endo -78.03 -7.12 16.23 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.789 2.326 . . . . 0.0 112.187 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mt -69.97 31.3 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.482 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.56 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . -127.9 -61.19 0.13 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.409 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 20.2 p80 -73.67 162.24 29.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.914 0.388 . . . . 0.0 110.616 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 20' ' ' VAL . 72.5 mt -119.84 155.73 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.592 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.439 ' N ' HG22 ' A' ' 19' ' ' ILE . 58.3 t -108.84 148.61 12.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.458 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.563 ' HB2' HD22 ' A' ' 40' ' ' LEU . . . -136.0 141.2 44.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.666 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.604 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 66.4 t30 -73.99 132.94 42.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.702 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -48.89 -25.07 1.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.566 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -85.24 -33.12 22.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.533 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -79.49 -4.74 52.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.478 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.469 ' C ' ' H ' ' A' ' 28' ' ' SER . 24.2 ttp180 -70.69 -17.15 62.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.383 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.58 29.22 1.04 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 26' ' ' ARG . 6.1 m -127.66 138.06 52.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.343 . . . . 0.0 110.575 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -62.53 -24.48 67.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.53 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.86 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -61.06 -53.31 58.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.378 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.03 -32.66 6.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.824 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.94 -27.89 49.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.692 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -63.9 -53.01 57.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.502 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.433 ' SD ' HD12 ' A' ' 19' ' ' ILE . 4.2 mtm -59.76 -16.49 28.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.486 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.31 -8.35 55.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.509 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.14 0.79 58.9 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -139.88 -33.68 0.58 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.817 0.342 . . . . 0.0 110.514 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.506 HD13 ' HA ' ' A' ' 38' ' ' ILE . 1.7 mm -127.74 158.17 39.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.444 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.498 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 4.4 ttpm? -90.16 102.34 15.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.236 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.563 HD22 ' HB2' ' A' ' 21' ' ' ALA . 4.7 mt -88.44 130.09 35.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.02 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 mm -108.25 113.71 44.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.086 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -75.72 125.16 28.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.022 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -127.16 115.75 19.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.314 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -79.38 125.9 30.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.447 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.82 -26.71 4.77 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.604 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 3.5 mm? -64.62 140.63 58.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.765 0.317 . . . . 0.0 110.59 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.674 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -92.36 -39.87 0.36 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.625 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.674 ' CD ' ' N ' ' A' ' 47' ' ' THR . 16.4 Cg_exo -64.73 -160.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.808 2.339 . . . . 0.0 111.92 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -111.46 -55.34 2.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.467 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -132.37 132.28 42.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.525 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.527 ' CD1' ' O ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -109.26 109.05 19.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.702 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.68 -41.2 72.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.44 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.482 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 79.3 p -165.66 -174.09 2.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.426 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -79.46 19.53 0.61 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.494 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.42 HH11 ' HG2' ' A' ' 55' ' ' ARG . 0.6 OUTLIER -142.22 3.34 1.55 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.159 -179.695 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.527 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 15.3 m -152.22 152.05 31.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.987 0.422 . . . . 0.0 111.091 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.475 ' SG ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -150.82 158.74 44.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.148 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.9 mt -130.4 132.81 64.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.902 0.382 . . . . 0.0 110.873 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.05 138.1 53.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.068 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -100.56 134.42 43.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.921 0.391 . . . . 0.0 110.931 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 t -131.33 138.66 52.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.336 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 64' ' ' ALA . 4.7 t -116.05 147.38 41.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.395 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -38.84 -37.24 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.49 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.469 ' HB3' HG23 ' A' ' 62' ' ' THR . . . -50.25 -37.05 33.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.461 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 62' ' ' THR . 18.6 m-20 -71.74 -40.35 69.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.698 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.58 HD11 ' C ' ' A' ' 100' ' ' TYR . 1.3 tt -55.42 -43.42 75.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.492 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.456 ' N ' HD23 ' A' ' 66' ' ' LEU . 11.4 t -49.81 -38.21 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.515 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.39 -67.19 0.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.418 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.2 12.33 81.73 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -156.84 138.09 13.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 110.745 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.24 -38.93 3.04 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -82.52 -22.95 34.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.685 0.279 . . . . 0.0 110.805 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.3 ttp85 -68.81 -40.62 79.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.684 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.98 -24.4 2.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.683 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -70.04 -44.65 68.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.597 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.2 mt -58.19 -46.52 85.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.614 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.7 t -45.27 -42.37 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.697 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.4 mmm-85 -45.03 -51.75 9.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.666 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 t -62.44 -26.55 40.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.797 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -82.74 -37.51 24.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.72 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 81' ' ' ASN . 3.1 t-20 -82.31 -8.9 59.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.882 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.5 ' HB3' HD11 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -51.85 -78.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.558 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -153.22 -71.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.472 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -178.67 57.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.296 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.77 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -108.49 143.25 37.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.731 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.85 92.4 9.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.529 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -93.05 162.2 26.0 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.0 mt -116.7 148.48 19.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.809 0.338 . . . . 0.0 110.494 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.84 118.54 55.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.719 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.71 135.69 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.476 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.422 ' H ' ' HA ' ' A' ' 118' ' ' PRO . 46.8 t -119.58 148.92 22.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.691 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -98.79 133.35 43.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.235 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -86.09 140.34 30.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.877 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.417 ' HB ' ' H ' ' A' ' 95' ' ' ARG . 2.2 m -145.91 -79.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.256 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.417 ' H ' ' HB ' ' A' ' 94' ' ' THR . 64.6 mtt-85 -141.07 -70.45 0.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.358 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 20.7 mmt -63.09 -11.45 19.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.42 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.637 ' O ' ' N ' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -54.78 -95.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.669 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.626 ' N ' ' OG ' ' A' ' 97' ' ' SER . 3.0 pt-20 -36.27 -29.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.996 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.512 ' N ' ' O ' ' A' ' 97' ' ' SER . 2.3 mm-40 -65.9 -55.24 17.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.906 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.58 ' C ' HD11 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -117.62 12.74 14.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.968 -179.564 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.637 ' N ' ' O ' ' A' ' 97' ' ' SER . 21.2 t80 -68.24 -37.37 10.78 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.244 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 50.4 Cg_endo -78.3 -30.93 3.05 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.04 1.827 . . . . 0.0 111.959 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.84 95.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.962 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.476 ' O ' HD23 ' A' ' 104' ' ' LEU . 4.6 tt -73.48 -45.84 51.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.044 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.457 ' O ' HG23 ' A' ' 109' ' ' VAL . 5.3 tt0 -54.65 -34.61 62.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.013 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -63.11 -36.75 84.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.162 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' A' ' 111' ' ' ASP . 1.7 m-85 -79.54 -53.33 6.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.194 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.7 m -51.99 -36.34 49.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.33 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.602 ' O ' ' N ' ' A' ' 113' ' ' GLY . 8.9 t -65.82 -59.9 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.494 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.879 ' O ' HD23 ' A' ' 110' ' ' LEU . 2.2 tt -67.04 -22.6 65.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.496 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 107' ' ' PHE . 1.3 m-20 -84.53 -55.41 4.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.81 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.9 mp -106.14 -28.42 10.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.987 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 49.69 50.05 32.36 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 2.3 mtm -105.84 -165.79 1.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.784 0.326 . . . . 0.0 110.368 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.8 t -90.44 110.5 22.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.538 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 117' ' ' LEU . 3.8 tt -111.15 126.17 54.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.522 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.551 ' N ' HD23 ' A' ' 116' ' ' LEU . 5.3 tp -146.15 107.6 4.22 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.682 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.422 ' HA ' ' H ' ' A' ' 91' ' ' VAL . 71.9 Cg_endo -78.78 169.58 19.37 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.388 2.058 . . . . 0.0 112.185 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.604 HG23 ' N ' ' A' ' 120' ' ' ALA . 19.4 m -131.91 -118.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.576 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.604 ' N ' HG23 ' A' ' 119' ' ' VAL . . . -167.27 -40.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.538 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.3 m -136.08 155.71 49.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.398 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -59.91 -20.75 59.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.547 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.683 ' N ' ' SD ' ' A' ' 123' ' ' MET . 0.8 OUTLIER -78.06 -33.05 51.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.585 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.634 ' O ' ' N ' ' A' ' 128' ' ' LEU . 1.6 mm-40 -54.26 -55.36 28.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.758 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -51.51 -58.22 6.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.249 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.729 ' HB2' HD13 ' A' ' 30' ' ' LEU . 3.9 t -48.89 -33.39 10.62 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.16 -30.13 24.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.874 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.634 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.5 OUTLIER -74.42 -49.72 21.34 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.074 179.676 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.99 -55.14 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.279 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 44.2 mt -51.03 -54.04 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.408 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -42.31 -35.15 0.92 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.596 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.96 -60.25 3.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.598 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.7 t -63.85 -38.63 82.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.351 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -60.03 -31.86 70.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.401 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -61.74 -50.18 73.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.429 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.493 ' C ' ' H ' ' A' ' 138' ' ' LYS . 3.9 tp-100 -50.5 -53.08 32.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.389 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.537 ' O ' ' O ' ' A' ' 138' ' ' LYS . 14.5 p -71.7 15.03 0.15 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.495 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.537 ' O ' ' O ' ' A' ' 137' ' ' THR . 19.8 mmtm 46.67 107.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.583 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.527 -179.996 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mmm . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -115.6 168.76 9.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.509 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -145.87 -109.88 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.674 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -123.51 66.4 35.09 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.748 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.98 163.85 35.89 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.777 2.318 . . . . 0.0 112.117 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.23 170.79 17.4 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.807 2.338 . . . . 0.0 112.028 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.49 ' O ' ' CB ' ' A' ' 8' ' ' ASP . 9.5 t0 -118.47 43.13 2.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.727 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.68 ' O ' ' N ' ' A' ' 10' ' ' GLY . 6.6 t0 80.38 -23.36 0.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.6 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 9' ' ' THR . 3.3 t 25.91 36.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.802 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.68 ' N ' ' O ' ' A' ' 8' ' ' ASP . . . -62.68 -58.1 13.58 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 12' ' ' VAL . 60.9 Cg_exo -46.28 74.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.884 2.389 . . . . 0.0 112.091 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.65 ' N ' ' O ' ' A' ' 10' ' ' GLY . 1.3 p -37.61 121.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.723 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.551 ' O ' ' C ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -117.43 78.5 1.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.414 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.583 ' O ' HG23 ' A' ' 14' ' ' VAL . 22.6 m -24.83 94.98 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.939 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.452 ' N ' ' O ' ' A' ' 13' ' ' HIS . 66.3 Cg_endo -80.33 150.5 19.84 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.71 2.273 . . . . 0.0 112.083 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.44 -83.06 0.65 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.566 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.509 ' O ' HD11 ' A' ' 38' ' ' ILE . . . -69.11 103.61 1.11 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.486 ' C ' ' ND1' ' A' ' 18' ' ' HIS . 4.1 p80 -112.55 155.06 24.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.659 0.266 . . . . 0.0 110.429 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 20' ' ' VAL . 24.9 mm -107.24 159.41 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.737 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.545 HG11 ' OE2' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -125.96 141.22 46.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.609 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -126.12 143.87 50.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.586 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 25' ' ' TRP . 30.1 t30 -64.33 131.46 47.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.524 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -41.42 -32.89 0.36 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.515 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -78.15 -30.44 49.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.517 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.582 ' N ' ' O ' ' A' ' 22' ' ' ASN . 18.8 t-105 -77.91 -10.78 59.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.586 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.508 ' C ' ' H ' ' A' ' 28' ' ' SER . 10.8 ttt-85 -60.08 -37.0 78.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.732 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.06 40.81 0.26 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.508 ' H ' ' C ' ' A' ' 26' ' ' ARG . 69.8 m -128.47 136.54 50.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.753 0.311 . . . . 0.0 110.662 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -67.9 -21.25 65.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.222 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.942 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -71.72 -52.48 17.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.288 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.523 ' O ' HD22 ' A' ' 40' ' ' LEU . . . -49.02 -27.64 3.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.482 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -79.07 -34.7 43.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.738 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -58.34 -43.94 88.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.764 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.429 ' C ' ' H ' ' A' ' 36' ' ' GLY . 28.2 mtt -54.33 -32.64 57.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.804 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -71.0 8.96 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.593 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 34' ' ' MET . . . -95.34 -11.37 56.0 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -142.59 -49.19 0.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.812 0.339 . . . . 0.0 110.671 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.509 HD11 ' O ' ' A' ' 17' ' ' GLY . 10.4 tp -106.03 165.95 3.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.326 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.451 ' N ' HG13 ' A' ' 38' ' ' ILE . 22.7 tttp -85.68 143.99 28.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.285 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.523 HD22 ' O ' ' A' ' 31' ' ' ALA . 19.8 tp -127.82 156.25 42.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.449 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 50.1 mt -145.77 142.56 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.359 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.04 127.63 51.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.688 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.545 ' OE2' HG11 ' A' ' 20' ' ' VAL . 57.3 mt-10 -127.36 124.23 38.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.443 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.39 94.54 9.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.778 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 166.59 -32.26 0.21 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.474 ' O ' ' OD1' ' A' ' 22' ' ' ASN . 11.1 mp -66.92 159.62 27.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 110.491 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.555 ' H ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -103.79 -48.21 0.15 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.758 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.555 ' CD ' ' H ' ' A' ' 47' ' ' THR . 37.8 Cg_exo -56.36 -171.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.762 2.308 . . . . 0.0 112.039 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -97.92 -55.44 2.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.737 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -125.79 128.65 48.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.909 0.385 . . . . 0.0 110.649 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.687 ' CE2' ' O ' ' A' ' 53' ' ' SER . 4.0 t80 -107.87 105.43 15.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.594 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 mp -74.32 -30.53 62.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.438 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.687 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 2.0 p 177.41 -173.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.399 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -86.54 65.0 8.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.587 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -178.75 -30.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.824 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.422 ' HG ' ' HB2' ' A' ' 86' ' ' LYS . 1.2 m -140.29 132.4 27.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.918 0.389 . . . . 0.0 111.136 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 30.9 p -134.91 173.76 11.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.984 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.2 mt -139.99 131.74 32.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.289 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.0 tp -112.53 117.37 32.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.85 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -83.94 117.49 23.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.97 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.8 t -116.25 140.86 36.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.207 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.4 p -126.25 156.73 39.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.965 0.412 . . . . 0.0 110.92 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 96' ' ' MET . 2.9 tt0 -40.42 -43.43 1.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.731 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -43.48 -30.16 0.53 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.381 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -82.69 -47.72 11.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.308 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.538 HD11 ' C ' ' A' ' 100' ' ' TYR . 1.3 tt -50.82 -38.3 47.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.357 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.555 HG22 ' SD ' ' A' ' 96' ' ' MET . 3.2 t -45.95 -53.09 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.436 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -44.28 -76.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.481 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.29 -24.4 29.1 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -151.56 133.43 14.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 0.0 110.704 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.13 -54.94 0.73 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -62.68 -35.36 79.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.681 0.277 . . . . 0.0 110.6 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.475 HH11 ' HB3' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -49.51 -40.78 38.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.877 0.37 . . . . 0.0 110.165 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.431 ' N ' ' HD2' ' A' ' 73' ' ' ARG . 1.8 ttpp -54.6 -35.87 63.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.043 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.2 ttt85 -69.22 -42.31 75.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.151 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 34.8 mt -61.71 -21.5 64.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.271 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.2 t -81.35 -39.28 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.486 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -61.04 -20.99 63.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.647 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.4 t -70.36 -50.06 49.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.012 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 49.2 ttt-85 -71.24 -43.58 66.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.907 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -52.66 -27.48 17.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.68 ' OG ' ' N ' ' A' ' 83' ' ' ASN . 0.3 OUTLIER -46.6 -74.42 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.82 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.68 ' N ' ' OG ' ' A' ' 82' ' ' SER . 2.7 m120 -140.18 -98.22 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.834 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -165.56 37.59 0.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.781 0.324 . . . . 0.0 110.718 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.92 157.52 17.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.605 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.422 ' HB2' ' HG ' ' A' ' 56' ' ' CYS . 7.6 mmmt -88.94 100.05 12.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.493 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -95.71 141.26 15.48 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 60.7 mt -103.02 135.65 39.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.816 0.341 . . . . 0.0 110.435 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.4 t -108.93 103.75 16.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.656 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.1 t -93.94 142.07 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.351 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.486 ' O ' HG22 ' A' ' 119' ' ' VAL . 93.8 t -122.64 149.59 26.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.674 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -107.67 107.12 17.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.633 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -68.17 132.82 47.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.211 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.2 m -137.42 -79.51 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.785 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.3 mtp85 -141.17 -70.25 0.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.581 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.555 ' SD ' HG22 ' A' ' 67' ' ' VAL . 16.2 mtt -63.77 -10.78 21.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.496 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.643 ' O ' ' N ' ' A' ' 99' ' ' GLN . 82.8 p -62.02 -88.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.769 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.444 ' N ' ' OG ' ' A' ' 97' ' ' SER . 0.2 OUTLIER -36.09 -22.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.006 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.643 ' N ' ' O ' ' A' ' 97' ' ' SER . 7.0 mt-30 -73.62 -54.77 7.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.913 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.538 ' C ' HD11 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -117.52 12.67 14.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.617 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.699 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 3.1 t80 -63.03 -34.94 15.16 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.647 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.699 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 14.7 Cg_exo -66.66 -49.99 1.43 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.604 2.203 . . . . 0.0 111.821 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -47.19 -49.2 23.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.423 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.568 ' O ' ' OG1' ' A' ' 108' ' ' THR . 2.7 tp -65.37 -51.2 62.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.423 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.543 ' O ' HG23 ' A' ' 109' ' ' VAL . 2.7 tt0 -49.93 -33.51 17.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.632 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.29 -52.98 15.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.571 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.92 -52.18 66.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.671 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.568 ' OG1' ' O ' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -58.82 -30.04 67.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.596 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 105' ' ' GLN . 2.3 t -70.98 -41.38 76.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.627 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 110' ' ' LEU . 16.5 tp -81.36 -33.78 32.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.643 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.73 -47.19 10.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.471 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 113' ' ' GLY . 2.3 mm? -102.16 -28.33 12.37 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.184 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.5 ' CA ' ' O ' ' A' ' 109' ' ' VAL . . . 34.66 38.23 0.12 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -89.33 -156.12 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.734 0.302 . . . . 0.0 110.339 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.5 t -101.35 116.22 44.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.717 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.839 ' C ' HD12 ' A' ' 117' ' ' LEU . 7.4 mp -104.71 138.15 41.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.522 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.839 HD12 ' C ' ' A' ' 116' ' ' LEU . 6.0 mp -147.32 85.63 6.74 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.732 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -61.72 165.59 13.52 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.751 2.301 . . . . 0.0 111.764 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 91' ' ' VAL . 6.8 m -132.74 -115.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.515 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.454 ' N ' HG23 ' A' ' 119' ' ' VAL . . . -178.71 -43.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.324 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.498 ' OG ' ' OE1' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -133.16 172.44 12.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.434 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -73.88 -16.63 61.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.645 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.481 ' O ' ' N ' ' A' ' 127' ' ' CYS . 54.8 mtp -85.57 -42.0 14.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.695 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.672 ' O ' ' N ' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -46.75 -53.92 10.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.527 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.16 -57.85 11.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.232 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.792 ' OG ' HD13 ' A' ' 30' ' ' LEU . 11.1 m -53.95 -33.3 56.48 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.481 ' N ' ' O ' ' A' ' 123' ' ' MET . 6.8 t -85.36 -29.37 24.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.666 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.856 ' O ' HD12 ' A' ' 128' ' ' LEU . 1.6 tp -80.51 -36.53 33.1 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.608 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 64.4 t -63.92 -40.73 90.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.785 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.9 mt -63.32 -51.56 69.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.349 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -42.87 -42.24 3.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.316 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.7 mt -61.39 -57.36 12.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.528 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.6 t -49.07 -55.91 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.627 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -42.96 -30.62 0.43 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.533 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.69 -52.22 33.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.398 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -59.68 -31.84 69.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.434 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 86.2 m -86.08 -16.88 36.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.527 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.48 106.75 1.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.63 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.545 179.966 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 mtp . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -74.28 105.44 5.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.499 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.28 -172.81 3.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.523 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -95.89 146.46 31.36 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.496 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -41.32 132.79 3.32 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.646 2.231 . . . . 0.0 112.11 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.83 87.85 1.36 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.478 2.119 . . . . 0.0 112.063 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.581 ' O ' ' O ' ' A' ' 8' ' ' ASP . 9.5 t0 -138.98 68.78 1.37 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.672 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.581 ' O ' ' O ' ' A' ' 7' ' ' ASP . 1.4 m-20 29.71 99.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.681 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 t -118.43 18.55 13.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.605 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.33 67.03 1.52 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -65.02 104.82 0.61 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.6 2.2 . . . . 0.0 112.01 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.5 p -84.19 138.04 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.682 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -159.05 52.81 0.4 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.484 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.2 m -100.17 148.45 34.9 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.534 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -40.05 159.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.835 2.357 . . . . 0.0 112.223 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.413 ' HB2' ' NE2' ' A' ' 18' ' ' HIS . 0.8 OUTLIER -103.65 -84.37 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.302 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -167.79 44.25 0.24 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.413 ' NE2' ' HB2' ' A' ' 16' ' ' LEU . 5.2 p80 -148.81 154.65 39.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 110.639 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.465 HG22 ' N ' ' A' ' 20' ' ' VAL . 33.0 mm -126.52 157.09 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.262 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.465 ' N ' HG22 ' A' ' 19' ' ' ILE . 63.3 t -113.11 148.36 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.015 0.436 . . . . 0.0 110.898 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 41' ' ' ILE . . . -137.84 159.33 42.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.203 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.564 ' O ' ' N ' ' A' ' 25' ' ' TRP . 57.6 t30 -92.15 139.49 30.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.839 0.352 . . . . 0.0 110.721 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -39.29 -47.49 1.7 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.585 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -63.28 -31.76 73.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.594 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.661 ' NE1' ' OD2' ' A' ' 49' ' ' ASP . 1.6 t-105 -76.79 -1.82 30.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.67 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.473 ' C ' ' HE ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -76.21 -26.93 56.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.538 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.82 33.11 3.1 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.4 m -122.7 142.38 50.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.8 0.333 . . . . 0.0 110.597 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -66.13 -23.11 66.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.33 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.917 HD13 ' OG ' ' A' ' 126' ' ' SER . 0.4 OUTLIER -67.85 -55.33 13.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.539 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.412 ' N ' ' HG ' ' A' ' 30' ' ' LEU . . . -48.25 -22.59 0.69 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.023 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -81.41 -45.97 15.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.905 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -50.73 -33.37 22.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.834 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.69 ' SD ' HD13 ' A' ' 40' ' ' LEU . 11.9 mtt -66.18 -33.58 76.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.752 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -70.12 -17.36 63.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.658 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.97 4.31 86.07 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm -147.82 -56.7 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.899 0.38 . . . . 0.0 110.485 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.535 ' O ' ' O ' ' A' ' 34' ' ' MET . 7.8 tp -112.18 165.13 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.426 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.433 ' H ' HG13 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -88.03 110.54 20.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.573 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.69 HD13 ' SD ' ' A' ' 34' ' ' MET . 17.7 tp -96.96 137.0 36.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.757 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.456 ' O ' ' N ' ' A' ' 21' ' ' ALA . 20.6 mt -113.49 139.33 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.412 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -105.93 142.8 35.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.85 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -153.99 116.96 4.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.456 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -77.87 134.29 37.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.569 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 122.98 -32.2 4.48 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 75.2 mt -59.84 144.53 48.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.735 0.302 . . . . 0.0 110.668 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.535 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -88.42 -64.52 0.2 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.727 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.535 ' CD ' ' CB ' ' A' ' 47' ' ' THR . 9.6 Cg_endo -54.15 -174.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.779 2.32 . . . . 0.0 112.18 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.661 ' OD2' ' NE1' ' A' ' 25' ' ' TRP . 35.1 t0 -93.26 -66.17 0.94 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.431 ' CE2' ' CG ' ' A' ' 49' ' ' ASP . 68.6 m-85 -118.28 162.19 18.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.609 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.95 142.52 50.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.081 0.467 . . . . 0.0 110.977 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.437 ' HA ' HD13 ' A' ' 52' ' ' LEU . 0.8 OUTLIER -119.88 -24.85 6.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.776 179.502 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.412 ' OG ' ' C ' ' A' ' 52' ' ' LEU . 0.7 OUTLIER -169.77 179.27 3.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.059 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -77.69 4.64 11.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.818 0.342 . . . . 0.0 110.52 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -133.65 -4.39 2.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.879 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.7 m -129.66 134.66 47.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.95 0.405 . . . . 0.0 110.947 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.3 p -146.45 171.06 15.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.118 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 mt -138.82 138.48 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.995 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.11 136.49 54.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.135 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.424 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 29.5 t80 -96.98 115.3 27.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.846 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 92' ' ' GLU . 6.7 t -121.75 149.05 24.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.193 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.6 t -135.87 163.78 29.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 0.0 110.908 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.784 ' OE2' HG23 ' A' ' 67' ' ' VAL . 4.8 tp10 -41.21 -48.68 3.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.589 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -47.61 -29.8 3.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.522 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 1.1 m-20 -77.43 -45.47 25.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.529 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.407 ' CD1' ' HA ' ' A' ' 101' ' ' PHE . 1.6 tt -48.94 -40.48 30.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.651 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.784 HG23 ' OE2' ' A' ' 63' ' ' GLU . 24.9 t -64.91 -42.57 95.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.672 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.529 ' C ' ' H ' ' A' ' 70' ' ' ASN . . . -91.16 26.3 2.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.597 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.95 -3.81 0.35 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 68' ' ' ALA . 50.0 t30 -89.93 37.77 0.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.815 0.341 . . . . 0.0 110.504 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -175.54 -32.77 0.04 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -82.73 -38.27 23.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.842 0.353 . . . . 0.0 110.441 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.3 ttt-85 -48.34 -50.49 30.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.646 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -54.59 -43.76 72.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.569 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -49.95 -50.87 45.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.557 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.2 mt -53.52 -41.59 66.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.799 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 62.5 t -57.06 -33.36 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.762 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -49.22 77.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.622 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.8 t -47.42 -41.56 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.505 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.1 ttt-85 -82.02 -21.12 37.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.476 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -65.0 -25.0 67.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.588 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 t -58.04 -68.38 0.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.507 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -160.29 -69.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.577 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -178.5 66.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.541 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.6 mp -91.43 127.92 37.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.53 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.1 87.96 4.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.429 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -104.72 175.7 22.58 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.6 mt -106.27 137.62 35.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 0.0 110.454 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.6 t -109.48 116.92 53.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.779 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.5 t -104.38 134.89 44.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.427 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.6 t -124.6 134.61 66.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.636 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 61' ' ' VAL . 5.0 tt0 -98.03 100.35 11.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.487 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.435 ' HB2' ' NZ ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -70.14 134.47 48.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.629 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.622 HG22 ' HG2' ' A' ' 95' ' ' ARG . 6.4 m -127.07 -64.97 0.97 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.637 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.622 ' HG2' HG22 ' A' ' 94' ' ' THR . 0.0 OUTLIER -150.5 -73.1 0.17 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.395 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -64.14 -4.06 3.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.142 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.654 ' O ' ' N ' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -75.53 -87.6 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.361 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 97' ' ' SER . 1.7 mt-10 -35.84 -26.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.991 0.424 . . . . 0.0 110.365 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.833 ' NE2' ' CD2' ' A' ' 100' ' ' TYR . 0.1 OUTLIER -69.56 -56.08 8.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.972 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.833 ' CD2' ' NE2' ' A' ' 99' ' ' GLN . 2.7 m-85 -116.57 12.68 15.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.922 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.731 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 22.0 t80 -69.63 -32.69 3.22 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.075 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.731 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 16.0 Cg_exo -64.8 -50.24 2.47 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.526 2.151 . . . . 0.0 111.997 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.84 -36.84 49.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.66 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.466 ' O ' ' OG1' ' A' ' 108' ' ' THR . 1.3 tp -77.26 -34.59 55.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.394 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.95 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.8 OUTLIER -68.07 -38.27 82.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.355 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -65.65 -28.19 68.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.34 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.69 -54.19 5.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.49 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -54.11 -32.05 53.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.703 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 105' ' ' GLN . 79.3 t -62.81 -62.75 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.743 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 85.8 mt -66.44 -20.01 65.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.776 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -83.99 -56.68 3.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.6 mp -105.93 -26.56 11.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.062 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 48.93 46.53 32.28 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 5.0 tpp -95.99 -156.92 0.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 0.0 110.448 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.68 106.39 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.56 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 mp -101.5 124.94 47.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.329 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.5 mt -137.9 87.27 16.92 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.711 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -55.27 165.67 2.89 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.601 2.201 . . . . 0.0 111.831 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.536 HG23 ' H ' ' A' ' 120' ' ' ALA . 15.3 m -133.11 -116.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.72 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.536 ' H ' HG23 ' A' ' 119' ' ' VAL . . . 172.68 -32.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.364 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.1 p -129.39 153.49 47.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.44 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -64.68 -22.58 67.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.682 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.612 ' N ' ' SD ' ' A' ' 123' ' ' MET . 0.0 OUTLIER -83.4 -40.46 19.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.816 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.636 ' O ' ' N ' ' A' ' 128' ' ' LEU . 3.5 mm-40 -45.71 -50.76 13.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.641 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.41 -58.01 10.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.865 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.917 ' OG ' HD13 ' A' ' 30' ' ' LEU . 6.3 m -49.86 -33.95 18.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -82.88 -31.68 27.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.667 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -72.92 -33.21 65.83 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.407 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 92.0 t -81.43 -51.41 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.557 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 54.6 mt -55.11 -44.6 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.702 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -52.23 -42.7 63.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.944 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 tp -52.18 -56.64 13.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.821 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 86.7 t -55.25 -55.85 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.009 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -47.07 -48.15 22.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.99 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -74.79 -21.91 59.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.018 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -78.75 -42.59 27.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.719 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.555 ' O ' HG23 ' A' ' 137' ' ' THR . 5.9 t -114.26 31.52 6.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.575 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.2 tptt -50.96 101.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.492 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.587 -179.893 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 mtt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -139.09 -36.76 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.447 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.485 ' C ' ' CG ' ' A' ' 4' ' ' ASN . 9.1 mtpp -81.95 95.62 7.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.53 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.485 ' CG ' ' C ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -164.77 145.78 6.39 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.467 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.81 150.62 73.96 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.575 2.183 . . . . 0.0 112.025 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -38.62 99.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.923 2.415 . . . . 0.0 112.278 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -111.72 70.36 0.71 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.489 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.596 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 0.0 OUTLIER 35.9 48.62 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.735 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 t -61.19 0.4 0.26 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.425 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 8' ' ' ASP . . . -174.09 -86.11 0.06 OUTLIER Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -58.34 159.03 20.54 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.801 2.334 . . . . 0.0 111.939 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.589 ' O ' ' N ' ' A' ' 14' ' ' VAL . 41.1 t -109.61 112.42 40.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.734 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 58.66 -72.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.692 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -127.94 153.92 78.28 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.657 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.75 72.98 3.66 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.015 2.477 . . . . 0.0 112.094 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mt -81.42 -1.56 46.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.793 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 65.12 57.4 11.89 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.448 ' CD2' ' H ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -90.61 166.15 13.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.418 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.7 mt -128.18 144.33 38.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.717 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -103.44 141.2 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.461 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.17 138.07 54.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.611 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 47.7 t30 -74.2 122.92 23.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.548 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -47.18 -25.22 0.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.556 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.484 ' HB3' ' ND2' ' A' ' 22' ' ' ASN . 7.6 tttm -76.34 -36.11 58.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.412 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.565 ' CG ' ' O ' ' A' ' 25' ' ' TRP . 34.8 t-105 -91.43 -1.34 57.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.501 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.54 ' C ' ' H ' ' A' ' 28' ' ' SER . 24.0 ttt180 -70.46 -15.16 62.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.571 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.56 24.19 0.49 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.54 ' H ' ' C ' ' A' ' 26' ' ' ARG . 0.4 OUTLIER -123.8 144.03 49.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.826 0.346 . . . . 0.0 110.618 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.56 ' O ' ' OE2' ' A' ' 33' ' ' GLU . 40.9 mt-30 -75.13 -16.93 60.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.537 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.803 HD13 ' N ' ' A' ' 31' ' ' ALA . 1.9 tm? -53.26 -65.05 0.63 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.238 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.803 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -49.69 -37.91 30.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.829 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -55.14 -30.85 60.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.896 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.647 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 0.4 OUTLIER -72.75 -45.94 56.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.746 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.593 ' SD ' HG11 ' A' ' 129' ' ' VAL . 3.8 mtm -44.84 -31.39 1.21 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.364 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -69.46 9.74 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.676 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -89.51 -31.39 11.58 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -131.24 -43.86 1.04 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.929 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.466 ' HA ' HD12 ' A' ' 38' ' ' ILE . 10.1 tp -103.03 162.33 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.698 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.415 ' N ' HG13 ' A' ' 38' ' ' ILE . 8.1 tttt -86.34 150.02 24.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.435 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.571 ' CD2' ' HB1' ' A' ' 31' ' ' ALA . 13.2 tp -137.17 131.6 32.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 mt -115.21 123.73 71.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.272 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.444 ' CD1' ' HD2' ' A' ' 26' ' ' ARG . 75.0 m-85 -88.74 120.35 30.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.801 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -126.14 132.45 51.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.45 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -95.2 103.75 15.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.628 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 154.29 -19.33 0.63 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.51 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 3.9 mm? -66.8 146.13 54.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 0.0 110.599 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.498 ' H ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -87.3 -58.54 0.28 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.804 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.498 ' HD2' ' H ' ' A' ' 47' ' ' THR . 37.7 Cg_endo -69.14 -158.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.616 2.211 . . . . 0.0 112.158 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.604 ' CG ' ' H ' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -90.76 -61.34 1.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.776 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -121.84 160.32 24.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.83 0.347 . . . . 0.0 110.871 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.505 ' CD2' HD12 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -142.06 101.48 3.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.535 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 mp -76.89 -38.7 53.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.465 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 54' ' ' ASN . 15.1 t -168.39 176.01 6.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.471 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.426 ' N ' ' OG ' ' A' ' 53' ' ' SER . 20.2 m-80 -76.65 49.49 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.451 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -161.28 -37.63 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.595 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.7 t -120.25 143.15 48.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.846 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.681 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -150.64 165.93 31.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.011 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.681 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 75.1 mt -137.55 131.64 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.76 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.495 HD23 ' OD1' ' A' ' 49' ' ' ASP . 0.4 OUTLIER -118.39 127.04 53.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.202 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.604 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 19.5 t80 -90.28 130.02 36.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.005 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 37.3 t -126.75 146.95 31.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.204 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.7 t -129.46 153.72 47.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.923 0.392 . . . . 0.0 110.944 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.426 ' HG3' ' H ' ' A' ' 97' ' ' SER . 0.5 OUTLIER -41.35 -44.42 2.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.617 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -48.41 -30.13 4.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.604 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.51 -31.13 37.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.528 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.734 HD23 ' N ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -64.45 -43.15 95.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.362 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.734 ' N ' HD23 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -46.03 -32.33 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.59 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 69' ' ' GLY . . . -103.2 -53.8 2.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.656 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 68' ' ' ALA . . . 36.12 37.41 0.18 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -115.38 -57.55 2.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.76 0.314 . . . . 0.0 110.639 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.8 -37.77 33.1 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.409 ' OH ' HD21 ' A' ' 59' ' ' LEU . 1.1 t80 -67.69 -23.37 65.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 0.0 110.653 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.2 tmm_? -60.51 -46.65 89.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.668 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -68.65 -24.63 64.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.33 -50.33 54.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.751 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.519 ' O ' HD21 ' A' ' 112' ' ' LEU . 22.0 mt -58.07 -26.04 62.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 80' ' ' ARG . 92.4 t -73.52 -45.7 50.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.028 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -42.17 -48.78 4.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.836 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 37.4 t -58.48 -27.46 33.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.453 ' N ' ' O ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -80.6 -37.65 30.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.57 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -63.33 -15.13 56.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.671 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 83' ' ' ASN . 92.9 p -59.79 -111.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.521 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.531 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER -117.86 -68.34 0.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.539 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.531 ' CG ' ' O ' ' A' ' 83' ' ' ASN . 16.0 m-20 176.98 63.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.428 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.461 ' CD1' ' OD1' ' A' ' 83' ' ' ASN . 4.0 mp -98.05 133.87 41.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.743 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -84.83 101.39 12.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.299 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.65 129.56 9.21 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.3 mt -86.51 135.86 24.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.796 0.332 . . . . 0.0 110.453 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.3 t -101.7 107.47 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.663 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.5 t -89.95 138.29 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.336 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.1 t -125.53 148.55 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.367 . . . . 0.0 110.899 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -118.97 110.1 16.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.188 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -66.45 146.33 54.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.749 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.424 HG22 ' CG ' ' A' ' 95' ' ' ARG . 5.1 m -141.67 -75.39 0.3 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.468 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.424 ' CG ' HG22 ' A' ' 94' ' ' THR . 5.8 mtp85 -141.22 -69.62 0.38 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.702 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 5.6 mmt -69.3 -10.77 59.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.631 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.645 ' HA ' HD13 ' A' ' 66' ' ' LEU . 5.3 p -50.56 -94.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.737 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 97' ' ' SER . 5.3 mt-10 -36.31 -25.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.906 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.583 ' N ' ' O ' ' A' ' 97' ' ' SER . 3.4 mm100 -73.75 -51.31 16.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.709 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.61 ' C ' HD11 ' A' ' 66' ' ' LEU . 1.1 t80 -114.59 11.83 17.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.649 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.729 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 28.8 t80 -69.76 -32.58 3.09 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.889 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.729 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 11.0 Cg_exo -67.1 -58.93 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.553 2.169 . . . . 0.0 111.938 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -47.85 -38.53 16.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.836 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 38.8 tp -73.15 -53.78 10.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.658 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -47.69 -36.5 11.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.642 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -64.53 -41.28 96.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.412 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -73.16 -46.0 53.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.648 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -35.19 74.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.894 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.672 ' O ' ' N ' ' A' ' 113' ' ' GLY . 3.6 t -76.65 -54.41 13.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.892 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.63 -29.73 69.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.915 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -84.66 -51.04 7.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.377 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.519 HD21 ' O ' ' A' ' 76' ' ' LEU . 8.9 mp -105.04 -28.5 11.01 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.584 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 55.01 16.13 7.67 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.768 ' N ' ' SD ' ' A' ' 114' ' ' MET . 0.0 OUTLIER -70.94 -155.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 0.0 110.762 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.2 t -109.65 138.21 38.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.711 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.606 ' O ' HD12 ' A' ' 117' ' ' LEU . 1.5 pp -129.38 127.05 40.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.508 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.606 HD12 ' O ' ' A' ' 116' ' ' LEU . 1.3 mp -132.73 101.24 14.27 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.482 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -79.01 156.36 26.56 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.526 2.151 . . . . 0.0 112.256 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.573 HG23 ' H ' ' A' ' 120' ' ' ALA . 5.6 m -130.35 -110.64 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.545 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.573 ' H ' HG23 ' A' ' 119' ' ' VAL . . . 170.96 -29.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.563 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.567 ' OG ' ' N ' ' A' ' 122' ' ' GLN . 0.4 OUTLIER -149.22 179.94 7.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.553 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.567 ' N ' ' OG ' ' A' ' 121' ' ' SER . 1.7 pt20 -73.69 -45.76 50.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.584 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.421 ' CG ' ' N ' ' A' ' 124' ' ' GLU . 8.7 ptt? -45.28 -43.21 10.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.646 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.624 ' O ' ' N ' ' A' ' 128' ' ' LEU . 16.6 mm-40 -59.74 -56.24 24.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.549 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.94 -58.38 8.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.104 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 122' ' ' GLN . 0.0 OUTLIER -47.47 -34.16 7.04 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 42.1 t -85.51 -31.02 22.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.321 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.624 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -76.01 -45.25 35.47 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.842 0.353 . . . . 0.0 110.625 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.593 HG11 ' SD ' ' A' ' 34' ' ' MET . 14.8 t -58.82 -54.67 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.616 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 96.3 mt -54.79 -52.62 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.616 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -48.9 -32.0 8.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.429 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.2 tp -61.71 -62.92 1.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.474 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.4 t -68.47 -36.89 76.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.506 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.426 ' O ' ' OG1' ' A' ' 137' ' ' THR . 28.7 tt0 -58.35 -31.94 68.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.542 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -63.59 -55.7 21.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.559 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -48.58 -38.61 21.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.567 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 137' ' ' THR . 25.3 m 41.68 30.98 0.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.739 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -86.67 123.53 31.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.544 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.543 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 mmt . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.62 91.45 8.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.562 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 pttp -152.52 28.68 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.555 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 63.19 74.06 0.47 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.561 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.62 155.16 44.83 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.778 2.319 . . . . 0.0 112.06 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -39.16 162.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 123.045 2.497 . . . . 0.0 112.28 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -83.68 56.17 3.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.541 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 10' ' ' GLY . 1.1 m-20 68.24 54.69 0.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.557 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.1 t -72.58 23.0 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.641 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 8' ' ' ASP . . . 49.89 71.12 0.66 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -42.6 130.21 5.2 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.973 2.448 . . . . 0.0 112.297 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.601 ' O ' HG13 ' A' ' 12' ' ' VAL . 6.0 p -61.29 103.46 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.645 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.467 ' CG ' ' O ' ' A' ' 13' ' ' HIS . 12.9 p-80 -141.26 127.05 19.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.53 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.1 m -95.82 148.19 34.17 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.548 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -67.21 177.98 3.37 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.731 2.287 . . . . 0.0 112.235 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 16' ' ' LEU . 5.0 mp -127.44 8.43 6.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.637 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.74 103.37 0.75 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -150.09 159.65 44.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.68 0.276 . . . . 0.0 110.302 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.0 159.5 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.893 0.377 . . . . 0.0 110.77 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.0 t -114.26 143.46 23.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.347 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -133.96 150.51 51.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.697 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.667 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 18.3 t-20 -80.78 138.68 36.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.612 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -58.47 -32.69 68.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.778 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -75.5 -76.54 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.462 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.701 ' O ' ' N ' ' A' ' 27' ' ' GLY . 65.5 t-105 -54.86 -24.31 22.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.065 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.678 ' O ' ' N ' ' A' ' 28' ' ' SER . 4.8 ttt-85 22.39 39.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.953 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.701 ' N ' ' O ' ' A' ' 25' ' ' TRP . . . 16.47 47.49 0.01 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 26' ' ' ARG . 3.0 m 46.3 174.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 0.0 110.53 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -42.07 -23.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.477 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.879 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -46.67 -45.4 19.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.781 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.452 ' N ' ' HG ' ' A' ' 30' ' ' LEU . . . -63.59 -25.73 68.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.54 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -80.8 -30.85 35.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -68.94 -37.38 78.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.624 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.431 ' CE ' HD11 ' A' ' 30' ' ' LEU . 6.0 mtt -48.22 -26.26 1.86 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.537 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -69.63 -2.46 11.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.569 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.61 -8.78 62.03 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -136.51 -46.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.399 . . . . 0.0 110.458 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.504 ' HA ' HD12 ' A' ' 38' ' ' ILE . 6.1 tp -126.0 172.31 13.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.183 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.479 ' H ' HG13 ' A' ' 38' ' ' ILE . 52.0 tttp -85.5 127.13 34.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.889 0.376 . . . . 0.0 110.525 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.821 HD13 ' N ' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -120.07 131.03 54.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.397 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.821 ' N ' HD13 ' A' ' 40' ' ' LEU . 44.9 mt -114.14 152.68 15.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.533 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 3.1 m-85 -118.39 121.06 39.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.687 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -125.34 126.87 45.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.343 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -88.15 144.51 26.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.756 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.51 5.42 57.86 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.667 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 8.1 mt -77.39 155.6 31.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 0.0 110.693 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.562 ' H ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -93.87 -63.72 0.14 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.788 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.562 ' HD2' ' H ' ' A' ' 47' ' ' THR . 18.6 Cg_endo -61.47 -178.31 0.27 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.662 2.242 . . . . 0.0 111.811 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.63 ' OD2' ' NE1' ' A' ' 25' ' ' TRP . 4.1 m-20 -97.91 -32.86 11.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.562 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -147.03 125.09 12.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.412 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.437 ' OH ' ' CD2' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -108.4 110.29 21.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.698 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.18 -43.71 32.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.394 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 55' ' ' ARG . 0.7 OUTLIER -163.38 153.08 15.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.622 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -58.95 70.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.718 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.589 ' N ' ' O ' ' A' ' 53' ' ' SER . 4.6 ttt-85 173.59 -26.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.652 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.6 m -140.56 131.32 25.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.497 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.591 ' SG ' HD13 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -121.88 175.38 6.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.561 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.0 mt -138.54 130.77 38.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.611 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.1 tp -111.75 131.81 55.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.383 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -100.92 122.72 43.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.558 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.463 ' HB ' HG22 ' A' ' 91' ' ' VAL . 61.9 t -117.78 146.37 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.501 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -121.18 141.78 50.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.694 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -38.67 -37.92 0.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.511 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -50.02 -39.72 42.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.544 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.67 -40.75 84.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.512 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.516 HD13 ' HA ' ' A' ' 97' ' ' SER . 1.3 tt -57.66 -37.97 74.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.479 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 67' ' ' VAL . 71.7 t -45.48 -15.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.361 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 66' ' ' LEU . . . -110.3 -56.88 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.456 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 47.75 24.82 3.13 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -155.71 43.17 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.792 0.329 . . . . 0.0 110.652 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -166.55 -37.83 0.02 OUTLIER Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.478 ' O ' ' N ' ' A' ' 75' ' ' ARG . 20.7 t80 -82.67 -25.15 33.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.763 0.316 . . . . 0.0 110.888 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -45.52 -33.04 2.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.495 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.96 -26.91 67.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.461 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.774 HH21 ' HE ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -76.68 -34.11 58.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.349 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.0 -38.13 89.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.577 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.05 -41.0 89.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.497 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.774 ' HE ' HH21 ' A' ' 75' ' ' ARG . 0.0 OUTLIER -47.62 -28.52 2.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.85 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.7 t -71.19 -27.81 30.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.876 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -79.06 -48.02 15.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.709 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.466 ' O ' ' C ' ' A' ' 82' ' ' SER . 12.7 t-20 -50.88 -49.82 58.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.773 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.466 ' C ' ' O ' ' A' ' 81' ' ' ASN . 1.7 t -33.88 -66.47 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.679 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -155.66 -141.15 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.628 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -129.02 54.06 1.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.587 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.832 ' O ' HD12 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -99.99 140.4 34.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.523 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.48 88.96 6.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.478 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.01 179.6 51.05 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 44.1 mt -121.8 115.75 47.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.801 0.334 . . . . 0.0 110.415 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.0 t -85.13 109.84 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.592 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.5 t -95.05 145.25 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.65 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.463 HG22 ' HB ' ' A' ' 61' ' ' VAL . 18.4 t -132.87 142.67 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.547 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -103.74 129.84 51.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.74 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -83.58 131.48 34.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.373 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.2 m -134.82 -84.47 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.758 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 41.4 mtp180 -131.39 -69.49 0.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.58 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -9.16 57.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.547 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.635 ' O ' ' N ' ' A' ' 101' ' ' PHE . 44.3 p -61.47 -92.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.812 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 97' ' ' SER . 8.3 pt-20 -36.28 -26.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.239 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.556 ' N ' ' O ' ' A' ' 97' ' ' SER . 35.6 mt-30 -70.53 -55.2 9.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 0.0 110.937 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.51 ' C ' HD11 ' A' ' 66' ' ' LEU . 2.7 t80 -115.21 12.59 16.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.814 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.726 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 1.1 t80 -68.04 -33.9 5.54 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.674 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.726 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 17.3 Cg_exo -64.0 -55.38 0.65 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.587 2.191 . . . . 0.0 111.897 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.66 -36.82 26.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.465 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.06 -41.19 64.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.465 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.39 -31.54 71.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.321 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.41 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -71.03 -46.3 62.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.231 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.406 ' O ' ' N ' ' A' ' 111' ' ' ASP . 1.3 m-85 -74.66 -49.43 21.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.401 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.4 m -43.83 -36.42 2.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.289 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' A' ' 113' ' ' GLY . 2.3 t -70.3 -54.01 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.206 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 106' ' ' LYS . 1.4 mt -66.25 -24.75 66.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.573 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 107' ' ' PHE . 16.0 t0 -84.53 -52.88 5.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.338 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.401 ' HA ' HD13 ' A' ' 112' ' ' LEU . 3.2 mm? -105.83 -28.38 10.67 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.5 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 54.27 43.33 75.07 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 2.2 ttm -110.68 -172.96 2.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.706 0.288 . . . . 0.0 110.335 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.5 t -89.0 120.4 37.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.645 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.668 HD23 ' N ' ' A' ' 117' ' ' LEU . 4.8 tt -110.34 124.27 51.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.479 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.668 ' N ' HD23 ' A' ' 116' ' ' LEU . 2.0 tt -131.83 104.99 14.06 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.734 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.23 156.97 17.27 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.703 2.269 . . . . 0.0 112.097 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 120' ' ' ALA . 0.3 OUTLIER -130.12 -101.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.592 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 119' ' ' VAL . . . 175.16 -45.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.632 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.8 m -130.13 167.24 18.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.557 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -70.09 -22.68 63.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.656 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 29.9 mtp -73.6 -43.78 58.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.676 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 128' ' ' LEU . 4.9 mm-40 -47.42 -55.69 8.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.666 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 128' ' ' LEU . . . -57.43 -57.93 10.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.134 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.615 ' OG ' HD13 ' A' ' 30' ' ' LEU . 65.0 m -44.74 -36.01 2.97 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.48 -31.72 22.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.005 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.591 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.7 OUTLIER -73.49 -31.36 63.69 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.749 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 25.4 t -80.05 -42.33 21.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.576 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.5 mt -62.05 -49.37 84.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.626 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -57.09 -37.87 72.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.589 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.4 ' HA ' HD22 ' A' ' 132' ' ' LEU . 0.2 OUTLIER -55.11 -40.89 70.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.815 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 45.4 t -74.42 -42.53 49.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.631 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -56.37 -52.78 63.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.627 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -56.17 -39.52 72.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.657 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -58.51 -58.89 6.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.552 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 71.9 p -44.08 -72.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.553 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -158.33 -168.16 2.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.619 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.552 179.966 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.448 ' O ' ' C ' ' A' ' 2' ' ' GLU . 45.8 mtt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 1' ' ' MET . 14.7 mm-40 36.4 80.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.534 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -94.99 138.86 32.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.362 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.59 152.85 55.14 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.55 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.465 ' O ' ' CG ' ' A' ' 7' ' ' ASP . 20.9 Cg_endo -64.61 109.85 1.31 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.905 2.404 . . . . 0.0 111.964 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.61 112.33 0.67 Allowed 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.482 2.121 . . . . 0.0 112.115 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.465 ' CG ' ' O ' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -155.77 50.78 0.55 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.588 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 10' ' ' GLY . 2.0 m-20 38.87 41.24 0.51 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.475 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.8 t -43.97 -13.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.46 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 8' ' ' ASP . . . 173.97 89.86 0.08 OUTLIER Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -81.62 46.12 2.15 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.892 2.395 . . . . 0.0 112.124 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.5 t -117.81 150.11 20.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.581 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.521 ' ND1' ' N ' ' A' ' 13' ' ' HIS . 1.1 p-80 -97.35 178.98 5.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.508 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.614 ' O ' HG23 ' A' ' 14' ' ' VAL . 28.1 m -140.47 84.19 14.38 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.545 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -80.57 -9.84 13.39 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.947 2.431 . . . . 0.0 112.286 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.634 HD12 ' O ' ' A' ' 16' ' ' LEU . 0.9 OUTLIER -159.54 150.64 19.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.699 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.451 ' O ' HD11 ' A' ' 38' ' ' ILE . . . 134.11 -110.56 0.88 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -87.96 166.15 14.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.711 0.291 . . . . 0.0 110.523 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.663 HD11 HG21 ' A' ' 133' ' ' VAL . 91.0 mt -113.67 149.6 15.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.621 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.3 t -97.48 147.03 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.494 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 41' ' ' ILE . . . -133.58 160.41 37.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.491 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 56.5 t30 -93.82 141.23 28.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.531 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -55.22 -34.88 64.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.639 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.501 ' C ' ' H ' ' A' ' 26' ' ' ARG . 2.9 ttpp -79.42 -50.45 10.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.659 ' CE2' ' OD2' ' A' ' 49' ' ' ASP . 53.5 t-105 -64.58 6.11 0.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.926 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.501 ' H ' ' C ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -85.44 1.26 49.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.627 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.84 20.79 26.5 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.4 m -116.77 155.28 29.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.854 0.359 . . . . 0.0 110.688 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -73.28 -21.64 60.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.469 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.556 ' CD1' ' C ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -57.16 -65.73 0.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.089 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -42.5 -32.76 0.58 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.303 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -70.68 -56.85 5.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.345 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 36' ' ' GLY . 96.0 mt-10 -54.16 -40.83 67.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.347 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.569 ' C ' ' H ' ' A' ' 36' ' ' GLY . 4.5 mtp -45.0 -47.63 11.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.404 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -65.82 11.68 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.499 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.569 ' H ' ' C ' ' A' ' 34' ' ' MET . . . -86.06 -29.38 25.78 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -125.62 -47.95 1.68 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.852 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.451 HD11 ' O ' ' A' ' 17' ' ' GLY . 0.2 OUTLIER -109.93 171.84 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.742 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.445 ' H ' HG12 ' A' ' 38' ' ' ILE . 11.3 ttpp -90.2 140.38 29.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.597 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.7 tp -126.09 144.57 50.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.666 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.45 ' O ' ' N ' ' A' ' 21' ' ' ALA . 29.5 mt -120.36 151.34 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.503 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -117.65 139.79 50.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.668 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -148.24 120.2 8.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.485 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.13 124.47 27.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.595 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 132.38 -27.94 3.51 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.488 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 48.2 mt -59.39 139.46 57.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.604 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.614 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 1.1 m -90.08 -39.22 0.41 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.061 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 47' ' ' THR . 58.5 Cg_endo -80.67 -163.93 0.25 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.271 1.981 . . . . 0.0 112.074 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.659 ' OD2' ' CE2' ' A' ' 25' ' ' TRP . 30.5 m-20 -99.0 -46.23 5.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.795 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -140.8 155.88 46.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.688 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.51 94.03 3.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.493 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.615 ' CD1' HG22 ' A' ' 133' ' ' VAL . 1.7 tp -64.05 -20.34 65.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.332 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.647 ' C ' ' H ' ' A' ' 55' ' ' ARG . 4.2 m 173.05 161.55 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.423 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.2 22.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.962 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.647 ' H ' ' C ' ' A' ' 53' ' ' SER . 4.8 mmt85 -132.02 -29.11 1.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.645 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 57' ' ' CYS . 2.3 t -132.77 152.94 51.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.859 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.502 ' N ' ' SG ' ' A' ' 56' ' ' CYS . 0.5 OUTLIER -148.13 171.4 15.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.286 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.4 mt -138.77 134.88 43.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.818 0.342 . . . . 0.0 110.824 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.01 125.22 36.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.504 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.48 ' HB3' ' CZ2' ' A' ' 25' ' ' TRP . 14.4 t80 -87.65 128.78 35.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.615 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.421 ' HB ' HG22 ' A' ' 91' ' ' VAL . 58.2 t -121.52 149.85 24.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.492 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.8 p -126.1 145.35 50.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.664 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -44.31 -41.91 6.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.422 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -44.0 -31.11 0.83 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.362 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -82.84 -39.31 21.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.531 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.72 HD11 ' C ' ' A' ' 100' ' ' TYR . 1.3 tt -49.14 -38.31 24.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.35 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 87.9 t -46.03 -36.16 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.594 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.69 116.72 9.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.54 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -121.77 3.56 10.89 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.58 4.77 2.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.813 0.339 . . . . 0.0 110.543 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -134.88 -33.48 0.29 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.474 ' O ' ' N ' ' A' ' 75' ' ' ARG . 4.3 t80 -80.11 -35.63 36.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.765 0.317 . . . . 0.0 110.532 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.423 ' NH2' ' HB3' ' A' ' 107' ' ' PHE . 22.0 ttt85 -43.58 -36.13 1.99 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.528 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -63.66 -34.79 78.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.507 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.474 ' N ' ' O ' ' A' ' 72' ' ' TYR . 0.3 OUTLIER -62.16 -35.91 80.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.47 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 mt -68.19 -40.47 82.2 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.424 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.8 t -63.46 -47.13 93.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.388 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -41.41 -32.33 0.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.329 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.1 t -71.05 -55.4 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.515 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.46 ' HB3' ' NH1' ' A' ' 80' ' ' ARG . 0.9 OUTLIER -54.08 -31.77 52.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.568 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.51 ' O ' ' C ' ' A' ' 82' ' ' SER . 3.7 t30 -54.37 -49.44 69.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.499 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.51 ' C ' ' O ' ' A' ' 81' ' ' ASN . 17.1 p -30.79 -76.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.428 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.458 ' OD1' ' OD1' ' A' ' 84' ' ' ASN . 1.5 t-20 -161.08 -89.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.476 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.564 ' ND2' ' O ' ' A' ' 84' ' ' ASN . 3.0 p-10 -151.48 48.47 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.295 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.1 mt -69.32 154.93 41.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.6 pttt -126.56 89.08 2.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.234 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.437 ' CA ' ' O ' ' A' ' 57' ' ' CYS . . . -109.26 176.28 19.55 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.7 mt -114.36 129.63 70.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.789 0.328 . . . . 0.0 110.646 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 t -104.24 107.35 22.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.46 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.3 t -90.24 143.82 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.652 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.421 HG22 ' HB ' ' A' ' 61' ' ' VAL . 82.0 t -129.0 143.24 41.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.53 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -102.4 115.62 30.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.565 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -71.6 143.2 49.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.514 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 89.9 m -137.49 -82.1 0.35 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.484 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.515 ' CG ' ' N ' ' A' ' 96' ' ' MET . 14.1 ptm180 -151.14 -44.79 0.12 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.464 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.515 ' N ' ' CG ' ' A' ' 95' ' ' ARG . 1.7 mtt -88.52 -2.92 58.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.139 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.718 ' HA ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -70.65 -71.91 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.492 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -40.76 -22.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.609 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.524 ' N ' ' O ' ' A' ' 97' ' ' SER . 68.3 mm-40 -72.3 -54.44 9.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.038 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.72 ' C ' HD11 ' A' ' 66' ' ' LEU . 1.1 t80 -116.6 12.15 14.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.038 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.612 ' N ' ' O ' ' A' ' 97' ' ' SER . 0.3 OUTLIER -62.51 -62.18 6.2 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.604 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 101' ' ' PHE . 9.6 Cg_endo -53.49 -48.75 20.24 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.653 2.235 . . . . 0.0 112.013 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.05 -31.36 7.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.51 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.752 HD23 ' HG1' ' A' ' 108' ' ' THR . 0.7 OUTLIER -85.31 -22.29 28.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.511 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.523 ' O ' HG23 ' A' ' 109' ' ' VAL . 1.4 tt0 -84.63 -32.37 23.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.699 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.77 -41.93 71.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.671 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.51 ' O ' ' CG ' ' A' ' 111' ' ' ASP . 2.9 m-85 -78.62 -51.01 10.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.603 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.752 ' HG1' HD23 ' A' ' 104' ' ' LEU . 97.1 m -51.37 -37.49 48.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.485 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 105' ' ' GLN . 22.2 t -67.55 -59.15 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.452 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.2 -19.05 65.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.526 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.51 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 12.5 m-20 -84.39 -57.8 3.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.029 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.47 HD23 ' C ' ' A' ' 111' ' ' ASP . 2.7 mt -107.5 -29.01 9.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.629 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 72.04 42.48 51.55 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -86.62 -171.05 3.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.576 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 40.7 t -117.76 105.23 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.587 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.491 ' N ' HD12 ' A' ' 116' ' ' LEU . 6.0 mp -95.64 142.39 28.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.514 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 tp -156.23 88.92 2.82 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.527 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -56.04 163.82 5.6 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.751 2.301 . . . . 0.0 112.085 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.703 ' O ' ' HB2' ' A' ' 120' ' ' ALA . 1.5 m -129.37 -106.83 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.655 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 119' ' ' VAL . . . 159.24 -47.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.434 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.13 143.68 51.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.544 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -51.94 -24.98 7.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.708 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 5.4 mtp -70.24 -51.72 28.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.623 ' O ' ' N ' ' A' ' 128' ' ' LEU . 9.6 mm-40 -44.71 -52.32 8.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.679 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.628 ' O ' HG23 ' A' ' 129' ' ' VAL . . . -55.18 -58.1 9.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.225 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.516 ' N ' HD21 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -49.73 -37.01 27.61 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.223 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.87 -31.2 35.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.128 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.623 ' N ' ' O ' ' A' ' 124' ' ' GLU . 1.8 mt -79.91 -26.94 40.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.879 0.371 . . . . 0.0 110.501 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 125' ' ' ALA . 61.3 t -81.56 -41.0 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.566 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 70.5 mt -73.16 -39.94 57.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.67 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -58.64 -25.58 62.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.533 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 132' ' ' LEU . 10.9 tp -77.01 -58.01 3.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.466 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.663 HG21 HD11 ' A' ' 19' ' ' ILE . 11.1 t -60.45 -41.79 88.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.605 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -52.76 -49.82 64.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.602 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -64.25 -28.71 69.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.527 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -87.58 -12.02 46.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.525 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.455 ' O ' ' C ' ' A' ' 138' ' ' LYS . 47.5 m -95.69 -45.88 6.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.551 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.551 ' O ' ' O ' ' A' ' 139' ' ' GLU . 13.7 tttp -35.18 144.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.628 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.551 ' O ' ' O ' ' A' ' 138' ' ' LYS . 1.7 tp10 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.566 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.419 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.8 mmt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.3 122.21 37.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.545 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.569 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 44.9 mttm -119.36 -63.13 1.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.732 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.569 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 0.5 OUTLIER 166.1 -53.85 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.913 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 4' ' ' ASN . 87.9 Cg_exo -41.59 157.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.792 2.328 . . . . 0.0 112.444 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -39.62 117.05 0.35 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.024 2.483 . . . . 0.0 112.37 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 14.1 p-10 -160.53 51.47 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.454 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 9' ' ' THR . 92.6 m-20 60.54 -82.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.566 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.709 HG22 ' O ' ' A' ' 9' ' ' THR . 90.1 m 37.46 37.61 0.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.633 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.28 63.58 0.04 OUTLIER Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -67.87 140.02 49.32 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.712 2.275 . . . . 0.0 112.087 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.9 t -132.8 -64.26 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.571 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.22 21.07 9.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.5 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.82 59.47 7.22 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.441 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.54 -52.8 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.95 2.434 . . . . 0.0 112.265 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.5 tp -129.37 114.28 16.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.808 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -153.34 17.24 0.68 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -114.22 154.6 27.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.804 0.335 . . . . 0.0 110.602 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 73.3 mt -106.21 153.49 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.625 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.9 t -110.47 124.04 66.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.654 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.01 149.88 27.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.66 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -74.78 140.65 44.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.424 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.71 -28.65 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.417 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.5 ' C ' ' H ' ' A' ' 26' ' ' ARG . 12.5 ttmm -83.54 -52.88 6.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.395 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.458 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 42.5 t-105 -74.79 24.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.307 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.5 ' H ' ' C ' ' A' ' 24' ' ' LYS . 18.7 ttp85 -81.28 -63.89 1.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.704 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.78 52.46 0.51 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 26' ' ' ARG . 11.1 p -111.85 141.21 45.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.337 . . . . 0.0 110.634 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.41 ' OE1' ' NE2' ' A' ' 122' ' ' GLN . 45.2 mt-30 -56.35 -28.55 59.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.713 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.563 ' CD1' ' C ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -61.07 -66.07 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.393 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.06 -24.67 63.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.923 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.02 -51.25 68.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.814 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -70.33 -45.83 65.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.857 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.457 ' HE1' ' O ' ' A' ' 126' ' ' SER . 36.0 mmt -49.92 -26.62 4.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.815 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -77.01 -0.54 24.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 0.0 110.562 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.22 6.83 50.98 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -148.79 -47.85 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.812 0.339 . . . . 0.0 110.537 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.456 HG12 ' H ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -113.56 169.78 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.595 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.456 ' H ' HG12 ' A' ' 38' ' ' ILE . 5.4 tptm -94.94 152.82 18.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.487 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.86 137.99 28.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.48 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.4 mt -116.62 131.72 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.531 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -88.15 132.42 34.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.799 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -139.94 121.8 15.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.544 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -79.77 145.04 33.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.647 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.4 -33.89 5.83 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.597 HD22 ' CD2' ' A' ' 51' ' ' TYR . 77.3 mt -48.83 137.6 12.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 110.619 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.536 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -88.11 -52.63 0.38 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.929 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 47' ' ' THR . 33.9 Cg_endo -67.61 -157.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.04 1.826 . . . . 0.0 112.15 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.433 ' OD2' ' CD2' ' A' ' 25' ' ' TRP . 1.6 m-20 -98.63 -54.91 2.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.879 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.458 ' CZ ' ' CD1' ' A' ' 25' ' ' TRP . 83.0 m-85 -124.12 145.77 49.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.794 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.597 ' CD2' HD22 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -123.17 103.07 8.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.488 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.551 ' O ' HD23 ' A' ' 52' ' ' LEU . 1.0 OUTLIER -81.71 -35.11 30.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.493 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.626 ' C ' ' H ' ' A' ' 55' ' ' ARG . 4.2 t -178.28 164.59 1.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.426 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -67.38 23.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.477 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.626 ' H ' ' C ' ' A' ' 53' ' ' SER . 5.4 ttt-85 -134.72 -4.93 2.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.142 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.555 ' SG ' ' C ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -161.57 144.98 12.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.87 0.366 . . . . 0.0 110.974 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.419 ' SG ' ' HA2' ' A' ' 87' ' ' GLY . 12.5 p -151.13 164.38 36.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.438 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.0 mt -129.06 148.67 33.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.678 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.7 tt -133.78 120.02 19.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.287 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -85.71 121.66 28.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.792 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.425 ' N ' ' O ' ' A' ' 90' ' ' VAL . 74.7 t -122.15 143.98 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.229 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 63' ' ' GLU . 42.1 p -124.09 148.25 47.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.627 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 66' ' ' LEU . 3.3 tm-20 -38.57 -40.51 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.73 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -44.85 -33.32 1.9 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.661 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.562 ' OD2' ' CE1' ' A' ' 72' ' ' TYR . 3.6 m-20 -82.06 -26.34 33.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.634 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.533 HD23 ' N ' ' A' ' 67' ' ' VAL . 1.4 tt -68.41 -50.07 55.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.671 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.533 ' N ' HD23 ' A' ' 66' ' ' LEU . 2.3 p -62.43 -27.67 43.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.424 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.47 -64.96 0.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.561 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 70' ' ' ASN . . . 71.3 111.17 0.04 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.512 ' CB ' ' O ' ' A' ' 69' ' ' GLY . 5.1 t-20 81.75 139.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.77 0.319 . . . . 0.0 110.51 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.43 -71.31 0.38 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.562 ' CE1' ' OD2' ' A' ' 65' ' ' ASP . 4.0 t80 -50.56 -47.49 57.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.928 0.395 . . . . 0.0 110.375 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -43.15 -36.01 1.55 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.701 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -67.25 -43.94 80.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.542 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 12.3 mtt85 -58.36 -25.41 61.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.544 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 mt -79.42 -38.45 34.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.36 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.3 t -49.25 -30.46 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.278 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -54.65 -29.3 51.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.349 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.6 t -69.12 -35.94 70.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.218 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -79.53 -20.22 47.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.405 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -51.03 -59.69 3.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.471 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.459 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 0.1 OUTLIER -69.0 -68.99 0.36 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.454 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 82' ' ' SER . 4.5 t-20 78.01 60.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.491 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.538 ' OD1' ' O ' ' A' ' 84' ' ' ASN . 2.1 p30 -148.48 11.82 0.9 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.757 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 pp -155.09 153.09 30.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.809 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.7 mmtm -76.62 110.0 10.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.126 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.419 ' HA2' ' SG ' ' A' ' 57' ' ' CYS . . . -86.64 101.76 2.67 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.8 mt -84.48 138.57 18.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 37.0 t -117.96 127.6 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.858 0.361 . . . . 0.0 111.149 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 61' ' ' VAL . 14.7 t -117.49 121.84 68.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.166 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.0 t -114.79 139.69 39.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.783 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -98.75 129.53 45.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.679 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.56 ' NZ ' ' O ' ' A' ' 119' ' ' VAL . 21.7 mttp -78.57 138.39 38.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.428 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 12.2 m -140.12 -85.22 0.22 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.669 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -128.8 -63.38 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.592 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.734 ' N ' ' SD ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -77.91 -9.24 58.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.48 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 99' ' ' GLN . 4.7 p -48.47 -102.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.348 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 97' ' ' SER . 24.2 mt-10 -36.31 -21.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.589 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.68 ' N ' ' O ' ' A' ' 97' ' ' SER . 3.8 tp-100 -69.56 -55.61 9.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.094 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.422 ' CZ ' ' HB1' ' A' ' 103' ' ' ALA . 4.8 t80 -117.33 3.11 12.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.801 0.334 . . . . 0.0 110.797 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.601 ' CD1' ' C ' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -47.06 -58.77 6.44 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.507 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 101' ' ' PHE . 14.9 Cg_endo -59.05 -48.68 13.33 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.556 2.171 . . . . 0.0 112.277 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.422 ' HB1' ' CZ ' ' A' ' 100' ' ' TYR . . . -45.47 -32.39 2.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.855 0.359 . . . . 0.0 110.227 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 tp -87.29 -30.95 20.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.806 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 102' ' ' PRO . 38.1 tt0 -58.26 -40.09 80.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.16 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -63.51 -37.08 85.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.088 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.27 -38.78 34.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.472 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.0 m -72.93 -30.84 64.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.569 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.584 ' O ' ' CA ' ' A' ' 113' ' ' GLY . 10.8 t -77.36 -43.93 30.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.989 0.423 . . . . 0.0 110.53 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.3 tp -70.92 -31.15 67.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.613 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -84.51 -50.14 7.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.308 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mt -104.88 -28.32 11.19 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.597 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.584 ' CA ' ' O ' ' A' ' 109' ' ' VAL . . . 43.47 35.19 2.75 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.93 -159.62 0.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.362 . . . . 0.0 110.547 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 49.4 t -96.29 123.13 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.426 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.14 133.91 53.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.67 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.8 mt -146.07 88.28 6.39 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.481 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -80.56 158.99 22.22 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.883 2.389 . . . . 0.0 112.189 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.57 HG23 ' N ' ' A' ' 120' ' ' ALA . 28.2 m -127.2 -136.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.428 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.57 ' N ' HG23 ' A' ' 119' ' ' VAL . . . -153.5 -40.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.279 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.9 p -138.39 158.34 44.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.357 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.41 ' NE2' ' OE1' ' A' ' 29' ' ' GLN . 21.1 mt-30 -58.17 -26.36 62.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.62 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.85 -45.23 90.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.74 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.638 ' O ' ' N ' ' A' ' 128' ' ' LEU . 1.2 mp0 -54.97 -58.41 7.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.657 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 129' ' ' VAL . . . -52.18 -58.06 7.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.296 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.499 ' N ' HD21 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -43.68 -40.29 4.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.327 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.7 m -85.39 -27.12 26.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.208 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.638 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.5 OUTLIER -77.35 -26.86 52.43 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.942 0.401 . . . . 0.0 110.742 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 125' ' ' ALA . 3.5 t -68.87 -61.45 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.642 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.412 HG13 ' SD ' ' A' ' 34' ' ' MET . 6.8 mt -58.33 -45.08 89.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.441 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -45.7 -29.62 1.32 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.829 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.4 mt -76.44 -48.75 18.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.772 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.556 ' O ' ' OG1' ' A' ' 137' ' ' THR . 19.2 t -67.81 -51.93 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.817 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.75 -33.72 49.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -63.69 -58.96 5.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.841 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.434 ' HG3' ' N ' ' A' ' 137' ' ' THR . 2.0 pt20 -62.77 -41.06 99.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.943 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.556 ' OG1' ' O ' ' A' ' 133' ' ' VAL . 1.0 OUTLIER -68.98 47.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.784 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.44 ' HG2' ' N ' ' A' ' 139' ' ' GLU . 2.7 ttmp? -108.74 157.91 18.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.403 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.44 ' N ' ' HG2' ' A' ' 138' ' ' LYS . 3.1 pt-20 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.628 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.666 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.6 p-80 -136.53 152.39 50.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.856 0.36 . . . . 0.0 110.778 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.446 ' HB ' HD12 ' A' ' 40' ' ' LEU . 3.4 mm -122.98 135.51 62.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.261 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.7 t -97.04 151.63 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.802 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.3 128.26 25.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.502 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.425 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 55.5 t-20 -56.57 131.27 48.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.566 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -43.79 -38.3 3.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.681 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.596 ' C ' ' H ' ' A' ' 26' ' ' ARG . 15.5 ttpt -72.62 -48.41 39.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.48 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.514 ' CE2' ' OD2' ' A' ' 49' ' ' ASP . 24.2 t-105 -67.89 19.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.537 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.596 ' H ' ' C ' ' A' ' 24' ' ' LYS . 61.2 ttt-85 -89.47 -34.97 16.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.439 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.97 36.71 0.24 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.561 ' H ' ' C ' ' A' ' 26' ' ' ARG . 5.8 p -117.86 144.69 45.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.769 0.319 . . . . 0.0 110.644 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -72.93 -18.97 61.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.441 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.802 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -68.56 -57.61 5.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.315 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.406 ' N ' ' HG ' ' A' ' 30' ' ' LEU . . . -41.93 -23.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.531 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 30' ' ' LEU . 2.4 tp60 -72.12 -47.61 49.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.567 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 36' ' ' GLY . 3.5 mt-10 -50.94 -51.26 54.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.456 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.522 ' C ' ' H ' ' A' ' 36' ' ' GLY . 5.6 mtt -43.93 -42.14 5.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.573 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -71.1 17.16 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.598 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.522 ' H ' ' C ' ' A' ' 34' ' ' MET . . . -104.15 -10.69 33.68 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.5 mtmm -152.01 -43.1 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.854 0.359 . . . . 0.0 110.479 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.445 HD12 ' HA ' ' A' ' 38' ' ' ILE . 10.1 tp -109.36 160.65 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.519 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.8 tttm -86.19 146.05 26.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.582 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.446 HD12 ' HB ' ' A' ' 19' ' ' ILE . 13.9 tp -131.4 137.87 48.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.701 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 57.8 mt -123.16 141.89 41.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.486 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -96.75 133.69 40.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.798 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.76 120.04 25.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.387 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -89.85 111.55 22.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.651 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 133.4 -8.52 5.01 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.425 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 66.3 mt -92.61 148.71 21.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.773 0.32 . . . . 0.0 110.67 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.536 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -96.04 -47.9 0.25 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 47' ' ' THR . 58.0 Cg_exo -47.87 164.35 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.727 2.285 . . . . 0.0 112.27 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.601 ' OD2' ' CD1' ' A' ' 60' ' ' TYR . 1.2 m-20 -85.44 -53.04 5.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.476 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -135.71 120.7 18.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.891 0.377 . . . . 0.0 110.607 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.549 ' CD1' ' O ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -99.48 112.78 24.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.383 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.91 -44.08 15.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.65 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.549 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 5.0 t -139.46 -162.23 1.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.676 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -90.22 -8.98 49.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.624 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.422 HH21 ' HZ1' ' A' ' 86' ' ' LYS . 11.2 mtp180 -125.83 -8.8 6.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.828 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.61 132.82 56.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.962 0.411 . . . . 0.0 111.1 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.1 163.67 30.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.892 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 96.5 mt -135.72 124.16 38.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.977 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.9 tp -115.82 138.21 51.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.372 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.601 ' CD1' ' OD2' ' A' ' 49' ' ' ASP . 2.8 p90 -96.17 132.91 41.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.91 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 92' ' ' GLU . 77.0 t -130.59 149.97 34.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.176 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.42 ' O ' ' C ' ' A' ' 63' ' ' GLU . 1.0 OUTLIER -138.05 157.06 47.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.631 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 62' ' ' THR . 5.7 tm-20 -39.18 -43.16 1.04 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.32 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -47.0 -39.91 13.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.343 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 62' ' ' THR . 61.9 m-20 -69.01 -44.63 72.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.333 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.407 HD11 ' C ' ' A' ' 100' ' ' TYR . 1.5 tt -49.05 -44.44 41.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.523 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 32.2 t -49.48 -41.22 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.552 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.41 -71.63 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.646 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.44 -52.82 1.89 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -97.09 103.23 15.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.789 0.328 . . . . 0.0 110.559 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.66 -51.43 0.8 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -67.37 -24.53 65.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.724 0.297 . . . . 0.0 110.902 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -42.19 97.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 110.589 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -46.31 -46.15 17.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.583 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -59.09 -38.05 78.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.747 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 76' ' ' LEU . 97.6 mt -70.41 -34.81 72.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.708 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 63.8 t -61.45 -40.27 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.856 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 -56.85 -23.42 43.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.799 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.0 t -79.91 -49.51 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.561 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.6 ttt-85 -66.9 -25.54 66.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.645 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -71.05 -11.61 61.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.654 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.554 ' OG ' ' N ' ' A' ' 83' ' ' ASN . 60.4 p -67.92 -117.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.581 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.61 ' C ' HD22 ' A' ' 84' ' ' ASN . 7.1 t30 -121.02 -93.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.679 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.61 HD22 ' C ' ' A' ' 83' ' ' ASN . 1.5 m-80 -138.02 60.27 1.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.495 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.5 mp -93.48 123.43 36.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.575 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.422 ' HZ1' HH21 ' A' ' 55' ' ' ARG . 1.2 pttp -112.58 85.84 2.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.172 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -93.67 -165.33 37.21 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.8 mt -131.28 135.83 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.773 0.32 . . . . 0.0 110.488 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.2 t -107.99 118.82 56.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.614 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 61' ' ' VAL . 19.7 t -93.69 140.72 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.401 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.66 132.59 70.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.716 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 61' ' ' VAL . 3.6 tt0 -101.71 104.43 15.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.387 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -68.65 131.95 46.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.579 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.6 m -126.14 -74.26 0.6 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.633 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.3 mtp85 -140.84 -70.3 0.38 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.457 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.33 -1.93 7.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.49 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.609 ' O ' ' N ' ' A' ' 101' ' ' PHE . 4.1 t -68.7 -91.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.788 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 97' ' ' SER . 22.1 mt-10 -36.41 -27.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.954 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 97' ' ' SER . 2.3 mt-30 -71.64 -51.51 22.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.181 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.407 ' C ' HD11 ' A' ' 66' ' ' LEU . 6.1 m-85 -117.13 11.62 14.23 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.19 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.727 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 35.5 t80 -69.82 -32.9 3.23 Favored Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.78 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.727 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 10.8 Cg_exo -67.33 -42.34 7.67 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.588 2.192 . . . . 0.0 111.939 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.05 -48.32 78.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.635 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 tp -71.16 -47.99 54.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.585 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.682 ' O ' HG23 ' A' ' 109' ' ' VAL . 7.7 tt0 -50.59 -33.63 22.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.73 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -56.39 15.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.871 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.6 -52.14 62.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.787 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.1 m -42.18 -40.43 2.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.79 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 105' ' ' GLN . 85.9 t -66.2 -58.66 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.476 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.435 ' HA ' HD13 ' A' ' 110' ' ' LEU . 0.9 OUTLIER -62.56 -23.08 66.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.461 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.48 -55.51 4.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mt -106.33 -28.58 10.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.184 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 56.76 20.04 30.94 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 6.5 tpp -73.04 -161.09 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.724 0.297 . . . . 0.0 110.404 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.12 127.63 65.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.607 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.596 ' N ' HD12 ' A' ' 116' ' ' LEU . 5.0 mp -122.27 115.44 22.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.472 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.3 mt -124.99 88.32 54.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -53.25 171.56 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.629 2.219 . . . . 0.0 111.735 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 120' ' ' ALA . 4.0 m -143.06 -113.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.652 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.404 ' H ' HG23 ' A' ' 119' ' ' VAL . . . -177.51 -37.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.263 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.8 p -141.12 -170.74 3.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.348 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -81.26 -28.22 34.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.598 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -48.42 59.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.757 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 128' ' ' LEU . 0.4 OUTLIER -44.7 -46.1 10.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.25 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.66 -54.92 24.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.959 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.791 ' HB3' HD13 ' A' ' 30' ' ' LEU . 59.7 p -54.98 -30.85 60.1 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -85.19 -35.32 21.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.256 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.596 ' N ' ' O ' ' A' ' 124' ' ' GLU . 4.2 mp -74.58 -34.33 62.86 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.569 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 133' ' ' VAL . 62.0 t -74.19 -55.0 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.562 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 97.2 mt -58.17 -50.93 76.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.581 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -48.94 -30.28 5.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.321 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.1 tp -82.58 -42.03 18.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.478 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 129' ' ' VAL . 95.8 t -63.75 -36.79 77.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.644 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.96 -22.46 65.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.656 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.475 179.942 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.677 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -72.78 155.1 40.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.846 0.355 . . . . 0.0 110.702 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.406 ' HB ' HD12 ' A' ' 40' ' ' LEU . 17.9 mm -109.35 143.8 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.399 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.6 t -94.6 145.41 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.586 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -136.82 137.25 39.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.541 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 25' ' ' TRP . 63.2 t-20 -64.7 135.29 55.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.467 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.406 ' N ' ' OD1' ' A' ' 22' ' ' ASN . 7.2 tt0 -43.18 -32.3 0.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.369 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -70.36 -36.78 74.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.334 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.502 ' N ' ' O ' ' A' ' 22' ' ' ASN . 0.2 OUTLIER -68.46 -13.62 62.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.208 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.448 ' HD3' ' CD1' ' A' ' 42' ' ' PHE . 7.7 tpt85 -61.98 -40.85 97.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.611 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.6 51.01 0.85 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.69 152.16 37.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.794 0.33 . . . . 0.0 110.622 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -75.55 -21.05 58.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.363 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.849 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -68.67 -56.61 7.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.598 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.432 ' N ' ' HG ' ' A' ' 30' ' ' LEU . . . -53.14 -33.08 50.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.831 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -82.4 -28.94 31.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.727 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -67.33 -31.78 72.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.52 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.689 ' N ' ' SD ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -74.83 -27.04 60.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.465 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -65.78 -8.65 22.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.681 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.35 -29.02 11.7 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.2 -48.85 3.75 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.98 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.429 HG23 ' N ' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -123.24 172.2 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.94 0.4 . . . . 0.0 110.882 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.429 ' N ' HG23 ' A' ' 38' ' ' ILE . 36.8 tttp -86.13 127.6 34.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.541 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.406 HD12 ' HB ' ' A' ' 19' ' ' ILE . 13.4 tp -118.59 129.75 55.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.755 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 mt -108.59 140.66 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.31 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.448 ' CD1' ' HD3' ' A' ' 26' ' ' ARG . 6.2 m-85 -104.14 129.05 51.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.719 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.416 ' HB3' HD13 ' A' ' 46' ' ' LEU . 2.8 mt-10 -130.63 113.2 13.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.439 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -75.18 128.47 35.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.477 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.65 -47.41 1.02 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 46' ' ' LEU . 9.7 mp -46.96 148.15 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.716 0.293 . . . . 0.0 110.387 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.56 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -99.45 -47.54 0.21 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.903 0.382 . . . . 0.0 110.668 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 47' ' ' THR . 31.4 Cg_exo -54.95 176.93 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.791 2.327 . . . . 0.0 112.153 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.47 ' OD1' ' CE2' ' A' ' 25' ' ' TRP . 8.1 m-20 -87.11 -56.14 3.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.436 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -129.65 143.62 50.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.357 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -116.61 108.35 15.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.71 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.78 -38.26 76.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.487 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.602 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 5.8 m -160.01 -143.54 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.439 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.31 18.81 17.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.584 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.537 ' HA ' HD13 ' A' ' 85' ' ' LEU . 7.6 mtp180 -144.49 9.84 1.41 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.602 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 86' ' ' LYS . 42.7 t -163.53 145.4 9.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.684 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.15 172.72 12.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.296 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.6 mt -131.08 126.33 59.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.72 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.24 117.73 30.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.27 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -87.74 117.46 26.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.95 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 73.2 t -99.3 149.48 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.948 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.446 ' H ' ' CG ' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -121.29 156.37 32.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.842 0.353 . . . . 0.0 110.831 -179.665 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.732 ' HB2' HG21 ' A' ' 94' ' ' THR . 12.0 pt-20 -46.05 -44.67 15.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.56 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.501 ' N ' ' CG ' ' A' ' 63' ' ' GLU . . . -51.39 -19.86 1.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.701 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.672 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -79.33 -53.08 7.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.698 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.683 HD13 ' HA ' ' A' ' 97' ' ' SER . 1.3 tt -56.33 -50.23 72.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.662 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.0 t -52.98 -13.77 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.711 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.42 35.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.758 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 65' ' ' ASP . . . -65.36 -16.71 63.11 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -51.86 -45.85 64.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.762 0.315 . . . . 0.0 110.666 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.48 -47.55 6.34 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 75' ' ' ARG . 2.1 t80 -53.53 -26.39 20.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.862 0.363 . . . . 0.0 110.624 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 72' ' ' TYR . 6.2 ttp85 -36.28 -35.67 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.717 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.523 ' HZ2' ' HA ' ' A' ' 74' ' ' LYS . 2.7 mmtm -70.31 -48.79 55.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.654 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -54.44 -28.92 47.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.695 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 27.5 mt -70.61 -58.11 4.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.689 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 80' ' ' ARG . 65.3 t -50.76 -36.91 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.592 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.38 -21.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.465 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.478 ' N ' ' O ' ' A' ' 77' ' ' VAL . 41.1 t -77.88 -33.25 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.766 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.551 ' N ' ' O ' ' A' ' 77' ' ' VAL . 0.9 OUTLIER -82.31 -39.54 22.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.773 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -59.27 -21.24 59.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.901 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 t -95.19 -54.61 3.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.722 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -132.93 -171.0 2.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.652 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -147.03 45.76 1.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.27 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.537 HD13 ' HA ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -98.69 155.64 17.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.688 -179.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.523 ' O ' ' SG ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -80.41 122.27 26.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.239 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.433 ' H ' ' HG2' ' A' ' 114' ' ' MET . . . -127.89 164.19 21.31 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.5 mt -107.66 121.86 61.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.853 0.359 . . . . 0.0 110.448 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.1 t -97.2 125.68 50.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.872 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.66 149.4 5.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.047 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.0 t -132.77 145.08 34.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.892 0.377 . . . . 0.0 110.862 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -92.59 120.69 33.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.399 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -67.34 139.85 57.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.793 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.777 HG23 ' H ' ' A' ' 95' ' ' ARG . 1.9 t -151.08 -108.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.523 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.777 ' H ' HG23 ' A' ' 94' ' ' THR . 4.1 mtt180 -130.07 -74.7 0.54 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.259 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.472 ' SD ' ' OE1' ' A' ' 99' ' ' GLN . 26.6 mmt -55.36 -7.16 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.279 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.683 ' HA ' HD13 ' A' ' 66' ' ' LEU . 1.4 t -54.92 -88.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.671 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.449 ' N ' ' OG ' ' A' ' 97' ' ' SER . 2.2 mm-40 -43.01 -21.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.032 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.472 ' OE1' ' SD ' ' A' ' 96' ' ' MET . 47.9 mt-30 -71.11 -55.07 8.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.845 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -117.08 12.26 14.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.824 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.709 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 0.3 OUTLIER -63.7 -35.46 16.5 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.414 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.709 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 2.7 Cg_exo -71.9 -53.94 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.734 2.289 . . . . 0.0 111.813 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -45.88 -27.77 0.95 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.617 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.57 -44.38 12.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.507 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.455 ' NE2' ' CZ ' ' A' ' 101' ' ' PHE . 9.5 tt0 -60.64 -32.15 71.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.616 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -73.75 -34.94 64.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.739 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -81.95 -37.35 26.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.801 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.1 p -73.35 -35.78 66.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.928 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.696 ' O ' ' N ' ' A' ' 113' ' ' GLY . 4.0 t -66.84 -55.95 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.942 0.401 . . . . 0.0 110.652 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.35 -30.42 66.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.55 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -84.5 -51.22 7.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.438 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.85 -28.87 10.37 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.538 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.696 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 60.93 33.81 85.12 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.433 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 3.3 mtt -84.84 -179.5 7.1 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 110.543 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.0 t -103.05 124.25 57.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.628 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.5 mp -105.35 143.78 33.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.241 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 117' ' ' LEU . 2.1 tt -157.29 88.59 2.57 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.746 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -58.49 146.27 91.28 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.671 2.247 . . . . 0.0 111.823 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.461 HG23 ' H ' ' A' ' 120' ' ' ALA . 2.3 m -108.23 -107.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.548 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.461 ' H ' HG23 ' A' ' 119' ' ' VAL . . . 179.41 -30.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.391 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 97.2 p -144.23 -173.36 3.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.39 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -85.21 -24.45 27.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.588 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.412 ' O ' ' N ' ' A' ' 127' ' ' CYS . 37.9 mtt -81.37 -41.41 22.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.733 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 128' ' ' LEU . 6.5 mm-40 -45.03 -43.51 9.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.437 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.91 -57.78 6.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.007 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.651 ' CB ' HD13 ' A' ' 30' ' ' LEU . 51.5 p -55.61 -29.67 59.57 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.412 ' N ' ' O ' ' A' ' 123' ' ' MET . 47.1 t -85.04 -35.65 21.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.135 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.721 ' O ' HD12 ' A' ' 128' ' ' LEU . 1.7 tp -72.1 -50.41 28.36 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.11 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.512 ' O ' HG23 ' A' ' 133' ' ' VAL . 54.2 t -55.34 -57.0 8.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.781 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.5 mm -55.77 -45.28 79.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.679 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -57.17 -33.34 67.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.443 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.3 tp -67.17 -37.6 84.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.544 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 129' ' ' VAL . 0.4 OUTLIER -84.15 -42.44 17.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.636 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -61.01 -41.64 96.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.838 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.818 -179.78 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.644 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -133.34 148.83 51.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.343 . . . . 0.0 110.717 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.4 mm -116.75 149.34 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.474 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.1 t -119.32 135.0 61.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.65 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.58 137.23 52.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.31 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.653 HD22 ' N ' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -67.88 135.13 52.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.784 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.653 ' N ' HD22 ' A' ' 22' ' ' ASN . 4.8 tp10 -54.68 -38.21 66.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.587 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.5 ttmm -80.15 -65.89 0.95 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.514 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.614 ' NE1' ' OD2' ' A' ' 49' ' ' ASP . 19.3 t-105 -42.54 -48.41 5.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.507 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.671 ' O ' ' N ' ' A' ' 28' ' ' SER . 5.4 ttm180 26.33 85.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.481 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 28' ' ' SER . . . -43.39 -8.9 0.01 OUTLIER Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.671 ' N ' ' O ' ' A' ' 26' ' ' ARG . 0.4 OUTLIER 74.31 -143.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.849 0.357 . . . . 0.0 110.39 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 28' ' ' SER . 3.5 mt-30 -39.92 -20.08 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.326 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.029 HD13 ' OG ' ' A' ' 126' ' ' SER . 0.3 OUTLIER -71.57 -52.09 19.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.384 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.81 -29.75 68.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.647 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -65.35 -54.34 30.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.543 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.651 ' O ' ' N ' ' A' ' 36' ' ' GLY . 3.8 mm-40 -59.37 -41.14 88.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.38 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.636 ' SD ' HD13 ' A' ' 40' ' ' LEU . 4.7 mtt -36.85 -33.98 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.459 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 33' ' ' GLU . 42.5 mt-30 -75.28 17.22 0.27 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.434 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -106.62 -4.82 36.92 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm -138.58 -41.33 0.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.685 0.279 . . . . 0.0 110.903 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.479 HG13 ' H ' ' A' ' 39' ' ' LYS . 4.8 tp -132.78 172.43 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.536 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.479 ' H ' HG13 ' A' ' 38' ' ' ILE . 43.0 tttp -85.54 125.9 33.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.613 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.636 HD13 ' SD ' ' A' ' 34' ' ' MET . 18.5 tp -114.98 149.73 36.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.666 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.436 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 3.7 mt -132.14 151.16 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.676 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.429 ' CE2' ' NH2' ' A' ' 26' ' ' ARG . 81.7 m-85 -115.99 131.09 57.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.446 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -137.01 128.37 28.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.608 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -92.13 122.28 34.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.362 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 139.97 -30.96 2.32 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.526 ' O ' ' OD1' ' A' ' 22' ' ' ASN . 1.4 mt -68.61 161.82 27.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.748 0.309 . . . . 0.0 110.477 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.735 ' H ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -111.38 -40.54 0.1 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.914 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.735 ' CD ' ' H ' ' A' ' 47' ' ' THR . 24.7 Cg_exo -59.27 -173.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.59 2.193 . . . . 0.0 112.023 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.614 ' OD2' ' NE1' ' A' ' 25' ' ' TRP . 8.1 m-20 -97.47 -49.89 4.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.368 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -134.33 145.08 48.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.308 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.05 118.74 35.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.873 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 tp -100.75 -30.37 11.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.258 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.624 ' C ' ' H ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -173.35 147.69 1.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.45 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.531 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -56.02 2.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.513 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.624 ' H ' ' C ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -124.2 1.27 8.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.529 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 86' ' ' LYS . 7.6 t -156.44 139.26 15.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.962 0.41 . . . . 0.0 110.829 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -142.52 175.03 10.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.007 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.7 mt -137.68 133.15 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.847 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 tp -117.44 134.99 54.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.161 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.428 ' N ' ' OD2' ' A' ' 49' ' ' ASP . 41.6 t80 -107.99 126.66 52.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.881 0.372 . . . . 0.0 110.977 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.407 ' HB ' HG22 ' A' ' 91' ' ' VAL . 98.7 t -113.24 148.6 16.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.958 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.7 t -115.65 150.79 36.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.586 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.585 ' HG2' HG21 ' A' ' 94' ' ' THR . 1.8 pp20? -47.68 -35.15 9.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.485 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.645 ' O ' HG12 ' A' ' 67' ' ' VAL . . . -57.88 -21.12 41.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.287 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 88.7 m-20 -83.89 -37.73 22.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.776 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.572 HD13 ' HA ' ' A' ' 97' ' ' SER . 0.9 OUTLIER -57.26 -47.09 82.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.568 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.645 HG12 ' O ' ' A' ' 64' ' ' ALA . 15.0 p -49.75 -16.19 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.619 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 65' ' ' ASP . . . -81.81 -76.0 0.27 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.624 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.622 ' O ' ' NH2' ' A' ' 73' ' ' ARG . . . 68.7 9.49 59.07 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.87 75.44 0.27 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.831 0.348 . . . . 0.0 110.602 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.13 -61.46 0.2 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -73.32 -27.41 61.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.719 0.295 . . . . 0.0 110.653 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.622 ' NH2' ' O ' ' A' ' 69' ' ' GLY . 4.9 ttp180 -48.27 -29.41 3.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.57 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.455 ' O ' ' CD ' ' A' ' 74' ' ' LYS . 1.2 tmtt? -66.58 -30.11 70.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.525 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.403 ' HE ' ' HB2' ' A' ' 75' ' ' ARG . 16.2 tpp180 -65.49 -35.67 81.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.59 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.2 mt -67.61 -50.07 59.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.661 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.6 t -54.46 -38.77 42.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.584 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.72 -41.0 75.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.607 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.2 t -64.91 -35.66 75.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.636 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.73 -28.5 26.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.661 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -80.98 -13.25 59.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.625 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -25.59 34.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.438 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.481 ' CG ' ' N ' ' A' ' 84' ' ' ASN . 51.4 t-20 -174.99 -112.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.635 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.481 ' N ' ' CG ' ' A' ' 83' ' ' ASN . 0.1 OUTLIER -170.82 74.42 0.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.416 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.845 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -133.03 161.37 34.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.714 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 86' ' ' LYS . 1.9 pttt -81.83 118.38 22.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.456 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.74 137.82 9.9 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.0 mt -93.09 141.17 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.764 0.316 . . . . 0.0 110.451 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.432 ' O ' HG12 ' A' ' 89' ' ' VAL . 3.3 t -115.96 108.71 25.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.648 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 117' ' ' LEU . 0.8 OUTLIER -90.76 144.34 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.397 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.407 HG22 ' HB ' ' A' ' 61' ' ' VAL . 59.2 t -130.52 140.0 49.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.685 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -90.8 126.42 36.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.546 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -90.74 140.5 29.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.639 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.585 HG21 ' HG2' ' A' ' 63' ' ' GLU . 18.5 p -144.56 -73.1 0.26 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.473 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.411 ' O ' ' OE1' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -149.8 -72.65 0.18 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.456 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.445 ' O ' ' CD2' ' A' ' 66' ' ' LEU . 48.6 mtt -60.02 -5.82 1.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.457 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.604 ' O ' ' N ' ' A' ' 99' ' ' GLN . 0.2 OUTLIER -73.18 -84.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.522 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.59 ' H ' ' CD ' ' A' ' 98' ' ' GLU . 1.8 mp0 -36.27 -24.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.687 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.604 ' N ' ' O ' ' A' ' 97' ' ' SER . 1.6 mm100 -69.03 -55.88 9.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.01 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.419 ' C ' HD11 ' A' ' 66' ' ' LEU . 17.8 m-85 -117.55 10.89 13.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.725 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.582 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -60.8 -61.1 8.66 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.319 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 101' ' ' PHE . 9.5 Cg_endo -54.11 -42.28 68.43 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.678 2.252 . . . . 0.0 111.921 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.04 -41.54 35.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.332 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 tp -77.08 -41.2 43.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.399 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.501 ' HG3' HD22 ' A' ' 116' ' ' LEU . 65.5 tt0 -51.23 -35.12 35.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.342 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.91 -51.0 64.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.275 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -62.88 -55.09 29.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.452 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.52 -40.67 27.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.429 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.686 ' O ' ' N ' ' A' ' 113' ' ' GLY . 6.7 t -67.57 -56.65 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.273 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.88 -28.32 68.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.558 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.48 -52.09 6.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.387 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.7 mp -105.91 -28.72 10.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.36 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 56.56 34.06 63.46 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -88.69 -155.8 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.75 0.31 . . . . 0.0 110.285 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.601 ' C ' HD12 ' A' ' 116' ' ' LEU . 6.2 t -116.83 130.16 72.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.886 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 116' ' ' LEU . 7.0 mp -117.6 125.98 51.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.444 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.646 ' O ' HG13 ' A' ' 90' ' ' VAL . 1.2 mp -126.2 85.28 60.11 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.546 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -58.94 156.94 30.97 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.81 2.34 . . . . 0.0 111.925 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.662 HG23 ' H ' ' A' ' 120' ' ' ALA . 5.9 m -126.16 -107.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.492 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.662 ' H ' HG23 ' A' ' 119' ' ' VAL . . . 172.92 -28.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.126 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.78 165.46 31.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.356 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -64.85 -41.24 95.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.6 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -62.48 -42.42 99.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.648 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.571 ' O ' ' N ' ' A' ' 128' ' ' LEU . 18.3 mm-40 -45.81 -53.53 9.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.247 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 128' ' ' LEU . . . -60.01 -57.99 10.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.702 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 1.029 ' OG ' HD13 ' A' ' 30' ' ' LEU . 14.6 m -46.23 -33.0 3.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 1.8 t -85.13 -35.6 21.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.947 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.571 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -71.28 -50.46 32.49 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.081 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.0 t -56.75 -56.4 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.171 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 mm -51.29 -51.7 22.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.329 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -50.4 -41.66 52.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.299 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.9 tp -46.41 -54.4 9.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.525 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.429 HG23 ' H ' ' A' ' 133' ' ' VAL . 1.3 t -67.63 -46.07 83.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.283 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -51.0 -39.27 55.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.183 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.292 179.701 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.669 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -73.67 162.24 29.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.914 0.388 . . . . 0.0 110.616 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 20' ' ' VAL . 72.5 mt -119.84 155.73 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.592 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.439 ' N ' HG22 ' A' ' 19' ' ' ILE . 58.3 t -108.84 148.61 12.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.458 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.563 ' HB2' HD22 ' A' ' 40' ' ' LEU . . . -136.0 141.2 44.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.666 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.604 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 66.4 t30 -73.99 132.94 42.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.702 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -48.89 -25.07 1.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.566 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -85.24 -33.12 22.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.533 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -79.49 -4.74 52.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.478 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.469 ' C ' ' H ' ' A' ' 28' ' ' SER . 24.2 ttp180 -70.69 -17.15 62.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.383 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.58 29.22 1.04 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 26' ' ' ARG . 6.1 m -127.66 138.06 52.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.343 . . . . 0.0 110.575 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -62.53 -24.48 67.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.53 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.86 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -61.06 -53.31 58.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.378 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.03 -32.66 6.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.824 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.94 -27.89 49.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.692 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -63.9 -53.01 57.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.502 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.433 ' SD ' HD12 ' A' ' 19' ' ' ILE . 4.2 mtm -59.76 -16.49 28.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.486 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.31 -8.35 55.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.509 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.14 0.79 58.9 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -139.88 -33.68 0.58 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.817 0.342 . . . . 0.0 110.514 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.506 HD13 ' HA ' ' A' ' 38' ' ' ILE . 1.7 mm -127.74 158.17 39.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.444 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.498 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 4.4 ttpm? -90.16 102.34 15.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.236 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.563 HD22 ' HB2' ' A' ' 21' ' ' ALA . 4.7 mt -88.44 130.09 35.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.02 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 mm -108.25 113.71 44.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.086 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -75.72 125.16 28.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.022 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -127.16 115.75 19.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.314 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -79.38 125.9 30.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.447 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.82 -26.71 4.77 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.604 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 3.5 mm? -64.62 140.63 58.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.765 0.317 . . . . 0.0 110.59 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.674 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -92.36 -39.87 0.36 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.625 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.674 ' CD ' ' N ' ' A' ' 47' ' ' THR . 16.4 Cg_exo -64.73 -160.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.808 2.339 . . . . 0.0 111.92 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -111.46 -55.34 2.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.467 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -132.37 132.28 42.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.525 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.527 ' CD1' ' O ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -109.26 109.05 19.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.702 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.68 -41.2 72.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.44 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.482 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 79.3 p -165.66 -174.09 2.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.426 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.552 ' H ' ' ND2' ' A' ' 54' ' ' ASN . 0.3 OUTLIER -79.46 19.53 0.61 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.494 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.42 ' HG2' HH11 ' A' ' 55' ' ' ARG . 0.6 OUTLIER -142.22 3.34 1.55 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.159 -179.695 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.527 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 15.3 m -152.22 152.05 31.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.987 0.422 . . . . 0.0 111.091 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.475 ' SG ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -150.82 158.74 44.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.148 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.9 mt -130.4 132.81 64.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.902 0.382 . . . . 0.0 110.873 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.05 138.1 53.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.068 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -100.56 134.42 43.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.921 0.391 . . . . 0.0 110.931 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 t -131.33 138.66 52.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.336 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 64' ' ' ALA . 4.7 t -116.05 147.38 41.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.395 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -38.84 -37.24 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.49 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.469 ' HB3' HG23 ' A' ' 62' ' ' THR . . . -50.25 -37.05 33.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.461 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 62' ' ' THR . 18.6 m-20 -71.74 -40.35 69.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.698 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.58 HD11 ' C ' ' A' ' 100' ' ' TYR . 1.3 tt -55.42 -43.42 75.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.492 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.456 ' N ' HD23 ' A' ' 66' ' ' LEU . 11.4 t -49.81 -38.21 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.515 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.39 -67.19 0.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.418 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.2 12.33 81.73 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -156.84 138.09 13.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 110.745 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.24 -38.93 3.04 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -82.52 -22.95 34.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.685 0.279 . . . . 0.0 110.805 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.3 ttp85 -68.81 -40.62 79.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.684 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.98 -24.4 2.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.683 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -70.04 -44.65 68.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.597 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.2 mt -58.19 -46.52 85.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.614 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.7 t -45.27 -42.37 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.697 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.4 mmm-85 -45.03 -51.75 9.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.666 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 t -62.44 -26.55 40.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.797 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -82.74 -37.51 24.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.72 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 81' ' ' ASN . 3.1 t-20 -82.31 -8.9 59.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.882 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.5 ' HB3' HD11 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -51.85 -78.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.558 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -153.22 -71.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.472 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -178.67 57.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.296 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.77 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -108.49 143.25 37.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.731 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.85 92.4 9.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.529 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -93.05 162.2 26.0 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.0 mt -116.7 148.48 19.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.809 0.338 . . . . 0.0 110.494 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.84 118.54 55.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.719 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.71 135.69 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.476 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.422 ' H ' ' HA ' ' A' ' 118' ' ' PRO . 46.8 t -119.58 148.92 22.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.691 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -98.79 133.35 43.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.235 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -86.09 140.34 30.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.877 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.417 ' HB ' ' H ' ' A' ' 95' ' ' ARG . 2.2 m -145.91 -79.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.256 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.417 ' H ' ' HB ' ' A' ' 94' ' ' THR . 64.6 mtt-85 -141.07 -70.45 0.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.358 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 20.7 mmt -63.09 -11.45 19.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.42 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.637 ' O ' ' N ' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -54.78 -95.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.669 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.626 ' N ' ' OG ' ' A' ' 97' ' ' SER . 3.0 pt-20 -36.27 -29.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.996 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.512 ' N ' ' O ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -65.9 -55.24 17.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.906 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.58 ' C ' HD11 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -117.62 12.74 14.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.968 -179.564 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.637 ' N ' ' O ' ' A' ' 97' ' ' SER . 21.2 t80 -68.24 -37.37 10.78 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.244 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 50.4 Cg_endo -78.3 -30.93 3.05 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.04 1.827 . . . . 0.0 111.959 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.84 95.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.962 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.476 HD23 ' O ' ' A' ' 104' ' ' LEU . 4.6 tt -73.48 -45.84 51.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.044 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.457 ' O ' HG23 ' A' ' 109' ' ' VAL . 5.3 tt0 -54.65 -34.61 62.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.013 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -63.11 -36.75 84.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.162 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' A' ' 111' ' ' ASP . 1.7 m-85 -79.54 -53.33 6.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.194 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.7 m -51.99 -36.34 49.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.33 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.602 ' O ' ' N ' ' A' ' 113' ' ' GLY . 8.9 t -65.82 -59.9 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.494 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.879 HD23 ' O ' ' A' ' 110' ' ' LEU . 2.2 tt -67.04 -22.6 65.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.496 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 107' ' ' PHE . 1.3 m-20 -84.53 -55.41 4.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.81 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.9 mp -106.14 -28.42 10.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.987 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 49.69 50.05 32.36 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 2.3 mtm -105.84 -165.79 1.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.784 0.326 . . . . 0.0 110.368 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.8 t -90.44 110.5 22.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.538 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 117' ' ' LEU . 3.8 tt -111.15 126.17 54.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.522 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.551 ' N ' HD23 ' A' ' 116' ' ' LEU . 5.3 tp -146.15 107.6 4.22 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.682 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.422 ' HA ' ' H ' ' A' ' 91' ' ' VAL . 71.9 Cg_endo -78.78 169.58 19.37 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.388 2.058 . . . . 0.0 112.185 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.604 HG23 ' N ' ' A' ' 120' ' ' ALA . 19.4 m -131.91 -118.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.576 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.604 ' N ' HG23 ' A' ' 119' ' ' VAL . . . -167.27 -40.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.538 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.3 m -136.08 155.71 49.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.398 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -59.91 -20.75 59.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.547 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.683 ' SD ' ' N ' ' A' ' 123' ' ' MET . 0.8 OUTLIER -78.06 -33.05 51.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.585 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.634 ' O ' ' N ' ' A' ' 128' ' ' LEU . 1.6 mm-40 -54.26 -55.36 28.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.758 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -51.51 -58.22 6.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.249 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.729 ' HB2' HD13 ' A' ' 30' ' ' LEU . 3.9 t -48.89 -33.39 10.62 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.16 -30.13 24.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.874 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.634 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.5 OUTLIER -74.42 -49.72 21.34 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.074 179.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.99 -55.14 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.279 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 44.2 mt -51.03 -54.04 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.408 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -42.31 -35.15 0.92 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.596 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.96 -60.25 3.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.598 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.7 t -63.85 -38.63 82.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.351 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -60.03 -31.86 70.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.401 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.429 179.855 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.509 ' O ' HD11 ' A' ' 38' ' ' ILE . . . . . . . . 0 CA--C 1.525 0.692 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.486 ' C ' ' ND1' ' A' ' 18' ' ' HIS . 4.1 p80 -112.55 155.06 24.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.659 0.266 . . . . 0.0 110.429 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 20' ' ' VAL . 24.9 mm -107.24 159.41 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.737 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.545 HG11 ' OE2' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -125.96 141.22 46.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.609 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -126.12 143.87 50.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.586 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 25' ' ' TRP . 30.1 t30 -64.33 131.46 47.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.524 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -41.42 -32.89 0.36 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.515 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -78.15 -30.44 49.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.517 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.582 ' N ' ' O ' ' A' ' 22' ' ' ASN . 18.8 t-105 -77.91 -10.78 59.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.586 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.508 ' C ' ' H ' ' A' ' 28' ' ' SER . 10.8 ttt-85 -60.08 -37.0 78.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.732 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.06 40.81 0.26 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.508 ' H ' ' C ' ' A' ' 26' ' ' ARG . 69.8 m -128.47 136.54 50.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.753 0.311 . . . . 0.0 110.662 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -67.9 -21.25 65.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.222 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.942 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -71.72 -52.48 17.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.288 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.523 ' O ' HD22 ' A' ' 40' ' ' LEU . . . -49.02 -27.64 3.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.482 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -79.07 -34.7 43.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.738 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -58.34 -43.94 88.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.764 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.429 ' C ' ' H ' ' A' ' 36' ' ' GLY . 28.2 mtt -54.33 -32.64 57.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.804 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -71.0 8.96 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.593 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 34' ' ' MET . . . -95.34 -11.37 56.0 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -142.59 -49.19 0.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.812 0.339 . . . . 0.0 110.671 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.509 HD11 ' O ' ' A' ' 17' ' ' GLY . 10.4 tp -106.03 165.95 3.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.326 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.451 ' N ' HG13 ' A' ' 38' ' ' ILE . 22.7 tttp -85.68 143.99 28.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.285 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.523 HD22 ' O ' ' A' ' 31' ' ' ALA . 19.8 tp -127.82 156.25 42.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.449 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 50.1 mt -145.77 142.56 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.359 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.04 127.63 51.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.688 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.545 ' OE2' HG11 ' A' ' 20' ' ' VAL . 57.3 mt-10 -127.36 124.23 38.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.443 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.39 94.54 9.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.778 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 166.59 -32.26 0.21 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.474 ' O ' ' OD1' ' A' ' 22' ' ' ASN . 11.1 mp -66.92 159.62 27.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 110.491 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.555 ' H ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -103.79 -48.21 0.15 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.758 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.555 ' CD ' ' H ' ' A' ' 47' ' ' THR . 37.8 Cg_exo -56.36 -171.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.762 2.308 . . . . 0.0 112.039 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -97.92 -55.44 2.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.737 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -125.79 128.65 48.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.909 0.385 . . . . 0.0 110.649 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.687 ' CE2' ' O ' ' A' ' 53' ' ' SER . 4.0 t80 -107.87 105.43 15.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.594 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 mp -74.32 -30.53 62.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.438 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.687 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 2.0 p 177.41 -173.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.399 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -86.54 65.0 8.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.587 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -178.75 -30.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.824 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.422 ' HG ' ' HB2' ' A' ' 86' ' ' LYS . 1.2 m -140.29 132.4 27.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.918 0.389 . . . . 0.0 111.136 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 30.9 p -134.91 173.76 11.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.984 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.2 mt -139.99 131.74 32.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.289 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.0 tp -112.53 117.37 32.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.85 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -83.94 117.49 23.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.97 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.8 t -116.25 140.86 36.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.207 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.4 p -126.25 156.73 39.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.965 0.412 . . . . 0.0 110.92 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 96' ' ' MET . 2.9 tt0 -40.42 -43.43 1.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.731 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -43.48 -30.16 0.53 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.381 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -82.69 -47.72 11.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.308 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.538 HD11 ' C ' ' A' ' 100' ' ' TYR . 1.3 tt -50.82 -38.3 47.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.357 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.555 HG22 ' SD ' ' A' ' 96' ' ' MET . 3.2 t -45.95 -53.09 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.436 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -44.28 -76.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.481 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.29 -24.4 29.1 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -151.56 133.43 14.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 0.0 110.704 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.13 -54.94 0.73 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -62.68 -35.36 79.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.681 0.277 . . . . 0.0 110.6 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.475 ' HB3' HH11 ' A' ' 73' ' ' ARG . 0.2 OUTLIER -49.51 -40.78 38.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.877 0.37 . . . . 0.0 110.165 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.431 ' N ' ' HD2' ' A' ' 73' ' ' ARG . 1.8 ttpp -54.6 -35.87 63.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.043 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.2 ttt85 -69.22 -42.31 75.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.151 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 34.8 mt -61.71 -21.5 64.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.271 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.2 t -81.35 -39.28 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.486 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -61.04 -20.99 63.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.647 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.4 t -70.36 -50.06 49.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.012 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 49.2 ttt-85 -71.24 -43.58 66.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.907 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -52.66 -27.48 17.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.68 ' OG ' ' N ' ' A' ' 83' ' ' ASN . 0.3 OUTLIER -46.6 -74.42 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.82 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.68 ' N ' ' OG ' ' A' ' 82' ' ' SER . 1.8 m-80 -140.18 -98.22 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.834 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -165.56 37.59 0.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.781 0.324 . . . . 0.0 110.718 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.92 157.52 17.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.605 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.422 ' HB2' ' HG ' ' A' ' 56' ' ' CYS . 7.6 mmmt -88.94 100.05 12.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.493 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -95.71 141.26 15.48 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 60.7 mt -103.02 135.65 39.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.816 0.341 . . . . 0.0 110.435 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.4 t -108.93 103.75 16.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.656 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.1 t -93.94 142.07 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.351 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.486 ' O ' HG22 ' A' ' 119' ' ' VAL . 93.8 t -122.64 149.59 26.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.674 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -107.67 107.12 17.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.633 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -68.17 132.82 47.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.211 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.2 m -137.42 -79.51 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.785 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.3 mtp85 -141.17 -70.25 0.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.581 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.555 ' SD ' HG22 ' A' ' 67' ' ' VAL . 16.2 mtt -63.77 -10.78 21.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.496 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.643 ' O ' ' N ' ' A' ' 99' ' ' GLN . 82.8 p -62.02 -88.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.769 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.444 ' N ' ' OG ' ' A' ' 97' ' ' SER . 0.2 OUTLIER -36.09 -22.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.006 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.643 ' N ' ' O ' ' A' ' 97' ' ' SER . 7.0 mt-30 -73.62 -54.77 7.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.913 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.538 ' C ' HD11 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -117.52 12.67 14.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.617 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.699 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 3.1 t80 -63.03 -34.94 15.16 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.647 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.699 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 14.7 Cg_exo -66.66 -49.99 1.43 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.604 2.203 . . . . 0.0 111.821 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -47.19 -49.2 23.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.423 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.568 ' O ' ' OG1' ' A' ' 108' ' ' THR . 2.7 tp -65.37 -51.2 62.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.423 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.543 ' O ' HG23 ' A' ' 109' ' ' VAL . 2.7 tt0 -49.93 -33.51 17.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.632 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.29 -52.98 15.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.571 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.92 -52.18 66.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.671 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.568 ' OG1' ' O ' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -58.82 -30.04 67.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.596 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 105' ' ' GLN . 2.3 t -70.98 -41.38 76.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.627 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 110' ' ' LEU . 16.5 tp -81.36 -33.78 32.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.643 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.73 -47.19 10.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.471 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 113' ' ' GLY . 2.3 mm? -102.16 -28.33 12.37 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.184 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.5 ' CA ' ' O ' ' A' ' 109' ' ' VAL . . . 34.66 38.23 0.12 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -89.33 -156.12 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.734 0.302 . . . . 0.0 110.339 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.5 t -101.35 116.22 44.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.717 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.839 ' C ' HD12 ' A' ' 117' ' ' LEU . 7.4 mp -104.71 138.15 41.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.522 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.839 HD12 ' C ' ' A' ' 116' ' ' LEU . 6.0 mp -147.32 85.63 6.74 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.732 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -61.72 165.59 13.52 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.751 2.301 . . . . 0.0 111.764 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 91' ' ' VAL . 6.8 m -132.74 -115.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.515 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.454 ' N ' HG23 ' A' ' 119' ' ' VAL . . . -178.71 -43.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.324 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.498 ' OG ' ' OE1' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -133.16 172.44 12.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.434 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -73.88 -16.63 61.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.645 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.481 ' O ' ' N ' ' A' ' 127' ' ' CYS . 54.8 mtp -85.57 -42.0 14.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.695 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.672 ' O ' ' N ' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -46.75 -53.92 10.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.527 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.16 -57.85 11.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.232 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.792 ' OG ' HD13 ' A' ' 30' ' ' LEU . 11.1 m -53.95 -33.3 56.48 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.481 ' N ' ' O ' ' A' ' 123' ' ' MET . 6.8 t -85.36 -29.37 24.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.666 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.856 ' O ' HD12 ' A' ' 128' ' ' LEU . 1.6 tp -80.51 -36.53 33.1 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.608 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 64.4 t -63.92 -40.73 90.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.785 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.9 mt -63.32 -51.56 69.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.349 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.439 HE21 ' HB2' ' A' ' 131' ' ' GLN . 1.3 tp-100 -42.87 -42.24 3.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.316 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.7 mt -61.39 -57.36 12.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.528 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.6 t -49.07 -55.91 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.627 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -42.96 -30.62 0.43 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.533 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.398 179.86 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.679 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -148.81 154.65 39.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 110.639 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.465 HG22 ' N ' ' A' ' 20' ' ' VAL . 33.0 mm -126.52 157.09 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.262 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.465 ' N ' HG22 ' A' ' 19' ' ' ILE . 63.3 t -113.11 148.36 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.015 0.436 . . . . 0.0 110.898 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 41' ' ' ILE . . . -137.84 159.33 42.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.203 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.564 ' O ' ' N ' ' A' ' 25' ' ' TRP . 57.6 t30 -92.15 139.49 30.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.839 0.352 . . . . 0.0 110.721 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -39.29 -47.49 1.7 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.585 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -63.28 -31.76 73.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.594 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.661 ' NE1' ' OD2' ' A' ' 49' ' ' ASP . 1.6 t-105 -76.79 -1.82 30.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.67 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.473 ' C ' ' HE ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -76.21 -26.93 56.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.538 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.82 33.11 3.1 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.4 m -122.7 142.38 50.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.8 0.333 . . . . 0.0 110.597 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -66.13 -23.11 66.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.33 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.917 HD13 ' OG ' ' A' ' 126' ' ' SER . 0.4 OUTLIER -67.85 -55.33 13.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.539 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.412 ' N ' ' HG ' ' A' ' 30' ' ' LEU . . . -48.25 -22.59 0.69 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.023 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -81.41 -45.97 15.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.905 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -50.73 -33.37 22.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.834 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.69 ' SD ' HD13 ' A' ' 40' ' ' LEU . 11.9 mtt -66.18 -33.58 76.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.752 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -70.12 -17.36 63.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.658 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.97 4.31 86.07 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm -147.82 -56.7 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.899 0.38 . . . . 0.0 110.485 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.535 ' O ' ' O ' ' A' ' 34' ' ' MET . 7.8 tp -112.18 165.13 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.426 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.433 ' H ' HG13 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -88.03 110.54 20.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.573 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.69 HD13 ' SD ' ' A' ' 34' ' ' MET . 17.7 tp -96.96 137.0 36.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.757 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.456 ' O ' ' N ' ' A' ' 21' ' ' ALA . 20.6 mt -113.49 139.33 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.412 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -105.93 142.8 35.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.85 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -153.99 116.96 4.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.456 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -77.87 134.29 37.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.569 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 122.98 -32.2 4.48 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 75.2 mt -59.84 144.53 48.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.735 0.302 . . . . 0.0 110.668 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.535 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -88.42 -64.52 0.2 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.727 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.535 ' CD ' ' CB ' ' A' ' 47' ' ' THR . 9.6 Cg_endo -54.15 -174.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.779 2.32 . . . . 0.0 112.18 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.661 ' OD2' ' NE1' ' A' ' 25' ' ' TRP . 35.1 t0 -93.26 -66.17 0.94 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.431 ' CE2' ' CG ' ' A' ' 49' ' ' ASP . 68.6 m-85 -118.28 162.19 18.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.609 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.95 142.52 50.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.081 0.467 . . . . 0.0 110.977 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.437 ' HA ' HD13 ' A' ' 52' ' ' LEU . 0.8 OUTLIER -119.88 -24.85 6.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.776 179.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.412 ' OG ' ' C ' ' A' ' 52' ' ' LEU . 0.7 OUTLIER -169.77 179.27 3.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.059 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -77.69 4.64 11.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.818 0.342 . . . . 0.0 110.52 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -133.65 -4.39 2.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.879 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.7 m -129.66 134.66 47.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.95 0.405 . . . . 0.0 110.947 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.3 p -146.45 171.06 15.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.118 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 mt -138.82 138.48 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.995 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.11 136.49 54.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.135 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.424 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 29.5 t80 -96.98 115.3 27.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.846 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 92' ' ' GLU . 6.7 t -121.75 149.05 24.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.193 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.6 t -135.87 163.78 29.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 0.0 110.908 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.784 ' OE2' HG23 ' A' ' 67' ' ' VAL . 4.8 tp10 -41.21 -48.68 3.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.589 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -47.61 -29.8 3.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.522 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 1.1 m-20 -77.43 -45.47 25.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.529 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.407 ' CD1' ' HA ' ' A' ' 101' ' ' PHE . 1.6 tt -48.94 -40.48 30.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.651 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.784 HG23 ' OE2' ' A' ' 63' ' ' GLU . 24.9 t -64.91 -42.57 95.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.672 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.529 ' C ' ' H ' ' A' ' 70' ' ' ASN . . . -91.16 26.3 2.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.597 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.95 -3.81 0.35 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 68' ' ' ALA . 50.0 t30 -89.93 37.77 0.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.815 0.341 . . . . 0.0 110.504 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -175.54 -32.77 0.04 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -82.73 -38.27 23.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.842 0.353 . . . . 0.0 110.441 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.3 ttt-85 -48.34 -50.49 30.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.646 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -54.59 -43.76 72.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.569 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -49.95 -50.87 45.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.557 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.2 mt -53.52 -41.59 66.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.799 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 62.5 t -57.06 -33.36 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.762 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -49.22 77.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.622 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.8 t -47.42 -41.56 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.505 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.1 ttt-85 -82.02 -21.12 37.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.476 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -65.0 -25.0 67.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.588 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 t -58.04 -68.38 0.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.507 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -160.29 -69.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.577 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -178.5 66.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.541 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.6 mp -91.43 127.92 37.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.53 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.1 87.96 4.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.429 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -104.72 175.7 22.58 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.6 mt -106.27 137.62 35.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 0.0 110.454 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.6 t -109.48 116.92 53.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.779 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.5 t -104.38 134.89 44.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.427 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.6 t -124.6 134.61 66.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.636 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 61' ' ' VAL . 5.0 tt0 -98.03 100.35 11.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.487 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.435 ' HB2' ' NZ ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -70.14 134.47 48.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.629 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.622 HG22 ' HG2' ' A' ' 95' ' ' ARG . 6.4 m -127.07 -64.97 0.97 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.637 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.622 ' HG2' HG22 ' A' ' 94' ' ' THR . 0.0 OUTLIER -150.5 -73.1 0.17 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.395 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -64.14 -4.06 3.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.142 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.654 ' O ' ' N ' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -75.53 -87.6 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.361 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 97' ' ' SER . 1.7 mt-10 -35.84 -26.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.991 0.424 . . . . 0.0 110.365 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.69 ' OE1' ' CD2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -69.56 -56.08 8.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.972 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.69 ' CD2' ' OE1' ' A' ' 99' ' ' GLN . 2.7 m-85 -116.57 12.68 15.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.922 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.731 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 22.0 t80 -69.63 -32.69 3.22 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.075 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.731 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 16.0 Cg_exo -64.8 -50.24 2.47 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.526 2.151 . . . . 0.0 111.997 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.84 -36.84 49.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.66 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.466 ' O ' ' OG1' ' A' ' 108' ' ' THR . 1.3 tp -77.26 -34.59 55.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.394 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.95 ' O ' HG23 ' A' ' 109' ' ' VAL . 1.8 tt0 -68.07 -38.27 82.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.355 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -65.65 -28.19 68.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.34 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.69 -54.19 5.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.49 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -54.11 -32.05 53.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.703 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 105' ' ' GLN . 79.3 t -62.81 -62.75 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.743 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 85.8 mt -66.44 -20.01 65.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.776 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -83.99 -56.68 3.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.6 mp -105.93 -26.56 11.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.062 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 48.93 46.53 32.28 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 5.0 tpp -95.99 -156.92 0.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 0.0 110.448 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.68 106.39 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.56 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 mp -101.5 124.94 47.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.329 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.5 mt -137.9 87.27 16.92 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.711 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -55.27 165.67 2.89 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.601 2.201 . . . . 0.0 111.831 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.536 HG23 ' H ' ' A' ' 120' ' ' ALA . 15.3 m -133.11 -116.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.72 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.536 ' H ' HG23 ' A' ' 119' ' ' VAL . . . 172.68 -32.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.364 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.1 p -129.39 153.49 47.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.44 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -64.68 -22.58 67.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.682 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.612 ' SD ' ' N ' ' A' ' 123' ' ' MET . 0.0 OUTLIER -83.4 -40.46 19.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.816 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.636 ' O ' ' N ' ' A' ' 128' ' ' LEU . 3.5 mm-40 -45.71 -50.76 13.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.641 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.41 -58.01 10.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.865 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.917 ' OG ' HD13 ' A' ' 30' ' ' LEU . 6.3 m -49.86 -33.95 18.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -82.88 -31.68 27.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.667 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -72.92 -33.21 65.83 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.407 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 92.0 t -81.43 -51.41 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.557 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 54.6 mt -55.11 -44.6 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.702 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -52.23 -42.7 63.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.944 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 tp -52.18 -56.64 13.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.821 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 86.7 t -55.25 -55.85 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.009 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -47.07 -48.15 22.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.99 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.018 -179.562 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.646 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.448 ' CD2' ' H ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -90.61 166.15 13.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.418 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.7 mt -128.18 144.33 38.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.717 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -103.44 141.2 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.461 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.17 138.07 54.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.611 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.439 HD22 ' N ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -74.2 122.92 23.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.548 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.439 ' N ' HD22 ' A' ' 22' ' ' ASN . 1.6 tp10 -47.18 -25.22 0.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.556 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -76.34 -36.11 58.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.412 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.565 ' O ' ' CG ' ' A' ' 25' ' ' TRP . 34.8 t-105 -91.43 -1.34 57.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.501 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.54 ' C ' ' H ' ' A' ' 28' ' ' SER . 24.0 ttt180 -70.46 -15.16 62.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.571 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.56 24.19 0.49 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.54 ' H ' ' C ' ' A' ' 26' ' ' ARG . 0.4 OUTLIER -123.8 144.03 49.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.826 0.346 . . . . 0.0 110.618 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.56 ' O ' ' OE2' ' A' ' 33' ' ' GLU . 40.9 mt-30 -75.13 -16.93 60.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.537 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.803 HD13 ' N ' ' A' ' 31' ' ' ALA . 1.9 tm? -53.26 -65.05 0.63 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.238 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.803 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -49.69 -37.91 30.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.829 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.14 -30.85 60.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.896 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.647 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 0.4 OUTLIER -72.75 -45.94 56.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.746 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.593 ' SD ' HG11 ' A' ' 129' ' ' VAL . 3.8 mtm -44.84 -31.39 1.21 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.364 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -69.46 9.74 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.676 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -89.51 -31.39 11.58 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -131.24 -43.86 1.04 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.929 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 38' ' ' ILE . 10.1 tp -103.03 162.33 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.698 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.415 ' N ' HG13 ' A' ' 38' ' ' ILE . 8.1 tttt -86.34 150.02 24.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.435 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.571 ' CD2' ' HB1' ' A' ' 31' ' ' ALA . 13.2 tp -137.17 131.6 32.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 mt -115.21 123.73 71.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.272 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.444 ' CD1' ' HD2' ' A' ' 26' ' ' ARG . 75.0 m-85 -88.74 120.35 30.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.801 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -126.14 132.45 51.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.45 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -95.2 103.75 15.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.628 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 154.29 -19.33 0.63 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.505 ' N ' HD22 ' A' ' 46' ' ' LEU . 3.9 mm? -66.8 146.13 54.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 0.0 110.599 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.498 ' H ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -87.3 -58.54 0.28 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.804 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.498 ' HD2' ' H ' ' A' ' 47' ' ' THR . 37.7 Cg_endo -69.14 -158.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.616 2.211 . . . . 0.0 112.158 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.604 ' CG ' ' H ' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -90.76 -61.34 1.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.776 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -121.84 160.32 24.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.83 0.347 . . . . 0.0 110.871 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.505 ' CD2' HD12 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -142.06 101.48 3.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.535 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 mp -76.89 -38.7 53.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.465 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 54' ' ' ASN . 15.1 t -168.39 176.01 6.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.471 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.426 ' N ' ' OG ' ' A' ' 53' ' ' SER . 20.2 m-80 -76.65 49.49 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.451 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -161.28 -37.63 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.595 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.7 t -120.25 143.15 48.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.846 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.681 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -150.64 165.93 31.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.011 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.681 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 75.1 mt -137.55 131.64 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.76 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.495 HD23 ' OD1' ' A' ' 49' ' ' ASP . 0.4 OUTLIER -118.39 127.04 53.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.202 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.604 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 19.5 t80 -90.28 130.02 36.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.005 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 37.3 t -126.75 146.95 31.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.204 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.7 t -129.46 153.72 47.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.923 0.392 . . . . 0.0 110.944 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.426 ' HG3' ' H ' ' A' ' 97' ' ' SER . 0.5 OUTLIER -41.35 -44.42 2.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.617 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -48.41 -30.13 4.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.604 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.51 -31.13 37.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.528 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.734 HD23 ' N ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -64.45 -43.15 95.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.362 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.734 ' N ' HD23 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -46.03 -32.33 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.59 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 69' ' ' GLY . . . -103.2 -53.8 2.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.656 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 68' ' ' ALA . . . 36.12 37.41 0.18 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -115.38 -57.55 2.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.76 0.314 . . . . 0.0 110.639 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.8 -37.77 33.1 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.409 ' OH ' HD21 ' A' ' 59' ' ' LEU . 1.1 t80 -67.69 -23.37 65.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 0.0 110.653 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.2 tmm_? -60.51 -46.65 89.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.668 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -68.65 -24.63 64.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.33 -50.33 54.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.751 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.519 ' O ' HD21 ' A' ' 112' ' ' LEU . 22.0 mt -58.07 -26.04 62.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 80' ' ' ARG . 92.4 t -73.52 -45.7 50.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.028 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -42.17 -48.78 4.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.836 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 37.4 t -58.48 -27.46 33.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.453 ' N ' ' O ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -80.6 -37.65 30.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.57 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -63.33 -15.13 56.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.671 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 83' ' ' ASN . 92.9 p -59.79 -111.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.521 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.531 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER -117.86 -68.34 0.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.539 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.531 ' CG ' ' O ' ' A' ' 83' ' ' ASN . 16.0 m-20 176.98 63.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.428 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.461 ' CD1' ' OD1' ' A' ' 83' ' ' ASN . 4.0 mp -98.05 133.87 41.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.743 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -84.83 101.39 12.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.299 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.65 129.56 9.21 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.3 mt -86.51 135.86 24.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.796 0.332 . . . . 0.0 110.453 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.3 t -101.7 107.47 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.663 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.5 t -89.95 138.29 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.336 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.1 t -125.53 148.55 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.367 . . . . 0.0 110.899 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -118.97 110.1 16.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.188 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -66.45 146.33 54.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.749 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.424 HG22 ' CG ' ' A' ' 95' ' ' ARG . 5.1 m -141.67 -75.39 0.3 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.468 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.424 ' CG ' HG22 ' A' ' 94' ' ' THR . 5.8 mtp85 -141.22 -69.62 0.38 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.702 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 5.6 mmt -69.3 -10.77 59.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.631 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.645 ' HA ' HD13 ' A' ' 66' ' ' LEU . 5.3 p -50.56 -94.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.737 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 97' ' ' SER . 5.3 mt-10 -36.31 -25.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.906 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.583 ' N ' ' O ' ' A' ' 97' ' ' SER . 3.4 mm100 -73.75 -51.31 16.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.709 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.61 ' C ' HD11 ' A' ' 66' ' ' LEU . 1.1 t80 -114.59 11.83 17.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.649 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.729 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 28.8 t80 -69.76 -32.58 3.09 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.889 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.729 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 11.0 Cg_exo -67.1 -58.93 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.553 2.169 . . . . 0.0 111.938 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -47.85 -38.53 16.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.836 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 38.8 tp -73.15 -53.78 10.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.658 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -47.69 -36.5 11.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.642 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -64.53 -41.28 96.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.412 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -73.16 -46.0 53.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.648 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -35.19 74.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.894 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.672 ' O ' ' N ' ' A' ' 113' ' ' GLY . 3.6 t -76.65 -54.41 13.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.892 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.63 -29.73 69.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.915 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -84.66 -51.04 7.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.377 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.519 HD21 ' O ' ' A' ' 76' ' ' LEU . 8.9 mp -105.04 -28.5 11.01 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.584 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 55.01 16.13 7.67 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.768 ' N ' ' SD ' ' A' ' 114' ' ' MET . 0.0 OUTLIER -70.94 -155.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 0.0 110.762 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.2 t -109.65 138.21 38.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.711 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.606 ' O ' HD12 ' A' ' 117' ' ' LEU . 1.5 pp -129.38 127.05 40.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.508 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.606 HD12 ' O ' ' A' ' 116' ' ' LEU . 1.3 mp -132.73 101.24 14.27 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.482 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -79.01 156.36 26.56 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.526 2.151 . . . . 0.0 112.256 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.573 HG23 ' H ' ' A' ' 120' ' ' ALA . 5.6 m -130.35 -110.64 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.545 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.573 ' H ' HG23 ' A' ' 119' ' ' VAL . . . 170.96 -29.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.563 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.567 ' OG ' ' N ' ' A' ' 122' ' ' GLN . 0.4 OUTLIER -149.22 179.94 7.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.553 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.567 ' N ' ' OG ' ' A' ' 121' ' ' SER . 0.4 OUTLIER -73.69 -45.76 50.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.584 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.421 ' CG ' ' N ' ' A' ' 124' ' ' GLU . 8.7 ptt? -45.28 -43.21 10.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.646 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.624 ' O ' ' N ' ' A' ' 128' ' ' LEU . 16.6 mm-40 -59.74 -56.24 24.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.549 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.94 -58.38 8.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.104 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 122' ' ' GLN . 0.0 OUTLIER -47.47 -34.16 7.04 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 42.1 t -85.51 -31.02 22.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.321 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.624 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -76.01 -45.25 35.47 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.842 0.353 . . . . 0.0 110.625 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.593 HG11 ' SD ' ' A' ' 34' ' ' MET . 14.8 t -58.82 -54.67 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.616 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 96.3 mt -54.79 -52.62 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.616 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -48.9 -32.0 8.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.429 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.2 tp -61.71 -62.92 1.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.474 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.4 t -68.47 -36.89 76.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.506 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -58.35 -31.94 68.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.542 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.559 -179.954 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.681 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -150.09 159.65 44.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.68 0.276 . . . . 0.0 110.302 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.0 159.5 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.893 0.377 . . . . 0.0 110.77 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.0 t -114.26 143.46 23.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.347 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -133.96 150.51 51.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.697 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.667 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 18.3 t-20 -80.78 138.68 36.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.612 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -58.47 -32.69 68.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.778 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -75.5 -76.54 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.462 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.701 ' O ' ' N ' ' A' ' 27' ' ' GLY . 65.5 t-105 -54.86 -24.31 22.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.065 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.678 ' O ' ' N ' ' A' ' 28' ' ' SER . 4.8 ttt-85 22.39 39.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.953 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.701 ' N ' ' O ' ' A' ' 25' ' ' TRP . . . 16.47 47.49 0.01 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 26' ' ' ARG . 3.0 m 46.3 174.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 0.0 110.53 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -42.07 -23.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.477 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.879 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -46.67 -45.4 19.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.781 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.452 ' N ' ' HG ' ' A' ' 30' ' ' LEU . . . -63.59 -25.73 68.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.54 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.8 -30.85 35.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -68.94 -37.38 78.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.624 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.431 ' CE ' HD11 ' A' ' 30' ' ' LEU . 6.0 mtt -48.22 -26.26 1.86 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.537 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -69.63 -2.46 11.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.569 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.61 -8.78 62.03 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -136.51 -46.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.399 . . . . 0.0 110.458 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 38' ' ' ILE . 6.1 tp -126.0 172.31 13.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.183 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.479 ' H ' HG13 ' A' ' 38' ' ' ILE . 52.0 tttp -85.5 127.13 34.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.889 0.376 . . . . 0.0 110.525 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.821 HD13 ' N ' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -120.07 131.03 54.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.397 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.821 ' N ' HD13 ' A' ' 40' ' ' LEU . 44.9 mt -114.14 152.68 15.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.533 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 3.1 m-85 -118.39 121.06 39.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.687 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -125.34 126.87 45.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.343 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -88.15 144.51 26.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.756 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.51 5.42 57.86 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.667 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 8.1 mt -77.39 155.6 31.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 0.0 110.693 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.562 ' H ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -93.87 -63.72 0.14 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.788 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.562 ' HD2' ' H ' ' A' ' 47' ' ' THR . 18.6 Cg_endo -61.47 -178.31 0.27 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.662 2.242 . . . . 0.0 111.811 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.63 ' OD2' ' NE1' ' A' ' 25' ' ' TRP . 4.1 m-20 -97.91 -32.86 11.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.562 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -147.03 125.09 12.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.412 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.437 ' OH ' ' CD2' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -108.4 110.29 21.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.698 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.18 -43.71 32.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.394 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 55' ' ' ARG . 0.7 OUTLIER -163.38 153.08 15.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.622 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -58.95 70.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.718 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.589 ' N ' ' O ' ' A' ' 53' ' ' SER . 4.6 ttt-85 173.59 -26.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.652 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.6 m -140.56 131.32 25.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.497 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.591 ' SG ' HD13 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -121.88 175.38 6.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.561 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.0 mt -138.54 130.77 38.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.611 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.1 tp -111.75 131.81 55.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.383 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -100.92 122.72 43.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.558 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.463 ' HB ' HG22 ' A' ' 91' ' ' VAL . 61.9 t -117.78 146.37 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.501 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -121.18 141.78 50.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.694 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -38.67 -37.92 0.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.511 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -50.02 -39.72 42.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.544 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.67 -40.75 84.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.512 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.516 HD13 ' HA ' ' A' ' 97' ' ' SER . 1.3 tt -57.66 -37.97 74.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.479 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 67' ' ' VAL . 71.7 t -45.48 -15.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.361 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 66' ' ' LEU . . . -110.3 -56.88 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.456 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 47.75 24.82 3.13 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -155.71 43.17 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.792 0.329 . . . . 0.0 110.652 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -166.55 -37.83 0.02 OUTLIER Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.478 ' O ' ' N ' ' A' ' 75' ' ' ARG . 20.7 t80 -82.67 -25.15 33.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.763 0.316 . . . . 0.0 110.888 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -45.52 -33.04 2.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.495 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.96 -26.91 67.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.461 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.774 HH21 ' HE ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -76.68 -34.11 58.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.349 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.0 -38.13 89.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.577 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.05 -41.0 89.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.497 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.774 ' HE ' HH21 ' A' ' 75' ' ' ARG . 0.0 OUTLIER -47.62 -28.52 2.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.85 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.7 t -71.19 -27.81 30.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.876 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -79.06 -48.02 15.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.709 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.466 ' O ' ' C ' ' A' ' 82' ' ' SER . 12.7 t-20 -50.88 -49.82 58.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.773 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.466 ' C ' ' O ' ' A' ' 81' ' ' ASN . 1.7 t -33.88 -66.47 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.679 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -155.66 -141.15 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.628 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -129.02 54.06 1.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.587 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.832 ' O ' HD12 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -99.99 140.4 34.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.523 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.48 88.96 6.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.478 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.01 179.6 51.05 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 44.1 mt -121.8 115.75 47.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.801 0.334 . . . . 0.0 110.415 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.0 t -85.13 109.84 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.592 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.5 t -95.05 145.25 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.65 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.463 HG22 ' HB ' ' A' ' 61' ' ' VAL . 18.4 t -132.87 142.67 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.547 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -103.74 129.84 51.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.74 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -83.58 131.48 34.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.373 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.2 m -134.82 -84.47 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.758 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 41.4 mtp180 -131.39 -69.49 0.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.58 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -9.16 57.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.547 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.635 ' O ' ' N ' ' A' ' 101' ' ' PHE . 44.3 p -61.47 -92.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.812 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 97' ' ' SER . 8.3 pt-20 -36.28 -26.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.239 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.556 ' N ' ' O ' ' A' ' 97' ' ' SER . 35.6 mt-30 -70.53 -55.2 9.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 0.0 110.937 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.51 ' C ' HD11 ' A' ' 66' ' ' LEU . 2.7 t80 -115.21 12.59 16.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.814 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.726 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 1.1 t80 -68.04 -33.9 5.54 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.674 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.726 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 17.3 Cg_exo -64.0 -55.38 0.65 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.587 2.191 . . . . 0.0 111.897 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.66 -36.82 26.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.465 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.06 -41.19 64.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.465 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.39 -31.54 71.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.321 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.41 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -71.03 -46.3 62.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.231 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.406 ' O ' ' N ' ' A' ' 111' ' ' ASP . 1.3 m-85 -74.66 -49.43 21.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.401 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.4 m -43.83 -36.42 2.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.289 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' A' ' 113' ' ' GLY . 2.3 t -70.3 -54.01 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.206 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 106' ' ' LYS . 1.4 mt -66.25 -24.75 66.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.573 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 107' ' ' PHE . 16.0 t0 -84.53 -52.88 5.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.338 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.401 ' HA ' HD13 ' A' ' 112' ' ' LEU . 3.2 mm? -105.83 -28.38 10.67 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.5 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 54.27 43.33 75.07 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 2.2 ttm -110.68 -172.96 2.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.706 0.288 . . . . 0.0 110.335 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.5 t -89.0 120.4 37.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.645 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.668 HD23 ' N ' ' A' ' 117' ' ' LEU . 4.8 tt -110.34 124.27 51.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.479 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.668 ' N ' HD23 ' A' ' 116' ' ' LEU . 2.0 tt -131.83 104.99 14.06 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.734 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.23 156.97 17.27 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.703 2.269 . . . . 0.0 112.097 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 120' ' ' ALA . 0.3 OUTLIER -130.12 -101.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.592 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 119' ' ' VAL . . . 175.16 -45.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.632 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.8 m -130.13 167.24 18.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.557 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -70.09 -22.68 63.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.656 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 29.9 mtp -73.6 -43.78 58.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.676 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 128' ' ' LEU . 4.9 mm-40 -47.42 -55.69 8.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.666 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 128' ' ' LEU . . . -57.43 -57.93 10.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.134 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.615 ' OG ' HD13 ' A' ' 30' ' ' LEU . 65.0 m -44.74 -36.01 2.97 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.48 -31.72 22.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.005 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.591 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.7 OUTLIER -73.49 -31.36 63.69 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.749 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 25.4 t -80.05 -42.33 21.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.576 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.5 mt -62.05 -49.37 84.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.626 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -57.09 -37.87 72.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.589 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.4 ' HA ' HD22 ' A' ' 132' ' ' LEU . 0.2 OUTLIER -55.11 -40.89 70.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.815 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 45.4 t -74.42 -42.53 49.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.631 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -56.37 -52.78 63.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.627 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.657 -179.787 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.451 ' O ' HD11 ' A' ' 38' ' ' ILE . . . . . . . . 0 CA--C 1.525 0.68 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.539 ' CD2' HD12 ' A' ' 41' ' ' ILE . 21.1 p-80 -87.96 166.15 14.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.711 0.291 . . . . 0.0 110.523 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.663 HD11 HG21 ' A' ' 133' ' ' VAL . 91.0 mt -113.67 149.6 15.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.621 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.3 t -97.48 147.03 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.494 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 41' ' ' ILE . . . -133.58 160.41 37.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.491 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 56.5 t30 -93.82 141.23 28.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.531 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -55.22 -34.88 64.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.639 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.501 ' C ' ' H ' ' A' ' 26' ' ' ARG . 2.9 ttpp -79.42 -50.45 10.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.659 ' CE2' ' OD2' ' A' ' 49' ' ' ASP . 53.5 t-105 -64.58 6.11 0.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.926 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.501 ' H ' ' C ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -85.44 1.26 49.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.627 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.84 20.79 26.5 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.4 m -116.77 155.28 29.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.854 0.359 . . . . 0.0 110.688 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -73.28 -21.64 60.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.469 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.556 ' C ' ' CD1' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -57.16 -65.73 0.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.089 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -42.5 -32.76 0.58 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.303 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -70.68 -56.85 5.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.345 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 36' ' ' GLY . 96.0 mt-10 -54.16 -40.83 67.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.347 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.569 ' C ' ' H ' ' A' ' 36' ' ' GLY . 4.5 mtp -45.0 -47.63 11.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.404 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -65.82 11.68 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.499 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.569 ' H ' ' C ' ' A' ' 34' ' ' MET . . . -86.06 -29.38 25.78 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -125.62 -47.95 1.68 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.852 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.451 HD11 ' O ' ' A' ' 17' ' ' GLY . 0.2 OUTLIER -109.93 171.84 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.742 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.445 ' H ' HG12 ' A' ' 38' ' ' ILE . 11.3 ttpp -90.2 140.38 29.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.597 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.7 tp -126.09 144.57 50.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.666 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.539 HD12 ' CD2' ' A' ' 18' ' ' HIS . 29.5 mt -120.36 151.34 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.503 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -117.65 139.79 50.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.668 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -148.24 120.2 8.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.485 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.13 124.47 27.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.595 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 132.38 -27.94 3.51 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.488 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 48.2 mt -59.39 139.46 57.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.604 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.614 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 1.1 m -90.08 -39.22 0.41 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.061 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 47' ' ' THR . 58.5 Cg_endo -80.67 -163.93 0.25 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.271 1.981 . . . . 0.0 112.074 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.659 ' OD2' ' CE2' ' A' ' 25' ' ' TRP . 30.5 m-20 -99.0 -46.23 5.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.795 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -140.8 155.88 46.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.688 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.51 94.03 3.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.493 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.615 ' CD1' HG22 ' A' ' 133' ' ' VAL . 1.7 tp -64.05 -20.34 65.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.332 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.647 ' C ' ' H ' ' A' ' 55' ' ' ARG . 4.2 m 173.05 161.55 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.423 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.2 22.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.962 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.647 ' H ' ' C ' ' A' ' 53' ' ' SER . 4.8 mmt85 -132.02 -29.11 1.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.645 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 57' ' ' CYS . 2.3 t -132.77 152.94 51.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.859 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.502 ' N ' ' SG ' ' A' ' 56' ' ' CYS . 0.5 OUTLIER -148.13 171.4 15.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.286 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.4 mt -138.77 134.88 43.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.818 0.342 . . . . 0.0 110.824 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.01 125.22 36.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.504 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.48 ' HB3' ' CZ2' ' A' ' 25' ' ' TRP . 14.4 t80 -87.65 128.78 35.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.615 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.421 ' HB ' HG22 ' A' ' 91' ' ' VAL . 58.2 t -121.52 149.85 24.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.492 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.8 p -126.1 145.35 50.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.664 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -44.31 -41.91 6.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.422 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -44.0 -31.11 0.83 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.362 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -82.84 -39.31 21.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.531 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.72 HD11 ' C ' ' A' ' 100' ' ' TYR . 1.3 tt -49.14 -38.31 24.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.35 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 87.9 t -46.03 -36.16 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.594 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.69 116.72 9.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.54 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -121.77 3.56 10.89 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.58 4.77 2.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.813 0.339 . . . . 0.0 110.543 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -134.88 -33.48 0.29 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.474 ' O ' ' N ' ' A' ' 75' ' ' ARG . 4.3 t80 -80.11 -35.63 36.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.765 0.317 . . . . 0.0 110.532 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.423 ' NH2' ' HB3' ' A' ' 107' ' ' PHE . 22.0 ttt85 -43.58 -36.13 1.99 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.528 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -63.66 -34.79 78.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.507 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.474 ' N ' ' O ' ' A' ' 72' ' ' TYR . 0.3 OUTLIER -62.16 -35.91 80.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.47 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 mt -68.19 -40.47 82.2 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.424 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.8 t -63.46 -47.13 93.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.388 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -41.41 -32.33 0.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.329 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.1 t -71.05 -55.4 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.515 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.46 ' HB3' ' NH1' ' A' ' 80' ' ' ARG . 0.9 OUTLIER -54.08 -31.77 52.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.568 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.51 ' O ' ' C ' ' A' ' 82' ' ' SER . 3.7 t30 -54.37 -49.44 69.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.499 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.51 ' C ' ' O ' ' A' ' 81' ' ' ASN . 17.1 p -30.79 -76.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.428 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.458 ' OD1' ' OD1' ' A' ' 84' ' ' ASN . 1.5 t-20 -161.08 -89.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.476 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.564 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 3.0 p-10 -151.48 48.47 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.295 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.1 mt -69.32 154.93 41.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.6 pttt -126.56 89.08 2.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.234 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.437 ' CA ' ' O ' ' A' ' 57' ' ' CYS . . . -109.26 176.28 19.55 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.7 mt -114.36 129.63 70.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.789 0.328 . . . . 0.0 110.646 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 t -104.24 107.35 22.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.46 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.3 t -90.24 143.82 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.652 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.421 HG22 ' HB ' ' A' ' 61' ' ' VAL . 82.0 t -129.0 143.24 41.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.53 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -102.4 115.62 30.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.565 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -71.6 143.2 49.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.514 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 89.9 m -137.49 -82.1 0.35 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.484 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.515 ' CG ' ' N ' ' A' ' 96' ' ' MET . 14.1 ptm180 -151.14 -44.79 0.12 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.464 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.515 ' N ' ' CG ' ' A' ' 95' ' ' ARG . 1.7 mtt -88.52 -2.92 58.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.139 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.718 ' HA ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -70.65 -71.91 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.492 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -40.76 -22.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.609 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.524 ' N ' ' O ' ' A' ' 97' ' ' SER . 10.3 mm100 -72.3 -54.44 9.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.038 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.72 ' C ' HD11 ' A' ' 66' ' ' LEU . 1.1 t80 -116.6 12.15 14.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.038 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.612 ' N ' ' O ' ' A' ' 97' ' ' SER . 0.3 OUTLIER -62.51 -62.18 6.2 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.604 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 101' ' ' PHE . 9.6 Cg_endo -53.49 -48.75 20.24 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.653 2.235 . . . . 0.0 112.013 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.05 -31.36 7.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.51 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.752 HD23 ' HG1' ' A' ' 108' ' ' THR . 0.7 OUTLIER -85.31 -22.29 28.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.511 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.523 ' O ' HG23 ' A' ' 109' ' ' VAL . 1.4 tt0 -84.63 -32.37 23.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.699 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.77 -41.93 71.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.671 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.51 ' O ' ' CG ' ' A' ' 111' ' ' ASP . 2.9 m-85 -78.62 -51.01 10.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.603 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.752 ' HG1' HD23 ' A' ' 104' ' ' LEU . 97.1 m -51.37 -37.49 48.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.485 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 105' ' ' GLN . 22.2 t -67.55 -59.15 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.452 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.2 -19.05 65.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.526 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.51 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 12.5 m-20 -84.39 -57.8 3.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.029 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.47 HD23 ' C ' ' A' ' 111' ' ' ASP . 2.7 mt -107.5 -29.01 9.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.629 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 72.04 42.48 51.55 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -86.62 -171.05 3.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.576 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 40.7 t -117.76 105.23 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.587 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.491 ' N ' HD12 ' A' ' 116' ' ' LEU . 6.0 mp -95.64 142.39 28.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.514 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 tp -156.23 88.92 2.82 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.527 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -56.04 163.82 5.6 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.751 2.301 . . . . 0.0 112.085 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.703 ' O ' ' HB2' ' A' ' 120' ' ' ALA . 1.5 m -129.37 -106.83 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.655 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 119' ' ' VAL . . . 159.24 -47.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.434 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.13 143.68 51.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.544 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -51.94 -24.98 7.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.708 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 5.4 mtp -70.24 -51.72 28.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.623 ' O ' ' N ' ' A' ' 128' ' ' LEU . 9.6 mm-40 -44.71 -52.32 8.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.679 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.628 ' O ' HG23 ' A' ' 129' ' ' VAL . . . -55.18 -58.1 9.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.225 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.516 ' N ' HD21 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -49.73 -37.01 27.61 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.223 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.87 -31.2 35.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.128 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.623 ' N ' ' O ' ' A' ' 124' ' ' GLU . 1.8 mt -79.91 -26.94 40.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.879 0.371 . . . . 0.0 110.501 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 125' ' ' ALA . 61.3 t -81.56 -41.0 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.566 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 70.5 mt -73.16 -39.94 57.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.67 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -58.64 -25.58 62.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.533 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 132' ' ' LEU . 10.9 tp -77.01 -58.01 3.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.466 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.663 HG21 HD11 ' A' ' 19' ' ' ILE . 11.1 t -60.45 -41.79 88.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.605 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -52.76 -49.82 64.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.602 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.527 -179.937 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.644 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -114.22 154.6 27.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.804 0.335 . . . . 0.0 110.602 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 73.3 mt -106.21 153.49 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.625 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.9 t -110.47 124.04 66.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.654 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.01 149.88 27.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.66 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -74.78 140.65 44.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.424 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.71 -28.65 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.417 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.5 ' C ' ' H ' ' A' ' 26' ' ' ARG . 12.5 ttmm -83.54 -52.88 6.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.395 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.458 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 42.5 t-105 -74.79 24.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.307 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.5 ' H ' ' C ' ' A' ' 24' ' ' LYS . 18.7 ttp85 -81.28 -63.89 1.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.704 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.78 52.46 0.51 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 26' ' ' ARG . 11.1 p -111.85 141.21 45.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.337 . . . . 0.0 110.634 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.704 HE21 ' NE2' ' A' ' 122' ' ' GLN . 7.5 mt-30 -56.35 -28.55 59.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.713 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.563 ' C ' ' CD1' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -61.07 -66.07 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.393 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.06 -24.67 63.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.923 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.02 -51.25 68.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.814 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -70.33 -45.83 65.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.857 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.457 ' HE1' ' O ' ' A' ' 126' ' ' SER . 36.0 mmt -49.92 -26.62 4.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.815 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -77.01 -0.54 24.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 0.0 110.562 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.22 6.83 50.98 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -148.79 -47.85 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.812 0.339 . . . . 0.0 110.537 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.456 HG12 ' H ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -113.56 169.78 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.595 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.456 ' H ' HG12 ' A' ' 38' ' ' ILE . 5.4 tptm -94.94 152.82 18.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.487 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.86 137.99 28.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.48 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.4 mt -116.62 131.72 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.531 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -88.15 132.42 34.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.799 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -139.94 121.8 15.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.544 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -79.77 145.04 33.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.647 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.4 -33.89 5.83 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.597 HD22 ' CD2' ' A' ' 51' ' ' TYR . 77.3 mt -48.83 137.6 12.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 110.619 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.536 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -88.11 -52.63 0.38 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.929 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 47' ' ' THR . 33.9 Cg_endo -67.61 -157.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.04 1.826 . . . . 0.0 112.15 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.433 ' OD2' ' CD2' ' A' ' 25' ' ' TRP . 1.6 m-20 -98.63 -54.91 2.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.879 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.458 ' CZ ' ' CD1' ' A' ' 25' ' ' TRP . 83.0 m-85 -124.12 145.77 49.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.794 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.597 ' CD2' HD22 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -123.17 103.07 8.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.488 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.551 HD23 ' O ' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -81.71 -35.11 30.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.493 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.626 ' C ' ' H ' ' A' ' 55' ' ' ARG . 4.2 t -178.28 164.59 1.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.426 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -67.38 23.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.477 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.626 ' H ' ' C ' ' A' ' 53' ' ' SER . 5.4 ttt-85 -134.72 -4.93 2.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.142 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.555 ' SG ' ' C ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -161.57 144.98 12.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.87 0.366 . . . . 0.0 110.974 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.419 ' SG ' ' HA2' ' A' ' 87' ' ' GLY . 12.5 p -151.13 164.38 36.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.438 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.0 mt -129.06 148.67 33.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.678 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.7 tt -133.78 120.02 19.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.287 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -85.71 121.66 28.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.792 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.425 ' N ' ' O ' ' A' ' 90' ' ' VAL . 74.7 t -122.15 143.98 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.229 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 63' ' ' GLU . 42.1 p -124.09 148.25 47.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.627 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 66' ' ' LEU . 3.3 tm-20 -38.57 -40.51 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.73 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -44.85 -33.32 1.9 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.661 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.562 ' OD2' ' CE1' ' A' ' 72' ' ' TYR . 3.6 m-20 -82.06 -26.34 33.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.634 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.533 HD23 ' N ' ' A' ' 67' ' ' VAL . 1.4 tt -68.41 -50.07 55.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.671 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.533 ' N ' HD23 ' A' ' 66' ' ' LEU . 2.3 p -62.43 -27.67 43.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.424 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.47 -64.96 0.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.561 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 70' ' ' ASN . . . 71.3 111.17 0.04 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.512 ' CB ' ' O ' ' A' ' 69' ' ' GLY . 5.1 t-20 81.75 139.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.77 0.319 . . . . 0.0 110.51 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.43 -71.31 0.38 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.562 ' CE1' ' OD2' ' A' ' 65' ' ' ASP . 4.0 t80 -50.56 -47.49 57.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.928 0.395 . . . . 0.0 110.375 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -43.15 -36.01 1.55 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.701 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -67.25 -43.94 80.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.542 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 12.3 mtt85 -58.36 -25.41 61.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.544 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 mt -79.42 -38.45 34.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.36 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.3 t -49.25 -30.46 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.278 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -54.65 -29.3 51.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.349 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.6 t -69.12 -35.94 70.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.218 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -79.53 -20.22 47.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.405 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -51.03 -59.69 3.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.471 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.459 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 0.1 OUTLIER -69.0 -68.99 0.36 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.454 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 82' ' ' SER . 4.5 t-20 78.01 60.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.491 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.538 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 2.1 p30 -148.48 11.82 0.9 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.757 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 pp -155.09 153.09 30.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.809 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.7 mmtm -76.62 110.0 10.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.126 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.419 ' HA2' ' SG ' ' A' ' 57' ' ' CYS . . . -86.64 101.76 2.67 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.8 mt -84.48 138.57 18.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 37.0 t -117.96 127.6 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.858 0.361 . . . . 0.0 111.149 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 61' ' ' VAL . 14.7 t -117.49 121.84 68.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.166 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.0 t -114.79 139.69 39.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.783 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -98.75 129.53 45.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.679 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.56 ' NZ ' ' O ' ' A' ' 119' ' ' VAL . 21.7 mttp -78.57 138.39 38.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.428 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 12.2 m -140.12 -85.22 0.22 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.669 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -128.8 -63.38 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.592 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.734 ' SD ' ' N ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -77.91 -9.24 58.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.48 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 99' ' ' GLN . 4.7 p -48.47 -102.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.348 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 97' ' ' SER . 24.2 mt-10 -36.31 -21.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.589 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.68 ' N ' ' O ' ' A' ' 97' ' ' SER . 11.5 tp60 -69.56 -55.61 9.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.094 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.422 ' CZ ' ' HB1' ' A' ' 103' ' ' ALA . 4.8 t80 -117.33 3.11 12.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.801 0.334 . . . . 0.0 110.797 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.601 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -47.06 -58.77 6.44 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.507 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 101' ' ' PHE . 14.9 Cg_endo -59.05 -48.68 13.33 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.556 2.171 . . . . 0.0 112.277 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.422 ' HB1' ' CZ ' ' A' ' 100' ' ' TYR . . . -45.47 -32.39 2.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.855 0.359 . . . . 0.0 110.227 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 tp -87.29 -30.95 20.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.806 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 102' ' ' PRO . 38.1 tt0 -58.26 -40.09 80.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.16 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -63.51 -37.08 85.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.088 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.27 -38.78 34.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.472 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.0 m -72.93 -30.84 64.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.569 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.584 ' O ' ' CA ' ' A' ' 113' ' ' GLY . 10.8 t -77.36 -43.93 30.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.989 0.423 . . . . 0.0 110.53 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.3 tp -70.92 -31.15 67.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.613 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -84.51 -50.14 7.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.308 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mt -104.88 -28.32 11.19 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.597 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.584 ' CA ' ' O ' ' A' ' 109' ' ' VAL . . . 43.47 35.19 2.75 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.93 -159.62 0.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.362 . . . . 0.0 110.547 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 49.4 t -96.29 123.13 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.426 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.14 133.91 53.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.67 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.8 mt -146.07 88.28 6.39 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.481 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -80.56 158.99 22.22 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.883 2.389 . . . . 0.0 112.189 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.57 HG23 ' N ' ' A' ' 120' ' ' ALA . 28.2 m -127.2 -136.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.428 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.57 ' N ' HG23 ' A' ' 119' ' ' VAL . . . -153.5 -40.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.279 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.9 p -138.39 158.34 44.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.357 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.704 ' NE2' HE21 ' A' ' 29' ' ' GLN . 21.1 mt-30 -58.17 -26.36 62.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.62 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.85 -45.23 90.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.74 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.638 ' O ' ' N ' ' A' ' 128' ' ' LEU . 1.2 mp0 -54.97 -58.41 7.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.657 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 129' ' ' VAL . . . -52.18 -58.06 7.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.296 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.499 ' N ' HD21 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -43.68 -40.29 4.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.7 m -85.39 -27.12 26.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.208 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.638 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.5 OUTLIER -77.35 -26.86 52.43 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.942 0.401 . . . . 0.0 110.742 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 125' ' ' ALA . 3.5 t -68.87 -61.45 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.642 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.412 HG13 ' SD ' ' A' ' 34' ' ' MET . 6.8 mt -58.33 -45.08 89.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.441 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -45.7 -29.62 1.32 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.829 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.4 mt -76.44 -48.75 18.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.772 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.2 t -67.81 -51.93 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.817 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.75 -33.72 49.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.841 -179.776 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.7 mtt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -73.01 8.23 1.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.635 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -91.83 -166.57 1.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.568 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.33 155.22 78.78 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.591 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.98 162.8 40.77 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.841 2.361 . . . . 0.0 112.078 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -64.31 160.17 40.19 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.801 2.334 . . . . 0.0 112.063 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.526 ' O ' ' CG ' ' A' ' 7' ' ' ASP . 12.9 t70 -107.1 49.25 0.81 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.705 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 7' ' ' ASP . 36.1 m-20 35.33 73.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.814 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.439 HG22 ' H ' ' A' ' 9' ' ' THR . 2.3 t -81.47 -1.32 45.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.006 0.431 . . . . 0.0 110.217 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.35 70.98 0.09 OUTLIER Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.532 ' C ' ' H ' ' A' ' 13' ' ' HIS . 66.4 Cg_endo -78.33 97.71 1.15 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.949 2.432 . . . . 0.0 112.567 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.437 ' H ' HG23 ' A' ' 12' ' ' VAL . 2.1 t -74.0 27.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.131 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.532 ' H ' ' C ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -109.76 38.82 2.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.467 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.747 ' N ' ' CD ' ' A' ' 15' ' ' PRO . 2.3 t -86.3 -33.09 0.45 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.715 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.747 ' CD ' ' N ' ' A' ' 14' ' ' VAL . 24.6 Cg_exo -59.11 -4.75 2.35 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.608 2.206 . . . . 0.0 112.139 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 16' ' ' LEU . 1.4 mm? -68.57 -89.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.484 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -123.02 92.75 0.47 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.6 p-80 -136.53 152.39 50.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.856 0.36 . . . . 0.0 110.778 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.446 ' HB ' HD12 ' A' ' 40' ' ' LEU . 3.4 mm -122.98 135.51 62.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.261 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.7 t -97.04 151.63 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.802 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.3 128.26 25.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.502 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.425 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 55.5 t-20 -56.57 131.27 48.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.566 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -43.79 -38.3 3.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.681 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.596 ' C ' ' H ' ' A' ' 26' ' ' ARG . 15.5 ttpt -72.62 -48.41 39.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.48 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.514 ' CE2' ' OD2' ' A' ' 49' ' ' ASP . 24.2 t-105 -67.89 19.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.537 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.596 ' H ' ' C ' ' A' ' 24' ' ' LYS . 61.2 ttt-85 -89.47 -34.97 16.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.439 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.97 36.71 0.24 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.561 ' H ' ' C ' ' A' ' 26' ' ' ARG . 5.8 p -117.86 144.69 45.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.769 0.319 . . . . 0.0 110.644 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -72.93 -18.97 61.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.441 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.802 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -68.56 -57.61 5.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.315 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.406 ' N ' ' HG ' ' A' ' 30' ' ' LEU . . . -41.93 -23.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.531 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 30' ' ' LEU . 2.4 tp60 -72.12 -47.61 49.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.567 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 36' ' ' GLY . 3.5 mt-10 -50.94 -51.26 54.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.456 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.522 ' C ' ' H ' ' A' ' 36' ' ' GLY . 5.6 mtt -43.93 -42.14 5.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.573 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -71.1 17.16 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.598 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.522 ' H ' ' C ' ' A' ' 34' ' ' MET . . . -104.15 -10.69 33.68 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.5 mtmm -152.01 -43.1 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.854 0.359 . . . . 0.0 110.479 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.445 HD12 ' HA ' ' A' ' 38' ' ' ILE . 10.1 tp -109.36 160.65 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.519 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.8 tttm -86.19 146.05 26.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.582 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.446 HD12 ' HB ' ' A' ' 19' ' ' ILE . 13.9 tp -131.4 137.87 48.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.701 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 57.8 mt -123.16 141.89 41.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.486 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -96.75 133.69 40.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.798 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.76 120.04 25.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.387 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -89.85 111.55 22.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.651 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 133.4 -8.52 5.01 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.425 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 66.3 mt -92.61 148.71 21.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.773 0.32 . . . . 0.0 110.67 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.536 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -96.04 -47.9 0.25 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 47' ' ' THR . 58.0 Cg_exo -47.87 164.35 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.727 2.285 . . . . 0.0 112.27 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.601 ' OD2' ' CD1' ' A' ' 60' ' ' TYR . 1.2 m-20 -85.44 -53.04 5.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.476 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -135.71 120.7 18.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.891 0.377 . . . . 0.0 110.607 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.549 ' CD1' ' O ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -99.48 112.78 24.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.383 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.526 HD22 HE22 ' A' ' 136' ' ' GLN . 0.5 OUTLIER -82.91 -44.08 15.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.65 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.549 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 5.0 t -139.46 -162.23 1.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.676 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -90.22 -8.98 49.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.624 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.422 HH21 ' HZ1' ' A' ' 86' ' ' LYS . 11.2 mtp180 -125.83 -8.8 6.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.828 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.61 132.82 56.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.962 0.411 . . . . 0.0 111.1 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.1 163.67 30.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.892 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 96.5 mt -135.72 124.16 38.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.977 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.9 tp -115.82 138.21 51.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.372 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.601 ' CD1' ' OD2' ' A' ' 49' ' ' ASP . 2.8 p90 -96.17 132.91 41.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.91 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 92' ' ' GLU . 77.0 t -130.59 149.97 34.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.176 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.42 ' O ' ' C ' ' A' ' 63' ' ' GLU . 1.0 OUTLIER -138.05 157.06 47.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.631 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 62' ' ' THR . 5.7 tm-20 -39.18 -43.16 1.04 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.32 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -47.0 -39.91 13.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.343 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 62' ' ' THR . 61.9 m-20 -69.01 -44.63 72.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.333 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.407 HD11 ' C ' ' A' ' 100' ' ' TYR . 1.5 tt -49.05 -44.44 41.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.523 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 32.2 t -49.48 -41.22 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.552 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.41 -71.63 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.646 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.44 -52.82 1.89 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -97.09 103.23 15.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.789 0.328 . . . . 0.0 110.559 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.66 -51.43 0.8 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -67.37 -24.53 65.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.724 0.297 . . . . 0.0 110.902 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -42.19 97.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 110.589 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -46.31 -46.15 17.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.583 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -59.09 -38.05 78.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.747 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 76' ' ' LEU . 97.6 mt -70.41 -34.81 72.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.708 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 63.8 t -61.45 -40.27 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.856 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 -56.85 -23.42 43.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.799 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.0 t -79.91 -49.51 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.561 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.6 ttt-85 -66.9 -25.54 66.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.645 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -71.05 -11.61 61.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.654 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.554 ' OG ' ' N ' ' A' ' 83' ' ' ASN . 60.4 p -67.92 -117.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.581 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.61 ' C ' HD22 ' A' ' 84' ' ' ASN . 7.1 t30 -121.02 -93.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.679 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.61 HD22 ' C ' ' A' ' 83' ' ' ASN . 1.5 m-80 -138.02 60.27 1.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.495 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.5 mp -93.48 123.43 36.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.575 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.422 ' HZ1' HH21 ' A' ' 55' ' ' ARG . 1.2 pttp -112.58 85.84 2.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.172 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -93.67 -165.33 37.21 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.8 mt -131.28 135.83 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.773 0.32 . . . . 0.0 110.488 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.2 t -107.99 118.82 56.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.614 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 61' ' ' VAL . 19.7 t -93.69 140.72 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.401 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.66 132.59 70.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.716 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 61' ' ' VAL . 3.6 tt0 -101.71 104.43 15.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.387 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -68.65 131.95 46.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.579 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.6 m -126.14 -74.26 0.6 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.633 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.3 mtp85 -140.84 -70.3 0.38 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.457 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.33 -1.93 7.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.49 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.609 ' O ' ' N ' ' A' ' 101' ' ' PHE . 4.1 t -68.7 -91.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.788 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 97' ' ' SER . 22.1 mt-10 -36.41 -27.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.954 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 97' ' ' SER . 2.3 mt-30 -71.64 -51.51 22.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.181 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.407 ' C ' HD11 ' A' ' 66' ' ' LEU . 6.1 m-85 -117.13 11.62 14.23 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.19 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.727 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 35.5 t80 -69.82 -32.9 3.23 Favored Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.78 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.727 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 10.8 Cg_exo -67.33 -42.34 7.67 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.588 2.192 . . . . 0.0 111.939 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.05 -48.32 78.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.635 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 tp -71.16 -47.99 54.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.585 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.682 ' O ' HG23 ' A' ' 109' ' ' VAL . 7.7 tt0 -50.59 -33.63 22.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.73 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -56.39 15.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.871 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.6 -52.14 62.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.787 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.1 m -42.18 -40.43 2.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.79 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 105' ' ' GLN . 85.9 t -66.2 -58.66 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.476 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.435 ' HA ' HD13 ' A' ' 110' ' ' LEU . 0.9 OUTLIER -62.56 -23.08 66.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.461 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.48 -55.51 4.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mt -106.33 -28.58 10.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.184 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 56.76 20.04 30.94 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 6.5 tpp -73.04 -161.09 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.724 0.297 . . . . 0.0 110.404 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.12 127.63 65.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.607 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.596 ' N ' HD12 ' A' ' 116' ' ' LEU . 5.0 mp -122.27 115.44 22.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.472 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.3 mt -124.99 88.32 54.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -53.25 171.56 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.629 2.219 . . . . 0.0 111.735 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 120' ' ' ALA . 4.0 m -143.06 -113.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.652 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.404 ' H ' HG23 ' A' ' 119' ' ' VAL . . . -177.51 -37.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.263 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.8 p -141.12 -170.74 3.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.348 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -81.26 -28.22 34.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.598 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -48.42 59.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.757 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 128' ' ' LEU . 0.4 OUTLIER -44.7 -46.1 10.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.25 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.66 -54.92 24.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.959 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.791 ' HB3' HD13 ' A' ' 30' ' ' LEU . 59.7 p -54.98 -30.85 60.1 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -85.19 -35.32 21.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.256 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.596 ' N ' ' O ' ' A' ' 124' ' ' GLU . 4.2 mp -74.58 -34.33 62.86 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.569 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 133' ' ' VAL . 62.0 t -74.19 -55.0 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.562 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 97.2 mt -58.17 -50.93 76.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.581 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -48.94 -30.28 5.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.321 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.1 tp -82.58 -42.03 18.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.478 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 129' ' ' VAL . 95.8 t -63.75 -36.79 77.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.644 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.96 -22.46 65.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.656 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -81.5 -38.41 26.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.475 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.526 HE22 HD22 ' A' ' 52' ' ' LEU . 6.5 tt0 -66.65 -50.84 61.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.525 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -38.95 -57.78 1.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.485 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.518 ' O ' ' C ' ' A' ' 139' ' ' GLU . 1.3 mtpp -35.65 153.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.479 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.518 ' C ' ' O ' ' A' ' 138' ' ' LYS . 3.2 mm-40 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.554 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 mmt . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -79.21 132.06 36.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.689 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.0 55.61 1.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.356 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.428 ' N ' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -85.49 -54.63 0.42 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.924 -179.572 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 4' ' ' ASN . 73.6 Cg_endo -79.69 146.3 18.79 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.661 2.241 . . . . 0.0 112.353 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -74.0 102.98 1.59 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.665 2.243 . . . . 0.0 112.067 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.538 ' O ' ' C ' ' A' ' 8' ' ' ASP . 4.6 m-20 -117.88 57.02 0.84 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.65 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.538 ' C ' ' O ' ' A' ' 7' ' ' ASP . 14.5 p-10 28.82 51.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.639 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.4 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 7.7 t -73.45 15.14 0.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.557 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.606 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -59.23 -70.98 0.84 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -64.39 87.42 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.822 2.348 . . . . 0.0 112.109 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 10' ' ' GLY . 5.8 t -103.81 -31.37 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.489 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.615 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 2.8 p80 -148.98 106.06 3.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.625 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.495 ' N ' ' CD ' ' A' ' 15' ' ' PRO . 3.9 m -127.09 51.65 6.87 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.469 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 14' ' ' VAL . 29.1 Cg_endo -66.2 -28.9 47.71 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.838 2.359 . . . . 0.0 112.209 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mt -72.23 2.48 5.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.582 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -102.44 -66.92 0.76 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.417 ' NE2' HG23 ' A' ' 14' ' ' VAL . 1.4 m-70 -72.78 155.1 40.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.846 0.355 . . . . 0.0 110.702 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.406 ' HB ' HD12 ' A' ' 40' ' ' LEU . 17.9 mm -109.35 143.8 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.399 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.6 t -94.6 145.41 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.586 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -136.82 137.25 39.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.541 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 25' ' ' TRP . 63.2 t-20 -64.7 135.29 55.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.467 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.406 ' N ' ' OD1' ' A' ' 22' ' ' ASN . 7.2 tt0 -43.18 -32.3 0.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.369 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -70.36 -36.78 74.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.334 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.502 ' N ' ' O ' ' A' ' 22' ' ' ASN . 0.2 OUTLIER -68.46 -13.62 62.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.208 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.448 ' HD3' ' CD1' ' A' ' 42' ' ' PHE . 7.7 tpt85 -61.98 -40.85 97.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.611 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.6 51.01 0.85 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.69 152.16 37.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.794 0.33 . . . . 0.0 110.622 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -75.55 -21.05 58.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.363 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.849 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -68.67 -56.61 7.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.598 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.432 ' N ' ' HG ' ' A' ' 30' ' ' LEU . . . -53.14 -33.08 50.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.831 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -82.4 -28.94 31.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.727 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -67.33 -31.78 72.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.52 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.689 ' N ' ' SD ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -74.83 -27.04 60.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.465 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -65.78 -8.65 22.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.681 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.35 -29.02 11.7 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.2 -48.85 3.75 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.98 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.429 HG23 ' N ' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -123.24 172.2 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.94 0.4 . . . . 0.0 110.882 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.429 ' N ' HG23 ' A' ' 38' ' ' ILE . 36.8 tttp -86.13 127.6 34.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.541 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.406 HD12 ' HB ' ' A' ' 19' ' ' ILE . 13.4 tp -118.59 129.75 55.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.755 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 mt -108.59 140.66 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.31 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.448 ' CD1' ' HD3' ' A' ' 26' ' ' ARG . 6.2 m-85 -104.14 129.05 51.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.719 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.416 ' HB3' HD13 ' A' ' 46' ' ' LEU . 2.8 mt-10 -130.63 113.2 13.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.439 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -75.18 128.47 35.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.477 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.65 -47.41 1.02 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 46' ' ' LEU . 9.7 mp -46.96 148.15 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.716 0.293 . . . . 0.0 110.387 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.56 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -99.45 -47.54 0.21 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.903 0.382 . . . . 0.0 110.668 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 47' ' ' THR . 31.4 Cg_exo -54.95 176.93 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.791 2.327 . . . . 0.0 112.153 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.47 ' OD1' ' CE2' ' A' ' 25' ' ' TRP . 8.1 m-20 -87.11 -56.14 3.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.436 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -129.65 143.62 50.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.357 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -116.61 108.35 15.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.71 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.78 -38.26 76.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.487 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.602 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 5.8 m -160.01 -143.54 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.439 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.31 18.81 17.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.584 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.537 ' HA ' HD13 ' A' ' 85' ' ' LEU . 7.6 mtp180 -144.49 9.84 1.41 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.602 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 86' ' ' LYS . 42.7 t -163.53 145.4 9.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.684 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.15 172.72 12.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.296 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.6 mt -131.08 126.33 59.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.72 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.24 117.73 30.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.27 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -87.74 117.46 26.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.95 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 73.2 t -99.3 149.48 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.948 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.446 ' H ' ' CG ' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -121.29 156.37 32.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.842 0.353 . . . . 0.0 110.831 -179.665 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.732 ' HB2' HG21 ' A' ' 94' ' ' THR . 12.0 pt-20 -46.05 -44.67 15.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.56 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.501 ' N ' ' CG ' ' A' ' 63' ' ' GLU . . . -51.39 -19.86 1.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.701 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.672 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -79.33 -53.08 7.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.698 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.683 HD13 ' HA ' ' A' ' 97' ' ' SER . 1.3 tt -56.33 -50.23 72.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.662 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.0 t -52.98 -13.77 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.711 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.42 35.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.758 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 65' ' ' ASP . . . -65.36 -16.71 63.11 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -51.86 -45.85 64.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.762 0.315 . . . . 0.0 110.666 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.48 -47.55 6.34 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 75' ' ' ARG . 2.1 t80 -53.53 -26.39 20.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.862 0.363 . . . . 0.0 110.624 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 72' ' ' TYR . 6.2 ttp85 -36.28 -35.67 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.717 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.523 ' HZ2' ' HA ' ' A' ' 74' ' ' LYS . 2.7 mmtm -70.31 -48.79 55.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.654 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -54.44 -28.92 47.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.695 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 27.5 mt -70.61 -58.11 4.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.689 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 80' ' ' ARG . 65.3 t -50.76 -36.91 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.592 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.38 -21.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.465 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.478 ' N ' ' O ' ' A' ' 77' ' ' VAL . 41.1 t -77.88 -33.25 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.766 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.551 ' N ' ' O ' ' A' ' 77' ' ' VAL . 0.9 OUTLIER -82.31 -39.54 22.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.773 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -59.27 -21.24 59.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.901 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 t -95.19 -54.61 3.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.722 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -132.93 -171.0 2.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.652 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -147.03 45.76 1.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.27 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.537 HD13 ' HA ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -98.69 155.64 17.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.688 -179.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.523 ' O ' ' SG ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -80.41 122.27 26.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.239 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.433 ' H ' ' HG2' ' A' ' 114' ' ' MET . . . -127.89 164.19 21.31 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.5 mt -107.66 121.86 61.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.853 0.359 . . . . 0.0 110.448 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.1 t -97.2 125.68 50.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.872 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.66 149.4 5.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.047 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.0 t -132.77 145.08 34.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.892 0.377 . . . . 0.0 110.862 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -92.59 120.69 33.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.399 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -67.34 139.85 57.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.793 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.777 HG23 ' H ' ' A' ' 95' ' ' ARG . 1.9 t -151.08 -108.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.523 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.777 ' H ' HG23 ' A' ' 94' ' ' THR . 4.1 mtt180 -130.07 -74.7 0.54 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.259 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.472 ' SD ' ' OE1' ' A' ' 99' ' ' GLN . 26.6 mmt -55.36 -7.16 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.279 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.683 ' HA ' HD13 ' A' ' 66' ' ' LEU . 1.4 t -54.92 -88.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.671 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.449 ' N ' ' OG ' ' A' ' 97' ' ' SER . 2.2 mm-40 -43.01 -21.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.032 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.472 ' OE1' ' SD ' ' A' ' 96' ' ' MET . 47.9 mt-30 -71.11 -55.07 8.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.845 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -117.08 12.26 14.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.824 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.709 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 0.3 OUTLIER -63.7 -35.46 16.5 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.414 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.709 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 2.7 Cg_exo -71.9 -53.94 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.734 2.289 . . . . 0.0 111.813 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -45.88 -27.77 0.95 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.617 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.57 -44.38 12.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.507 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.455 ' NE2' ' CZ ' ' A' ' 101' ' ' PHE . 9.5 tt0 -60.64 -32.15 71.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.616 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -73.75 -34.94 64.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.739 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -81.95 -37.35 26.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.801 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.1 p -73.35 -35.78 66.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.928 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.696 ' O ' ' N ' ' A' ' 113' ' ' GLY . 4.0 t -66.84 -55.95 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.942 0.401 . . . . 0.0 110.652 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.35 -30.42 66.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.55 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -84.5 -51.22 7.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.438 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.85 -28.87 10.37 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.538 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.696 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 60.93 33.81 85.12 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.433 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 3.3 mtt -84.84 -179.5 7.1 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 110.543 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.0 t -103.05 124.25 57.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.628 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.5 mp -105.35 143.78 33.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.241 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 117' ' ' LEU . 2.1 tt -157.29 88.59 2.57 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.746 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -58.49 146.27 91.28 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.671 2.247 . . . . 0.0 111.823 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.461 HG23 ' H ' ' A' ' 120' ' ' ALA . 2.3 m -108.23 -107.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.548 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.461 ' H ' HG23 ' A' ' 119' ' ' VAL . . . 179.41 -30.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.391 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 97.2 p -144.23 -173.36 3.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.39 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -85.21 -24.45 27.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.588 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.412 ' O ' ' N ' ' A' ' 127' ' ' CYS . 37.9 mtt -81.37 -41.41 22.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.733 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 128' ' ' LEU . 6.5 mm-40 -45.03 -43.51 9.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.437 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.91 -57.78 6.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.007 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.651 ' CB ' HD13 ' A' ' 30' ' ' LEU . 51.5 p -55.61 -29.67 59.57 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.412 ' N ' ' O ' ' A' ' 123' ' ' MET . 47.1 t -85.04 -35.65 21.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.135 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.721 ' O ' HD12 ' A' ' 128' ' ' LEU . 1.7 tp -72.1 -50.41 28.36 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.11 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.512 ' O ' HG23 ' A' ' 133' ' ' VAL . 54.2 t -55.34 -57.0 8.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.781 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.5 mm -55.77 -45.28 79.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.679 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -57.17 -33.34 67.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.443 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.3 tp -67.17 -37.6 84.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.544 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 129' ' ' VAL . 0.4 OUTLIER -84.15 -42.44 17.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.636 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -61.01 -41.64 96.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.838 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.438 ' HG2' ' N ' ' A' ' 136' ' ' GLN . 8.2 pt-20 -76.1 -33.71 59.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.818 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.438 ' N ' ' HG2' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -49.09 -42.75 39.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.634 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 58.1 p -103.88 40.79 1.38 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.816 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.1 pttp -49.84 159.15 0.42 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.468 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.668 -179.969 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 mtt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER -118.37 177.85 4.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.595 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -173.96 41.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.659 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -131.93 163.73 48.01 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.563 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -44.16 154.71 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.725 2.283 . . . . 0.0 112.07 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.42 160.4 49.31 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.805 2.336 . . . . 0.0 111.997 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 8' ' ' ASP . 4.8 p-10 -106.02 40.11 1.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.651 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.472 ' O ' ' C ' ' A' ' 9' ' ' THR . 0.6 OUTLIER 79.89 -76.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.891 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.763 ' O ' HG22 ' A' ' 9' ' ' THR . 98.8 m 33.39 44.81 0.07 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.514 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.66 65.22 0.06 OUTLIER Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -46.98 142.1 11.38 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.893 2.395 . . . . 0.0 112.363 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 12' ' ' VAL . 14.8 p -101.08 -1.29 9.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.528 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -72.66 170.72 13.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.6 m -126.39 148.93 65.9 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.394 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -72.13 179.86 4.56 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.74 2.293 . . . . 0.0 112.16 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 27.0 tp -132.44 -43.47 0.93 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.729 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.52 84.71 0.06 OUTLIER Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -133.34 148.83 51.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.343 . . . . 0.0 110.717 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.4 mm -116.75 149.34 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.474 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.1 t -119.32 135.0 61.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.65 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.58 137.23 52.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.31 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.653 HD22 ' N ' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -67.88 135.13 52.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.784 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.653 ' N ' HD22 ' A' ' 22' ' ' ASN . 4.8 tp10 -54.68 -38.21 66.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.587 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.5 ttmm -80.15 -65.89 0.95 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.514 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.614 ' NE1' ' OD2' ' A' ' 49' ' ' ASP . 19.3 t-105 -42.54 -48.41 5.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.507 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.671 ' O ' ' N ' ' A' ' 28' ' ' SER . 5.4 ttm180 26.33 85.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.481 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 28' ' ' SER . . . -43.39 -8.9 0.01 OUTLIER Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.671 ' N ' ' O ' ' A' ' 26' ' ' ARG . 0.4 OUTLIER 74.31 -143.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.849 0.357 . . . . 0.0 110.39 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 28' ' ' SER . 3.5 mt-30 -39.92 -20.08 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.326 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.029 HD13 ' OG ' ' A' ' 126' ' ' SER . 0.3 OUTLIER -71.57 -52.09 19.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.384 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.81 -29.75 68.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.647 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -65.35 -54.34 30.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.543 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.651 ' O ' ' N ' ' A' ' 36' ' ' GLY . 3.8 mm-40 -59.37 -41.14 88.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.38 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.636 ' SD ' HD13 ' A' ' 40' ' ' LEU . 4.7 mtt -36.85 -33.98 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.459 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 33' ' ' GLU . 42.5 mt-30 -75.28 17.22 0.27 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.434 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -106.62 -4.82 36.92 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm -138.58 -41.33 0.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.685 0.279 . . . . 0.0 110.903 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.479 HG13 ' H ' ' A' ' 39' ' ' LYS . 4.8 tp -132.78 172.43 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.536 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.479 ' H ' HG13 ' A' ' 38' ' ' ILE . 43.0 tttp -85.54 125.9 33.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.613 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.636 HD13 ' SD ' ' A' ' 34' ' ' MET . 18.5 tp -114.98 149.73 36.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.666 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.436 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 3.7 mt -132.14 151.16 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.676 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.429 ' CE2' ' NH2' ' A' ' 26' ' ' ARG . 81.7 m-85 -115.99 131.09 57.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.446 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -137.01 128.37 28.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.608 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -92.13 122.28 34.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.362 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 139.97 -30.96 2.32 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.526 ' O ' ' OD1' ' A' ' 22' ' ' ASN . 1.4 mt -68.61 161.82 27.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.748 0.309 . . . . 0.0 110.477 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.735 ' H ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -111.38 -40.54 0.1 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.914 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.735 ' CD ' ' H ' ' A' ' 47' ' ' THR . 24.7 Cg_exo -59.27 -173.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.59 2.193 . . . . 0.0 112.023 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.614 ' OD2' ' NE1' ' A' ' 25' ' ' TRP . 8.1 m-20 -97.47 -49.89 4.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.368 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -134.33 145.08 48.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.308 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.05 118.74 35.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.873 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 tp -100.75 -30.37 11.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.258 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.624 ' C ' ' H ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -173.35 147.69 1.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.45 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.531 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -56.02 2.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.513 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.624 ' H ' ' C ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -124.2 1.27 8.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.529 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 86' ' ' LYS . 7.6 t -156.44 139.26 15.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.962 0.41 . . . . 0.0 110.829 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -142.52 175.03 10.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.007 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.7 mt -137.68 133.15 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.847 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 tp -117.44 134.99 54.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.161 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.428 ' N ' ' OD2' ' A' ' 49' ' ' ASP . 41.6 t80 -107.99 126.66 52.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.881 0.372 . . . . 0.0 110.977 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.407 ' HB ' HG22 ' A' ' 91' ' ' VAL . 98.7 t -113.24 148.6 16.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.958 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.7 t -115.65 150.79 36.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.586 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.585 ' HG2' HG21 ' A' ' 94' ' ' THR . 1.8 pp20? -47.68 -35.15 9.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.485 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.645 ' O ' HG12 ' A' ' 67' ' ' VAL . . . -57.88 -21.12 41.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.287 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 88.7 m-20 -83.89 -37.73 22.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.776 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.572 HD13 ' HA ' ' A' ' 97' ' ' SER . 0.9 OUTLIER -57.26 -47.09 82.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.568 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.645 HG12 ' O ' ' A' ' 64' ' ' ALA . 15.0 p -49.75 -16.19 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.619 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 65' ' ' ASP . . . -81.81 -76.0 0.27 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.624 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.622 ' O ' ' NH2' ' A' ' 73' ' ' ARG . . . 68.7 9.49 59.07 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.87 75.44 0.27 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.831 0.348 . . . . 0.0 110.602 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.13 -61.46 0.2 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -73.32 -27.41 61.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.719 0.295 . . . . 0.0 110.653 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.622 ' NH2' ' O ' ' A' ' 69' ' ' GLY . 4.9 ttp180 -48.27 -29.41 3.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.57 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.455 ' O ' ' CD ' ' A' ' 74' ' ' LYS . 1.2 tmtt? -66.58 -30.11 70.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.525 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.403 ' HE ' ' HB2' ' A' ' 75' ' ' ARG . 16.2 tpp180 -65.49 -35.67 81.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.59 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.2 mt -67.61 -50.07 59.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.661 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.6 t -54.46 -38.77 42.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.584 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.72 -41.0 75.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.607 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.2 t -64.91 -35.66 75.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.636 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.73 -28.5 26.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.661 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -80.98 -13.25 59.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.625 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -25.59 34.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.438 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.481 ' CG ' ' N ' ' A' ' 84' ' ' ASN . 51.4 t-20 -174.99 -112.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.635 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.481 ' N ' ' CG ' ' A' ' 83' ' ' ASN . 0.1 OUTLIER -170.82 74.42 0.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.416 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.845 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -133.03 161.37 34.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.714 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 86' ' ' LYS . 1.9 pttt -81.83 118.38 22.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.456 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.74 137.82 9.9 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.0 mt -93.09 141.17 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.764 0.316 . . . . 0.0 110.451 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.432 ' O ' HG12 ' A' ' 89' ' ' VAL . 3.3 t -115.96 108.71 25.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.648 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 117' ' ' LEU . 0.8 OUTLIER -90.76 144.34 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.397 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.407 HG22 ' HB ' ' A' ' 61' ' ' VAL . 59.2 t -130.52 140.0 49.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.685 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -90.8 126.42 36.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.546 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -90.74 140.5 29.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.639 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.585 HG21 ' HG2' ' A' ' 63' ' ' GLU . 18.5 p -144.56 -73.1 0.26 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.473 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.411 ' O ' ' OE1' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -149.8 -72.65 0.18 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.456 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.445 ' O ' ' CD2' ' A' ' 66' ' ' LEU . 48.6 mtt -60.02 -5.82 1.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.457 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.604 ' O ' ' N ' ' A' ' 99' ' ' GLN . 0.2 OUTLIER -73.18 -84.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.522 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.59 ' H ' ' CD ' ' A' ' 98' ' ' GLU . 1.8 mp0 -36.27 -24.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.687 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.604 ' N ' ' O ' ' A' ' 97' ' ' SER . 1.6 mm100 -69.03 -55.88 9.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.01 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.419 ' C ' HD11 ' A' ' 66' ' ' LEU . 17.8 m-85 -117.55 10.89 13.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.725 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.582 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -60.8 -61.1 8.66 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.319 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 101' ' ' PHE . 9.5 Cg_endo -54.11 -42.28 68.43 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.678 2.252 . . . . 0.0 111.921 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.04 -41.54 35.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.332 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 tp -77.08 -41.2 43.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.399 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.501 ' HG3' HD22 ' A' ' 116' ' ' LEU . 65.5 tt0 -51.23 -35.12 35.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.342 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.91 -51.0 64.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.275 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -62.88 -55.09 29.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.452 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.52 -40.67 27.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.429 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.686 ' O ' ' N ' ' A' ' 113' ' ' GLY . 6.7 t -67.57 -56.65 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.273 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.88 -28.32 68.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.558 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.48 -52.09 6.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.387 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.7 mp -105.91 -28.72 10.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.36 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 56.56 34.06 63.46 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -88.69 -155.8 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.75 0.31 . . . . 0.0 110.285 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.601 ' C ' HD12 ' A' ' 116' ' ' LEU . 6.2 t -116.83 130.16 72.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.886 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 116' ' ' LEU . 7.0 mp -117.6 125.98 51.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.444 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.646 ' O ' HG13 ' A' ' 90' ' ' VAL . 1.2 mp -126.2 85.28 60.11 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.546 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -58.94 156.94 30.97 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.81 2.34 . . . . 0.0 111.925 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.662 HG23 ' H ' ' A' ' 120' ' ' ALA . 5.9 m -126.16 -107.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.492 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.662 ' H ' HG23 ' A' ' 119' ' ' VAL . . . 172.92 -28.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.126 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.78 165.46 31.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.356 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -64.85 -41.24 95.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.6 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -62.48 -42.42 99.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.648 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.571 ' O ' ' N ' ' A' ' 128' ' ' LEU . 18.3 mm-40 -45.81 -53.53 9.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.247 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 128' ' ' LEU . . . -60.01 -57.99 10.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.702 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 1.029 ' OG ' HD13 ' A' ' 30' ' ' LEU . 14.6 m -46.23 -33.0 3.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 1.8 t -85.13 -35.6 21.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.947 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.571 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -71.28 -50.46 32.49 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.081 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.0 t -56.75 -56.4 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.171 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 mm -51.29 -51.7 22.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.329 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -50.4 -41.66 52.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.299 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.9 tp -46.41 -54.4 9.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.525 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.429 HG23 ' H ' ' A' ' 133' ' ' VAL . 1.3 t -67.63 -46.07 83.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.283 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -51.0 -39.27 55.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.183 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.494 ' O ' ' C ' ' A' ' 139' ' ' GLU . 4.0 mm-40 -68.03 -30.62 69.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.292 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -82.3 -43.17 17.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.213 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.44 -35.11 65.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.375 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -133.99 76.14 1.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.432 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.494 ' C ' ' O ' ' A' ' 135' ' ' GLU . 1.4 mt-10 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.489 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 mmt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -176.18 117.34 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.551 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -99.67 -87.32 0.36 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.502 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.526 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 7.1 p30 -149.34 49.91 0.74 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.687 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 4' ' ' ASN . 37.5 Cg_endo -70.1 111.05 2.78 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.743 2.295 . . . . 0.0 111.953 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -47.14 109.49 0.22 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.582 2.188 . . . . 0.0 112.233 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -129.89 40.6 3.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.454 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 66.09 90.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.656 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -100.95 1.98 40.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.251 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.58 -72.24 0.09 OUTLIER Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.99 121.46 8.32 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.712 2.275 . . . . 0.0 111.813 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.1 t -84.12 -56.43 5.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.842 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.467 ' O ' ' C ' ' A' ' 14' ' ' VAL . 3.2 p-80 -127.52 33.86 4.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.877 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.467 ' C ' ' O ' ' A' ' 13' ' ' HIS . 0.0 OUTLIER 35.19 79.52 0.29 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.958 0.409 . . . . 0.0 110.58 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.56 ' C ' ' H ' ' A' ' 17' ' ' GLY . 61.5 Cg_endo -78.03 -7.12 16.23 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.789 2.326 . . . . 0.0 112.187 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mt -69.97 31.3 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.482 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.56 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . -127.9 -61.19 0.13 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.409 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 20.2 p80 -73.67 162.24 29.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.914 0.388 . . . . 0.0 110.616 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 20' ' ' VAL . 72.5 mt -119.84 155.73 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.592 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.439 ' N ' HG22 ' A' ' 19' ' ' ILE . 58.3 t -108.84 148.61 12.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.458 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.563 ' HB2' HD22 ' A' ' 40' ' ' LEU . . . -136.0 141.2 44.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.666 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.604 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 66.4 t30 -73.99 132.94 42.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.702 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -48.89 -25.07 1.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.566 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -85.24 -33.12 22.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.533 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -79.49 -4.74 52.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.478 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.469 ' C ' ' H ' ' A' ' 28' ' ' SER . 24.2 ttp180 -70.69 -17.15 62.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.383 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.58 29.22 1.04 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 26' ' ' ARG . 6.1 m -127.66 138.06 52.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.343 . . . . 0.0 110.575 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -62.53 -24.48 67.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.53 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.86 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -61.06 -53.31 58.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.378 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.03 -32.66 6.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.824 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.94 -27.89 49.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.692 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -63.9 -53.01 57.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.502 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.433 ' SD ' HD12 ' A' ' 19' ' ' ILE . 4.2 mtm -59.76 -16.49 28.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.486 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.31 -8.35 55.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.509 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.14 0.79 58.9 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -139.88 -33.68 0.58 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.817 0.342 . . . . 0.0 110.514 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.506 HD13 ' HA ' ' A' ' 38' ' ' ILE . 1.7 mm -127.74 158.17 39.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.444 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.498 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 4.4 ttpm? -90.16 102.34 15.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.236 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.563 HD22 ' HB2' ' A' ' 21' ' ' ALA . 4.7 mt -88.44 130.09 35.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.02 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 mm -108.25 113.71 44.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.086 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -75.72 125.16 28.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.022 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -127.16 115.75 19.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.314 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -79.38 125.9 30.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.447 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.82 -26.71 4.77 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.604 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 3.5 mm? -64.62 140.63 58.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.765 0.317 . . . . 0.0 110.59 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.674 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -92.36 -39.87 0.36 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.625 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.674 ' CD ' ' N ' ' A' ' 47' ' ' THR . 16.4 Cg_exo -64.73 -160.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.808 2.339 . . . . 0.0 111.92 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -111.46 -55.34 2.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.467 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -132.37 132.28 42.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.525 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.527 ' CD1' ' O ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -109.26 109.05 19.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.702 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.68 -41.2 72.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.44 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.482 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 79.3 p -165.66 -174.09 2.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.426 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.552 ' H ' ' ND2' ' A' ' 54' ' ' ASN . 0.3 OUTLIER -79.46 19.53 0.61 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.494 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.42 ' HG2' HH11 ' A' ' 55' ' ' ARG . 0.6 OUTLIER -142.22 3.34 1.55 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.159 -179.695 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.527 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 15.3 m -152.22 152.05 31.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.987 0.422 . . . . 0.0 111.091 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.475 ' SG ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -150.82 158.74 44.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.148 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.9 mt -130.4 132.81 64.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.902 0.382 . . . . 0.0 110.873 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.05 138.1 53.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.068 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -100.56 134.42 43.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.921 0.391 . . . . 0.0 110.931 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 t -131.33 138.66 52.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.336 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 64' ' ' ALA . 4.7 t -116.05 147.38 41.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.395 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -38.84 -37.24 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.49 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.469 ' HB3' HG23 ' A' ' 62' ' ' THR . . . -50.25 -37.05 33.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.461 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 62' ' ' THR . 18.6 m-20 -71.74 -40.35 69.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.698 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.58 HD11 ' C ' ' A' ' 100' ' ' TYR . 1.3 tt -55.42 -43.42 75.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.492 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.456 ' N ' HD23 ' A' ' 66' ' ' LEU . 11.4 t -49.81 -38.21 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.515 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.39 -67.19 0.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.418 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.2 12.33 81.73 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -156.84 138.09 13.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 110.745 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.24 -38.93 3.04 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -82.52 -22.95 34.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.685 0.279 . . . . 0.0 110.805 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.3 ttp85 -68.81 -40.62 79.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.684 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.98 -24.4 2.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.683 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -70.04 -44.65 68.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.597 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.2 mt -58.19 -46.52 85.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.614 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.7 t -45.27 -42.37 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.697 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.4 mmm-85 -45.03 -51.75 9.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.666 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 t -62.44 -26.55 40.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.797 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -82.74 -37.51 24.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.72 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 81' ' ' ASN . 3.1 t-20 -82.31 -8.9 59.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.882 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.5 ' HB3' HD11 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -51.85 -78.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.558 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -153.22 -71.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.472 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -178.67 57.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.296 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.77 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -108.49 143.25 37.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.731 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.85 92.4 9.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.529 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -93.05 162.2 26.0 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.0 mt -116.7 148.48 19.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.809 0.338 . . . . 0.0 110.494 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.84 118.54 55.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.719 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.71 135.69 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.476 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.422 ' H ' ' HA ' ' A' ' 118' ' ' PRO . 46.8 t -119.58 148.92 22.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.691 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -98.79 133.35 43.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.235 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -86.09 140.34 30.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.877 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.417 ' HB ' ' H ' ' A' ' 95' ' ' ARG . 2.2 m -145.91 -79.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.256 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.417 ' H ' ' HB ' ' A' ' 94' ' ' THR . 64.6 mtt-85 -141.07 -70.45 0.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.358 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 20.7 mmt -63.09 -11.45 19.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.42 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.637 ' O ' ' N ' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -54.78 -95.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.669 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.626 ' N ' ' OG ' ' A' ' 97' ' ' SER . 3.0 pt-20 -36.27 -29.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.996 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.512 ' N ' ' O ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -65.9 -55.24 17.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.906 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.58 ' C ' HD11 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -117.62 12.74 14.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.968 -179.564 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.637 ' N ' ' O ' ' A' ' 97' ' ' SER . 21.2 t80 -68.24 -37.37 10.78 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.244 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 50.4 Cg_endo -78.3 -30.93 3.05 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.04 1.827 . . . . 0.0 111.959 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.84 95.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.962 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.476 HD23 ' O ' ' A' ' 104' ' ' LEU . 4.6 tt -73.48 -45.84 51.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.044 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.457 ' O ' HG23 ' A' ' 109' ' ' VAL . 5.3 tt0 -54.65 -34.61 62.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.013 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -63.11 -36.75 84.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.162 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' A' ' 111' ' ' ASP . 1.7 m-85 -79.54 -53.33 6.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.194 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.7 m -51.99 -36.34 49.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.33 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.602 ' O ' ' N ' ' A' ' 113' ' ' GLY . 8.9 t -65.82 -59.9 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.494 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.879 HD23 ' O ' ' A' ' 110' ' ' LEU . 2.2 tt -67.04 -22.6 65.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.496 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 107' ' ' PHE . 1.3 m-20 -84.53 -55.41 4.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.81 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.9 mp -106.14 -28.42 10.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.987 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 49.69 50.05 32.36 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 2.3 mtm -105.84 -165.79 1.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.784 0.326 . . . . 0.0 110.368 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.8 t -90.44 110.5 22.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.538 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 117' ' ' LEU . 3.8 tt -111.15 126.17 54.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.522 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.551 ' N ' HD23 ' A' ' 116' ' ' LEU . 5.3 tp -146.15 107.6 4.22 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.682 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.422 ' HA ' ' H ' ' A' ' 91' ' ' VAL . 71.9 Cg_endo -78.78 169.58 19.37 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.388 2.058 . . . . 0.0 112.185 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.604 HG23 ' N ' ' A' ' 120' ' ' ALA . 19.4 m -131.91 -118.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.576 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.604 ' N ' HG23 ' A' ' 119' ' ' VAL . . . -167.27 -40.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.538 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.3 m -136.08 155.71 49.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.398 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -59.91 -20.75 59.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.547 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.683 ' SD ' ' N ' ' A' ' 123' ' ' MET . 0.8 OUTLIER -78.06 -33.05 51.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.585 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.634 ' O ' ' N ' ' A' ' 128' ' ' LEU . 1.6 mm-40 -54.26 -55.36 28.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.758 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -51.51 -58.22 6.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.249 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.729 ' HB2' HD13 ' A' ' 30' ' ' LEU . 3.9 t -48.89 -33.39 10.62 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.16 -30.13 24.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.874 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.634 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.5 OUTLIER -74.42 -49.72 21.34 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.074 179.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.99 -55.14 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.279 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 44.2 mt -51.03 -54.04 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.408 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -42.31 -35.15 0.92 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.596 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.96 -60.25 3.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.598 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.7 t -63.85 -38.63 82.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.351 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -60.03 -31.86 70.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.401 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -61.74 -50.18 73.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.429 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.493 ' C ' ' H ' ' A' ' 138' ' ' LYS . 3.9 tp-100 -50.5 -53.08 32.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.389 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.537 ' O ' ' O ' ' A' ' 138' ' ' LYS . 14.5 p -71.7 15.03 0.15 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.495 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.537 ' O ' ' O ' ' A' ' 137' ' ' THR . 19.8 mmtm 46.67 107.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.583 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.527 -179.996 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mmm . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -115.6 168.76 9.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.509 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -145.87 -109.88 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.674 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -123.51 66.4 35.09 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.748 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.98 163.85 35.89 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.777 2.318 . . . . 0.0 112.117 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.23 170.79 17.4 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.807 2.338 . . . . 0.0 112.028 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.49 ' O ' ' CB ' ' A' ' 8' ' ' ASP . 9.5 t0 -118.47 43.13 2.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.727 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.68 ' O ' ' N ' ' A' ' 10' ' ' GLY . 6.6 t0 80.38 -23.36 0.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.6 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 9' ' ' THR . 3.3 t 25.91 36.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.802 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.68 ' N ' ' O ' ' A' ' 8' ' ' ASP . . . -62.68 -58.1 13.58 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 12' ' ' VAL . 60.9 Cg_exo -46.28 74.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.884 2.389 . . . . 0.0 112.091 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.65 ' N ' ' O ' ' A' ' 10' ' ' GLY . 1.3 p -37.61 121.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.723 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.551 ' O ' ' C ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -117.43 78.5 1.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.414 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.583 ' O ' HG23 ' A' ' 14' ' ' VAL . 22.6 m -24.83 94.98 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.939 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.452 ' N ' ' O ' ' A' ' 13' ' ' HIS . 66.3 Cg_endo -80.33 150.5 19.84 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.71 2.273 . . . . 0.0 112.083 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.44 -83.06 0.65 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.566 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.509 ' O ' HD11 ' A' ' 38' ' ' ILE . . . -69.11 103.61 1.11 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.486 ' C ' ' ND1' ' A' ' 18' ' ' HIS . 4.1 p80 -112.55 155.06 24.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.659 0.266 . . . . 0.0 110.429 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 20' ' ' VAL . 24.9 mm -107.24 159.41 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.737 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.545 HG11 ' OE2' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -125.96 141.22 46.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.609 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -126.12 143.87 50.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.586 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 25' ' ' TRP . 30.1 t30 -64.33 131.46 47.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.524 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -41.42 -32.89 0.36 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.515 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -78.15 -30.44 49.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.517 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.582 ' N ' ' O ' ' A' ' 22' ' ' ASN . 18.8 t-105 -77.91 -10.78 59.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.586 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.508 ' C ' ' H ' ' A' ' 28' ' ' SER . 10.8 ttt-85 -60.08 -37.0 78.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.732 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.06 40.81 0.26 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.508 ' H ' ' C ' ' A' ' 26' ' ' ARG . 69.8 m -128.47 136.54 50.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.753 0.311 . . . . 0.0 110.662 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -67.9 -21.25 65.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.222 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.942 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -71.72 -52.48 17.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.288 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.523 ' O ' HD22 ' A' ' 40' ' ' LEU . . . -49.02 -27.64 3.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.482 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -79.07 -34.7 43.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.738 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -58.34 -43.94 88.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.764 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.429 ' C ' ' H ' ' A' ' 36' ' ' GLY . 28.2 mtt -54.33 -32.64 57.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.804 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -71.0 8.96 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.593 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 34' ' ' MET . . . -95.34 -11.37 56.0 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -142.59 -49.19 0.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.812 0.339 . . . . 0.0 110.671 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.509 HD11 ' O ' ' A' ' 17' ' ' GLY . 10.4 tp -106.03 165.95 3.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.326 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.451 ' N ' HG13 ' A' ' 38' ' ' ILE . 22.7 tttp -85.68 143.99 28.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.285 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.523 HD22 ' O ' ' A' ' 31' ' ' ALA . 19.8 tp -127.82 156.25 42.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.449 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 50.1 mt -145.77 142.56 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.359 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.04 127.63 51.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.688 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.545 ' OE2' HG11 ' A' ' 20' ' ' VAL . 57.3 mt-10 -127.36 124.23 38.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.443 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.39 94.54 9.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.778 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 166.59 -32.26 0.21 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.474 ' O ' ' OD1' ' A' ' 22' ' ' ASN . 11.1 mp -66.92 159.62 27.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 110.491 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.555 ' H ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -103.79 -48.21 0.15 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.758 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.555 ' CD ' ' H ' ' A' ' 47' ' ' THR . 37.8 Cg_exo -56.36 -171.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.762 2.308 . . . . 0.0 112.039 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -97.92 -55.44 2.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.737 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -125.79 128.65 48.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.909 0.385 . . . . 0.0 110.649 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.687 ' CE2' ' O ' ' A' ' 53' ' ' SER . 4.0 t80 -107.87 105.43 15.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.594 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 mp -74.32 -30.53 62.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.438 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.687 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 2.0 p 177.41 -173.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.399 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -86.54 65.0 8.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.587 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -178.75 -30.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.824 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.422 ' HG ' ' HB2' ' A' ' 86' ' ' LYS . 1.2 m -140.29 132.4 27.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.918 0.389 . . . . 0.0 111.136 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 30.9 p -134.91 173.76 11.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.984 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.2 mt -139.99 131.74 32.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.289 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.0 tp -112.53 117.37 32.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.85 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -83.94 117.49 23.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.97 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.8 t -116.25 140.86 36.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.207 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.4 p -126.25 156.73 39.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.965 0.412 . . . . 0.0 110.92 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 96' ' ' MET . 2.9 tt0 -40.42 -43.43 1.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.731 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -43.48 -30.16 0.53 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.381 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -82.69 -47.72 11.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.308 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.538 HD11 ' C ' ' A' ' 100' ' ' TYR . 1.3 tt -50.82 -38.3 47.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.357 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.555 HG22 ' SD ' ' A' ' 96' ' ' MET . 3.2 t -45.95 -53.09 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.436 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -44.28 -76.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.481 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.29 -24.4 29.1 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -151.56 133.43 14.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 0.0 110.704 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.13 -54.94 0.73 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -62.68 -35.36 79.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.681 0.277 . . . . 0.0 110.6 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.475 ' HB3' HH11 ' A' ' 73' ' ' ARG . 0.2 OUTLIER -49.51 -40.78 38.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.877 0.37 . . . . 0.0 110.165 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.431 ' N ' ' HD2' ' A' ' 73' ' ' ARG . 1.8 ttpp -54.6 -35.87 63.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.043 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.2 ttt85 -69.22 -42.31 75.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.151 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 34.8 mt -61.71 -21.5 64.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.271 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.2 t -81.35 -39.28 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.486 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -61.04 -20.99 63.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.647 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.4 t -70.36 -50.06 49.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.012 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 49.2 ttt-85 -71.24 -43.58 66.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.907 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -52.66 -27.48 17.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.68 ' OG ' ' N ' ' A' ' 83' ' ' ASN . 0.3 OUTLIER -46.6 -74.42 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.82 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.68 ' N ' ' OG ' ' A' ' 82' ' ' SER . 1.8 m-80 -140.18 -98.22 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.834 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -165.56 37.59 0.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.781 0.324 . . . . 0.0 110.718 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.92 157.52 17.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.605 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.422 ' HB2' ' HG ' ' A' ' 56' ' ' CYS . 7.6 mmmt -88.94 100.05 12.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.493 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -95.71 141.26 15.48 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 60.7 mt -103.02 135.65 39.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.816 0.341 . . . . 0.0 110.435 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.4 t -108.93 103.75 16.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.656 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.1 t -93.94 142.07 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.351 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.486 ' O ' HG22 ' A' ' 119' ' ' VAL . 93.8 t -122.64 149.59 26.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.674 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -107.67 107.12 17.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.633 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -68.17 132.82 47.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.211 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.2 m -137.42 -79.51 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.785 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.3 mtp85 -141.17 -70.25 0.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.581 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.555 ' SD ' HG22 ' A' ' 67' ' ' VAL . 16.2 mtt -63.77 -10.78 21.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.496 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.643 ' O ' ' N ' ' A' ' 99' ' ' GLN . 82.8 p -62.02 -88.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.769 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.444 ' N ' ' OG ' ' A' ' 97' ' ' SER . 0.2 OUTLIER -36.09 -22.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.006 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.643 ' N ' ' O ' ' A' ' 97' ' ' SER . 7.0 mt-30 -73.62 -54.77 7.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.913 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.538 ' C ' HD11 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -117.52 12.67 14.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.617 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.699 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 3.1 t80 -63.03 -34.94 15.16 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.647 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.699 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 14.7 Cg_exo -66.66 -49.99 1.43 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.604 2.203 . . . . 0.0 111.821 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -47.19 -49.2 23.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.423 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.568 ' O ' ' OG1' ' A' ' 108' ' ' THR . 2.7 tp -65.37 -51.2 62.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.423 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.543 ' O ' HG23 ' A' ' 109' ' ' VAL . 2.7 tt0 -49.93 -33.51 17.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.632 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.29 -52.98 15.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.571 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.92 -52.18 66.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.671 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.568 ' OG1' ' O ' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -58.82 -30.04 67.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.596 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 105' ' ' GLN . 2.3 t -70.98 -41.38 76.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.627 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 110' ' ' LEU . 16.5 tp -81.36 -33.78 32.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.643 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.73 -47.19 10.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.471 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 113' ' ' GLY . 2.3 mm? -102.16 -28.33 12.37 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.184 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.5 ' CA ' ' O ' ' A' ' 109' ' ' VAL . . . 34.66 38.23 0.12 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -89.33 -156.12 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.734 0.302 . . . . 0.0 110.339 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.5 t -101.35 116.22 44.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.717 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.839 ' C ' HD12 ' A' ' 117' ' ' LEU . 7.4 mp -104.71 138.15 41.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.522 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.839 HD12 ' C ' ' A' ' 116' ' ' LEU . 6.0 mp -147.32 85.63 6.74 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.732 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -61.72 165.59 13.52 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.751 2.301 . . . . 0.0 111.764 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 91' ' ' VAL . 6.8 m -132.74 -115.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.515 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.454 ' N ' HG23 ' A' ' 119' ' ' VAL . . . -178.71 -43.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.324 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.498 ' OG ' ' OE1' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -133.16 172.44 12.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.434 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -73.88 -16.63 61.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.645 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.481 ' O ' ' N ' ' A' ' 127' ' ' CYS . 54.8 mtp -85.57 -42.0 14.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.695 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.672 ' O ' ' N ' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -46.75 -53.92 10.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.527 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.16 -57.85 11.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.232 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.792 ' OG ' HD13 ' A' ' 30' ' ' LEU . 11.1 m -53.95 -33.3 56.48 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.481 ' N ' ' O ' ' A' ' 123' ' ' MET . 6.8 t -85.36 -29.37 24.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.666 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.856 ' O ' HD12 ' A' ' 128' ' ' LEU . 1.6 tp -80.51 -36.53 33.1 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.608 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 64.4 t -63.92 -40.73 90.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.785 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.9 mt -63.32 -51.56 69.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.349 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.439 HE21 ' HB2' ' A' ' 131' ' ' GLN . 1.3 tp-100 -42.87 -42.24 3.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.316 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.7 mt -61.39 -57.36 12.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.528 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.6 t -49.07 -55.91 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.627 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -42.96 -30.62 0.43 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.533 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.69 -52.22 33.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.398 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -59.68 -31.84 69.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.434 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 86.2 m -86.08 -16.88 36.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.527 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.48 106.75 1.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.63 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.545 179.966 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 mtp . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -74.28 105.44 5.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.499 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.28 -172.81 3.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.523 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -95.89 146.46 31.36 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.496 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -41.32 132.79 3.32 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.646 2.231 . . . . 0.0 112.11 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.83 87.85 1.36 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.478 2.119 . . . . 0.0 112.063 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.581 ' O ' ' O ' ' A' ' 8' ' ' ASP . 9.5 t0 -138.98 68.78 1.37 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.672 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.581 ' O ' ' O ' ' A' ' 7' ' ' ASP . 1.4 m-20 29.71 99.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.681 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 t -118.43 18.55 13.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.605 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.33 67.03 1.52 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -65.02 104.82 0.61 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.6 2.2 . . . . 0.0 112.01 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.5 p -84.19 138.04 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.682 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -159.05 52.81 0.4 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.484 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.2 m -100.17 148.45 34.9 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.534 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -40.05 159.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.835 2.357 . . . . 0.0 112.223 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.413 ' HB2' ' NE2' ' A' ' 18' ' ' HIS . 0.8 OUTLIER -103.65 -84.37 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.302 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -167.79 44.25 0.24 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.413 ' NE2' ' HB2' ' A' ' 16' ' ' LEU . 5.2 p80 -148.81 154.65 39.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 110.639 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.465 HG22 ' N ' ' A' ' 20' ' ' VAL . 33.0 mm -126.52 157.09 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.262 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.465 ' N ' HG22 ' A' ' 19' ' ' ILE . 63.3 t -113.11 148.36 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.015 0.436 . . . . 0.0 110.898 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 41' ' ' ILE . . . -137.84 159.33 42.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.203 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.564 ' O ' ' N ' ' A' ' 25' ' ' TRP . 57.6 t30 -92.15 139.49 30.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.839 0.352 . . . . 0.0 110.721 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -39.29 -47.49 1.7 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.585 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -63.28 -31.76 73.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.594 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.661 ' NE1' ' OD2' ' A' ' 49' ' ' ASP . 1.6 t-105 -76.79 -1.82 30.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.67 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.473 ' C ' ' HE ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -76.21 -26.93 56.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.538 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.82 33.11 3.1 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.4 m -122.7 142.38 50.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.8 0.333 . . . . 0.0 110.597 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -66.13 -23.11 66.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.33 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.917 HD13 ' OG ' ' A' ' 126' ' ' SER . 0.4 OUTLIER -67.85 -55.33 13.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.539 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.412 ' N ' ' HG ' ' A' ' 30' ' ' LEU . . . -48.25 -22.59 0.69 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.023 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -81.41 -45.97 15.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.905 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -50.73 -33.37 22.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.834 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.69 ' SD ' HD13 ' A' ' 40' ' ' LEU . 11.9 mtt -66.18 -33.58 76.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.752 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -70.12 -17.36 63.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.658 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.97 4.31 86.07 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm -147.82 -56.7 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.899 0.38 . . . . 0.0 110.485 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.535 ' O ' ' O ' ' A' ' 34' ' ' MET . 7.8 tp -112.18 165.13 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.426 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.433 ' H ' HG13 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -88.03 110.54 20.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.573 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.69 HD13 ' SD ' ' A' ' 34' ' ' MET . 17.7 tp -96.96 137.0 36.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.757 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.456 ' O ' ' N ' ' A' ' 21' ' ' ALA . 20.6 mt -113.49 139.33 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.412 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -105.93 142.8 35.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.85 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -153.99 116.96 4.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.456 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -77.87 134.29 37.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.569 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 122.98 -32.2 4.48 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 75.2 mt -59.84 144.53 48.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.735 0.302 . . . . 0.0 110.668 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.535 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -88.42 -64.52 0.2 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.727 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.535 ' CD ' ' CB ' ' A' ' 47' ' ' THR . 9.6 Cg_endo -54.15 -174.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.779 2.32 . . . . 0.0 112.18 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.661 ' OD2' ' NE1' ' A' ' 25' ' ' TRP . 35.1 t0 -93.26 -66.17 0.94 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.431 ' CE2' ' CG ' ' A' ' 49' ' ' ASP . 68.6 m-85 -118.28 162.19 18.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.609 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.95 142.52 50.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.081 0.467 . . . . 0.0 110.977 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.437 ' HA ' HD13 ' A' ' 52' ' ' LEU . 0.8 OUTLIER -119.88 -24.85 6.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.776 179.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.412 ' OG ' ' C ' ' A' ' 52' ' ' LEU . 0.7 OUTLIER -169.77 179.27 3.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.059 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -77.69 4.64 11.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.818 0.342 . . . . 0.0 110.52 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -133.65 -4.39 2.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.879 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.7 m -129.66 134.66 47.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.95 0.405 . . . . 0.0 110.947 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.3 p -146.45 171.06 15.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.118 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 mt -138.82 138.48 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.995 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.11 136.49 54.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.135 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.424 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 29.5 t80 -96.98 115.3 27.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.846 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 92' ' ' GLU . 6.7 t -121.75 149.05 24.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.193 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.6 t -135.87 163.78 29.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 0.0 110.908 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.784 ' OE2' HG23 ' A' ' 67' ' ' VAL . 4.8 tp10 -41.21 -48.68 3.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.589 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -47.61 -29.8 3.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.522 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 1.1 m-20 -77.43 -45.47 25.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.529 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.407 ' CD1' ' HA ' ' A' ' 101' ' ' PHE . 1.6 tt -48.94 -40.48 30.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.651 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.784 HG23 ' OE2' ' A' ' 63' ' ' GLU . 24.9 t -64.91 -42.57 95.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.672 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.529 ' C ' ' H ' ' A' ' 70' ' ' ASN . . . -91.16 26.3 2.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.597 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.95 -3.81 0.35 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 68' ' ' ALA . 50.0 t30 -89.93 37.77 0.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.815 0.341 . . . . 0.0 110.504 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -175.54 -32.77 0.04 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -82.73 -38.27 23.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.842 0.353 . . . . 0.0 110.441 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.3 ttt-85 -48.34 -50.49 30.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.646 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -54.59 -43.76 72.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.569 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -49.95 -50.87 45.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.557 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.2 mt -53.52 -41.59 66.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.799 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 62.5 t -57.06 -33.36 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.762 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -49.22 77.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.622 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.8 t -47.42 -41.56 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.505 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.1 ttt-85 -82.02 -21.12 37.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.476 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -65.0 -25.0 67.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.588 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 t -58.04 -68.38 0.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.507 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -160.29 -69.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.577 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -178.5 66.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.541 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.6 mp -91.43 127.92 37.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.53 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.1 87.96 4.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.429 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -104.72 175.7 22.58 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.6 mt -106.27 137.62 35.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 0.0 110.454 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.6 t -109.48 116.92 53.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.779 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.5 t -104.38 134.89 44.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.427 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.6 t -124.6 134.61 66.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.636 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 61' ' ' VAL . 5.0 tt0 -98.03 100.35 11.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.487 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.435 ' HB2' ' NZ ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -70.14 134.47 48.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.629 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.622 HG22 ' HG2' ' A' ' 95' ' ' ARG . 6.4 m -127.07 -64.97 0.97 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.637 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.622 ' HG2' HG22 ' A' ' 94' ' ' THR . 0.0 OUTLIER -150.5 -73.1 0.17 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.395 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -64.14 -4.06 3.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.142 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.654 ' O ' ' N ' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -75.53 -87.6 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.361 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 97' ' ' SER . 1.7 mt-10 -35.84 -26.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.991 0.424 . . . . 0.0 110.365 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.69 ' OE1' ' CD2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -69.56 -56.08 8.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.972 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.69 ' CD2' ' OE1' ' A' ' 99' ' ' GLN . 2.7 m-85 -116.57 12.68 15.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.922 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.731 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 22.0 t80 -69.63 -32.69 3.22 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.075 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.731 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 16.0 Cg_exo -64.8 -50.24 2.47 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.526 2.151 . . . . 0.0 111.997 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.84 -36.84 49.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.66 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.466 ' O ' ' OG1' ' A' ' 108' ' ' THR . 1.3 tp -77.26 -34.59 55.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.394 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.95 ' O ' HG23 ' A' ' 109' ' ' VAL . 1.8 tt0 -68.07 -38.27 82.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.355 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -65.65 -28.19 68.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.34 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.69 -54.19 5.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.49 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -54.11 -32.05 53.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.703 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 105' ' ' GLN . 79.3 t -62.81 -62.75 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.743 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 85.8 mt -66.44 -20.01 65.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.776 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -83.99 -56.68 3.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.6 mp -105.93 -26.56 11.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.062 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 48.93 46.53 32.28 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 5.0 tpp -95.99 -156.92 0.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 0.0 110.448 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.68 106.39 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.56 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 mp -101.5 124.94 47.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.329 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.5 mt -137.9 87.27 16.92 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.711 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -55.27 165.67 2.89 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.601 2.201 . . . . 0.0 111.831 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.536 HG23 ' H ' ' A' ' 120' ' ' ALA . 15.3 m -133.11 -116.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.72 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.536 ' H ' HG23 ' A' ' 119' ' ' VAL . . . 172.68 -32.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.364 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.1 p -129.39 153.49 47.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.44 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -64.68 -22.58 67.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.682 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.612 ' SD ' ' N ' ' A' ' 123' ' ' MET . 0.0 OUTLIER -83.4 -40.46 19.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.816 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.636 ' O ' ' N ' ' A' ' 128' ' ' LEU . 3.5 mm-40 -45.71 -50.76 13.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.641 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.41 -58.01 10.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.865 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.917 ' OG ' HD13 ' A' ' 30' ' ' LEU . 6.3 m -49.86 -33.95 18.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -82.88 -31.68 27.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.667 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -72.92 -33.21 65.83 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.407 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 92.0 t -81.43 -51.41 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.557 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 54.6 mt -55.11 -44.6 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.702 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -52.23 -42.7 63.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.944 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 tp -52.18 -56.64 13.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.821 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 86.7 t -55.25 -55.85 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.009 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -47.07 -48.15 22.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.99 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -74.79 -21.91 59.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.018 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -78.75 -42.59 27.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.719 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.555 ' O ' HG23 ' A' ' 137' ' ' THR . 5.9 t -114.26 31.52 6.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.575 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.2 tptt -50.96 101.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.492 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.587 -179.893 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 mtt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -139.09 -36.76 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.447 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.485 ' C ' ' CG ' ' A' ' 4' ' ' ASN . 9.1 mtpp -81.95 95.62 7.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.53 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.485 ' CG ' ' C ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -164.77 145.78 6.39 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.467 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.81 150.62 73.96 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.575 2.183 . . . . 0.0 112.025 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -38.62 99.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.923 2.415 . . . . 0.0 112.278 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -111.72 70.36 0.71 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.489 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.596 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 0.0 OUTLIER 35.9 48.62 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.735 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 t -61.19 0.4 0.26 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.425 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 8' ' ' ASP . . . -174.09 -86.11 0.06 OUTLIER Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -58.34 159.03 20.54 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.801 2.334 . . . . 0.0 111.939 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.589 ' O ' ' N ' ' A' ' 14' ' ' VAL . 41.1 t -109.61 112.42 40.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.734 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 58.66 -72.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.692 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -127.94 153.92 78.28 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.657 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.75 72.98 3.66 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.015 2.477 . . . . 0.0 112.094 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mt -81.42 -1.56 46.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.793 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 65.12 57.4 11.89 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.448 ' CD2' ' H ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -90.61 166.15 13.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.418 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.7 mt -128.18 144.33 38.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.717 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -103.44 141.2 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.461 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.17 138.07 54.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.611 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.439 HD22 ' N ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -74.2 122.92 23.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.548 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.439 ' N ' HD22 ' A' ' 22' ' ' ASN . 1.6 tp10 -47.18 -25.22 0.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.556 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -76.34 -36.11 58.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.412 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.565 ' O ' ' CG ' ' A' ' 25' ' ' TRP . 34.8 t-105 -91.43 -1.34 57.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.501 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.54 ' C ' ' H ' ' A' ' 28' ' ' SER . 24.0 ttt180 -70.46 -15.16 62.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.571 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.56 24.19 0.49 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.54 ' H ' ' C ' ' A' ' 26' ' ' ARG . 0.4 OUTLIER -123.8 144.03 49.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.826 0.346 . . . . 0.0 110.618 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.56 ' O ' ' OE2' ' A' ' 33' ' ' GLU . 40.9 mt-30 -75.13 -16.93 60.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.537 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.803 HD13 ' N ' ' A' ' 31' ' ' ALA . 1.9 tm? -53.26 -65.05 0.63 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.238 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.803 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -49.69 -37.91 30.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.829 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.14 -30.85 60.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.896 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.647 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 0.4 OUTLIER -72.75 -45.94 56.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.746 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.593 ' SD ' HG11 ' A' ' 129' ' ' VAL . 3.8 mtm -44.84 -31.39 1.21 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.364 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -69.46 9.74 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.676 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -89.51 -31.39 11.58 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -131.24 -43.86 1.04 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.929 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 38' ' ' ILE . 10.1 tp -103.03 162.33 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.698 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.415 ' N ' HG13 ' A' ' 38' ' ' ILE . 8.1 tttt -86.34 150.02 24.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.435 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.571 ' CD2' ' HB1' ' A' ' 31' ' ' ALA . 13.2 tp -137.17 131.6 32.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 mt -115.21 123.73 71.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.272 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.444 ' CD1' ' HD2' ' A' ' 26' ' ' ARG . 75.0 m-85 -88.74 120.35 30.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.801 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -126.14 132.45 51.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.45 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -95.2 103.75 15.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.628 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 154.29 -19.33 0.63 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.505 ' N ' HD22 ' A' ' 46' ' ' LEU . 3.9 mm? -66.8 146.13 54.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 0.0 110.599 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.498 ' H ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -87.3 -58.54 0.28 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.804 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.498 ' HD2' ' H ' ' A' ' 47' ' ' THR . 37.7 Cg_endo -69.14 -158.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.616 2.211 . . . . 0.0 112.158 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.604 ' CG ' ' H ' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -90.76 -61.34 1.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.776 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -121.84 160.32 24.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.83 0.347 . . . . 0.0 110.871 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.505 ' CD2' HD12 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -142.06 101.48 3.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.535 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 mp -76.89 -38.7 53.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.465 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 54' ' ' ASN . 15.1 t -168.39 176.01 6.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.471 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.426 ' N ' ' OG ' ' A' ' 53' ' ' SER . 20.2 m-80 -76.65 49.49 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.451 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -161.28 -37.63 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.595 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.7 t -120.25 143.15 48.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.846 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.681 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -150.64 165.93 31.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.011 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.681 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 75.1 mt -137.55 131.64 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.76 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.495 HD23 ' OD1' ' A' ' 49' ' ' ASP . 0.4 OUTLIER -118.39 127.04 53.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.202 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.604 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 19.5 t80 -90.28 130.02 36.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.005 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 37.3 t -126.75 146.95 31.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.204 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.7 t -129.46 153.72 47.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.923 0.392 . . . . 0.0 110.944 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.426 ' HG3' ' H ' ' A' ' 97' ' ' SER . 0.5 OUTLIER -41.35 -44.42 2.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.617 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -48.41 -30.13 4.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.604 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.51 -31.13 37.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.528 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.734 HD23 ' N ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -64.45 -43.15 95.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.362 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.734 ' N ' HD23 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -46.03 -32.33 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.59 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 69' ' ' GLY . . . -103.2 -53.8 2.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.656 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 68' ' ' ALA . . . 36.12 37.41 0.18 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -115.38 -57.55 2.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.76 0.314 . . . . 0.0 110.639 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.8 -37.77 33.1 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.409 ' OH ' HD21 ' A' ' 59' ' ' LEU . 1.1 t80 -67.69 -23.37 65.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 0.0 110.653 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.2 tmm_? -60.51 -46.65 89.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.668 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -68.65 -24.63 64.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.33 -50.33 54.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.751 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.519 ' O ' HD21 ' A' ' 112' ' ' LEU . 22.0 mt -58.07 -26.04 62.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 80' ' ' ARG . 92.4 t -73.52 -45.7 50.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.028 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -42.17 -48.78 4.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.836 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 37.4 t -58.48 -27.46 33.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.453 ' N ' ' O ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -80.6 -37.65 30.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.57 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -63.33 -15.13 56.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.671 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 83' ' ' ASN . 92.9 p -59.79 -111.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.521 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.531 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER -117.86 -68.34 0.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.539 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.531 ' CG ' ' O ' ' A' ' 83' ' ' ASN . 16.0 m-20 176.98 63.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.428 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.461 ' CD1' ' OD1' ' A' ' 83' ' ' ASN . 4.0 mp -98.05 133.87 41.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.743 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -84.83 101.39 12.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.299 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.65 129.56 9.21 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.3 mt -86.51 135.86 24.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.796 0.332 . . . . 0.0 110.453 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.3 t -101.7 107.47 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.663 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.5 t -89.95 138.29 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.336 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.1 t -125.53 148.55 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.367 . . . . 0.0 110.899 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -118.97 110.1 16.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.188 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -66.45 146.33 54.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.749 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.424 HG22 ' CG ' ' A' ' 95' ' ' ARG . 5.1 m -141.67 -75.39 0.3 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.468 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.424 ' CG ' HG22 ' A' ' 94' ' ' THR . 5.8 mtp85 -141.22 -69.62 0.38 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.702 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 5.6 mmt -69.3 -10.77 59.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.631 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.645 ' HA ' HD13 ' A' ' 66' ' ' LEU . 5.3 p -50.56 -94.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.737 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 97' ' ' SER . 5.3 mt-10 -36.31 -25.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.906 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.583 ' N ' ' O ' ' A' ' 97' ' ' SER . 3.4 mm100 -73.75 -51.31 16.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.709 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.61 ' C ' HD11 ' A' ' 66' ' ' LEU . 1.1 t80 -114.59 11.83 17.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.649 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.729 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 28.8 t80 -69.76 -32.58 3.09 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.889 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.729 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 11.0 Cg_exo -67.1 -58.93 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.553 2.169 . . . . 0.0 111.938 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -47.85 -38.53 16.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.836 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 38.8 tp -73.15 -53.78 10.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.658 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -47.69 -36.5 11.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.642 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -64.53 -41.28 96.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.412 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -73.16 -46.0 53.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.648 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -35.19 74.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.894 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.672 ' O ' ' N ' ' A' ' 113' ' ' GLY . 3.6 t -76.65 -54.41 13.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.892 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.63 -29.73 69.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.915 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -84.66 -51.04 7.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.377 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.519 HD21 ' O ' ' A' ' 76' ' ' LEU . 8.9 mp -105.04 -28.5 11.01 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.584 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 55.01 16.13 7.67 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.768 ' N ' ' SD ' ' A' ' 114' ' ' MET . 0.0 OUTLIER -70.94 -155.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 0.0 110.762 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.2 t -109.65 138.21 38.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.711 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.606 ' O ' HD12 ' A' ' 117' ' ' LEU . 1.5 pp -129.38 127.05 40.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.508 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.606 HD12 ' O ' ' A' ' 116' ' ' LEU . 1.3 mp -132.73 101.24 14.27 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.482 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -79.01 156.36 26.56 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.526 2.151 . . . . 0.0 112.256 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.573 HG23 ' H ' ' A' ' 120' ' ' ALA . 5.6 m -130.35 -110.64 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.545 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.573 ' H ' HG23 ' A' ' 119' ' ' VAL . . . 170.96 -29.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.563 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.567 ' OG ' ' N ' ' A' ' 122' ' ' GLN . 0.4 OUTLIER -149.22 179.94 7.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.553 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.567 ' N ' ' OG ' ' A' ' 121' ' ' SER . 0.4 OUTLIER -73.69 -45.76 50.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.584 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.421 ' CG ' ' N ' ' A' ' 124' ' ' GLU . 8.7 ptt? -45.28 -43.21 10.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.646 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.624 ' O ' ' N ' ' A' ' 128' ' ' LEU . 16.6 mm-40 -59.74 -56.24 24.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.549 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.94 -58.38 8.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.104 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 122' ' ' GLN . 0.0 OUTLIER -47.47 -34.16 7.04 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 42.1 t -85.51 -31.02 22.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.321 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.624 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -76.01 -45.25 35.47 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.842 0.353 . . . . 0.0 110.625 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.593 HG11 ' SD ' ' A' ' 34' ' ' MET . 14.8 t -58.82 -54.67 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.616 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 96.3 mt -54.79 -52.62 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.616 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -48.9 -32.0 8.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.429 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.2 tp -61.71 -62.92 1.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.474 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.4 t -68.47 -36.89 76.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.506 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.426 ' O ' ' OG1' ' A' ' 137' ' ' THR . 28.7 tt0 -58.35 -31.94 68.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.542 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -63.59 -55.7 21.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.559 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -48.58 -38.61 21.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.567 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 137' ' ' THR . 25.3 m 41.68 30.98 0.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.739 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -86.67 123.53 31.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.544 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.543 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 mmt . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.62 91.45 8.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.562 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 pttp -152.52 28.68 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.555 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 63.19 74.06 0.47 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.561 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.62 155.16 44.83 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.778 2.319 . . . . 0.0 112.06 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -39.16 162.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 123.045 2.497 . . . . 0.0 112.28 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -83.68 56.17 3.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.541 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 10' ' ' GLY . 1.1 m-20 68.24 54.69 0.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.557 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.1 t -72.58 23.0 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.641 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 8' ' ' ASP . . . 49.89 71.12 0.66 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -42.6 130.21 5.2 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.973 2.448 . . . . 0.0 112.297 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.601 HG13 ' O ' ' A' ' 12' ' ' VAL . 6.0 p -61.29 103.46 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.645 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.467 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 12.9 p-80 -141.26 127.05 19.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.53 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.1 m -95.82 148.19 34.17 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.548 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -67.21 177.98 3.37 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.731 2.287 . . . . 0.0 112.235 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 16' ' ' LEU . 5.0 mp -127.44 8.43 6.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.637 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.74 103.37 0.75 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -150.09 159.65 44.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.68 0.276 . . . . 0.0 110.302 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.0 159.5 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.893 0.377 . . . . 0.0 110.77 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.0 t -114.26 143.46 23.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.347 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -133.96 150.51 51.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.697 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.667 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 18.3 t-20 -80.78 138.68 36.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.612 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -58.47 -32.69 68.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.778 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -75.5 -76.54 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.462 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.701 ' O ' ' N ' ' A' ' 27' ' ' GLY . 65.5 t-105 -54.86 -24.31 22.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.065 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.678 ' O ' ' N ' ' A' ' 28' ' ' SER . 4.8 ttt-85 22.39 39.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.953 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.701 ' N ' ' O ' ' A' ' 25' ' ' TRP . . . 16.47 47.49 0.01 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 26' ' ' ARG . 3.0 m 46.3 174.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 0.0 110.53 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -42.07 -23.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.477 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.879 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -46.67 -45.4 19.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.781 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.452 ' N ' ' HG ' ' A' ' 30' ' ' LEU . . . -63.59 -25.73 68.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.54 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.8 -30.85 35.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -68.94 -37.38 78.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.624 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.431 ' CE ' HD11 ' A' ' 30' ' ' LEU . 6.0 mtt -48.22 -26.26 1.86 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.537 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -69.63 -2.46 11.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.569 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.61 -8.78 62.03 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -136.51 -46.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.399 . . . . 0.0 110.458 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 38' ' ' ILE . 6.1 tp -126.0 172.31 13.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.183 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.479 ' H ' HG13 ' A' ' 38' ' ' ILE . 52.0 tttp -85.5 127.13 34.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.889 0.376 . . . . 0.0 110.525 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.821 HD13 ' N ' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -120.07 131.03 54.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.397 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.821 ' N ' HD13 ' A' ' 40' ' ' LEU . 44.9 mt -114.14 152.68 15.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.533 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 3.1 m-85 -118.39 121.06 39.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.687 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -125.34 126.87 45.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.343 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -88.15 144.51 26.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.756 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.51 5.42 57.86 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.667 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 8.1 mt -77.39 155.6 31.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 0.0 110.693 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.562 ' H ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -93.87 -63.72 0.14 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.788 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.562 ' HD2' ' H ' ' A' ' 47' ' ' THR . 18.6 Cg_endo -61.47 -178.31 0.27 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.662 2.242 . . . . 0.0 111.811 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.63 ' OD2' ' NE1' ' A' ' 25' ' ' TRP . 4.1 m-20 -97.91 -32.86 11.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.562 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -147.03 125.09 12.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.412 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.437 ' OH ' ' CD2' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -108.4 110.29 21.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.698 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.18 -43.71 32.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.394 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 55' ' ' ARG . 0.7 OUTLIER -163.38 153.08 15.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.622 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -58.95 70.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.718 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.589 ' N ' ' O ' ' A' ' 53' ' ' SER . 4.6 ttt-85 173.59 -26.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.652 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.6 m -140.56 131.32 25.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.497 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.591 ' SG ' HD13 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -121.88 175.38 6.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.561 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.0 mt -138.54 130.77 38.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.611 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.1 tp -111.75 131.81 55.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.383 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -100.92 122.72 43.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.558 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.463 ' HB ' HG22 ' A' ' 91' ' ' VAL . 61.9 t -117.78 146.37 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.501 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -121.18 141.78 50.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.694 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -38.67 -37.92 0.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.511 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -50.02 -39.72 42.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.544 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.67 -40.75 84.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.512 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.516 HD13 ' HA ' ' A' ' 97' ' ' SER . 1.3 tt -57.66 -37.97 74.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.479 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 67' ' ' VAL . 71.7 t -45.48 -15.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.361 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 66' ' ' LEU . . . -110.3 -56.88 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.456 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 47.75 24.82 3.13 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -155.71 43.17 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.792 0.329 . . . . 0.0 110.652 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -166.55 -37.83 0.02 OUTLIER Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.478 ' O ' ' N ' ' A' ' 75' ' ' ARG . 20.7 t80 -82.67 -25.15 33.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.763 0.316 . . . . 0.0 110.888 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -45.52 -33.04 2.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.495 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.96 -26.91 67.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.461 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.774 HH21 ' HE ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -76.68 -34.11 58.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.349 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.0 -38.13 89.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.577 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.05 -41.0 89.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.497 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.774 ' HE ' HH21 ' A' ' 75' ' ' ARG . 0.0 OUTLIER -47.62 -28.52 2.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.85 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.7 t -71.19 -27.81 30.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.876 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -79.06 -48.02 15.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.709 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.466 ' O ' ' C ' ' A' ' 82' ' ' SER . 12.7 t-20 -50.88 -49.82 58.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.773 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.466 ' C ' ' O ' ' A' ' 81' ' ' ASN . 1.7 t -33.88 -66.47 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.679 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -155.66 -141.15 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.628 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -129.02 54.06 1.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.587 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.832 ' O ' HD12 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -99.99 140.4 34.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.523 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.48 88.96 6.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.478 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.01 179.6 51.05 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 44.1 mt -121.8 115.75 47.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.801 0.334 . . . . 0.0 110.415 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.0 t -85.13 109.84 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.592 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.5 t -95.05 145.25 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.65 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.463 HG22 ' HB ' ' A' ' 61' ' ' VAL . 18.4 t -132.87 142.67 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.547 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -103.74 129.84 51.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.74 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -83.58 131.48 34.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.373 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.2 m -134.82 -84.47 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.758 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 41.4 mtp180 -131.39 -69.49 0.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.58 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -9.16 57.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.547 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.635 ' O ' ' N ' ' A' ' 101' ' ' PHE . 44.3 p -61.47 -92.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.812 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 97' ' ' SER . 8.3 pt-20 -36.28 -26.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.239 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.556 ' N ' ' O ' ' A' ' 97' ' ' SER . 35.6 mt-30 -70.53 -55.2 9.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 0.0 110.937 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.51 ' C ' HD11 ' A' ' 66' ' ' LEU . 2.7 t80 -115.21 12.59 16.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.814 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.726 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 1.1 t80 -68.04 -33.9 5.54 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.674 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.726 ' CD ' ' N ' ' A' ' 101' ' ' PHE . 17.3 Cg_exo -64.0 -55.38 0.65 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.587 2.191 . . . . 0.0 111.897 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.66 -36.82 26.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.465 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.06 -41.19 64.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.465 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.39 -31.54 71.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.321 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.41 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -71.03 -46.3 62.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.231 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.406 ' O ' ' N ' ' A' ' 111' ' ' ASP . 1.3 m-85 -74.66 -49.43 21.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.401 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.4 m -43.83 -36.42 2.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.289 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' A' ' 113' ' ' GLY . 2.3 t -70.3 -54.01 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.206 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 106' ' ' LYS . 1.4 mt -66.25 -24.75 66.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.573 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 107' ' ' PHE . 16.0 t0 -84.53 -52.88 5.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.338 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.401 ' HA ' HD13 ' A' ' 112' ' ' LEU . 3.2 mm? -105.83 -28.38 10.67 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.5 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 54.27 43.33 75.07 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 2.2 ttm -110.68 -172.96 2.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.706 0.288 . . . . 0.0 110.335 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.5 t -89.0 120.4 37.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.645 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.668 HD23 ' N ' ' A' ' 117' ' ' LEU . 4.8 tt -110.34 124.27 51.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.479 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.668 ' N ' HD23 ' A' ' 116' ' ' LEU . 2.0 tt -131.83 104.99 14.06 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.734 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.23 156.97 17.27 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.703 2.269 . . . . 0.0 112.097 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 120' ' ' ALA . 0.3 OUTLIER -130.12 -101.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.592 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 119' ' ' VAL . . . 175.16 -45.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.632 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.8 m -130.13 167.24 18.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.557 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -70.09 -22.68 63.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.656 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 29.9 mtp -73.6 -43.78 58.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.676 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 128' ' ' LEU . 4.9 mm-40 -47.42 -55.69 8.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.666 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 128' ' ' LEU . . . -57.43 -57.93 10.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.134 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.615 ' OG ' HD13 ' A' ' 30' ' ' LEU . 65.0 m -44.74 -36.01 2.97 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.48 -31.72 22.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.005 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.591 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.7 OUTLIER -73.49 -31.36 63.69 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.749 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 25.4 t -80.05 -42.33 21.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.576 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.5 mt -62.05 -49.37 84.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.626 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -57.09 -37.87 72.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.589 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.4 ' HA ' HD22 ' A' ' 132' ' ' LEU . 0.2 OUTLIER -55.11 -40.89 70.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.815 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 45.4 t -74.42 -42.53 49.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.631 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -56.37 -52.78 63.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.627 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -56.17 -39.52 72.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.657 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -58.51 -58.89 6.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.552 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 71.9 p -44.08 -72.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.553 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -158.33 -168.16 2.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.619 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.552 179.966 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.448 ' O ' ' C ' ' A' ' 2' ' ' GLU . 45.8 mtt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 1' ' ' MET . 14.7 mm-40 36.4 80.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.534 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -94.99 138.86 32.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.362 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.59 152.85 55.14 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.55 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.465 ' O ' ' CG ' ' A' ' 7' ' ' ASP . 20.9 Cg_endo -64.61 109.85 1.31 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.905 2.404 . . . . 0.0 111.964 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.61 112.33 0.67 Allowed 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.482 2.121 . . . . 0.0 112.115 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.465 ' CG ' ' O ' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -155.77 50.78 0.55 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.588 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 10' ' ' GLY . 2.0 m-20 38.87 41.24 0.51 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.475 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.8 t -43.97 -13.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.46 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 8' ' ' ASP . . . 173.97 89.86 0.08 OUTLIER Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -81.62 46.12 2.15 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.892 2.395 . . . . 0.0 112.124 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.5 t -117.81 150.11 20.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.581 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.521 ' ND1' ' N ' ' A' ' 13' ' ' HIS . 1.1 p-80 -97.35 178.98 5.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.508 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.614 ' O ' HG23 ' A' ' 14' ' ' VAL . 28.1 m -140.47 84.19 14.38 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.545 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -80.57 -9.84 13.39 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.947 2.431 . . . . 0.0 112.286 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.634 ' O ' HD12 ' A' ' 16' ' ' LEU . 0.9 OUTLIER -159.54 150.64 19.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.699 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.451 ' O ' HD11 ' A' ' 38' ' ' ILE . . . 134.11 -110.56 0.88 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.539 ' CD2' HD12 ' A' ' 41' ' ' ILE . 21.1 p-80 -87.96 166.15 14.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.711 0.291 . . . . 0.0 110.523 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.663 HD11 HG21 ' A' ' 133' ' ' VAL . 91.0 mt -113.67 149.6 15.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.621 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.3 t -97.48 147.03 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.494 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 41' ' ' ILE . . . -133.58 160.41 37.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.491 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 46' ' ' LEU . 56.5 t30 -93.82 141.23 28.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.531 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -55.22 -34.88 64.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.639 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.501 ' C ' ' H ' ' A' ' 26' ' ' ARG . 2.9 ttpp -79.42 -50.45 10.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.659 ' CE2' ' OD2' ' A' ' 49' ' ' ASP . 53.5 t-105 -64.58 6.11 0.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.926 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.501 ' H ' ' C ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -85.44 1.26 49.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.627 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.84 20.79 26.5 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.4 m -116.77 155.28 29.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.854 0.359 . . . . 0.0 110.688 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -73.28 -21.64 60.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.469 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.556 ' C ' ' CD1' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -57.16 -65.73 0.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.089 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -42.5 -32.76 0.58 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.303 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -70.68 -56.85 5.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.345 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 36' ' ' GLY . 96.0 mt-10 -54.16 -40.83 67.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.347 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.569 ' C ' ' H ' ' A' ' 36' ' ' GLY . 4.5 mtp -45.0 -47.63 11.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.404 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -65.82 11.68 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.499 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.569 ' H ' ' C ' ' A' ' 34' ' ' MET . . . -86.06 -29.38 25.78 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -125.62 -47.95 1.68 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.852 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.451 HD11 ' O ' ' A' ' 17' ' ' GLY . 0.2 OUTLIER -109.93 171.84 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.742 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.445 ' H ' HG12 ' A' ' 38' ' ' ILE . 11.3 ttpp -90.2 140.38 29.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.597 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.7 tp -126.09 144.57 50.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.666 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.539 HD12 ' CD2' ' A' ' 18' ' ' HIS . 29.5 mt -120.36 151.34 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.503 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -117.65 139.79 50.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.668 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -148.24 120.2 8.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.485 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.13 124.47 27.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.595 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 132.38 -27.94 3.51 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.488 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 48.2 mt -59.39 139.46 57.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.604 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.614 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 1.1 m -90.08 -39.22 0.41 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.061 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 47' ' ' THR . 58.5 Cg_endo -80.67 -163.93 0.25 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.271 1.981 . . . . 0.0 112.074 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.659 ' OD2' ' CE2' ' A' ' 25' ' ' TRP . 30.5 m-20 -99.0 -46.23 5.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.795 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -140.8 155.88 46.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.688 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.51 94.03 3.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.493 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.615 ' CD1' HG22 ' A' ' 133' ' ' VAL . 1.7 tp -64.05 -20.34 65.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.332 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.647 ' C ' ' H ' ' A' ' 55' ' ' ARG . 4.2 m 173.05 161.55 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.423 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.2 22.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.962 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.647 ' H ' ' C ' ' A' ' 53' ' ' SER . 4.8 mmt85 -132.02 -29.11 1.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.645 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 57' ' ' CYS . 2.3 t -132.77 152.94 51.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.859 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.502 ' N ' ' SG ' ' A' ' 56' ' ' CYS . 0.5 OUTLIER -148.13 171.4 15.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.286 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.4 mt -138.77 134.88 43.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.818 0.342 . . . . 0.0 110.824 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.01 125.22 36.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.504 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.48 ' HB3' ' CZ2' ' A' ' 25' ' ' TRP . 14.4 t80 -87.65 128.78 35.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.615 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.421 ' HB ' HG22 ' A' ' 91' ' ' VAL . 58.2 t -121.52 149.85 24.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.492 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.8 p -126.1 145.35 50.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.664 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -44.31 -41.91 6.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.422 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -44.0 -31.11 0.83 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.362 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -82.84 -39.31 21.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.531 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.72 HD11 ' C ' ' A' ' 100' ' ' TYR . 1.3 tt -49.14 -38.31 24.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.35 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 87.9 t -46.03 -36.16 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.594 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.69 116.72 9.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.54 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -121.77 3.56 10.89 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.58 4.77 2.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.813 0.339 . . . . 0.0 110.543 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -134.88 -33.48 0.29 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.474 ' O ' ' N ' ' A' ' 75' ' ' ARG . 4.3 t80 -80.11 -35.63 36.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.765 0.317 . . . . 0.0 110.532 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.423 ' NH2' ' HB3' ' A' ' 107' ' ' PHE . 22.0 ttt85 -43.58 -36.13 1.99 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.528 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -63.66 -34.79 78.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.507 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.474 ' N ' ' O ' ' A' ' 72' ' ' TYR . 0.3 OUTLIER -62.16 -35.91 80.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.47 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 mt -68.19 -40.47 82.2 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.424 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.8 t -63.46 -47.13 93.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.388 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -41.41 -32.33 0.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.329 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.1 t -71.05 -55.4 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.515 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.46 ' HB3' ' NH1' ' A' ' 80' ' ' ARG . 0.9 OUTLIER -54.08 -31.77 52.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.568 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.51 ' O ' ' C ' ' A' ' 82' ' ' SER . 3.7 t30 -54.37 -49.44 69.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.499 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.51 ' C ' ' O ' ' A' ' 81' ' ' ASN . 17.1 p -30.79 -76.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.428 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.458 ' OD1' ' OD1' ' A' ' 84' ' ' ASN . 1.5 t-20 -161.08 -89.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.476 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.564 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 3.0 p-10 -151.48 48.47 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.295 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.1 mt -69.32 154.93 41.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.6 pttt -126.56 89.08 2.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.234 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.437 ' CA ' ' O ' ' A' ' 57' ' ' CYS . . . -109.26 176.28 19.55 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.7 mt -114.36 129.63 70.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.789 0.328 . . . . 0.0 110.646 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 t -104.24 107.35 22.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.46 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.3 t -90.24 143.82 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.652 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.421 HG22 ' HB ' ' A' ' 61' ' ' VAL . 82.0 t -129.0 143.24 41.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.53 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -102.4 115.62 30.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.565 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -71.6 143.2 49.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.514 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 89.9 m -137.49 -82.1 0.35 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.484 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.515 ' CG ' ' N ' ' A' ' 96' ' ' MET . 14.1 ptm180 -151.14 -44.79 0.12 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.464 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.515 ' N ' ' CG ' ' A' ' 95' ' ' ARG . 1.7 mtt -88.52 -2.92 58.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.139 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.718 ' HA ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -70.65 -71.91 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.492 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -40.76 -22.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.609 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.524 ' N ' ' O ' ' A' ' 97' ' ' SER . 10.3 mm100 -72.3 -54.44 9.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.038 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.72 ' C ' HD11 ' A' ' 66' ' ' LEU . 1.1 t80 -116.6 12.15 14.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.038 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.612 ' N ' ' O ' ' A' ' 97' ' ' SER . 0.3 OUTLIER -62.51 -62.18 6.2 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.604 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 101' ' ' PHE . 9.6 Cg_endo -53.49 -48.75 20.24 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.653 2.235 . . . . 0.0 112.013 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.05 -31.36 7.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.51 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.752 HD23 ' HG1' ' A' ' 108' ' ' THR . 0.7 OUTLIER -85.31 -22.29 28.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.511 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.523 ' O ' HG23 ' A' ' 109' ' ' VAL . 1.4 tt0 -84.63 -32.37 23.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.699 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.77 -41.93 71.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.671 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.51 ' O ' ' CG ' ' A' ' 111' ' ' ASP . 2.9 m-85 -78.62 -51.01 10.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.603 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.752 ' HG1' HD23 ' A' ' 104' ' ' LEU . 97.1 m -51.37 -37.49 48.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.485 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 105' ' ' GLN . 22.2 t -67.55 -59.15 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.452 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.2 -19.05 65.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.526 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.51 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 12.5 m-20 -84.39 -57.8 3.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.029 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.47 HD23 ' C ' ' A' ' 111' ' ' ASP . 2.7 mt -107.5 -29.01 9.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.629 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . 72.04 42.48 51.55 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -86.62 -171.05 3.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.576 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 40.7 t -117.76 105.23 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.587 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.491 ' N ' HD12 ' A' ' 116' ' ' LEU . 6.0 mp -95.64 142.39 28.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.514 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 tp -156.23 88.92 2.82 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.527 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -56.04 163.82 5.6 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.751 2.301 . . . . 0.0 112.085 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.703 ' O ' ' HB2' ' A' ' 120' ' ' ALA . 1.5 m -129.37 -106.83 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.655 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 119' ' ' VAL . . . 159.24 -47.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.434 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.13 143.68 51.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.544 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -51.94 -24.98 7.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.708 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 5.4 mtp -70.24 -51.72 28.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.623 ' O ' ' N ' ' A' ' 128' ' ' LEU . 9.6 mm-40 -44.71 -52.32 8.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.679 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.628 ' O ' HG23 ' A' ' 129' ' ' VAL . . . -55.18 -58.1 9.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.225 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.516 ' N ' HD21 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -49.73 -37.01 27.61 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.223 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.87 -31.2 35.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.128 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.623 ' N ' ' O ' ' A' ' 124' ' ' GLU . 1.8 mt -79.91 -26.94 40.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.879 0.371 . . . . 0.0 110.501 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 125' ' ' ALA . 61.3 t -81.56 -41.0 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.566 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 70.5 mt -73.16 -39.94 57.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.67 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -58.64 -25.58 62.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.533 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 132' ' ' LEU . 10.9 tp -77.01 -58.01 3.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.466 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.663 HG21 HD11 ' A' ' 19' ' ' ILE . 11.1 t -60.45 -41.79 88.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.605 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -52.76 -49.82 64.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.602 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -64.25 -28.71 69.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.527 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -87.58 -12.02 46.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.525 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.455 ' O ' ' C ' ' A' ' 138' ' ' LYS . 47.5 m -95.69 -45.88 6.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.551 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.551 ' O ' ' O ' ' A' ' 139' ' ' GLU . 13.7 tttp -35.18 144.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.628 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.551 ' O ' ' O ' ' A' ' 138' ' ' LYS . 1.7 tp10 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.566 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.419 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.8 mmt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.3 122.21 37.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.545 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.445 ' O ' ' CB ' ' A' ' 4' ' ' ASN . 44.9 mttm -119.36 -63.13 1.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.732 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.487 ' N ' ' HD2' ' A' ' 5' ' ' PRO . 0.8 OUTLIER 166.1 -53.85 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.913 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 4' ' ' ASN . 87.9 Cg_exo -41.59 157.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.792 2.328 . . . . 0.0 112.444 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -39.62 117.05 0.35 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.024 2.483 . . . . 0.0 112.37 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 14.1 p-10 -160.53 51.47 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.454 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 9' ' ' THR . 92.6 m-20 60.54 -82.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.566 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.709 ' O ' HG22 ' A' ' 9' ' ' THR . 90.1 m 37.46 37.61 0.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.633 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.28 63.58 0.04 OUTLIER Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -67.87 140.02 49.32 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.712 2.275 . . . . 0.0 112.087 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.9 t -132.8 -64.26 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.571 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.22 21.07 9.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.5 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.82 59.47 7.22 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.441 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.54 -52.8 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.95 2.434 . . . . 0.0 112.265 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.5 tp -129.37 114.28 16.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.808 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -153.34 17.24 0.68 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -114.22 154.6 27.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.804 0.335 . . . . 0.0 110.602 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 73.3 mt -106.21 153.49 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.625 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.9 t -110.47 124.04 66.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.654 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.01 149.88 27.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.66 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -74.78 140.65 44.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.424 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.71 -28.65 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.417 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.5 ' C ' ' H ' ' A' ' 26' ' ' ARG . 12.5 ttmm -83.54 -52.88 6.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.395 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.458 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 42.5 t-105 -74.79 24.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.307 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.5 ' H ' ' C ' ' A' ' 24' ' ' LYS . 18.7 ttp85 -81.28 -63.89 1.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.704 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.78 52.46 0.51 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 26' ' ' ARG . 11.1 p -111.85 141.21 45.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.337 . . . . 0.0 110.634 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.704 HE21 ' NE2' ' A' ' 122' ' ' GLN . 7.5 mt-30 -56.35 -28.55 59.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.713 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.563 ' C ' ' CD1' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -61.07 -66.07 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.393 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.06 -24.67 63.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.923 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.02 -51.25 68.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.814 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -70.33 -45.83 65.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.857 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.457 ' HE1' ' O ' ' A' ' 126' ' ' SER . 36.0 mmt -49.92 -26.62 4.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.815 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -77.01 -0.54 24.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 0.0 110.562 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.22 6.83 50.98 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -148.79 -47.85 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.812 0.339 . . . . 0.0 110.537 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.456 HG12 ' H ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -113.56 169.78 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.595 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.456 ' H ' HG12 ' A' ' 38' ' ' ILE . 5.4 tptm -94.94 152.82 18.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.487 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.86 137.99 28.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.48 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.4 mt -116.62 131.72 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.531 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -88.15 132.42 34.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.799 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -139.94 121.8 15.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.544 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -79.77 145.04 33.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.647 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.4 -33.89 5.83 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.597 HD22 ' CD2' ' A' ' 51' ' ' TYR . 77.3 mt -48.83 137.6 12.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 110.619 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.536 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -88.11 -52.63 0.38 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.929 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 47' ' ' THR . 33.9 Cg_endo -67.61 -157.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.04 1.826 . . . . 0.0 112.15 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.433 ' OD2' ' CD2' ' A' ' 25' ' ' TRP . 1.6 m-20 -98.63 -54.91 2.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.879 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.458 ' CZ ' ' CD1' ' A' ' 25' ' ' TRP . 83.0 m-85 -124.12 145.77 49.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.794 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.597 ' CD2' HD22 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -123.17 103.07 8.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.488 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.551 HD23 ' O ' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -81.71 -35.11 30.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.493 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.626 ' C ' ' H ' ' A' ' 55' ' ' ARG . 4.2 t -178.28 164.59 1.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.426 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -67.38 23.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.477 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.626 ' H ' ' C ' ' A' ' 53' ' ' SER . 5.4 ttt-85 -134.72 -4.93 2.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.142 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.555 ' SG ' ' C ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -161.57 144.98 12.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.87 0.366 . . . . 0.0 110.974 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.419 ' SG ' ' HA2' ' A' ' 87' ' ' GLY . 12.5 p -151.13 164.38 36.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.438 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.0 mt -129.06 148.67 33.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.678 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.7 tt -133.78 120.02 19.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.287 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -85.71 121.66 28.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.792 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.425 ' N ' ' O ' ' A' ' 90' ' ' VAL . 74.7 t -122.15 143.98 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.229 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 63' ' ' GLU . 42.1 p -124.09 148.25 47.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.627 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 66' ' ' LEU . 3.3 tm-20 -38.57 -40.51 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.73 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -44.85 -33.32 1.9 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.661 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.562 ' OD2' ' CE1' ' A' ' 72' ' ' TYR . 3.6 m-20 -82.06 -26.34 33.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.634 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.533 HD23 ' N ' ' A' ' 67' ' ' VAL . 1.4 tt -68.41 -50.07 55.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.671 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.533 ' N ' HD23 ' A' ' 66' ' ' LEU . 2.3 p -62.43 -27.67 43.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.424 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.47 -64.96 0.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.561 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 70' ' ' ASN . . . 71.3 111.17 0.04 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.512 ' CB ' ' O ' ' A' ' 69' ' ' GLY . 5.1 t-20 81.75 139.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.77 0.319 . . . . 0.0 110.51 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.43 -71.31 0.38 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.562 ' CE1' ' OD2' ' A' ' 65' ' ' ASP . 4.0 t80 -50.56 -47.49 57.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.928 0.395 . . . . 0.0 110.375 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -43.15 -36.01 1.55 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.701 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -67.25 -43.94 80.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.542 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 12.3 mtt85 -58.36 -25.41 61.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.544 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 mt -79.42 -38.45 34.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.36 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.3 t -49.25 -30.46 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.278 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -54.65 -29.3 51.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.349 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.6 t -69.12 -35.94 70.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.218 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -79.53 -20.22 47.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.405 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -51.03 -59.69 3.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.471 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.459 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 0.1 OUTLIER -69.0 -68.99 0.36 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.454 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 82' ' ' SER . 4.5 t-20 78.01 60.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.491 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.538 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 2.1 p30 -148.48 11.82 0.9 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.757 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 pp -155.09 153.09 30.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.809 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.7 mmtm -76.62 110.0 10.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.126 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.419 ' HA2' ' SG ' ' A' ' 57' ' ' CYS . . . -86.64 101.76 2.67 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.8 mt -84.48 138.57 18.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 37.0 t -117.96 127.6 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.858 0.361 . . . . 0.0 111.149 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 61' ' ' VAL . 14.7 t -117.49 121.84 68.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.166 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.0 t -114.79 139.69 39.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.783 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -98.75 129.53 45.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.679 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.56 ' NZ ' ' O ' ' A' ' 119' ' ' VAL . 21.7 mttp -78.57 138.39 38.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.428 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 12.2 m -140.12 -85.22 0.22 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.669 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -128.8 -63.38 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.592 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.734 ' SD ' ' N ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -77.91 -9.24 58.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.48 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 99' ' ' GLN . 4.7 p -48.47 -102.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.348 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 97' ' ' SER . 24.2 mt-10 -36.31 -21.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.589 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.68 ' N ' ' O ' ' A' ' 97' ' ' SER . 11.5 tp60 -69.56 -55.61 9.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.094 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.422 ' CZ ' ' HB1' ' A' ' 103' ' ' ALA . 4.8 t80 -117.33 3.11 12.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.801 0.334 . . . . 0.0 110.797 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.601 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -47.06 -58.77 6.44 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.507 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 101' ' ' PHE . 14.9 Cg_endo -59.05 -48.68 13.33 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.556 2.171 . . . . 0.0 112.277 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.422 ' HB1' ' CZ ' ' A' ' 100' ' ' TYR . . . -45.47 -32.39 2.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.855 0.359 . . . . 0.0 110.227 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 tp -87.29 -30.95 20.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.806 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 102' ' ' PRO . 38.1 tt0 -58.26 -40.09 80.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.16 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -63.51 -37.08 85.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.088 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.27 -38.78 34.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.472 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.0 m -72.93 -30.84 64.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.569 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.584 ' O ' ' CA ' ' A' ' 113' ' ' GLY . 10.8 t -77.36 -43.93 30.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.989 0.423 . . . . 0.0 110.53 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.3 tp -70.92 -31.15 67.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.613 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -84.51 -50.14 7.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.308 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mt -104.88 -28.32 11.19 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.597 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.584 ' CA ' ' O ' ' A' ' 109' ' ' VAL . . . 43.47 35.19 2.75 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.93 -159.62 0.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.362 . . . . 0.0 110.547 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 49.4 t -96.29 123.13 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.426 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.14 133.91 53.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.67 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.8 mt -146.07 88.28 6.39 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.481 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -80.56 158.99 22.22 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.883 2.389 . . . . 0.0 112.189 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.57 HG23 ' N ' ' A' ' 120' ' ' ALA . 28.2 m -127.2 -136.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.428 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.57 ' N ' HG23 ' A' ' 119' ' ' VAL . . . -153.5 -40.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.279 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.9 p -138.39 158.34 44.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.357 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.704 ' NE2' HE21 ' A' ' 29' ' ' GLN . 21.1 mt-30 -58.17 -26.36 62.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.62 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.85 -45.23 90.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.74 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.638 ' O ' ' N ' ' A' ' 128' ' ' LEU . 1.2 mp0 -54.97 -58.41 7.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.657 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 129' ' ' VAL . . . -52.18 -58.06 7.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.296 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.499 ' N ' HD21 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -43.68 -40.29 4.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.7 m -85.39 -27.12 26.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.208 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.638 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.5 OUTLIER -77.35 -26.86 52.43 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.942 0.401 . . . . 0.0 110.742 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 125' ' ' ALA . 3.5 t -68.87 -61.45 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.642 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.412 HG13 ' SD ' ' A' ' 34' ' ' MET . 6.8 mt -58.33 -45.08 89.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.441 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -45.7 -29.62 1.32 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.829 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.4 mt -76.44 -48.75 18.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.772 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.556 ' O ' ' OG1' ' A' ' 137' ' ' THR . 19.2 t -67.81 -51.93 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.817 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.75 -33.72 49.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -63.69 -58.96 5.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.841 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.434 ' HG3' ' N ' ' A' ' 137' ' ' THR . 2.0 pt20 -62.77 -41.06 99.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.943 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.556 ' OG1' ' O ' ' A' ' 133' ' ' VAL . 1.0 OUTLIER -68.98 47.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.784 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.44 ' HG2' ' N ' ' A' ' 139' ' ' GLU . 2.7 ttmp? -108.74 157.91 18.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.403 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.44 ' N ' ' HG2' ' A' ' 138' ' ' LYS . 3.1 pt-20 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.628 -179.972 . . . . . . . . 1 1 . 1 stop_ save_